Details of Disease

General Information of Disease (ID: DISXGOUK)

• Disease Name: Gastric cancer
• Synonyms: gastric cancer, intestinal; malignant neoplasm of body of stomach; ca greater curvature of stomach; Ca body - stomach; gastric neoplasm; stomach cancer; malignant tumour of the stomach; malignant tumour of stomach; malignant tumour of lesser curve of stomach; malignant tumour of greater curve of stomach; malignant tumour of body of stomach; malignant tumor of the stomach; malignant tumor of stomach; malignant tumor of lesser curve of stomach; malignant tumor of greater curve of stomach; malignant tumor of body of stomach; malignant stomach neoplasm; malignant neoplasm of the stomach; malignant neoplasm of stomach; malignant neoplasm of lesser curve of stomach; malignant gastric tumour; malignant gastric tumor; malignant gastric neoplasm; gastric cancer, somatic; gastric cancer risk after h. pylori infection; gastric cancer; cancer of stomach; Ca lesser curvature - stomach
• Disease Class: 2B72: Stomach cancer
• Definition: A primary or metastatic malignant neoplasm involving the stomach.
• Disease Hierarchy:
  DIS3AOQ7: Aerodigestive tract cancer
  DISAT1Z9: Advanced cancer
  DISOKN4Y: Gastric neoplasm
  DISXGOUK: Gastric cancer
• ICD Code: ICD-11: ICD-11: 2B72
• Disease Identifiers:
  MONDO ID: MONDO_0001056
  MESH ID: D013274
  UMLS CUI: C0024623
  OMIM ID: 613659
  MedGen ID: 44264
  HPO ID: HP:0012126
  SNOMED CT ID: 363349007

Drug-Interaction Atlas (DIA) of This Disease

This Disease is Treated as An Indication in 16 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Aldesleukin	DM4YMIS	Approved	NA	[1]
Bortezomib	DMNO38U	Approved	Small molecular drug	[2]
Capecitabine	DMTS85L	Approved	Small molecular drug	[3]
Cetuximab	DMLNCE0	Approved	Antibody	[4]
Cisplatin	DMRHGI9	Approved	Small molecular drug	[5]
Citalopram	DM2G9AE	Approved	Small molecular drug	[6]
Docetaxel	DMDI269	Approved	Small molecular drug	[7]
Floxuridine	DM04LR2	Approved	Small molecular drug	[8]
Fludarabine	DMVRLT7	Approved	Small molecular drug	[9]
Fluorouracil	DMUM7HZ	Approved	Small molecular drug	[10]
Irinotecan	DMP6SC2	Approved	Small molecular drug	[11]
Levoleucovorin	DMH5LME	Approved	Small molecular drug	[12]
Oxaliplatin	DMQNWRD	Approved	Small molecular drug	[13]
Tebentafusp	DMUJ1WV	Approved	Monoclonal antibody	[14]
Trastuzumab	DMZQOUX	Approved	Antibody	[15]
Vidarabine	DM0N85H	Approved	Small molecular drug	[16]

This Disease is Treated as An Indication in 5 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Tusamitamab ravtansine	DMMPSA1	Phase 3	Antibody drug conjugate	[17]
Evorpacept	DMJTX7Q	Phase 2/3	NA	[18]
BNT141	DM9XRBT	Phase 2	Antibody	[19]
CT-041	DM5XX06	Phase 1/2	CAR-T cell therapy	[20]
SAR443216	DMUQNG6	Phase 1	Antibody	[21]

Molecular Interaction Atlas (MIA) of This Disease

This Disease Is Related to 890 DTT Molecule(s)

Gene Name	DTT ID	Evidence Level	Mode of Inheritance	REF
ABCG2	TTIMJ02	Limited	Biomarker	[22]
ADAM8	TTQWYMD	Limited	Biomarker	[23]
ADAMTS5	TTXSU2Y	Limited	Biomarker	[24]
ADH7	TT3LE7P	Limited	Altered Expression	[25]
ADORA2A	TTM2AOE	Limited	Biomarker	[26]
ADRA1B	TTBRKXS	Limited	Biomarker	[27]
ADRB1	TTR6W5O	Limited	Biomarker	[28]
AFP	TTCFEA1	Limited	Altered Expression	[29]
AHSG	TTKF4WV	Limited	Biomarker	[30]
ALKBH5	TTOHB1M	Limited	Biomarker	[31]
ALOX5	TTSJ6Q4	Limited	Biomarker	[32]
ANG	TTURHFP	Limited	Biomarker	[33]
ANTXR2	TTOD34I	Limited	Biomarker	[34]
ANXA5	TT2Z83I	Limited	Biomarker	[35]
BBC3	TT7JUKC	Limited	Biomarker	[36]
BCAT1	TTES57P	Limited	Altered Expression	[37]
BCL2L1	TTRE6AX	Limited	Biomarker	[38]
BCL6	TTC9YX5	Limited	Biomarker	[39]
BDNF	TTSMLOH	Limited	Altered Expression	[40]
BIRC5	TTTPU1G	Limited	Biomarker	[41]
BIRC7	TTHZ8TA	Limited	Biomarker	[42]
BMP1	TT0L58T	Limited	Biomarker	[43]
BMP7	TTKOBRA	Limited	Biomarker	[44]
BMX	TTN2I9E	Limited	Biomarker	[45]
BUB1	TT78309	Limited	Altered Expression	[46]
CAD	TT2YT1K	Limited	Altered Expression	[47]
CALCR	TTLWS2O	Limited	Biomarker	[48]
CCKAR	TTCG0AL	Limited	Altered Expression	[49]
CCNA2	TTAMQ62	Limited	Biomarker	[50]
CCR7	TT2GIDQ	Limited	Altered Expression	[51]
CD200	TT0BE68	Limited	Biomarker	[52]
CD40	TT1ERKL	Limited	Biomarker	[53]
CDH11	TTRGWZC	Limited	Biomarker	[54]
CDH2	TT1WS0T	Limited	Biomarker	[44]
CDK2	TT7HF4W	Limited	Biomarker	[55]
CDK9	TT1LVF2	Limited	Biomarker	[56]
CDKL2	TTMO45N	Limited	Biomarker	[57]
CHRNB2	TT5KPZR	Limited	Biomarker	[58]
CLCN3	TT8XNZ7	Limited	Biomarker	[59]
CLDN4	TTMTS9H	Limited	Altered Expression	[60]
CLIC1	TT8KZG6	Limited	Biomarker	[61]
CRAT	TTC8M31	Limited	Biomarker	[62]
CRK	TTFEUYR	Limited	Altered Expression	[63]
CRYAB	TT7RUHB	Limited	Biomarker	[64]
CSF3R	TTC70AJ	Limited	Biomarker	[65]
CTSL	TT36ETB	Limited	Biomarker	[44]
CXCR1	TTMWT8Z	Limited	Biomarker	[66]
CXCR2	TT30C9G	Limited	Altered Expression	[67]
CXCR6	TT2BVUA	Limited	Biomarker	[68]
DCLK1	TTOHTCY	Limited	Biomarker	[69]
DDIT4	TTVEOY6	Limited	Biomarker	[70]
DDR1	TTI1FPZ	Limited	Biomarker	[71]
DDX58	TTVB0O3	Limited	Biomarker	[72]
DKK1	TTE3RAC	Limited	Biomarker	[73]
DNAJB1	TTPXAWS	Limited	Biomarker	[74]
DNMT3L	TT3FDAV	Limited	Biomarker	[75]
EBI3	TTJF68X	Limited	Biomarker	[76]
EHMT2	TTS6RZT	Limited	Altered Expression	[77]
EPHA1	TTLFZVU	Limited	Biomarker	[78]
ERBB3	TTSINU2	Limited	Altered Expression	[79]
FAM83B	TT1Q347	Limited	Altered Expression	[80]
FGF4	TTCEKVZ	Limited	Biomarker	[81]
FGG	TTR31L7	Limited	Genetic Variation	[82]
FOXQ1	TTEJZOL	Limited	Biomarker	[83]
FST	TTDNM9W	Limited	Biomarker	[44]
FYN	TT2B9KF	Limited	Biomarker	[44]
FZD10	TTP1S2F	Limited	Biomarker	[84]
GAPDH	TTUGSWA	Limited	Biomarker	[85]
GAS6	TT69QD2	Limited	Biomarker	[86]
GDF5	TT37XV9	Limited	Biomarker	[87]
GLUL	TTURQ2G	Limited	Biomarker	[88]
GREM1	TTOUZN5	Limited	Biomarker	[44]
GSTA3	TT29VDX	Limited	Genetic Variation	[82]
HBEGF	TT15SL0	Limited	Biomarker	[89]
HIPK2	TTOB49C	Limited	Biomarker	[90]
HK2	TTK02H8	Limited	Biomarker	[91]
HOXA13	TTN26OM	Limited	Altered Expression	[92]
HOXA5	TTXSVQP	Limited	Biomarker	[93]
HOXB13	TTZ6I58	Limited	Altered Expression	[94]
HRAS	TT28ZON	Limited	Biomarker	[95]
HS6ST2	TTS6LBM	Limited	Biomarker	[96]
HSD17B2	TT0PT1R	Limited	Altered Expression	[97]
HSPD1	TT9HL5R	Limited	Altered Expression	[98]
HTRA1	TT8POQR	Limited	Altered Expression	[99]
IFNW1	TTS2TGF	Limited	Genetic Variation	[100]
IGFBP1	TTCJTWF	Limited	Biomarker	[101]
IL33	TT5MD4P	Limited	Biomarker	[102]
INHBA	TTVB30D	Limited	Biomarker	[103]
IRF3	TTYR7OH	Limited	Biomarker	[104]
IRS2	TTF95B8	Limited	Biomarker	[44]
ITGAV	TTT1R2L	Limited	Altered Expression	[105]
ITK	TT3C80U	Limited	Biomarker	[106]
KAT6B	TTH4VJL	Limited	Altered Expression	[107]
KDM5B	TTCLI75	Limited	Biomarker	[108]
KLK4	TT4319X	Limited	Biomarker	[109]
KLRK1	TTLRN4A	Limited	Altered Expression	[110]
LAG3	TTNVXAW	Limited	Altered Expression	[111]
LIF	TTGZ5WN	Limited	Altered Expression	[112]
LNPEP	TTY2KP7	Limited	Genetic Variation	[113]
LOXL2	TTFSUHX	Limited	Altered Expression	[114]
LYN	TT1RWNJ	Limited	Altered Expression	[115]
LYZ	TTAOZBW	Limited	Biomarker	[116]
MAP2K7	TT6QY3J	Limited	Biomarker	[117]
MAP3K6	TT64GC2	Limited	Unknown	[118]
MAPK3	TT1MG9E	Limited	Altered Expression	[92]
MDM4	TT9OUDQ	Limited	Genetic Variation	[119]
MIF	TT6804T	Limited	Biomarker	[120]
MMP21	TTYRF5E	Limited	Altered Expression	[121]
MSH2	TTCAWRT	Limited	Genetic Variation	[122]
MUC17	TTVO0JU	Limited	Biomarker	[123]
MUSK	TT6SA0X	Limited	Genetic Variation	[124]
NEDD9	TT1UREA	Limited	Biomarker	[125]
NEK8	TT8AH9I	Limited	Altered Expression	[126]
NLRC5	TTWZC78	Limited	Altered Expression	[127]
NNT	TTKIH76	Limited	Altered Expression	[128]
NOS3	TTCM4B3	Limited	Genetic Variation	[129]
NOX4	TTQRBSJ	Limited	Biomarker	[130]
NR1H2	TTXA6PH	Limited	Genetic Variation	[131]
NT5E	TTK0O6Y	Limited	Biomarker	[132]
NUAK1	TT65FL0	Limited	Altered Expression	[133]
PDE4D	TTSKMI8	Limited	Genetic Variation	[134]
PDGFRB	TTI7421	Limited	Altered Expression	[135]
PDK1	TTCZOF2	Limited	Biomarker	[136]
PDXK	TTXI3KF	Limited	Genetic Variation	[137]
PHB	TT6U071	Limited	Genetic Variation	[138]
PIM2	TT69J2Z	Limited	Biomarker	[139]
PIM3	TTCGOIN	Limited	Biomarker	[140]
PLOD2	TT8MEUD	Limited	Biomarker	[141]
PPIA	TTL2ADK	Limited	Biomarker	[142]
PRDX5	TTLPJWH	Limited	Altered Expression	[143]
PRKAR1A	TTNAHEX	Limited	Biomarker	[144]
PRKCI	TTWJTHX	Limited	Altered Expression	[145]
PRKDC	TTK3PY9	Limited	Biomarker	[146]
PRMT5	TTR1D7X	Limited	Biomarker	[147]
PSEN1	TTZ3S8C	Limited	Biomarker	[148]
PTGDR2	TTQDMX5	Limited	Altered Expression	[149]
PTGER4	TT79WV3	Limited	Altered Expression	[150]
PTK2B	TTTEFBV	Limited	Altered Expression	[151]
PTN	TTA9EJK	Limited	Altered Expression	[152]
PTPN1	TTELIN2	Limited	Altered Expression	[153]
RARB	TTISP28	Limited	Altered Expression	[154]
RBP4	TT0C8BY	Limited	Biomarker	[44]
REG3A	TTL4H8N	Limited	Altered Expression	[155]
RGS2	TTKB7T3	Limited	Altered Expression	[156]
RICTOR	TT143WL	Limited	Biomarker	[157]
RIPK2	TTCQ2E5	Limited	Genetic Variation	[158]
RNF43	TTD91BL	Limited	Biomarker	[159]
RNF6	TT4S09X	Limited	Biomarker	[160]
ROR2	TTUDPCI	Limited	Biomarker	[161]
RORA	TT1TYN7	Limited	Biomarker	[162]
RPSA	TTLUW5B	Limited	Biomarker	[163]
S100A6	TT716MY	Limited	Biomarker	[164]
S100B	TTQ0V86	Limited	Biomarker	[165]
SDHD	TTVH9W8	Limited	Genetic Variation	[166]
SERPINA1	TTA7UJC	Limited	Biomarker	[167]
SETD7	TTJ0FSU	Limited	Altered Expression	[168]
SKP2	TT5B2EO	Limited	Altered Expression	[169]
SLC16A3	TTG6VD5	Limited	Biomarker	[170]
SLC1A5	TTF7WRM	Limited	Biomarker	[171]
SLC22A16	TTITAVR	Limited	Biomarker	[172]
SLC5A5	TTW7HI9	Limited	Altered Expression	[173]
SLC6A8	TTYUHB5	Limited	Biomarker	[48]
SLC7A1	TT4S150	Limited	Biomarker	[62]
SOX5	TTXHSZK	Limited	Biomarker	[174]
SPHK1	TTOHFIY	Limited	Altered Expression	[175]
SQSTM1	TTOT2RY	Limited	Biomarker	[176]
STAT3	TTHJT3X	Limited	Biomarker	[177]
STK33	TTP34DQ	Limited	Biomarker	[178]
STYK1	TTRMCYJ	Limited	Altered Expression	[179]
SUV39H1	TTUWQTK	Limited	Biomarker	[180]
TBL1X	TTAL6S1	Limited	Altered Expression	[181]
THBD	TTAPV67	Limited	Posttranslational Modification	[182]
TIGIT	TTWNL74	Limited	Altered Expression	[183]
TK1	TTP3QRF	Limited	Biomarker	[184]
TLR5	TTCXP8J	Limited	Biomarker	[185]
TNFRSF4	TTL31H0	Limited	Altered Expression	[186]
TNFRSF9	TTPW9LJ	Limited	Biomarker	[187]
TREM2	TTQRMSJ	Limited	Altered Expression	[188]
TRIM59	TT613U4	Limited	Altered Expression	[189]
TRPC1	TTA76X0	Limited	Biomarker	[190]
TRPM2	TTEBMN7	Limited	Biomarker	[191]
TRPV6	TTBK14N	Limited	Biomarker	[62]
UGCG	TTPHEX3	Limited	Altered Expression	[192]
UGT1A1	TT34ZAF	Limited	Biomarker	[193]
ULK1	TT4D7MJ	Limited	Biomarker	[194]
UMPS	TTAFJUD	Limited	Biomarker	[195]
USP14	TTVSYP9	Limited	Biomarker	[196]
USP5	TTGYTMA	Limited	Biomarker	[197]
UTRN	TTNO1VA	Limited	Biomarker	[198]
WDR5	TT7OFWB	Limited	Biomarker	[199]
WNT7A	TT8NARC	Limited	Altered Expression	[200]
XDH	TT7RJY8	Limited	Genetic Variation	[201]
XPA	TTGT87E	Limited	Genetic Variation	[131]
FDXR	TT3W4IX	Disputed	Biomarker	[202]
SLC2A4	TTP6MT5	Disputed	Biomarker	[203]
ACKR3	TTRQJTC	moderate	Biomarker	[68]
ADAM17	TT6AZXG	moderate	Biomarker	[204]
ADRA1A	TTNGILX	moderate	Biomarker	[68]
ADRA2B	TTWM4TY	moderate	Biomarker	[68]
ADRB2	TTG8ZWP	moderate	Altered Expression	[205]
AKT2	TTH24WI	moderate	Biomarker	[206]
ALB	TTFNGC9	moderate	Genetic Variation	[207]
AMOT	TTI48OS	moderate	Altered Expression	[208]
ANXA1	TTUCK4B	moderate	Altered Expression	[209]
ASIC2	TTVMWLP	moderate	Biomarker	[210]
ATP4A	TTF1QVM	moderate	Genetic Variation	[211]
ATR	TT8ZYBQ	moderate	Genetic Variation	[212]
AXL	TTZPY6J	moderate	Altered Expression	[213]
BAP1	TT47RXJ	moderate	Biomarker	[214]
BRIP1	TTZV7LJ	moderate	Genetic Variation	[215]
BRS3	TTKYEPM	moderate	Biomarker	[68]
BTLA	TTER58P	moderate	Altered Expression	[216]
C5AR1	TTHXFA1	moderate	Biomarker	[217]
CAPN1	TT1WBIJ	moderate	Biomarker	[218]
CAPN2	TTG5QB7	moderate	Biomarker	[218]
CAV1	TTXUBN2	moderate	Altered Expression	[219]
CBX7	TTBN3HC	moderate	Biomarker	[220]
CD24	TTCTYNP	moderate	Biomarker	[221]
CD276	TT6CQUM	moderate	Biomarker	[222]
CD34	TTZAVYN	moderate	Altered Expression	[64]
CD36	TTPJMCU	moderate	Altered Expression	[223]
CDH5	TTXLCFO	moderate	Biomarker	[224]
CDK1	TTH6V3D	moderate	Biomarker	[225]
CDK5	TTL4Q97	moderate	Biomarker	[226]
CEACAM6	TTIGH2W	moderate	Biomarker	[227]
CLDN18	TT6PKBX	moderate	Biomarker	[228]
CMA1	TT8VUE0	moderate	Altered Expression	[229]
COL18A1	TT63DI9	moderate	Biomarker	[230]
CREB1	TTH4AN3	moderate	Altered Expression	[231]
CTAG1A	TTE5ITK	moderate	Biomarker	[232]
CXCR3	TT1UCIJ	moderate	Biomarker	[233]
CXXC5	TTVS4C3	moderate	Biomarker	[234]
DCN	TTB3XAN	moderate	Biomarker	[235]
DDR2	TTU98HG	moderate	Altered Expression	[236]
DDX5	TTZKPVC	moderate	Biomarker	[237]
DKK3	TTY2ZV6	moderate	Biomarker	[238]
DPYD	TTZPS91	moderate	Altered Expression	[239]
EDNRA	TTKRD0G	moderate	Biomarker	[68]
ENAH	TTY36UA	moderate	Biomarker	[240]
EPHA3	TTHS2LR	moderate	Biomarker	[241]
ERBB4	TTWALCO	moderate	Biomarker	[242]
F2R	TTL935N	moderate	Biomarker	[243]
F2RL2	TTVSEBF	moderate	Altered Expression	[244]
FAP	TTGPQ0F	moderate	Biomarker	[245]
FASN	TT7AOUD	moderate	Biomarker	[246]
FAT1	TTGUJYV	moderate	Biomarker	[247]
FHIT	TTMS54D	moderate	Altered Expression	[248]
FOLR1	TTVC37M	moderate	Biomarker	[249]
FUT4	TTNV1KZ	moderate	Biomarker	[250]
GATA4	TT1VDN2	moderate	Biomarker	[251]
GDF15	TT4MXVG	moderate	Altered Expression	[252]
GGT1	TTZVT7O	moderate	Biomarker	[253]
GRHL2	TTUGH4C	moderate	Posttranslational Modification	[254]
GRK2	TTAZ3MN	moderate	Biomarker	[255]
HDAC3	TT4YWTO	moderate	Altered Expression	[256]
HDAC5	TTUELN5	moderate	Altered Expression	[257]
HDAC6	TT5ZKDI	moderate	Biomarker	[258]
HDAC7	TTMUEK1	moderate	Biomarker	[259]
HNF4A	TT2F3CD	moderate	Biomarker	[260]
HSPA5	TTW26OG	moderate	Biomarker	[261]
HSPB1	TT9AZWY	moderate	Biomarker	[262]
IFNAR1	TTSYFMA	moderate	Biomarker	[263]
IGFBP7	TTUQ01B	moderate	Biomarker	[264]
IL19	TT87RWS	moderate	Altered Expression	[265]
IRAK1	TTXAJWN	moderate	Biomarker	[266]
ITCH	TT5SEWD	moderate	Biomarker	[244]
ITGA2	TTSJ542	moderate	Altered Expression	[267]
ITGA5	TTHIZP9	moderate	Biomarker	[268]
KCND3	TTPLQO0	moderate	Biomarker	[269]
KCNMA1	TTE87WJ	moderate	Biomarker	[270]
KDM2A	TT8XTY2	moderate	Biomarker	[271]
KDM5C	TT94UCF	moderate	Biomarker	[272]
KDM7A	TT0NYMP	moderate	Biomarker	[273]
KRT17	TTKV0EC	moderate	Biomarker	[274]
LAPTM4B	TTEJQT0	moderate	Altered Expression	[275]
LGMN	TTPTWV5	moderate	Biomarker	[276]
LIMK1	TTWL9TY	moderate	Altered Expression	[277]
LPAR2	TTB7Y8I	moderate	Biomarker	[68]
MAP2K1	TTIDAPM	moderate	Posttranslational Modification	[278]
MAP3K5	TTOQCD8	moderate	Altered Expression	[279]
MAPK9	TT3IVG2	moderate	Biomarker	[280]
MCL1	TTL53M6	moderate	Altered Expression	[281]
MECP2	TTTAU9R	moderate	Altered Expression	[282]
MERTK	TTO7LKR	moderate	Altered Expression	[283]
MIA	TT5HNVS	moderate	Biomarker	[44]
MMP13	TTHY57M	moderate	Biomarker	[284]
MRC1	TTKV8W5	moderate	Genetic Variation	[285]
MSI1	TTSM4BA	moderate	Altered Expression	[286]
MTAP	TTDBX7N	moderate	Biomarker	[287]
MYC	TTNQ5ZP	moderate	Biomarker	[288]
NECTIN4	TTPO9EG	moderate	Biomarker	[289]
NELL1	TT7H4BF	moderate	Biomarker	[290]
NR1D1	TTAD1O8	moderate	Biomarker	[291]
NR1H3	TTECBXN	moderate	Altered Expression	[292]
NR4A2	TT9HKN3	moderate	Altered Expression	[293]
NTSR1	TTTUMEP	moderate	Biomarker	[294]
NUAK2	TTHVOTQ	moderate	Altered Expression	[295]
PDCD2	TTYOVWN	moderate	Biomarker	[296]
PDPK1	TTYMGWX	moderate	Biomarker	[297]
PEBP1	TT1BGU8	moderate	Altered Expression	[298]
PHF8	TT81PFE	moderate	Biomarker	[299]
PLG	TTP86E2	moderate	Biomarker	[300]
PLK1	TTH4IP0	moderate	Biomarker	[301]
POSTN	TT8ALTZ	moderate	Biomarker	[302]
PPARG	TTT2SVW	moderate	Biomarker	[303]
PPME1	TTXQ54R	moderate	Biomarker	[304]
PPP2CA	TTHTKNY	moderate	Genetic Variation	[305]
PSCA	TT9T4AV	moderate	Genetic Variation	[306]
PSMB8	TTEAD9J	moderate	Biomarker	[307]
PTK2	TTON5IT	moderate	Biomarker	[270]
RALBP1	TTVSRUA	moderate	Altered Expression	[308]
RAPGEF3	TTOE7I0	moderate	Altered Expression	[309]
ROCK1	TTZN7RP	moderate	Altered Expression	[310]
ROCK2	TTGWKQJ	moderate	Biomarker	[311]
RORC	TTGV6LY	moderate	Biomarker	[237]
ROS1	TTSZ6Y3	moderate	Biomarker	[312]
SERPINE1	TTTO43N	moderate	Biomarker	[313]
SERPINH1	TTPSWQG	moderate	Altered Expression	[314]
SLC19A3	TT9BTWM	moderate	Posttranslational Modification	[315]
SLC22A3	TTG2UMS	moderate	Biomarker	[106]
SLC3A2	TT5CZSM	moderate	Biomarker	[316]
SLC7A5	TTPH2JB	moderate	Biomarker	[316]
SLC9A1	TTGSEFH	moderate	Biomarker	[317]
SRPK1	TTU3WV6	moderate	Altered Expression	[318]
SSTR4	TTAE1BR	moderate	Biomarker	[68]
STOML2	TTOI329	moderate	Biomarker	[319]
SUGT1	TT7Q9WR	moderate	Biomarker	[320]
TACR1	TTZPO1L	moderate	Biomarker	[321]
TBK1	TTMP03S	moderate	Biomarker	[322]
TFF1	TTNOJIZ	moderate	Biomarker	[323]
TGFB2	TTI0KH6	moderate	Altered Expression	[324]
TGFB3	TTWOMY8	moderate	Altered Expression	[156]
TGFBR1	TTP4520	moderate	Biomarker	[325]
TGM1	TT7A949	moderate	Biomarker	[326]
TLR9	TTSHG0T	moderate	Genetic Variation	[327]
TMEM97	TT9NXW4	moderate	Biomarker	[328]
TNFRSF10B	TTW20TU	moderate	Altered Expression	[329]
TNFRSF14	TTWGTC1	moderate	Altered Expression	[216]
TRIM37	TTAMCSL	moderate	Altered Expression	[330]
TYMP	TTO0IB8	moderate	Biomarker	[195]
UBE2T	TT0A1R8	moderate	Biomarker	[331]
VSIR	TT51SK8	moderate	Altered Expression	[332]
WEE1	TTJFOAL	moderate	Biomarker	[333]
WWP1	TTBWMKT	moderate	Biomarker	[334]
ZEB2	TTT2WK4	moderate	Biomarker	[335]
ABCC1	TTOI92F	Strong	Biomarker	[336]
ABCC4	TTUEAFL	Strong	Biomarker	[337]
ABL2	TT1A6HL	Strong	Altered Expression	[338]
ACLY	TT0Z6Y2	Strong	Altered Expression	[339]
ACO2	TTMTF2P	Strong	Altered Expression	[340]
ADAM10	TTVXEGU	Strong	Altered Expression	[341]
ADAM33	TTQICM2	Strong	Biomarker	[342]
ADAM9	TTTYQNS	Strong	Biomarker	[343]
ADAMTS1	TTS2TEI	Strong	Posttranslational Modification	[344]
ADH1A	TT5AHZ0	Strong	Genetic Variation	[345]
ADM	TTV14YH	Strong	Biomarker	[346]
ADORA1	TTK25J1	Strong	Biomarker	[347]
ADRA1D	TT34BHT	Strong	Genetic Variation	[348]
AGTR2	TTQVOEI	Strong	Biomarker	[349]
AICDA	TTKRTP6	Strong	Genetic Variation	[350]
AIF1	TT12MEP	Strong	Altered Expression	[351]
AKR1C3	TT5ZWB6	Strong	Posttranslational Modification	[352]
AKT3	TTO6SGY	Strong	Biomarker	[353]
ALCAM	TT2AFT6	Strong	Altered Expression	[354]
ALOX12	TT12ABZ	Strong	Altered Expression	[355]
ALOX15	TTN9T81	Strong	Altered Expression	[355]
AMD1	TTBFROQ	Strong	Biomarker	[356]
ANGPT1	TTWNQ1T	Strong	Biomarker	[357]
ANGPTL4	TTWALY5	Strong	Biomarker	[358]
ANO1	TTOJI4S	Strong	Altered Expression	[359]
APEX1	TTHGL48	Strong	Biomarker	[360]
APOA1	TT5S8DR	Strong	Biomarker	[361]
AQP3	TTLDNMQ	Strong	Altered Expression	[362]
AREG	TT76B3W	Strong	Altered Expression	[363]
ARF1	TT70KXY	Strong	Biomarker	[364]
ASIC1	TTRJYB6	Strong	Altered Expression	[365]
ATF4	TTQCKWT	Strong	Biomarker	[366]
ATM	TTKBM7V	Strong	Biomarker	[367]
ATP6V1A	TTL2PXZ	Strong	Altered Expression	[368]
AURKA	TTPS3C0	Strong	Genetic Variation	[369]
AURKC	TTLYXIT	Strong	Genetic Variation	[369]
AZGP1	TTUPYLV	Strong	Altered Expression	[370]
BAK1	TTFM7V0	Strong	Biomarker	[371]
BCL2A1	TTGT9C7	Strong	Biomarker	[372]
BDKRB2	TTGY8IW	Strong	Biomarker	[373]
BGN	TT0JPVF	Strong	Biomarker	[374]
BIRC2	TTQ5LRD	Strong	Biomarker	[375]
BMI1	TTIPNSR	Strong	Biomarker	[376]
BRAF	TT0EOB8	Strong	Biomarker	[273]
BSG	TT5UJWD	Strong	Altered Expression	[377]
BST2	TT90BJT	Strong	Altered Expression	[378]
BTG1	TTL7N2W	Strong	Altered Expression	[379]
C1QBP	TTWTD7F	Strong	Biomarker	[380]
CA1	TTHQPL7	Strong	Biomarker	[361]
CA2	TTANPDJ	Strong	Biomarker	[381]
CA9	TT2LVK8	Strong	Biomarker	[382]
CACNA2D1	TTFK1JQ	Strong	Posttranslational Modification	[383]
CACNA2D3	TTN7T29	Strong	Posttranslational Modification	[383]
CALR	TTUZ7OA	Strong	Biomarker	[384]
CAMKK2	TTV298Y	Strong	Biomarker	[385]
CASP10	TTX5HEK	Strong	Genetic Variation	[386]
CASP6	TTKW4ML	Strong	Biomarker	[387]
CASP7	TTM7Y45	Strong	Genetic Variation	[388]
CASP8	TT6SZNG	Strong	Biomarker	[389]
CASP9	TTB6T7O	Strong	Biomarker	[390]
CBR1	TTVG0SN	Strong	Altered Expression	[391]
CCK	TT90CMU	Strong	Biomarker	[392]
CCKBR	TTVFO0U	Strong	Altered Expression	[393]
CCL22	TTBTWI1	Strong	Biomarker	[394]
CCNB1	TT9P6OW	Strong	Altered Expression	[395]
CCR4	TT7HQD0	Strong	Altered Expression	[396]
CCR6	TTFDB30	Strong	Altered Expression	[397]
CD163	TTTZ9DE	Strong	Altered Expression	[302]
CD248	TTYJWT7	Strong	Altered Expression	[398]
CD33	TTJVYO3	Strong	Biomarker	[399]
CD47	TT28S46	Strong	Biomarker	[400]
CD55	TT5Z9WY	Strong	Genetic Variation	[401]
CD74	TTCMYP9	Strong	Biomarker	[402]
CD80	TT89Z17	Strong	Genetic Variation	[403]
CD9	TTZEIBV	Strong	Posttranslational Modification	[404]
CDC20	TTBKFDV	Strong	Altered Expression	[405]
CDK4	TT0PG8F	Strong	Altered Expression	[341]
CDK6	TTO0FDJ	Strong	Biomarker	[406]
CDK7	TTQYF7G	Strong	Altered Expression	[407]
CDKL1	TTBTI6P	Strong	Altered Expression	[408]
CDKN1C	TTBSUAR	Strong	Biomarker	[409]
CEACAM3	TTPX7I5	Strong	Biomarker	[410]
CEBPB	TTUI35N	Strong	Altered Expression	[411]
CGA	TTFC29G	Strong	Genetic Variation	[412]
CHEK1	TTTU902	Strong	Biomarker	[413]
CHRM2	TTYEG6Q	Strong	Genetic Variation	[414]
CHRM3	TTQ13Z5	Strong	Biomarker	[415]
CHRNA4	TT4H1MQ	Strong	Biomarker	[416]
CLK2	TT85TPS	Strong	Biomarker	[417]
CLN3	TTORF9W	Strong	Biomarker	[418]
CNTN1	TTPR8FK	Strong	Biomarker	[419]
COASY	TT4YO0Z	Strong	Genetic Variation	[420]
COL1A2	TTUABC1	Strong	Altered Expression	[421]
COL6A3	TT5WCAH	Strong	Altered Expression	[422]
CRYZ	TTP6UO8	Strong	Genetic Variation	[423]
CSE1L	TTTRULD	Strong	Altered Expression	[424]
CSK	TTX6F0Q	Strong	Biomarker	[425]
CTCFL	TTY0RZT	Strong	Altered Expression	[426]
CTLA4	TTI2S1D	Strong	Genetic Variation	[427]
CTSC	TT4H0V2	Strong	Biomarker	[418]
CTSE	TTLXC4Q	Strong	Altered Expression	[428]
CTSF	TTJOKD1	Strong	Altered Expression	[429]
CUBN	TT9YLCR	Strong	Genetic Variation	[430]
CXCL1	TTLK1RW	Strong	Biomarker	[67]
CXCL12	TT4UGTF	Strong	Biomarker	[431]
CXCL13	TT0NIZ1	Strong	Altered Expression	[432]
CXCR4	TTBID49	Strong	Biomarker	[431]
CXCR5	TTIW59R	Strong	Biomarker	[433]
CYP2A6	TTAQ6ZW	Strong	Biomarker	[434]
CYP2C19	TTZ58XG	Strong	Genetic Variation	[435]
DAPK3	TTERVQN	Strong	Biomarker	[436]
DCTPP1	TTZ1YIS	Strong	Altered Expression	[437]
DEFB4A	TTIVY12	Strong	Biomarker	[438]
DHPS	TTBO2A9	Strong	Altered Expression	[439]
DICER1	TTTEOPU	Strong	Altered Expression	[440]
DLK1	TTF4AVB	Strong	Altered Expression	[441]
DLL3	TT1C9K6	Strong	Biomarker	[442]
DOT1L	TTSZ8T1	Strong	Biomarker	[443]
DTL	TT8396I	Strong	Altered Expression	[444]
DUSP5	TTZN92A	Strong	Altered Expression	[445]
DUSP9	TT1GV6C	Strong	Altered Expression	[446]
E2F1	TTASI04	Strong	Biomarker	[447]
E2F2	TT5FYX0	Strong	Biomarker	[448]
ECE1	TTQ9RYT	Strong	Genetic Variation	[449]
EGLN2	TTMHFRY	Strong	Genetic Variation	[450]
EGR1	TTE8LGD	Strong	Biomarker	[451]
EIF4E	TTZGCP6	Strong	Biomarker	[452]
EIF5A2	TTH53G9	Strong	Biomarker	[453]
ENOX2	TTUJZRL	Strong	Biomarker	[454]
EPAS1	TTWPA54	Strong	Altered Expression	[455]
EPHA2	TTRJB2G	Strong	Biomarker	[456]
EPHA4	TTG84D3	Strong	Biomarker	[457]
EPHA8	TTHZ2LW	Strong	Biomarker	[341]
EPHB1	TT8MDAC	Strong	Biomarker	[458]
EPHB2	TTKPV6O	Strong	Biomarker	[22]
EPHB3	TT5LM7U	Strong	Biomarker	[459]
EPHB4	TTI4ZX2	Strong	Altered Expression	[460]
EREG	TTYSB89	Strong	Biomarker	[461]
ESR1	TTZAYWL	Strong	Biomarker	[462]
ESRRG	TT9ZRHB	Strong	Biomarker	[463]
ETS1	TTTGPSD	Strong	Altered Expression	[24]
ETS2	TT9AH0M	Strong	Altered Expression	[464]
EZH2	TT9MZCQ	Strong	Biomarker	[465]
EZR	TTE47YC	Strong	Biomarker	[466]
FABP1	TTIV96N	Strong	Altered Expression	[467]
FABP5	TTNT2S6	Strong	Biomarker	[468]
FAF1	TTSKL3G	Strong	Genetic Variation	[469]
FBXO11	TT6G10V	Strong	Altered Expression	[470]
FBXW7	TT29KY7	Strong	Altered Expression	[471]
FGF18	TT6ICRA	Strong	Altered Expression	[472]
FGF7	TTFY134	Strong	Altered Expression	[473]
FGFR4	TT1KX2S	Strong	Genetic Variation	[474]
FHL1	TTI7ENL	Strong	Altered Expression	[475]
FKBP10	TT4P8O2	Strong	Altered Expression	[476]
FKBP4	TTHY0FT	Strong	Altered Expression	[477]
FKBP5	TT0J5KQ	Strong	Genetic Variation	[478]
FNDC1	TTQJCV8	Strong	Altered Expression	[479]
FOLR2	TTT54CI	Strong	Genetic Variation	[480]
FOSL1	TTY8LZG	Strong	Altered Expression	[481]
FOXC2	TTLBAP1	Strong	Altered Expression	[482]
FOXM1	TTD3KOX	Strong	Biomarker	[483]
FOXO1	TTLRVIA	Strong	Biomarker	[484]
FOXP3	TT1X3QF	Strong	Biomarker	[410]
FPR1	TT5Y4EM	Strong	Biomarker	[485]
FPR2	TTOJ1NF	Strong	Biomarker	[486]
FSCN1	TTTRS9B	Strong	Biomarker	[487]
FTO	TTFW3BT	Strong	Altered Expression	[488]
FUT3	TTUPAD7	Strong	Biomarker	[489]
GAL	TTXZAJ5	Strong	Biomarker	[490]
GALNS	TTT9YPO	Strong	Altered Expression	[491]
GDF2	TTAP4T1	Strong	Biomarker	[492]
GGH	TTZJRL0	Strong	Biomarker	[493]
GHSR	TTWDC17	Strong	Biomarker	[494]
GJA4	TTQO1VY	Strong	Genetic Variation	[495]
GJA8	TTJ7ATH	Strong	Biomarker	[496]
GJB1	TTSJIRP	Strong	Biomarker	[497]
GJB6	TTAU8SJ	Strong	Altered Expression	[498]
GLI1	TTJOMH6	Strong	Biomarker	[499]
GLI2	TT045OH	Strong	Altered Expression	[500]
GLO1	TTV9A7R	Strong	Biomarker	[501]
GNAQ	TTL1SRG	Strong	Altered Expression	[502]
GPBAR1	TTSDVTR	Strong	Altered Expression	[503]
GPER1	TTDSB34	Strong	Altered Expression	[504]
GPI	TT19JIZ	Strong	Altered Expression	[505]
GPNMB	TT7315J	Strong	Biomarker	[506]
GPR35	TT254XD	Strong	Altered Expression	[507]
GPX1	TTYAHBP	Strong	Genetic Variation	[508]
GRIK2	TT0K5RG	Strong	Biomarker	[509]
GRIK3	TTNP6O2	Strong	Altered Expression	[510]
GRIN2B	TTN9D8E	Strong	Altered Expression	[511]
GSK3B	TTRSMW9	Strong	Altered Expression	[512]
GSTA1	TT4P8DE	Strong	Genetic Variation	[513]
GUCY2C	TTLDPRG	Strong	Altered Expression	[514]
GUSB	TTHS7CM	Strong	Altered Expression	[515]
HCK	TT42OGM	Strong	Biomarker	[516]
HCRT	TTU5HJP	Strong	Biomarker	[517]
HCRTR1	TT60Q8D	Strong	Biomarker	[517]
HDAC1	TT6R7JZ	Strong	Biomarker	[518]
HDAC2	TTSHTOI	Strong	Altered Expression	[519]
HDAC4	TTTQGH8	Strong	Biomarker	[520]
HDAC8	TTT6LFV	Strong	Biomarker	[521]
HDC	TTV9GOF	Strong	Altered Expression	[522]
HDGF	TTKGV26	Strong	Altered Expression	[523]
HGF	TT4V2JM	Strong	Biomarker	[524]
HLA-G	TTLKFB3	Strong	Altered Expression	[525]
HMGA2	TTSTVM0	Strong	Altered Expression	[526]
HMGB2	TTA78JQ	Strong	Biomarker	[527]
HMGCR	TTPADOQ	Strong	Biomarker	[528]
HMOX1	TTI6V2A	Strong	Altered Expression	[529]
HNRNPA1	TTPJ9XK	Strong	Altered Expression	[530]
HNRNPA2B1	TT8UPW6	Strong	Biomarker	[531]
HOXA11	TTEX4ZA	Strong	Posttranslational Modification	[532]
HPD	TT8DSFC	Strong	Biomarker	[533]
HPN	TT25MVL	Strong	Altered Expression	[534]
HPSE	TTR7GJO	Strong	Altered Expression	[535]
HRH2	TTQHJ1K	Strong	Genetic Variation	[536]
HRH4	TTXJ178	Strong	Biomarker	[537]
HSD11B2	TT9H85R	Strong	Altered Expression	[538]
HSD17B1	TTIWB6L	Strong	Biomarker	[539]
HSD17B13	TTDJYZR	Strong	Genetic Variation	[540]
HSF1	TTN6STZ	Strong	Altered Expression	[541]
HSP90AA1	TT78R5H	Strong	Biomarker	[542]
HSP90AB1	TTH5YN2	Strong	Biomarker	[542]
HSP90B1	TTFPKXQ	Strong	Biomarker	[543]
HSPA8	TTMQL3K	Strong	Biomarker	[544]
HSPA9	TTMTPG3	Strong	Altered Expression	[545]
HSPB3	TTLH8WG	Strong	Biomarker	[262]
HTR1A	TTSQIFT	Strong	Therapeutic	[546]
ICOSLG	TTB9Z8R	Strong	Genetic Variation	[547]
ID1	TTBXVDE	Strong	Biomarker	[548]
IDUA	TT0IUKX	Strong	Biomarker	[549]
IFNGR2	TT13TL0	Strong	Genetic Variation	[550]
IGF2R	TTPNE41	Strong	Altered Expression	[551]
IGFBP3	TTZHNQA	Strong	Biomarker	[552]
IGFBP5	TTDWEA8	Strong	Altered Expression	[553]
IGFBP6	TTLAYV8	Strong	Altered Expression	[554]
IKBKB	TTJ3E9X	Strong	Biomarker	[555]
IKZF3	TTCZVFZ	Strong	Biomarker	[556]
IL11	TTGUYTR	Strong	Biomarker	[557]
IL12A	TTRTK6Y	Strong	Posttranslational Modification	[558]
IL12RB2	TT4SWR8	Strong	Genetic Variation	[559]
IL17A	TTG0MT6	Strong	Biomarker	[560]
IL1RL1	TT4GZA4	Strong	Altered Expression	[102]
IL21	TT9QEJ6	Strong	Altered Expression	[561]
IL21R	TTZO9B0	Strong	Biomarker	[562]
IL22	TTLDX4N	Strong	Altered Expression	[561]
IL23A	TTC1GLB	Strong	Biomarker	[563]
IL32	TTD4G7L	Strong	Biomarker	[564]
IL4R	TTDWHC3	Strong	Genetic Variation	[565]
ILK	TT7ALZG	Strong	Altered Expression	[566]
IMP3	TTEJA2R	Strong	Altered Expression	[567]
IRF1	TT4TU3L	Strong	Biomarker	[568]
ITGA1	TTPERWV	Strong	Biomarker	[569]
ITGA8	TT1FW8B	Strong	Biomarker	[570]
ITGB1	TTBVIQC	Strong	Biomarker	[571]
ITGB3	TTJA1ZO	Strong	Biomarker	[572]
ITGB6	TTKQSXZ	Strong	Altered Expression	[573]
ITPR3	TTH1769	Strong	Biomarker	[574]
JAK2	TTRMX3V	Strong	Biomarker	[575]
KCNH1	TT9XKUC	Strong	Altered Expression	[576]
KCNH2	TTQ6VDM	Strong	Altered Expression	[577]
KDM1A	TTNR0UQ	Strong	Biomarker	[578]
KDM1B	TT8VP2T	Strong	Biomarker	[579]
KDM3A	TTKXS4A	Strong	Biomarker	[580]
KDM4A	TTZHPB8	Strong	Altered Expression	[581]
KDM5A	TTIG67W	Strong	Biomarker	[582]
KDM6B	TTDIJUQ	Strong	Altered Expression	[583]
KHDRBS1	TTAT6C7	Strong	Biomarker	[584]
KIF26B	TTQWICZ	Strong	Biomarker	[585]
KISS1	TTU2O6T	Strong	Altered Expression	[586]
KISS1R	TT3KBZY	Strong	Altered Expression	[586]
KLK1	TT5T3P6	Strong	Altered Expression	[587]
KLK6	TTLPF4X	Strong	Altered Expression	[588]
KMT2A	TT1GNDM	Strong	Genetic Variation	[589]
KMT5A	TTGC95K	Strong	Altered Expression	[590]
KRAS	TTM8FR7	Strong	Genetic Variation	[591]
KRT19	TT3JF9E	Strong	Biomarker	[592]
KRT6A	TT2FX8W	Strong	Biomarker	[593]
L1CAM	TTC9D3K	Strong	Altered Expression	[594]
LAMB3	TT2WOUQ	Strong	Altered Expression	[595]
LAMC2	TTNS7H3	Strong	Altered Expression	[596]
LASP1	TTZJA87	Strong	Biomarker	[597]
LATS2	TTML7FG	Strong	Altered Expression	[598]
LBP	TTVQJLY	Strong	Biomarker	[599]
LDHA	TTW76JE	Strong	Biomarker	[600]
LGALS2	TTRHK90	Strong	Biomarker	[601]
LGALS3	TTFPQV7	Strong	Biomarker	[602]
LGR4	TTY6C71	Strong	Biomarker	[603]
LGR5	TTTSGRH	Strong	Altered Expression	[604]
LIFR	TTID542	Strong	Altered Expression	[605]
LILRB1	TTC0QRJ	Strong	Biomarker	[606]
LILRB4	TTREOKA	Strong	Biomarker	[607]
LIN28A	TTO50LN	Strong	Altered Expression	[608]
LIPF	TTKYZA9	Strong	Biomarker	[609]
LOX	TTQHNAM	Strong	Altered Expression	[610]
LPAR1	TTQ6S1K	Strong	Biomarker	[611]
LRP5	TT7VMG4	Strong	Biomarker	[612]
LRP6	TTSXOWE	Strong	Posttranslational Modification	[613]
M6PR	TT95ICL	Strong	Biomarker	[418]
MAD1L1	TTNE9U7	Strong	Biomarker	[614]
MAGEA3	TTWSKHD	Strong	Biomarker	[615]
MAGEA4	TT9EQUY	Strong	Biomarker	[616]
MAP3K1	TTW8TJI	Strong	Genetic Variation	[617]
MAP3K14	TT4LIAC	Strong	Altered Expression	[618]
MAP3K20	TTTUZ3O	Strong	Biomarker	[619]
MAP3K8	TTGECUM	Strong	Altered Expression	[620]
MAP4K1	TTSHWUP	Strong	Altered Expression	[621]
MAP4K4	TT6NI13	Strong	Biomarker	[622]
MAPK1	TT4TQBX	Strong	Biomarker	[22]
MAPK7	TTU6FSC	Strong	Altered Expression	[623]
MAPK8IP1	TTXKZ8Q	Strong	Altered Expression	[624]
MARCKS	TTHRM39	Strong	Biomarker	[625]
MARK2	TTAJ45Y	Strong	Genetic Variation	[626]
MAT2A	TTSMPXQ	Strong	Biomarker	[627]
MBL2	TTMQDZ5	Strong	Biomarker	[427]
MBTPS1	TTNSM2I	Strong	Biomarker	[628]
MCAM	TTHRE05	Strong	Biomarker	[629]
MDK	TTV8UE7	Strong	Biomarker	[630]
MELK	TTBZOTY	Strong	Biomarker	[631]
MGMT	TTJ8DV7	Strong	Posttranslational Modification	[632]
MMP10	TTXLEG7	Strong	Biomarker	[633]
MMP11	TTZW4MV	Strong	Altered Expression	[634]
MMP12	TTXZ0KQ	Strong	Biomarker	[635]
MMP16	TTNP4CU	Strong	Altered Expression	[636]
MMP8	TTGA1IV	Strong	Altered Expression	[637]
MSI2	TTTXQF6	Strong	Altered Expression	[638]
MSMB	TTYH1ZK	Strong	Posttranslational Modification	[639]
MST1R	TTBQ3OC	Strong	Altered Expression	[640]
MTA1	TTO4HUS	Strong	Biomarker	[641]
MTDH	TTH6SA5	Strong	Biomarker	[642]
MTR	TTUTO39	Strong	Genetic Variation	[643]
MUC1	TTBHFYQ	Strong	Altered Expression	[644]
MUC16	TTC1PS3	Strong	Biomarker	[645]
MUC5AC	TTEL90S	Strong	Biomarker	[646]
MUTYH	TTNB0ZK	Strong	Altered Expression	[647]
MYB	TT8V13P	Strong	Biomarker	[76]
MYCBP	TTVW4XU	Strong	Altered Expression	[648]
MYLK	TT18ETS	Strong	Biomarker	[414]
NAGLU	TTDM6HZ	Strong	Genetic Variation	[649]
NCL	TTK1V5Q	Strong	Altered Expression	[650]
NCOA3	TT124R0	Strong	Biomarker	[651]
NDUFA13	TTRU1NG	Strong	Biomarker	[652]
NEK2	TT3VZ24	Strong	Biomarker	[653]
NFKB1	TTUIZKC	Strong	Altered Expression	[654]
NFKB2	TTKLNRV	Strong	Altered Expression	[477]
NOD1	TTYSRXM	Strong	Biomarker	[655]
NOD2	TTYPUHA	Strong	Genetic Variation	[656]
NODAL	TTK2O1Q	Strong	Altered Expression	[657]
NOTCH2	TT82FVD	Strong	Altered Expression	[658]
NPR1	TTM9IYA	Strong	Biomarker	[659]
NQO2	TTJLP0R	Strong	Genetic Variation	[660]
NR0B2	TT25A9Q	Strong	Altered Expression	[661]
NR4A3	TTJQB49	Strong	Biomarker	[662]
NR5A2	TTAU3SY	Strong	Biomarker	[663]
NRG1	TTEH395	Strong	Altered Expression	[664]
NRG4	TTWAGKJ	Strong	Altered Expression	[665]
NRP1	TTIPJCB	Strong	Altered Expression	[135]
NTN1	TT0AH4L	Strong	Altered Expression	[666]
NTRK3	TTXABCW	Strong	Altered Expression	[667]
ODC1	TTUMGNO	Strong	Genetic Variation	[668]
OLFM4	TTK1CX7	Strong	Altered Expression	[669]
OPRD1	TT27RFC	Strong	Genetic Variation	[670]
OSM	TTIVXSE	Strong	Biomarker	[671]
OSMR	TTAH0KM	Strong	Altered Expression	[671]
P2RY2	TTOZHQC	Strong	Biomarker	[458]
P2RY6	TTNVSKA	Strong	Biomarker	[672]
PAK1	TTFN95D	Strong	Biomarker	[673]
PAK2	TT279WO	Strong	Genetic Variation	[469]
PAK4	TT7Y3BZ	Strong	Biomarker	[674]
PAX5	TTA4REJ	Strong	Biomarker	[675]
PBK	TTMY6BZ	Strong	Biomarker	[676]
PCCA	TT1JDE3	Strong	Genetic Variation	[677]
PCNA	TTLG1PD	Strong	Altered Expression	[678]
PCSK7	TTD30LY	Strong	Biomarker	[679]
PDCD1LG2	TTW14O3	Strong	Biomarker	[680]
PFKFB3	TTTHMQJ	Strong	Biomarker	[681]
PGC	TT7K6AD	Strong	Genetic Variation	[682]
PIM1	TTTN5QW	Strong	Biomarker	[683]
PINX1	TT4FJ3A	Strong	Biomarker	[614]
PKMYT1	TTB4PAZ	Strong	Biomarker	[333]
PLA2G2A	TTO8QRU	Strong	Altered Expression	[684]
PLAU	TTGY7WI	Strong	Altered Expression	[685]
PLD1	TT3T17P	Strong	Altered Expression	[686]
PLK2	TT976FS	Strong	Biomarker	[687]
PLK4	TTGPNZQ	Strong	Altered Expression	[688]
PNMT	TT0NZIC	Strong	Biomarker	[689]
POLB	TTA0XPV	Strong	Genetic Variation	[690]
PPARD	TT2JWF6	Strong	Biomarker	[691]
PPAT	TTZFTY4	Strong	Genetic Variation	[677]
PPIB	TT6ZFQ4	Strong	Biomarker	[692]
PPM1D	TTENJAB	Strong	Biomarker	[693]
PPP1CA	TTFLH0E	Strong	Posttranslational Modification	[694]
PREP	TTNGKET	Strong	Biomarker	[418]
PRKCB	TTYPXQF	Strong	Biomarker	[695]
PRKCH	TTONI0R	Strong	Genetic Variation	[696]
PRKCZ	TTBSN0L	Strong	Biomarker	[198]
PRMT1	TTVOJAI	Strong	Biomarker	[462]
PRNP	TTY5F9C	Strong	Biomarker	[697]
PROM1	TTXMZ81	Strong	Altered Expression	[698]
PSIP1	TTH9LDP	Strong	Altered Expression	[477]
PSMD10	TT2H4LN	Strong	Biomarker	[699]
PTGER3	TTPNGDE	Strong	Genetic Variation	[700]
PTK6	TT6TH8V	Strong	Biomarker	[701]
PTK7	TTXH2ZN	Strong	Altered Expression	[702]
PTP4A3	TT7YM8D	Strong	Altered Expression	[703]
PTPN6	TT369M5	Strong	Altered Expression	[661]
RAB22A	TTAJ746	Strong	Biomarker	[704]
RAD51	TTC0G1L	Strong	Genetic Variation	[705]
RASA1	TTPNZ1F	Strong	Biomarker	[706]
RBPJ	TT72D4Z	Strong	Altered Expression	[707]
RECK	TTRZBW7	Strong	Biomarker	[708]
REG4	TTVZEHU	Strong	Biomarker	[709]
RGS6	TTJ96M8	Strong	Biomarker	[706]
RHOA	TTP2U16	Strong	Genetic Variation	[710]
RHOB	TT6LPFO	Strong	Altered Expression	[711]
ROBO1	TTND1YP	Strong	Altered Expression	[712]
ROR1	TTDEJAU	Strong	Biomarker	[713]
RPL15	TTQRVC9	Strong	Biomarker	[418]
RPS12	TTD81N3	Strong	Biomarker	[714]
RPS6KB2	TTMVQXO	Strong	Biomarker	[715]
RRM1	TTWP0NS	Strong	Biomarker	[716]
RRM2	TT1S4LJ	Strong	Altered Expression	[717]
RXRB	TTKLV96	Strong	Biomarker	[418]
S100A3	TTCDFR1	Strong	Altered Expression	[718]
S1PR1	TT9JZCK	Strong	Biomarker	[719]
SATB1	TTLFRIC	Strong	Altered Expression	[720]
SCN9A	TT4G2JS	Strong	Altered Expression	[721]
SELE	TT1PL7M	Strong	Genetic Variation	[722]
SERPINB5	TT1KW50	Strong	Genetic Variation	[723]
SETD2	TTPC3H4	Strong	Biomarker	[724]
SGCB	TTEDCQ0	Strong	Biomarker	[725]
SGK1	TTTV8EJ	Strong	Altered Expression	[726]
SGO1	TTBPKGD	Strong	Altered Expression	[727]
SGPP1	TTN0VRB	Strong	Biomarker	[728]
SLC16A1	TTN1J82	Strong	Altered Expression	[229]
SLC19A1	TT09I7D	Strong	Biomarker	[729]
SLC1A2	TT2F078	Strong	Biomarker	[730]
SLC22A1	TTM5Q4V	Strong	Biomarker	[731]
SLC23A2	TTOP832	Strong	Genetic Variation	[732]
SLC34A2	TTQPZTM	Strong	Biomarker	[733]
SLC38A1	TT1YE9Z	Strong	Biomarker	[734]
SLC52A2	TT6TKEN	Strong	Genetic Variation	[626]
SLC8A1	TTCF82X	Strong	Posttranslational Modification	[735]
SLCO2A1	TTKVTQO	Strong	Biomarker	[69]
SLIT2	TTDWK85	Strong	Biomarker	[712]
SMAD1	TT9GR53	Strong	Genetic Variation	[736]
SMAD7	TT0J32Z	Strong	Biomarker	[737]
SMARCA4	TTVQEZS	Strong	Biomarker	[738]
SMC2	TTS8D17	Strong	Altered Expression	[739]
SMYD2	TT7YJFO	Strong	Altered Expression	[740]
SMYD3	TTKLJYX	Strong	Biomarker	[741]
SNCG	TT5TQNZ	Strong	Biomarker	[742]
SOCS1	TT8COJM	Strong	Altered Expression	[743]
SOCS3	TTI0ME6	Strong	Altered Expression	[744]
SOD2	TT9O4C5	Strong	Genetic Variation	[745]
SP1	TTZEP6S	Strong	Biomarker	[746]
SPARC	TTBQFM7	Strong	Biomarker	[300]
SPOCK1	TTF23RE	Strong	Biomarker	[747]
SRC	TT6PKBN	Strong	Altered Expression	[748]
SREBF2	TTRQ4AP	Strong	Biomarker	[418]
SSRP1	TTETDKQ	Strong	Altered Expression	[527]
SSTR1	TTIND6G	Strong	Altered Expression	[749]
SSTR3	TTJX3UE	Strong	Biomarker	[750]
STC1	TTDLUER	Strong	Altered Expression	[751]
STK16	TTFGN19	Strong	Biomarker	[752]
STMN1	TT7W5OT	Strong	Biomarker	[753]
SULF2	TTLQTHB	Strong	Posttranslational Modification	[754]
TACC3	TTQ4UFD	Strong	Altered Expression	[755]
TACSTD2	TTP2HE5	Strong	Biomarker	[756]
TAGLN2	TTP6BIJ	Strong	Biomarker	[757]
TBL1XR1	TTYXT16	Strong	Biomarker	[758]
TBX21	TTNF9PH	Strong	Genetic Variation	[759]
TCF3	TTULOD8	Strong	Posttranslational Modification	[760]
TDG	TTEXRQD	Strong	Altered Expression	[761]
TEK	TT9VGXW	Strong	Altered Expression	[762]
TEP1	TTQGAVX	Strong	Genetic Variation	[763]
TERF1	TT1Y6J2	Strong	Biomarker	[764]
TERF2	TT5XSLT	Strong	Biomarker	[765]
TFAP2A	TTDY4BS	Strong	Biomarker	[766]
THBS1	TTKI0H1	Strong	Biomarker	[268]
THRA	TTTSEPU	Strong	Altered Expression	[767]
THRB	TTGER3L	Strong	Posttranslational Modification	[768]
TIAM1	TTNU6I5	Strong	Altered Expression	[769]
TIRAP	TTKU0LS	Strong	Genetic Variation	[599]
TKT	TT04R7I	Strong	Altered Expression	[770]
TKTL1	TTNQ1J3	Strong	Biomarker	[771]
TLR1	TTW14D0	Strong	Genetic Variation	[772]
TLR2	TTY7ZHS	Strong	Biomarker	[312]
TMSB4X	TTMVAIU	Strong	Altered Expression	[773]
TNFRSF12A	TTKPS7V	Strong	Altered Expression	[774]
TNFSF13	TTOI1RM	Strong	Altered Expression	[775]
TNFSF14	TTKVENM	Strong	Biomarker	[776]
TNK2	TTIET93	Strong	Altered Expression	[777]
TNKS	TTVUSO7	Strong	Biomarker	[778]
TNS4	TT1K65C	Strong	Altered Expression	[779]
TPX2	TT0PHL4	Strong	Altered Expression	[780]
TRIM24	TT9Q7AE	Strong	Altered Expression	[781]
TRIM28	TTQ2BKV	Strong	Biomarker	[782]
TRPC6	TTRBT3W	Strong	Altered Expression	[783]
TRPM7	TTFPVZO	Strong	Biomarker	[784]
TSG101	TTHU7JA	Strong	Altered Expression	[785]
TSLP	TTHMW3T	Strong	Biomarker	[786]
TTK	TTP7EGM	Strong	Biomarker	[549]
TXNIP	TTTLDZK	Strong	Biomarker	[787]
UCHL1	TTX9IFP	Strong	Biomarker	[788]
USP33	TT4E85Q	Strong	Biomarker	[712]
USP44	TTJLTNM	Strong	Altered Expression	[789]
VANGL1	TT18WJB	Strong	Altered Expression	[790]
VEGFD	TTOM5H4	Strong	Biomarker	[791]
VIPR1	TTCL30I	Strong	Altered Expression	[792]
WNK1	TTJ9UMX	Strong	Biomarker	[793]
WNT5A	TTKG7F8	Strong	Biomarker	[794]
WRN	TT2H5WQ	Strong	Posttranslational Modification	[754]
WWP2	TT6TU05	Strong	Biomarker	[795]
XPO1	TTCJUR4	Strong	Biomarker	[796]
XRCC5	TTCB9KW	Strong	Biomarker	[59]
YAP1	TT8UN2D	Strong	Biomarker	[691]
YES1	TT0SQ8J	Strong	Biomarker	[797]
ZNF217	TTY3BRA	Strong	Biomarker	[798]
ATAD2	TT9A0HI	Definitive	Biomarker	[462]
AURKB	TT9RTBL	Definitive	Biomarker	[799]
BMP2	TTP3IGX	Definitive	Biomarker	[800]
CCN1	TTPK79J	Definitive	Biomarker	[801]
CDK12	TTJ21A9	Definitive	Altered Expression	[802]
CEACAM1	TTA9CK4	Definitive	Biomarker	[803]
CLDN6	TTKSV48	Definitive	Biomarker	[804]
CSNK2A1	TTER6YH	Definitive	Biomarker	[805]
DEK	TT1NMGV	Definitive	Biomarker	[806]
EGFL7	TT7WD0H	Definitive	Biomarker	[807]
FAM83D	TTFIW7J	Definitive	Altered Expression	[808]
G3BP1	TTG0R8Z	Definitive	Biomarker	[809]
GALE	TTGRHIB	Definitive	Altered Expression	[810]
GJB4	TTBRDFI	Definitive	Posttranslational Modification	[811]
ICOS	TTE5VP6	Definitive	Biomarker	[812]
JUN	TTS7IR5	Definitive	Altered Expression	[813]
MAGEA6	TTJIWMO	Definitive	Biomarker	[814]
MAPK8	TT0K6EO	Definitive	Biomarker	[815]
MELTF	TT8OBT3	Definitive	Biomarker	[816]
NPM1	TTHBS98	Definitive	Biomarker	[817]
PCSK2	TT46F0P	Definitive	Biomarker	[818]
PDK3	TTDEQIP	Definitive	Altered Expression	[819]
SHCBP1	TTZ9WGL	Definitive	Biomarker	[820]
SPDEF	TT2ZUPY	Definitive	Biomarker	[821]
TGFA	TTTLQFR	Definitive	Genetic Variation	[822]
TNFSF15	TTEST6I	Definitive	Biomarker	[823]

This Disease Is Related to 14 DTP Molecule(s)

Gene Name	DTP ID	Evidence Level	Mode of Inheritance	REF
SLC25A3	DTCRIWV	Limited	Genetic Variation	[824]
SLC35B4	DTMALXP	Disputed	Biomarker	[825]
SLC52A3	DTBVQIO	moderate	Genetic Variation	[826]
ABCB6	DTF9Y2V	Strong	Biomarker	[697]
ANXA11	DTGQ2CF	Strong	Altered Expression	[827]
ATP12A	DT5NLZA	Strong	Genetic Variation	[211]
ATP7A	DT0LT17	Strong	Biomarker	[828]
SLC11A1	DT650XW	Strong	Genetic Variation	[829]
SLC16A7	DTLT3UG	Strong	Altered Expression	[170]
SLC25A37	DTLBGTZ	Strong	Biomarker	[830]
SLC26A2	DTFSLX5	Strong	Altered Expression	[831]
SLC4A1	DTB0Q3P	Strong	Altered Expression	[832]
SLC5A8	DTE3TAW	Strong	Posttranslational Modification	[833]
SLC6A6	DTHWCVA	Strong	Altered Expression	[834]

This Disease Is Related to 48 DME Molecule(s)

Gene Name	DME ID	Evidence Level	Mode of Inheritance	REF
ADH4	DEOCWU3	Limited	Altered Expression	[25]
ADH5	DEIOH6A	Limited	Genetic Variation	[25]
ADH6	DE017IC	Limited	Altered Expression	[25]
AKR1B10	DEP6GT1	Limited	Altered Expression	[835]
FADS1	DE05S8C	Limited	Genetic Variation	[124]
GCLC	DESYL1F	Limited	Altered Expression	[192]
GGCT	DEKW6PB	Limited	Altered Expression	[836]
GLS	DE3E0VT	Limited	Altered Expression	[836]
HPGD	DEHKSC6	Limited	Altered Expression	[837]
PON2	DEHJU7E	Limited	Biomarker	[838]
PTGDS	DER3H9C	Limited	Altered Expression	[149]
EGLN3	DEMQTKH	moderate	Biomarker	[839]
HINT1	DEWJATF	moderate	Biomarker	[840]
HK1	DEDMAGE	moderate	Biomarker	[841]
UGT2B15	DENZ6B1	moderate	Biomarker	[842]
ABO	DESIA7R	Strong	Genetic Variation	[843]
ACP5	DESITDW	Strong	Altered Expression	[844]
ACSS2	DEE76VW	Strong	Biomarker	[845]
ADH1C	DEM1HNL	Strong	Genetic Variation	[846]
AKR1A1	DED2FW3	Strong	Altered Expression	[25]
ASNS	DEXISVQ	Strong	Biomarker	[847]
BAAT	DERA3OF	Strong	Genetic Variation	[848]
CHDH	DEAHED0	Strong	Genetic Variation	[849]
CMPK1	DEMPH4I	Strong	Biomarker	[850]
CRMP1	DE0EUXB	Strong	Biomarker	[198]
CYP4F3	DEFCMPI	Strong	Genetic Variation	[851]
DDAH1	DEY0TQC	Strong	Altered Expression	[852]
EPHX1	DELB4KP	Strong	Genetic Variation	[853]
GLDC	DEIN8FB	Strong	Biomarker	[854]
GSTO2	DEHMPZR	Strong	Genetic Variation	[855]
HSD17B7	DEDMWFX	Strong	Genetic Variation	[540]
HSD3B1	DERDQWN	Strong	Biomarker	[540]
MTRR	DE6NIY9	Strong	Genetic Variation	[856]
NAT1	DE7OAB3	Strong	Genetic Variation	[857]
P4HA3	DE2L4RX	Strong	Biomarker	[858]
PLPP1	DE6WXTH	Strong	Biomarker	[418]
SAT1	DEMWO83	Strong	Posttranslational Modification	[859]
SMOX	DEOH5V3	Strong	Biomarker	[860]
SULT1A1	DEYWLRK	Strong	Genetic Variation	[861]
SULT1E1	DESTKG6	Strong	Altered Expression	[620]
SULT2A1	DE0P6LK	Strong	Biomarker	[862]
UGT1A10	DEL5N6Y	Strong	Genetic Variation	[863]
UGT1A4	DELOY3P	Strong	Genetic Variation	[863]
UGT1A6	DESD26P	Strong	Genetic Variation	[863]
UGT1A7	DEZO4N3	Strong	Genetic Variation	[863]
UGT1A8	DE2GB8N	Strong	Genetic Variation	[863]
UPP1	DEFZWAX	Strong	Altered Expression	[864]
MT2A	DEFKGT7	Definitive	Biomarker	[865]

This Disease Is Related to 1555 DOT Molecule(s)

Gene Name	DOT ID	Evidence Level	Mode of Inheritance	REF
ACTN4	OTCNZAJ5	Limited	Altered Expression	[866]
ADCY3	OTGOQM6B	Limited	Biomarker	[867]
ADGRE2	OTUYJVYG	Limited	Biomarker	[868]
ADGRE5	OTTSB84Q	Limited	Biomarker	[868]
AEBP1	OTBI1RZ6	Limited	Biomarker	[869]
AHRR	OTSJ12W6	Limited	Altered Expression	[870]
AKAP4	OTL4Z99V	Limited	Biomarker	[871]
ALDH1A3	OT1C9NKQ	Limited	Biomarker	[44]
ANKRD49	OTG9XX92	Limited	Biomarker	[872]
ANOS1	OTZJT4KN	Limited	Altered Expression	[873]
ANXA4	OTUCRYXL	Limited	Posttranslational Modification	[874]
AP2A1	OTEFZB21	Limited	Biomarker	[875]
ARF6	OTVV7KJO	Limited	Biomarker	[876]
ARFGEF3	OTGQV0CU	Limited	Biomarker	[877]
ARHGAP5	OTOQELUN	Limited	Biomarker	[878]
ARHGEF2	OTBQTFRT	Limited	Biomarker	[879]
ARHGEF28	OT3F32IU	Limited	Biomarker	[879]
ARHGEF39	OT9UKTQ5	Limited	Biomarker	[880]
ARID1A	OTRWDV3P	Limited	Biomarker	[881]
ARL2BP	OT7REEDA	Limited	Altered Expression	[87]
ARL4C	OTQ3QNNU	Limited	Biomarker	[882]
ARMCX1	OTOGL58Z	Limited	Altered Expression	[883]
ASS1	OT4ZMG0Q	Limited	Biomarker	[884]
ATF7	OTM8T3OD	Limited	Altered Expression	[885]
ATG12	OTJRO09Y	Limited	Altered Expression	[886]
AXIN2	OTRMGQNU	Limited	Genetic Variation	[887]
AZIN1	OTX5W77I	Limited	Altered Expression	[888]
BANF1	OTP7Z38L	Limited	Biomarker	[889]
BLID	OT479VJV	Limited	Biomarker	[890]
BOK	OTDQPDIX	Limited	Altered Expression	[891]
BRI3BP	OTWCFPRM	Limited	Biomarker	[892]
BRMS1	OTV5A6LL	Limited	Biomarker	[893]
BTG2	OTZF6K1H	Limited	Altered Expression	[894]
BUB3	OTU91HAU	Limited	Genetic Variation	[895]
C4BPA	OTHNH6Y8	Limited	Biomarker	[697]
CA11	OT8RX3AJ	Limited	Genetic Variation	[896]
CAP1	OTYM8A2N	Limited	Genetic Variation	[113]
CAP2	OTC1WFNO	Limited	Altered Expression	[897]
CAPRIN1	OTEJAMS3	Limited	Altered Expression	[898]
CAPZA1	OTAXA66U	Limited	Biomarker	[899]
CARD14	OTADQHOV	Limited	Biomarker	[697]
CBX5	OT8VYY84	Limited	Altered Expression	[900]
CCAR2	OTLUDG5T	Limited	Biomarker	[901]
CCDC125	OTEK4FFM	Limited	Altered Expression	[902]
CCDC8	OTO295IH	Limited	Biomarker	[581]
CCN4	OT69BER9	Limited	Altered Expression	[903]
CCN6	OTRFHQ2Z	Limited	Biomarker	[533]
CCND2	OTDULQF9	Limited	Biomarker	[904]
CCNG2	OTII38K2	Limited	Altered Expression	[905]
CD200R1	OT65Q9M6	Limited	Biomarker	[52]
CD63	OT2UGZA9	Limited	Biomarker	[906]
CD68	OTOYEY3J	Limited	Altered Expression	[907]
CD82	OTH8MC64	Limited	Altered Expression	[908]
CDC14A	OTL10OY6	Limited	Genetic Variation	[824]
CDC27	OTDT45XJ	Limited	Altered Expression	[909]
CDCA3	OTUI8QK3	Limited	Altered Expression	[910]
CDH17	OT9EV2XK	Limited	Altered Expression	[911]
CDKN2D	OT2TTZPZ	Limited	Biomarker	[44]
CDKN3	OTBE3H07	Limited	Biomarker	[912]
CDO1	OTLG1P77	Limited	Posttranslational Modification	[913]
CDX1	OTOHTMJE	Limited	Biomarker	[914]
CEACAM19	OTMECF5R	Limited	Biomarker	[915]
CELF2	OTLJJ4VT	Limited	Biomarker	[916]
CERS6	OTOP4GV1	Limited	Biomarker	[917]
CITED2	OT812TV7	Limited	Biomarker	[918]
CKB	OTUCKOTT	Limited	Posttranslational Modification	[748]
CLDN7	OTNE0XHQ	Limited	Biomarker	[919]
CLTB	OTPW9VRE	Limited	Altered Expression	[920]
CMIP	OTZN8Z4A	Limited	Biomarker	[921]
CMTM7	OTI7Q2JW	Limited	Altered Expression	[922]
COL10A1	OTC4G2YC	Limited	Altered Expression	[923]
COL12A1	OTHLTV53	Limited	Biomarker	[924]
COL1A1	OTI31178	Limited	Altered Expression	[431]
COL4A1	OTL6D1YE	Limited	Biomarker	[925]
COPS7A	OTLHKO3M	Limited	Biomarker	[926]
CORO1C	OTXDF9T3	Limited	Biomarker	[927]
CORO7	OTG7MEAJ	Limited	Biomarker	[928]
CPEB4	OTW1SCZW	Limited	Altered Expression	[929]
CPXM2	OTDJNOTR	Limited	Biomarker	[930]
CST1	OTE4I83Q	Limited	Biomarker	[931]
CST7	OTQWZUVQ	Limited	Biomarker	[44]
CTBP1	OTVYH2DH	Limited	Altered Expression	[932]
CUL4A	OTTBV70J	Limited	Biomarker	[933]
CUX1	OTU1LCNJ	Limited	Biomarker	[934]
CXCL16	OTD49T9R	Limited	Biomarker	[935]
CXCL5	OTZOUPCA	Limited	Biomarker	[67]
DCBLD2	OTB71I02	Limited	Posttranslational Modification	[936]
DCD	OTV5PBGJ	Limited	Biomarker	[937]
DDIT3	OTI8YKKE	Limited	Altered Expression	[329]
DDRGK1	OT3KCK0U	Limited	Altered Expression	[938]
DDX21	OTV73GMZ	Limited	Biomarker	[939]
DENND1A	OTONDAA0	Limited	Altered Expression	[940]
DENR	OTXP9HOY	Limited	Biomarker	[198]
DIXDC1	OT87DXEG	Limited	Biomarker	[941]
DLEC1	OTMKKBUW	Limited	Biomarker	[788]
DMAP1	OT1ZMQTU	Limited	Biomarker	[942]
DNAJA2	OTKF1VBT	Limited	Biomarker	[74]
DNAJB4	OTUD01BK	Limited	Biomarker	[74]
DNAJB6	OTMHIIAN	Limited	Biomarker	[74]
DNAJC14	OT7DPIVN	Limited	Biomarker	[74]
DNM1L	OTXK1Q1G	Limited	Biomarker	[198]
DOCK6	OTPNUVLT	Limited	Altered Expression	[879]
DOK1	OTGVRLW6	Limited	Biomarker	[943]
DPT	OTINRFC7	Limited	Altered Expression	[944]
DPYSL3	OTINJV20	Limited	Altered Expression	[873]
DTX1	OTYX91DX	Limited	Biomarker	[945]
DUOX1	OTQ2AEW0	Limited	Biomarker	[946]
DYNC1I1	OTFX1KCG	Limited	Biomarker	[947]
ECHS1	OTS0593S	Limited	Biomarker	[948]
ECM1	OT1K65VW	Limited	Biomarker	[949]
EEF1A2	OT9Z23K5	Limited	Altered Expression	[950]
EFNB2	OT0DCUOM	Limited	Biomarker	[951]
EIF4G3	OTZCRXLJ	Limited	Biomarker	[952]
EMILIN1	OT94R6M1	Limited	Biomarker	[953]
EPB41L3	OTS6CHG2	Limited	Altered Expression	[954]
EPB41L5	OTPPQPLU	Limited	Biomarker	[955]
EPGN	OT3EG75W	Limited	Altered Expression	[352]
EPHX3	OTU7LW2F	Limited	Biomarker	[44]
ERGIC1	OT351FKB	Limited	Biomarker	[956]
ESCO2	OTJEMAQU	Limited	Biomarker	[957]
FA2H	OT8HA13U	Limited	Biomarker	[958]
FAM107B	OT5RG4J0	Limited	Altered Expression	[959]
FAM3C	OTBR6U9G	Limited	Biomarker	[960]
FBXO2	OTF3677S	Limited	Biomarker	[961]
FBXW5	OT5TQK3H	Limited	Biomarker	[962]
FCGBP	OT63T6XQ	Limited	Biomarker	[44]
FGB	OT6RKLI9	Limited	Biomarker	[963]
FIBCD1	OTSVT07B	Limited	Altered Expression	[964]
FILIP1	OTMZD6D4	Limited	Biomarker	[44]
FLAD1	OTY8R02L	Limited	Genetic Variation	[124]
FLI1	OT0EV3LX	Limited	Biomarker	[965]
FOXF2	OTV20NGX	Limited	Biomarker	[966]
FOXK1	OTLZGS7J	Limited	Biomarker	[967]
FOXK2	OTFXDZ3R	Limited	Altered Expression	[968]
FOXL2	OTFRQUYL	Limited	Biomarker	[267]
FOXS1	OTPM9TZ5	Limited	Altered Expression	[969]
FRZB	OTTO3DPY	Limited	Biomarker	[970]
FZD3	OTIWDN78	Limited	Biomarker	[161]
FZD6	OTBCPII8	Limited	Biomarker	[161]
GATA2	OTBP2QQ2	Limited	Biomarker	[971]
GID8	OT0HJ277	Limited	Altered Expression	[972]
GKN1	OT7ZYFQ9	Limited	Biomarker	[973]
GLI3	OTKDOE94	Limited	Biomarker	[974]
GLIS2	OTOUUV1X	Limited	Biomarker	[975]
GNAT1	OTK2SNJA	Limited	Altered Expression	[976]
GPAA1	OTWVRR35	Limited	Altered Expression	[505]
GREM2	OTE91EWT	Limited	Altered Expression	[977]
GRINA	OTMC1O66	Limited	Biomarker	[978]
GSC	OT4DH7PR	Limited	Biomarker	[604]
GSE1	OT3J7CJB	Limited	Biomarker	[979]
GSPT2	OTN0K7F3	Limited	Biomarker	[980]
GTPBP4	OT6ZHAWC	Limited	Altered Expression	[981]
HACD1	OTEC7EP7	Limited	Genetic Variation	[113]
HACE1	OTEZULKD	Limited	Altered Expression	[982]
HIKESHI	OTPKV3UZ	Limited	Biomarker	[983]
HIPK1	OTSEA8RS	Limited	Biomarker	[984]
HM13	OTGEO1LP	Limited	Genetic Variation	[985]
HMMR	OT4M0JTZ	Limited	Biomarker	[986]
HOXC9	OT60K4M0	Limited	Altered Expression	[987]
HOXD3	OTBUZ35T	Limited	Biomarker	[988]
HRK	OTR4GWJ0	Limited	Posttranslational Modification	[989]
HSPB2	OTS01646	Limited	Biomarker	[262]
IARS2	OTDX4SCA	Limited	Biomarker	[990]
ID4	OTPMJ39I	Limited	Biomarker	[44]
IFITM3	OT2QP8D3	Limited	Biomarker	[991]
IFT80	OTMH0MBI	Limited	Biomarker	[992]
IL26	OT2WYCW4	Limited	Altered Expression	[993]
IL6R	OTCQL07Z	Limited	Biomarker	[44]
ING1	OTEZBRKW	Limited	Biomarker	[418]
ING3	OTDIJXFP	Limited	Biomarker	[994]
INPP5K	OTQFLQKA	Limited	Altered Expression	[995]
IQGAP1	OTZRWTGA	Limited	Biomarker	[276]
IQGAP3	OT4RZV2M	Limited	Altered Expression	[996]
IRF2	OTAZRUW3	Limited	Altered Expression	[997]
IRF2BPL	OTV8MNT1	Limited	Altered Expression	[966]
IRF9	OTK4MYQJ	Limited	Altered Expression	[902]
ISX	OTULQRWA	Limited	Altered Expression	[998]
JAZF1	OTXTYSYD	Limited	Biomarker	[999]
KAT7	OTUN98IC	Limited	Biomarker	[1000]
KDM5D	OTEKG0KD	Limited	Biomarker	[933]
KIRREL1	OTOA7ON7	Limited	Biomarker	[1001]
KLF16	OTTPV4NB	Limited	Biomarker	[1002]
KLF2	OTIP1UFX	Limited	Altered Expression	[1003]
KLF5	OT1ABI9N	Limited	Biomarker	[1004]
KLF8	OTUC5CDB	Limited	Biomarker	[203]
KLHL6	OTLDECOX	Limited	Altered Expression	[1005]
KLHL7	OT2OF1O8	Limited	Altered Expression	[1005]
KNL1	OT4Q3LHV	Limited	Altered Expression	[1006]
KRT18	OTVLQFIP	Limited	Biomarker	[1007]
KRT8	OTTM4X11	Limited	Biomarker	[1008]
KRTAP1-1	OT6EIYYO	Limited	Genetic Variation	[1009]
LARP7	OTLLOZTL	Limited	Biomarker	[1010]
LATS1	OTOOCG4R	Limited	Biomarker	[1011]
LETMD1	OTZTZ4RD	Limited	Biomarker	[892]
LGR6	OTPZ1PWR	Limited	Biomarker	[1012]
LIMD1	OTN1CG6R	Limited	Altered Expression	[1013]
LINGO2	OT3N88Q1	Limited	Genetic Variation	[100]
LMAN2	OT8UQKS6	Limited	Altered Expression	[1014]
LMO3	OTR7AJHN	Limited	Biomarker	[1015]
LMX1A	OTEEYD5L	Limited	Biomarker	[1016]
LRBA	OTOUZN9G	Limited	Biomarker	[1017]
LSR	OTR8Y32X	Limited	Biomarker	[1018]
LTBP2	OTS88GSD	Limited	Biomarker	[1019]
LY6E	OTMG16BZ	Limited	Altered Expression	[1020]
MAD2L1	OTXNGZCG	Limited	Altered Expression	[405]
MAGEB6	OTOTV1FU	Limited	Biomarker	[1021]
MAP1LC3A	OTPMGIU4	Limited	Altered Expression	[1022]
MAP3K6	OTOE0Z1R	Limited	Unknown	[118]
MARCHF8	OTH7PNN2	Limited	Biomarker	[1023]
MARK1	OTP7KL47	Limited	Biomarker	[44]
MBD3L2	OTTG4S9O	Limited	Biomarker	[44]
MBOAT7	OTHRCBLK	Limited	Altered Expression	[150]
MDGA2	OTIJ0T5J	Limited	Biomarker	[942]
MDP1	OTLUZISP	Limited	Altered Expression	[1024]
METTL14	OT6TPQMH	Limited	Biomarker	[1025]
METTL3	OTSXP1M3	Limited	Biomarker	[1026]
MICA	OTPEIEAR	Limited	Altered Expression	[1027]
MIIP	OT79EXZ7	Limited	Altered Expression	[1028]
MITF	OT6XJCZH	Limited	Altered Expression	[424]
MLF1	OTC5BKHU	Limited	Biomarker	[1029]
MLKL	OTDSLC81	Limited	Biomarker	[1030]
MPC1	OT6DYFUO	Limited	Biomarker	[1031]
MRFAP1	OT1AI7NF	Limited	Biomarker	[1032]
MRPL39	OTN9VRD2	Limited	Biomarker	[1033]
MSX1	OT5U41ZP	Limited	Biomarker	[1034]
MTMR2	OTNCYGBP	Limited	Altered Expression	[1035]
MUS81	OTVZ4E60	Limited	Biomarker	[1036]
MX1	OT6X8G5T	Limited	Biomarker	[44]
MYO6	OTJQYRC7	Limited	Altered Expression	[1037]
MYOZ2	OTMEIQJA	Limited	Altered Expression	[1038]
MZF1	OTMVZCPW	Limited	Altered Expression	[865]
NBAS	OTW9IBRI	Limited	Genetic Variation	[649]
NCAPG	OT1AI9EO	Limited	Altered Expression	[1006]
NCF2	OTAUW7L2	Limited	Altered Expression	[1039]
ND3	OT1OC3K3	Limited	Genetic Variation	[1009]
NECTIN1	OTTE5ZR6	Limited	Altered Expression	[1040]
NEO1	OTGJ1997	Limited	Altered Expression	[666]
NEU1	OTH9BY8Y	Limited	Altered Expression	[1041]
NEUROD1	OTZQ7QJ2	Limited	Biomarker	[1042]
NGLY1	OTZBQD5Q	Limited	Genetic Variation	[1043]
NONO	OTN36Q6U	Limited	Biomarker	[1044]
NRG2	OTMDE844	Limited	Altered Expression	[1045]
NUDT1	OTZSES3W	Limited	Biomarker	[1046]
OLFML2B	OTDNJFR4	Limited	Biomarker	[1047]
OPN1LW	OTFNUZ7O	Limited	Altered Expression	[1048]
PAG1	OTFOJUIQ	Limited	Altered Expression	[1048]
PAQR4	OTNO659U	Limited	Altered Expression	[1049]
PARPBP	OTPZDGW7	Limited	Biomarker	[1050]
PCBP4	OTDLL4NB	Limited	Altered Expression	[1048]
PCDH10	OT2GIT0E	Limited	Genetic Variation	[1051]
PCDH7	OTP091X8	Limited	Altered Expression	[1052]
PCDH9	OTX3BFV4	Limited	Biomarker	[1053]
PCDHB9	OT9S1QXZ	Limited	Altered Expression	[378]
PCDHGA9	OTKJE2H2	Limited	Biomarker	[1054]
PDHA1	OTGEU8IK	Limited	Biomarker	[1055]
PDIK1L	OTISF4KG	Limited	Biomarker	[1056]
PDLIM5	OTLQVV22	Limited	Biomarker	[1015]
PDRG1	OT8ZMFZE	Limited	Altered Expression	[1057]
PEG10	OTWD2278	Limited	Biomarker	[1058]
PHLDA1	OTFTWMIQ	Limited	Biomarker	[1059]
PIAS1	OTZVAHZI	Limited	Biomarker	[1060]
PIEZO1	OTBG1FU4	Limited	Altered Expression	[1061]
PITPNC1	OT64TTGC	Limited	Altered Expression	[1062]
PLIN2	OTRXJ9UN	Limited	Biomarker	[44]
PLS3	OTYBM4PK	Limited	Biomarker	[766]
PMEPA1	OTY8Z9UF	Limited	Biomarker	[1063]
PPBP	OT1FHGQS	Limited	Altered Expression	[1064]
PPIC	OTY5Q42N	Limited	Biomarker	[44]
PPP1R12A	OT4AVU95	Limited	Altered Expression	[1065]
PRB2	OTAD4JZ0	Limited	Biomarker	[1066]
PRDM16	OT0BGA27	Limited	Biomarker	[462]
PRDX1	OTZ3BEC4	Limited	Altered Expression	[1067]
PRDX2	OTLWCY9T	Limited	Biomarker	[1068]
PROX1	OT68R6IO	Limited	Altered Expression	[1069]
PRRX2	OT8UR4AU	Limited	Altered Expression	[1070]
PRSS50	OTC5JAVO	Limited	Biomarker	[1071]
PRX	OT34Z10B	Limited	Altered Expression	[1072]
PSPH	OTV1PVAX	Limited	Biomarker	[1073]
PTPRU	OTHDO0QG	Limited	Genetic Variation	[824]
RAB35	OTRH1E2T	Limited	Biomarker	[940]
RAB6B	OT5N57RK	Limited	Altered Expression	[1074]
RAD51B	OTCJVRMY	Limited	Biomarker	[1075]
RAI14	OT6USGBK	Limited	Altered Expression	[1076]
RAPSN	OTGMSWDQ	Limited	Genetic Variation	[124]
RASSF8	OTXKGIB3	Limited	Biomarker	[1077]
RBM47	OT6W67VM	Limited	Altered Expression	[1078]
RBP1	OTRP1MFC	Limited	Biomarker	[44]
RNF138	OTPU0CO4	Limited	Biomarker	[1079]
RNF180	OT2GKIKE	Limited	Biomarker	[1080]
RNF185	OTU1NS9O	Limited	Altered Expression	[1081]
RNF2	OTFPLOIN	Limited	Biomarker	[1082]
RNF31	OT4BZONL	Limited	Biomarker	[1083]
ROBO3	OTPVG40S	Limited	Biomarker	[72]
RPL6	OTRU71O4	Limited	Biomarker	[1084]
RPS15A	OT0BUA12	Limited	Altered Expression	[555]
RPS6	OTT4D1LN	Limited	Altered Expression	[1085]
RSRC1	OTFCJ4S0	Limited	Altered Expression	[1086]
RTKN	OTSS8XR6	Limited	Altered Expression	[518]
RUFY3	OTMA4YA4	Limited	Biomarker	[1087]
S100A1	OT1F2G4J	Limited	Biomarker	[165]
S100A10	OTI71243	Limited	Altered Expression	[1088]
SALL4	OTC08PR5	Limited	Biomarker	[149]
SCRN1	OTELM5C2	Limited	Genetic Variation	[1089]
SDAD1	OTP4468N	Limited	Biomarker	[1090]
SDHB	OTRE1M1T	Limited	Posttranslational Modification	[1091]
SERPINB6	OT7G55IK	Limited	Genetic Variation	[113]
SET	OTGYYQJO	Limited	Biomarker	[1092]
SGCE	OT9F17JB	Limited	Altered Expression	[1093]
SH2B1	OTJZO2CI	Limited	Altered Expression	[1094]
SH3BGRL	OTUOCTMT	Limited	Altered Expression	[1045]
SHMT2	OT5NCAZN	Limited	Altered Expression	[1095]
SLC2A4RG	OTW3LX8D	Limited	Biomarker	[879]
SMARCC2	OTC5SNMZ	Limited	Biomarker	[1096]
SORBS1	OTWH8762	Limited	Genetic Variation	[113]
SOX11	OT4LG7LA	Limited	Biomarker	[1097]
SPECC1	OTPEML48	Limited	Altered Expression	[1098]
SPRR2A	OT62ZU6B	Limited	Biomarker	[44]
SPZ1	OTQH8HJ5	Limited	Biomarker	[1099]
SRCIN1	OTQZNQQ5	Limited	Biomarker	[1100]
SRY	OT516T6D	Limited	Altered Expression	[1101]
SSH1	OT4BE2M4	Limited	Altered Expression	[1102]
STK11	OT1YZSP3	Limited	Altered Expression	[1103]
STK24	OTGUHOIL	Limited	Biomarker	[1104]
STUB1	OTSUYI9A	Limited	Biomarker	[1105]
SUSD2	OTSJTAZP	Limited	Biomarker	[1106]
SYT13	OTG94RJ4	Limited	Altered Expression	[1107]
SYT7	OTBWAOWY	Limited	Altered Expression	[156]
SYT8	OTH3V11B	Limited	Biomarker	[1108]
TBX3	OTM64N7K	Limited	Altered Expression	[1109]
TCF21	OT393IMA	Limited	Biomarker	[928]
TENM3	OTWY13GR	Limited	Biomarker	[869]
TENT5C	OTOWVQ4O	Limited	Biomarker	[1110]
TFAP2C	OTUDIW05	Limited	Biomarker	[44]
TFAP2E	OTA4B1SG	Limited	Biomarker	[447]
TIA1	OTGPN3P8	Limited	Altered Expression	[1111]
TIGAR	OTR7NMRJ	Limited	Altered Expression	[1112]
TIMMDC1	OTIK4I5R	Limited	Biomarker	[1113]
TLX1	OTVN0MNW	Limited	Biomarker	[1114]
TMEM41A	OTAAULKY	Limited	Biomarker	[1115]
TMEM45B	OTVQCO8N	Limited	Biomarker	[1116]
TMOD4	OTXLGJ4R	Limited	Biomarker	[899]
TMPRSS3	OT0GTO1Z	Limited	Biomarker	[1117]
TNFAIP8L1	OTVVKOTV	Limited	Biomarker	[1118]
TNFSF9	OTV9L89D	Limited	Biomarker	[44]
TNNI2	OTGGZFSC	Limited	Biomarker	[1119]
TNRC6A	OT493IOM	Limited	Biomarker	[1120]
TPR	OTUBBA4W	Limited	Biomarker	[1121]
TRAF3	OT5TQBGV	Limited	Biomarker	[1122]
TRIM14	OTLQKUG0	Limited	Biomarker	[1123]
TRIM23	OTVIGJ4T	Limited	Altered Expression	[1124]
TRIM29	OT2DNESG	Limited	Altered Expression	[1125]
ADAMTS15	OTYB6JS3	Disputed	Biomarker	[1126]
BAZ1B	OTD5KR2J	Disputed	Biomarker	[1127]
CCDC66	OTE8VSSO	Disputed	Biomarker	[1128]
DCAF6	OT3EYK1J	Disputed	Biomarker	[1129]
DCP1A	OT3NCON3	Disputed	Biomarker	[1130]
EGFL8	OTECTJ7K	Disputed	Altered Expression	[1131]
ELK1	OTH9MXD6	Disputed	Altered Expression	[1132]
FH	OTEQWU6Q	Disputed	Biomarker	[1133]
GAGE7	OTF8BTR9	Disputed	Biomarker	[1134]
ILF3	OTKMZ5K5	Disputed	Biomarker	[1135]
LBX2	OTGWRSI2	Disputed	Biomarker	[1136]
LRFN4	OT7RWBKE	Disputed	Altered Expression	[1137]
LRRN1	OT6MMO6L	Disputed	Biomarker	[1138]
NEDD4L	OT1B19RU	Disputed	Altered Expression	[1139]
NOP16	OT2829ZC	Disputed	Altered Expression	[1140]
NPTX1	OTKVHCV0	Disputed	Biomarker	[1141]
PALB2	OT6DNDBG	Disputed	Genetic Variation	[1142]
PIK3AP1	OTMW1B47	Disputed	Biomarker	[1143]
PLAAT1	OTM3M6P4	Disputed	Biomarker	[1144]
PRSS3	OTN3S5YB	Disputed	Biomarker	[1145]
PSMD2	OT6HZHN7	Disputed	Altered Expression	[1146]
STIL	OT9799VN	Disputed	Altered Expression	[1147]
TCF7	OT1ID822	Disputed	Altered Expression	[1148]
TLE1	OT50MRZ1	Disputed	Biomarker	[1149]
A4GNT	OT8GOL3T	moderate	Altered Expression	[1150]
ACACA	OT5CQPZY	moderate	Genetic Variation	[1151]
ACTR3	OT05LJSH	moderate	Biomarker	[1152]
ACYP2	OTRB4S6X	moderate	Genetic Variation	[1153]
ADAM29	OTGLTTKU	moderate	Altered Expression	[1154]
ADAMTS18	OTRMFI04	moderate	Posttranslational Modification	[1155]
AKAP1	OTIIB2JB	moderate	Altered Expression	[1156]
APIP	OT8ZABOU	moderate	Biomarker	[1157]
APOBEC3A	OTYO6F5P	moderate	Biomarker	[1152]
ARPIN	OTNNYP9A	moderate	Altered Expression	[1152]
ASCL2	OT3D62WB	moderate	Biomarker	[1158]
ATG16L1	OTEOYC5D	moderate	Biomarker	[1159]
ATG4A	OTDHXAPG	moderate	Biomarker	[1160]
ATP4B	OTIP2EYJ	moderate	Biomarker	[1161]
BAG1	OTRQNIA4	moderate	Biomarker	[1162]
BAG4	OTUPX3M2	moderate	Biomarker	[1163]
BAMBI	OTCEJ8W5	moderate	Altered Expression	[1164]
BCL2L11	OTNQQWFJ	moderate	Biomarker	[1165]
BCL6B	OT1T5KM6	moderate	Altered Expression	[1166]
BCL9	OTRBIPR4	moderate	Altered Expression	[1167]
BHLHA15	OTY7IER8	moderate	Altered Expression	[1168]
BMP8B	OTJC3AB9	moderate	Altered Expression	[1164]
BMS1	OTEGQ8ZO	moderate	Genetic Variation	[1151]
BTC	OTW4B2O0	moderate	Biomarker	[1169]
BTF3	OT5ZZFJL	moderate	Altered Expression	[1170]
BTN3A2	OT3DIBU3	moderate	Biomarker	[1171]
CAB39L	OTQEBL0W	moderate	Biomarker	[1172]
CALD1	OTNJKJ6Q	moderate	Biomarker	[1173]
CARD16	OT4NUHWB	moderate	Biomarker	[1174]
CAST	OTBXZZGF	moderate	Biomarker	[218]
CBX4	OT4XVRRF	moderate	Genetic Variation	[1175]
CCAR1	OTUXLQZZ	moderate	Biomarker	[1176]
CCN5	OTADU8JJ	moderate	Biomarker	[1177]
CCNB2	OTIEXTDK	moderate	Biomarker	[1178]
CD1D	OT3ROU4J	moderate	Biomarker	[1179]
CD226	OT4UG0KB	moderate	Biomarker	[1180]
CD247	OT45FGUX	moderate	Biomarker	[1181]
CDC42	OT5QBC5M	moderate	Biomarker	[879]
CDX2	OTCG4TSY	moderate	Biomarker	[1182]
CHAF1A	OTXSSY4H	moderate	Biomarker	[1183]
CHRDL1	OTGMWVVA	moderate	Altered Expression	[1184]
CISD2	OTVS7S2H	moderate	Altered Expression	[1185]
CLEC3B	OTFD29NF	moderate	Altered Expression	[1186]
CLIP4	OT75KVQK	moderate	Genetic Variation	[113]
COG2	OTKQH4N4	moderate	Biomarker	[1187]
COL5A2	OT5VOSQE	moderate	Biomarker	[1188]
COX5A	OTP0961M	moderate	Biomarker	[32]
COX8A	OTU0NR39	moderate	Biomarker	[32]
CPOX	OTIAY121	moderate	Biomarker	[32]
CREBRF	OT2GK1HI	moderate	Biomarker	[1189]
CST4	OTXXM8EH	moderate	Biomarker	[1190]
CTAG1B	OTIQGW6U	moderate	Biomarker	[232]
CTBP2	OTGZGT87	moderate	Altered Expression	[1191]
CXCL17	OTRCEVIZ	moderate	Biomarker	[1192]
DAB2IP	OTF456VC	moderate	Biomarker	[1193]
DAXX	OTX6O7PL	moderate	Biomarker	[1194]
DEDD	OTIL349E	moderate	Altered Expression	[1195]
DIRAS3	OT3XHLQA	moderate	Altered Expression	[1196]
DLC1	OTP8LMCR	moderate	Therapeutic	[1197]
DOK2	OTIJ38UF	moderate	Altered Expression	[1198]
DOK6	OTX55OIF	moderate	Biomarker	[1199]
DUSP6	OT4H6RKW	moderate	Biomarker	[1200]
E2F5	OT1XWING	moderate	Biomarker	[1201]
ECD	OT3L3PCU	moderate	Biomarker	[1202]
EFEMP1	OTZVUOOB	moderate	Biomarker	[970]
EHF	OTY6TPWD	moderate	Biomarker	[1203]
EIF3D	OTDOMP80	moderate	Altered Expression	[1204]
EIF3H	OT61RBF5	moderate	Biomarker	[1205]
EIF6	OTEXMUED	moderate	Genetic Variation	[1206]
ENOSF1	OT65D3ZK	moderate	Genetic Variation	[1207]
ERCC6	OT2QZKSF	moderate	Altered Expression	[1208]
ERCC8	OT0T4WKI	moderate	Genetic Variation	[1209]
ERO1A	OTVKOQWM	moderate	Altered Expression	[1210]
ERP29	OTNKANMH	moderate	Biomarker	[1211]
FADD	OTV7GFHH	moderate	Biomarker	[329]
FBXL7	OTNUK1DJ	moderate	Biomarker	[1212]
FBXO32	OTUE978R	moderate	Biomarker	[1213]
FGL1	OTT0QHQ1	moderate	Altered Expression	[1214]
FKTN	OTQ9GCXL	moderate	Biomarker	[1215]
FLNC	OT3F8J6Y	moderate	Biomarker	[1216]
FOXA2	OTJOCVOY	moderate	Biomarker	[1217]
FOXF1	OT2CJZ5K	moderate	Genetic Variation	[1218]
FOXI1	OT2UFOE2	moderate	Altered Expression	[1219]
FOXJ1	OT7LLBZ7	moderate	Altered Expression	[1220]
FSD1	OT8P6PT3	moderate	Altered Expression	[1221]
FSD1L	OTBQ48RF	moderate	Altered Expression	[1221]
FSTL1	OT6KEZUD	moderate	Biomarker	[353]
FUBP1	OT77SC9N	moderate	Biomarker	[1222]
FZR1	OT0WGWZS	moderate	Altered Expression	[1223]
GALNT5	OTCV61V1	moderate	Biomarker	[1224]
GEMIN2	OT4L6TLL	moderate	Biomarker	[133]
GFPT1	OTQBDO45	moderate	Biomarker	[1225]
GGTLC1	OTWJKUHQ	moderate	Biomarker	[253]
GPR155	OT2ZCDS7	moderate	Altered Expression	[1226]
GPR42	OTEB0ROY	moderate	Biomarker	[68]
GPX3	OT6PK94R	moderate	Posttranslational Modification	[1227]
GRAMD1B	OTCG1GX2	moderate	Altered Expression	[1228]
GSDMD	OTH39BKI	moderate	Biomarker	[1229]
GSDME	OT1ZWY32	moderate	Biomarker	[1230]
GSPT1	OT18H1B0	moderate	Biomarker	[1231]
GSTM2	OTG4WT05	moderate	Genetic Variation	[1232]
HCST	OTILCB4K	moderate	Biomarker	[1181]
HMGB3	OTCJ2EZY	moderate	Biomarker	[527]
HNRNPK	OTNPRM8U	moderate	Biomarker	[1233]
HOXA10	OTB6GQ09	moderate	Biomarker	[1234]
IFITM2	OTAT6TI6	moderate	Biomarker	[1235]
IGF2BP2	OT4ZSEEE	moderate	Altered Expression	[1236]
IGF2BP3	OTB97VIK	moderate	Altered Expression	[1236]
IL17B	OTS86H50	moderate	Biomarker	[1237]
ILF2	OTWWVM9X	moderate	Biomarker	[1238]
ILKAP	OT2A6FSA	moderate	Biomarker	[1239]
INSYN2B	OTJGTKK4	moderate	Biomarker	[1240]
IRX1	OT0ZN9EJ	moderate	Biomarker	[1241]
ITGBL1	OTJDHE17	moderate	Biomarker	[1242]
KCND2	OTIFUVV7	moderate	Altered Expression	[269]
KIFC1	OTNQDS00	moderate	Biomarker	[1243]
KLF12	OTVH4KD4	moderate	Biomarker	[1244]
KLF15	OTGMQMVR	moderate	Altered Expression	[1245]
KLF7	OTS3YVA0	moderate	Altered Expression	[1246]
KMT2B	OTMMAZQX	moderate	Biomarker	[1247]
KMT2D	OTTVHCLY	moderate	Biomarker	[1247]
KRT23	OTQW6UAG	moderate	Biomarker	[970]
LAMA4	OTHI7TA0	moderate	Biomarker	[1248]
LIN28B	OTVWP0FN	moderate	Biomarker	[290]
LMO1	OTB59SKB	moderate	Biomarker	[1249]
LOXL1	OTA0NEJU	moderate	Biomarker	[1250]
LOXL4	OT6XY2JL	moderate	Altered Expression	[1250]
LUM	OTSRC874	moderate	Altered Expression	[1251]
LYPD5	OTGP7UKA	moderate	Biomarker	[1252]
MAEL	OTZ2VU30	moderate	Biomarker	[1239]
MASTL	OTQ7YKK5	moderate	Altered Expression	[1253]
MCAT	OTH07FIW	moderate	Altered Expression	[229]
MCC	OTQVI1EM	moderate	Genetic Variation	[1254]
MCTS1	OT7SAOJP	moderate	Altered Expression	[229]
MED30	OTM3INJN	moderate	Biomarker	[1255]
MFN2	OTPYN8A3	moderate	Altered Expression	[1256]
MMP24	OTF8T3JM	moderate	Biomarker	[1257]
MMP28	OTHQZXM1	moderate	Altered Expression	[121]
MRAS	OTNCVCQW	moderate	Genetic Variation	[1258]
MRPL28	OT4LUTZU	moderate	Biomarker	[1259]
MRPL58	OTPTWLZY	moderate	Altered Expression	[1260]
MSC	OTBRPZL5	moderate	Biomarker	[604]
MT1F	OTZVUYG1	moderate	Altered Expression	[1261]
MTBP	OTWLCW9C	moderate	Altered Expression	[1262]
MTSS1	OT5DTDO2	moderate	Altered Expression	[1263]
MUC3A	OTI4XUDY	moderate	Altered Expression	[1264]
MUC6	OTPVL723	moderate	Biomarker	[1265]
MXI1	OTUQ9E0D	moderate	Altered Expression	[405]
MYH9	OT94Z706	moderate	Biomarker	[1266]
NASP	OTNE4THC	moderate	Biomarker	[1267]
NDUFB6	OTIXNT91	moderate	Altered Expression	[1268]
NET1	OTZHNMJV	moderate	Altered Expression	[1269]
NETO2	OT0YAMC0	moderate	Altered Expression	[1270]
NKX3-2	OTH4NRH7	moderate	Biomarker	[1271]
NOC3L	OTYOR3PV	moderate	Genetic Variation	[1272]
NOVA1	OT6A9KHY	moderate	Biomarker	[1273]
NOX1	OTZPJQCC	moderate	Biomarker	[1274]
NXT1	OT0VO6AY	moderate	Biomarker	[1259]
OSBPL8	OTD50E5Y	moderate	Altered Expression	[1275]
OTUB1	OT8WWM9O	moderate	Altered Expression	[1276]
OTX1	OTRGSGH9	moderate	Biomarker	[1277]
P4HB	OTTYNYPF	moderate	Altered Expression	[1278]
PAK5	OT32WQGL	moderate	Biomarker	[1279]
PARD3	OTH5BPLO	moderate	Altered Expression	[244]
PAX3	OTN5PJZV	moderate	Altered Expression	[1280]
PCBP1	OTHN0TD7	moderate	Biomarker	[1281]
PDCD5	OT6T2DDL	moderate	Biomarker	[1282]
PEBP4	OTKDCVC6	moderate	Biomarker	[1283]
PER2	OTU2B1DJ	moderate	Biomarker	[1284]
PIWIL3	OTQ1B8R4	moderate	Altered Expression	[1285]
PLEKHO1	OTMVUQ9W	moderate	Altered Expression	[1286]
PLXNA1	OTN0BING	moderate	Biomarker	[1287]
PODXL	OTPNQXF3	moderate	Biomarker	[1288]
POU2F2	OTPV0J0C	moderate	Biomarker	[1289]
POU5F1	OTDHHN7O	moderate	Biomarker	[548]
PPM1E	OTXRH3YA	moderate	Altered Expression	[1290]
PPP1R13L	OTNCPLWE	moderate	Altered Expression	[1291]
PPP1R1A	OTGTAGCV	moderate	Biomarker	[1292]
PPP2R5E	OT8GPFT5	moderate	Biomarker	[1293]
PRC1	OTHD0XS0	moderate	Altered Expression	[1294]
PRR11	OT2JJ08Z	moderate	Biomarker	[1295]
PRR13	OTXPP37T	moderate	Altered Expression	[1296]
PTBP3	OTVVYKIF	moderate	Biomarker	[1297]
PTPA	OTRGFOI7	moderate	Altered Expression	[226]
PVR	OT3N91T7	moderate	Biomarker	[1298]
RAB11FIP2	OTTX9RWE	moderate	Biomarker	[1299]
RAB12	OTM84KTU	moderate	Altered Expression	[1156]
RAB23	OTBAKFBR	moderate	Biomarker	[1300]
RAB32	OTTR4H7S	moderate	Posttranslational Modification	[1301]
RAB3IP	OT3UPQAA	moderate	Altered Expression	[1302]
RANBP9	OTM8COM5	moderate	Biomarker	[1303]
RARRES1	OTETUPP5	moderate	Biomarker	[1304]
RASSF6	OT25GVWY	moderate	Biomarker	[1305]
RBMS3	OTFSC9MR	moderate	Biomarker	[1306]
RGS3	OTYG5OXI	moderate	Biomarker	[1307]
RMC1	OT7K8MTJ	moderate	Altered Expression	[1308]
ROBO2	OTFJ9FQW	moderate	Biomarker	[1309]
RPRD1B	OTB41D5K	moderate	Biomarker	[1310]
RPS20	OTI8052R	moderate	Altered Expression	[1311]
S100A14	OTVFJJ91	moderate	Biomarker	[1312]
SASH1	OTQA8BD4	moderate	Biomarker	[1313]
SAT2	OT28QL7H	moderate	Biomarker	[1314]
SCIN	OT6U09OL	moderate	Biomarker	[1315]
SCYL1	OTQ0IN7P	moderate	Biomarker	[1316]
SEM1	OTASLBM1	moderate	Genetic Variation	[1317]
SEMA6A	OTDQ7QAW	moderate	Posttranslational Modification	[553]
SFRP1	OT0U9G41	moderate	Altered Expression	[1318]
SGPP2	OTIDIJCR	moderate	Altered Expression	[1319]
SGTA	OTKOJ3JB	moderate	Biomarker	[320]
SHBG	OTPWU5IW	moderate	Biomarker	[1320]
SIAH1	OT29A838	moderate	Biomarker	[464]
SIAH2	OTKED2XN	moderate	Biomarker	[1216]
SIPA1	OTXY5RXC	moderate	Altered Expression	[1321]
SIX1	OT70YYWM	moderate	Altered Expression	[1322]
SLFN5	OTT1AESL	moderate	Genetic Variation	[1323]
SLPI	OTUNFUU8	moderate	Biomarker	[1324]
SMAD4	OTWQWCKG	moderate	Genetic Variation	[1325]
SMIM10L2B	OT04IG2N	moderate	Posttranslational Modification	[1326]
SNAI2	OT7Y8EJ2	moderate	Biomarker	[858]
SNRPA	OT02TSQT	moderate	Altered Expression	[1327]
SOAT1	OTB4Y5RJ	moderate	Biomarker	[1328]
SOX4	OTSS40SS	moderate	Altered Expression	[1329]
SPINT1	OT1CLR5L	moderate	Biomarker	[1330]
SPOCD1	OTF4K46N	moderate	Genetic Variation	[1171]
SPOP	OTP0107S	moderate	Biomarker	[1331]
SPRY2	OTH0CRCZ	moderate	Biomarker	[1332]
ST6GAL1	OT7US3NO	moderate	Biomarker	[1333]
STIP1	OT7TXLOX	moderate	Biomarker	[1334]
SUB1	OTK71JYU	moderate	Biomarker	[1259]
SUFU	OT0IRYG1	moderate	Altered Expression	[1335]
SUMO1	OTJFD4P5	moderate	Posttranslational Modification	[1336]
SUZ12	OT655XF8	moderate	Altered Expression	[1337]
SYTL2	OTUIOWKL	moderate	Biomarker	[319]
TCEA1	OTBFO594	moderate	Biomarker	[1338]
TEAD1	OTK6971C	moderate	Altered Expression	[1339]
TES	OTL8PP6V	moderate	Biomarker	[1340]
TFAP4	OT1KQIUX	moderate	Altered Expression	[1341]
TFIP11	OT7NVSWU	moderate	Biomarker	[294]
THBS2	OTXET551	moderate	Biomarker	[1161]
THY1	OTVONVTB	moderate	Altered Expression	[1342]
TIMM9	OTK7PDNN	moderate	Altered Expression	[1343]
TLR10	OTQ1KVJO	moderate	Genetic Variation	[1344]
TMEM220	OTGTRDNX	moderate	Biomarker	[265]
TNFAIP8	OT1G9297	moderate	Biomarker	[1345]
TNFRSF6B	OTKAN9G7	moderate	Biomarker	[1346]
TOB1	OTNW949D	moderate	Altered Expression	[954]
TP53AIP1	OT1XVNDP	moderate	Altered Expression	[1347]
TP53BP2	OTOWJ2Y4	moderate	Biomarker	[244]
TPI1	OT14KP4B	moderate	Altered Expression	[1348]
TRAF2	OT1MEZZN	moderate	Altered Expression	[1349]
TRAT1	OTMPUNPD	moderate	Biomarker	[1350]
TRIM3	OT704FQ0	moderate	Biomarker	[1351]
TRIM32	OTJOV0PG	moderate	Biomarker	[1352]
TROAP	OTC8CE0R	moderate	Altered Expression	[1353]
TSPAN8	OT1F68WQ	moderate	Altered Expression	[1354]
ABI1	OT5H4M62	Strong	Altered Expression	[1355]
ABT1	OT9YGIDB	Strong	Biomarker	[418]
ACAD8	OT3JI5GB	Strong	Biomarker	[418]
ACE	OTDF1964	Strong	Genetic Variation	[1356]
ACP1	OTJ9CKLU	Strong	Genetic Variation	[1357]
ACSL4	OTI71MUJ	Strong	Altered Expression	[1358]
ACSS3	OTWB58F5	Strong	Altered Expression	[845]
ACTC1	OTJU04B1	Strong	Biomarker	[361]
ACTR2	OT3C8U5T	Strong	Biomarker	[1152]
ADAM12	OTZKOTDB	Strong	Biomarker	[1359]
ADAM23	OTVWT6JZ	Strong	Altered Expression	[1360]
ADAMTS8	OT2KFY1S	Strong	Posttranslational Modification	[1361]
ADAMTS9	OTV3Q0DS	Strong	Biomarker	[1362]
ADAR	OTQNOHR8	Strong	Biomarker	[1363]
ADARB1	OTGKSZEV	Strong	Biomarker	[1364]
ADD1	OTTF68DC	Strong	Genetic Variation	[1365]
ADGRB1	OTJSEXRC	Strong	Biomarker	[1366]
ADGRL2	OTCXD2YR	Strong	Altered Expression	[1367]
ADIPOR1	OT65ZFZN	Strong	Genetic Variation	[1368]
ADRM1	OTOU4EY6	Strong	Biomarker	[1369]
AFAP1	OTR473H8	Strong	Altered Expression	[1370]
AFAP1L2	OTJBI0VN	Strong	Biomarker	[1371]
AGA	OTNWT1WB	Strong	Biomarker	[412]
AGFG1	OTI8ZKC4	Strong	Biomarker	[1372]
AGGF1	OTA7U2T8	Strong	Altered Expression	[1373]
AGO2	OT4JY32Q	Strong	Biomarker	[533]
AIMP1	OTTA5C3U	Strong	Biomarker	[1374]
AKIP1	OT7XPG27	Strong	Altered Expression	[1375]
ALDH7A1	OTV57BZD	Strong	Biomarker	[418]
ALDOB	OT7FR69A	Strong	Biomarker	[361]
ALKBH1	OTADGU5D	Strong	Altered Expression	[488]
ALPP	OTZU4G9W	Strong	Biomarker	[1376]
ANAPC1	OT2YY35L	Strong	Posttranslational Modification	[1377]
ANGPTL2	OTB6JG41	Strong	Biomarker	[1152]
ANGPTL6	OTOQ5W67	Strong	Biomarker	[1378]
ANKRD36B	OT3MW415	Strong	Altered Expression	[814]
ANKRD9	OT7VGO6G	Strong	Genetic Variation	[1379]
ANLN	OTXJY54C	Strong	Biomarker	[1380]
ANP32B	OT3SQMLU	Strong	Altered Expression	[775]
ANXA3	OTDD8OI7	Strong	Altered Expression	[1381]
ANXA7	OTLMD0TK	Strong	Biomarker	[1382]
APAF1	OTJWIVY0	Strong	Altered Expression	[1383]
APBA2	OTXD8ID1	Strong	Biomarker	[1384]
APOBEC3B	OTHLNI51	Strong	Biomarker	[1385]
AQP12A	OTVEHDZ1	Strong	Altered Expression	[1386]
ARFGAP2	OTIP5ZJ7	Strong	Biomarker	[418]
ARHGAP26	OTNGQU7A	Strong	Altered Expression	[1387]
ARHGDIB	OT9PD6CS	Strong	Biomarker	[1388]
ARID2	OTIRJXWM	Strong	Biomarker	[1389]
ARNT2	OTAQD3YV	Strong	Altered Expression	[1390]
ARPC1B	OTYE3DN2	Strong	Altered Expression	[1391]
ARPC2	OTSOKOMY	Strong	Biomarker	[1392]
ARSF	OTC0L12N	Strong	Biomarker	[1393]
ASPG	OT5E2EKR	Strong	Biomarker	[1394]
ASPN	OTYJM80N	Strong	Altered Expression	[1146]
ATAD1	OTJ02XFL	Strong	Genetic Variation	[1395]
ATG5	OT4T5SMS	Strong	Biomarker	[1396]
ATOH1	OTBZYG2R	Strong	Biomarker	[1397]
ATP6V0D2	OTMOZJO0	Strong	Biomarker	[1398]
ATXN1	OTQF0HNR	Strong	Biomarker	[1399]
ATXN2L	OTP5M3R9	Strong	Biomarker	[1400]
AXIN1	OTRGZGZ5	Strong	Biomarker	[1401]
BARX2	OT0R3QD3	Strong	Biomarker	[1402]
BCAP31	OTKSACR4	Strong	Biomarker	[1403]
BCL2L10	OTYXQJ3I	Strong	Posttranslational Modification	[1404]
BCL2L12	OTS6IFZY	Strong	Biomarker	[1405]
BHLHE40	OTITX14U	Strong	Altered Expression	[1406]
BID	OTOSHSHU	Strong	Biomarker	[1407]
BLVRB	OTHCFN2C	Strong	Biomarker	[361]
BMP3	OTCTI0UW	Strong	Biomarker	[1408]
BNIP3	OT4SO7J4	Strong	Biomarker	[44]
BOP1	OTMZMQDO	Strong	Biomarker	[418]
BRCA1	OT5BN6VH	Strong	Biomarker	[1409]
BRINP1	OTEUVSCP	Strong	Altered Expression	[1093]
BRINP3	OT4VFHWN	Strong	Biomarker	[414]
BTG3	OT9ANHVT	Strong	Altered Expression	[1410]
BTG4	OTT3TKPI	Strong	Biomarker	[1411]
BTRC	OT2EZDGR	Strong	Genetic Variation	[1412]
BUB1B	OT8KME51	Strong	Biomarker	[1413]
C1orf56	OT0UYJMF	Strong	Biomarker	[1414]
CAB39	OT2CL9ST	Strong	Altered Expression	[886]
CACUL1	OT6P1ZVP	Strong	Altered Expression	[1415]
CACYBP	OTJMZD2T	Strong	Biomarker	[1416]
CADM1	OTRWG9QS	Strong	Biomarker	[1417]
CALN1	OTN2XE4T	Strong	Altered Expression	[1418]
CAMKMT	OTLJBRUW	Strong	Genetic Variation	[1419]
CANX	OTYP1F6J	Strong	Biomarker	[1420]
CAPG	OTJ86KI6	Strong	Altered Expression	[1421]
CARD10	OT2RPM4I	Strong	Biomarker	[1422]
CAVIN3	OTOLBK79	Strong	Posttranslational Modification	[1423]
CBFB	OTIAC6W4	Strong	Biomarker	[1424]
CBLL2	OTB4AD3V	Strong	Biomarker	[244]
CCDC134	OT70OQQV	Strong	Altered Expression	[1425]
CCDC136	OTPOV391	Strong	Biomarker	[1426]
CCL18	OT7JYSK9	Strong	Altered Expression	[1427]
CCN3	OTOW5YL4	Strong	Altered Expression	[1428]
CCNG1	OT17IA9L	Strong	Biomarker	[1429]
CCNH	OTKDU3SR	Strong	Biomarker	[1430]
CCNJ	OTCR4WVV	Strong	Biomarker	[1431]
CCNO	OT68CH0B	Strong	Biomarker	[1432]
CCT7	OTQNM3CY	Strong	Biomarker	[418]
CD151	OTF3UZS7	Strong	Altered Expression	[1433]
CD177	OTS79FNF	Strong	Biomarker	[1434]
CD81	OTQFXNAZ	Strong	Biomarker	[1435]
CD8A	OTDWQJXK	Strong	Biomarker	[380]
CD8B	OTMZ1T7J	Strong	Biomarker	[1430]
CD99	OTPUZ5DE	Strong	Biomarker	[1436]
CDCA5	OTZLCQ5U	Strong	Altered Expression	[1437]
CDH13	OTD2CYM5	Strong	Posttranslational Modification	[1438]
CDH4	OT8LH3HN	Strong	Posttranslational Modification	[1439]
CDK10	OTKP7TTR	Strong	Altered Expression	[1440]
CDK14	OT385ZH1	Strong	Altered Expression	[618]
CDK15	OT8S67QS	Strong	Altered Expression	[618]
CDK16	OTUBXIIT	Strong	Altered Expression	[618]
CDKN2B	OTAG24N1	Strong	Biomarker	[1259]
CEACAM7	OTKFDTZY	Strong	Biomarker	[410]
CELF1	OT6JQ5RS	Strong	Biomarker	[1441]
CEMIP	OTK80FYN	Strong	Biomarker	[703]
CENPF	OT7AG0SW	Strong	Altered Expression	[395]
CENPH	OTPOO9LK	Strong	Altered Expression	[1442]
CENPO	OTXAH83Y	Strong	Biomarker	[1443]
CENPX	OTG1RAKJ	Strong	Altered Expression	[1444]
CEP55	OTGSG2PA	Strong	Biomarker	[1445]
CETN1	OTGQ8JOZ	Strong	Genetic Variation	[1446]
CHD1	OT9R9G0H	Strong	Genetic Variation	[1447]
CHD5	OTS5EVHH	Strong	Biomarker	[1448]
CHD8	OTS7A6AF	Strong	Altered Expression	[1449]
CHFR	OTRAD2TT	Strong	Posttranslational Modification	[1450]
CHRNA3	OTCZQY1U	Strong	Posttranslational Modification	[1451]
CIAPIN1	OTWS90F9	Strong	Biomarker	[1452]
CILK1	OTWOYEYP	Strong	Altered Expression	[618]
CIP2A	OTVS2GXA	Strong	Altered Expression	[1453]
CISH	OT8T5NYL	Strong	Biomarker	[1454]
CKAP2	OTCLTC0J	Strong	Altered Expression	[1455]
CKS2	OTPTMHIV	Strong	Altered Expression	[1456]
CLDN1	OT27KV99	Strong	Biomarker	[1457]
CLDN11	OTNN6UTL	Strong	Altered Expression	[1458]
CLDN2	OTRF3D6Y	Strong	Biomarker	[1459]
CLDN3	OT71MN9S	Strong	Altered Expression	[1460]
CLEC4M	OT2WUIIP	Strong	Biomarker	[575]
CLIC4	OT6KTPKD	Strong	Biomarker	[1461]
CLOCK	OTNEOJY7	Strong	Genetic Variation	[1462]
CLSPN	OTZZXNDK	Strong	Biomarker	[1463]
CMPK2	OTOG90R0	Strong	Biomarker	[850]
CMTM3	OTS75IGC	Strong	Biomarker	[1464]
CMTM6	OT70T27A	Strong	Altered Expression	[1465]
CNDP2	OTJR9436	Strong	Biomarker	[1466]
CNMD	OTHND8EL	Strong	Biomarker	[1467]
CNN2	OTH3CSXA	Strong	Biomarker	[1468]
CNN3	OTJTAXAP	Strong	Biomarker	[1469]
CNPY2	OTGY8ESX	Strong	Biomarker	[418]
COG8	OTDEA7YO	Strong	Altered Expression	[1470]
COL4A2	OTJK1LKN	Strong	Biomarker	[925]
COL5A1	OT24078H	Strong	Biomarker	[1471]
COP1	OT6J2K12	Strong	Altered Expression	[1472]
COPA	OTZ1DTXU	Strong	Biomarker	[1473]
COPB2	OT82JIGC	Strong	Biomarker	[1474]
CORO1A	OTVAZOHC	Strong	Biomarker	[409]
COX1	OTG3O9BN	Strong	Genetic Variation	[1475]
COX2	OTTMVBJJ	Strong	Biomarker	[284]
CPEB1	OTLCXC6H	Strong	Biomarker	[1476]
CPSF1	OTAU1KOM	Strong	Biomarker	[418]
CPT1A	OTI862QH	Strong	Biomarker	[1088]
CREBZF	OTO3TOEU	Strong	Biomarker	[1477]
CRISP2	OT8HLTV5	Strong	Biomarker	[1099]
CRISP3	OTBSWMPL	Strong	Genetic Variation	[1478]
CSRP2	OT4SW0HI	Strong	Altered Expression	[1479]
CST6	OTZVHJTF	Strong	Biomarker	[1480]
CSTB	OT3U0JF8	Strong	Biomarker	[1481]
CT83	OTQEGHAB	Strong	Biomarker	[1482]
CTHRC1	OTV88X2G	Strong	Altered Expression	[1483]
CTNNA1	OTFC725Z	Strong	Genetic Variation	[1484]
CTNNA2	OTJ8G92T	Strong	Biomarker	[1265]
CTNNBL1	OT6KLHPA	Strong	Biomarker	[1485]
CTNND1	OTUMPSHR	Strong	Biomarker	[1486]
CTR9	OTP151PZ	Strong	Altered Expression	[1487]
CTTN	OTJRG4ES	Strong	Altered Expression	[1488]
CUL4B	OT2QX4DO	Strong	Biomarker	[1489]
CXCL14	OTM189TA	Strong	Altered Expression	[1490]
CYLD	OT37FKH0	Strong	Altered Expression	[1491]
CYP2W1	OTXSB1AE	Strong	Biomarker	[1492]
CYRIB	OTLRN4L1	Strong	Altered Expression	[1493]
CYTB	OTAHB98A	Strong	Biomarker	[1494]
DAB2	OTRMQTMZ	Strong	Biomarker	[1471]
DACH1	OTMKNAGG	Strong	Altered Expression	[1495]
DACT1	OT19Z704	Strong	Biomarker	[905]
DAP	OT5YLL7E	Strong	Genetic Variation	[1496]
DAP3	OTNPEZYM	Strong	Biomarker	[1497]
DAPK2	OTWODUQG	Strong	Biomarker	[198]
DCAF15	OTWBXZ0E	Strong	Biomarker	[1498]
DCLRE1C	OTW3KB1I	Strong	Biomarker	[1499]
DCTN4	OTM7C943	Strong	Altered Expression	[1500]
DDB1	OTTR2L3Z	Strong	Biomarker	[418]
DDB2	OTO8HVVB	Strong	Genetic Variation	[131]
DDX27	OT64NCZ6	Strong	Altered Expression	[1501]
DDX53	OTHK3EGZ	Strong	Biomarker	[1502]
DDX6	OTKWXVDY	Strong	Altered Expression	[1503]
DENND2D	OTXEFJWM	Strong	Altered Expression	[1504]
DES	OTI09KBW	Strong	Biomarker	[361]
DESI1	OTFNIW98	Strong	Altered Expression	[1505]
DESI2	OTHUOKOC	Strong	Altered Expression	[1505]
DEUP1	OTXLM86J	Strong	Genetic Variation	[1506]
DGLUCY	OTZD17IM	Strong	Biomarker	[1507]
DHH	OT3B7721	Strong	Altered Expression	[1508]
DHRS11	OTU3J0ZL	Strong	Genetic Variation	[540]
DHX15	OT4F98TK	Strong	Altered Expression	[1509]
DKK4	OTWCCVF6	Strong	Biomarker	[1492]
DLD	OT378CU9	Strong	Biomarker	[1510]
DLGAP3	OT0GR2F6	Strong	Biomarker	[1511]
DLGAP4	OTNELLIN	Strong	Biomarker	[1511]
DLGAP5	OTWCN39U	Strong	Altered Expression	[1511]
DNAJC12	OTNU59PT	Strong	Biomarker	[1512]
DNAJC2	OT3JDA0R	Strong	Biomarker	[1513]
DOCK1	OTCFV3ON	Strong	Genetic Variation	[1514]
DONSON	OTN5HE0W	Strong	Altered Expression	[1329]
DPAGT1	OTYEJAGZ	Strong	Biomarker	[418]
DSC2	OTODVH8K	Strong	Altered Expression	[1515]
DSG2	OTJPB2TO	Strong	Altered Expression	[1516]
DTD1	OT63V2KK	Strong	Altered Expression	[831]
DUSP4	OT6WAO12	Strong	Altered Expression	[1517]
DYNLL1	OTR69LHT	Strong	Biomarker	[1518]
EBAG9	OTTQLQCP	Strong	Biomarker	[1519]
EBF3	OTB0IWLW	Strong	Biomarker	[1520]
ECT2	OTQDUCT6	Strong	Genetic Variation	[1521]
EEF1A1	OT00THXS	Strong	Biomarker	[361]
EFNA1	OTU2NUA2	Strong	Genetic Variation	[1522]
EFNA2	OTEAUKRX	Strong	Altered Expression	[1523]
EFNB1	OT7JJW8P	Strong	Altered Expression	[1524]
EFS	OT06O7XL	Strong	Biomarker	[1525]
EGR2	OTAVQ78J	Strong	Biomarker	[1526]
EIF4A3	OTYYFE7K	Strong	Altered Expression	[1527]
ELAVL2	OT6EJ8MQ	Strong	Biomarker	[1528]
ELAVL3	OTI2VI8B	Strong	Genetic Variation	[1529]
ELF3	OTUTLEQO	Strong	Biomarker	[1530]
ELK4	OTVSSEOE	Strong	Biomarker	[438]
ELMO3	OTQHO9VM	Strong	Biomarker	[1531]
ELP1	OTYEWBF7	Strong	Altered Expression	[1487]
EMP1	OTSZHUHQ	Strong	Biomarker	[1532]
EMP3	OTODMJ1D	Strong	Biomarker	[1533]
EMX2	OT0V8OYK	Strong	Biomarker	[1534]
ENO1	OTB1KWJS	Strong	Biomarker	[1535]
EPN3	OTNNYDT6	Strong	Altered Expression	[1536]
ERCC3	OTVAW3P1	Strong	Biomarker	[1537]
ERCC4	OTFIOPG1	Strong	Biomarker	[1537]
ERCC5	OTQAKFJM	Strong	Genetic Variation	[1538]
ESCO1	OTZ9P12A	Strong	Altered Expression	[1539]
ESM1	OT331Y8V	Strong	Altered Expression	[1540]
ETHE1	OTP9A2BQ	Strong	Altered Expression	[1541]
ETV4	OT8C98UZ	Strong	Altered Expression	[1542]
EXO1	OTI87RS5	Strong	Genetic Variation	[1543]
EXOSC5	OTADUQ7H	Strong	Biomarker	[418]
EYA1	OTHU807A	Strong	Biomarker	[1544]
FAM168A	OTDXQCS5	Strong	Biomarker	[418]
FAM72A	OTBZYSR3	Strong	Genetic Variation	[386]
FAM72B	OT6AOG64	Strong	Genetic Variation	[386]
FAT4	OT7QONNV	Strong	Altered Expression	[1545]
FAU	OTGTVOWK	Strong	Biomarker	[1471]
FBLN1	OT5MHHOP	Strong	Altered Expression	[1546]
FBP2	OT9R1LF7	Strong	Altered Expression	[1547]
FBXL2	OT5EZ7PD	Strong	Biomarker	[1548]
FBXL5	OT93D50X	Strong	Biomarker	[1549]
FBXO24	OT4XOG70	Strong	Biomarker	[443]
FBXO8	OTZNGJGW	Strong	Altered Expression	[1550]
FEN1	OT6QGG7O	Strong	Biomarker	[1551]
FERMT2	OTZNPWWX	Strong	Altered Expression	[1552]
FEZF1	OTRX4NOT	Strong	Altered Expression	[1370]
FGA	OTMIHY80	Strong	Biomarker	[1553]
FGF13	OTHNNVSG	Strong	Biomarker	[1554]
FGF9	OT2SKDGM	Strong	Biomarker	[1555]
FKBP14	OT55W5WC	Strong	Altered Expression	[1556]
FKBP2	OTHBZHX0	Strong	Biomarker	[418]
FLOT2	OTZ0QR5L	Strong	Biomarker	[1557]
FNDC3B	OTBILGDR	Strong	Altered Expression	[1558]
FOXA1	OTEBY0TD	Strong	Biomarker	[1559]
FOXD3	OTXYV6GO	Strong	Posttranslational Modification	[1560]
FOXO3	OTHXQG4P	Strong	Biomarker	[29]
FOXO4	OT90X9LN	Strong	Biomarker	[1561]
FRAS1	OTLPESF3	Strong	Biomarker	[1562]
FRAT1	OT1PS84E	Strong	Altered Expression	[1563]
FRAT2	OT481GQ4	Strong	Altered Expression	[1563]
FUT1	OTODG57A	Strong	Genetic Variation	[489]
FUT2	OTLXM6WI	Strong	Genetic Variation	[489]
FUT5	OTOPGL9M	Strong	Altered Expression	[489]
FUT6	OTBZUQ7F	Strong	Biomarker	[489]
FZD2	OT952ML1	Strong	Biomarker	[1564]
FZD8	OTZ9IRFL	Strong	Biomarker	[1565]
FZD9	OTTZ9MKK	Strong	Biomarker	[1565]
GAB1	OTQKE6V4	Strong	Biomarker	[1566]
GABARAPL1	OT4U7SBG	Strong	Biomarker	[1567]
GADD45A	OTDRV63V	Strong	Biomarker	[1568]
GADD45G	OT8V1J4M	Strong	Biomarker	[1569]
GAL3ST1	OTSFFZRD	Strong	Altered Expression	[1570]
GALNT1	OTO3RO36	Strong	Biomarker	[1571]
GALNT2	OTZZ5386	Strong	Biomarker	[1572]
GALNT6	OTOQQVH1	Strong	Biomarker	[1573]
GAS1	OTKJXG52	Strong	Biomarker	[1574]
GATA6	OTO2BC0F	Strong	Altered Expression	[231]
GBA3	OT86XWU2	Strong	Biomarker	[1575]
GDE1	OTU6FSBF	Strong	Biomarker	[1576]
GDF1	OTZ1VRBH	Strong	Biomarker	[1577]
GHRH	OT94U6MO	Strong	Biomarker	[1578]
GIPC1	OTXLVCPJ	Strong	Altered Expression	[1579]
GIPC2	OT68YFO1	Strong	Altered Expression	[1580]
GIT1	OTHO92S5	Strong	Biomarker	[62]
GMPR2	OTKZSZPE	Strong	Biomarker	[381]
GNB3	OTA6HYBA	Strong	Genetic Variation	[1581]
GNL1	OTWTVIVM	Strong	Altered Expression	[1311]
GNL3	OTILGYO4	Strong	Biomarker	[1582]
GOLGA2	OT5S9KYM	Strong	Biomarker	[1583]
GOLM1	OTOZSV6O	Strong	Biomarker	[1584]
GOLPH3	OTDLGYM3	Strong	Biomarker	[1585]
GORASP1	OTQS91S7	Strong	Biomarker	[793]
GPC4	OTUJ14DW	Strong	Genetic Variation	[1586]
GPR37	OTIMDDI3	Strong	Biomarker	[1587]
GPRC5A	OTPOCWR7	Strong	Biomarker	[1588]
GPSM1	OTA0SJBG	Strong	Biomarker	[1589]
GRB7	OTF8Y9XY	Strong	Genetic Variation	[689]
GRP	OT8JDFNI	Strong	Altered Expression	[1590]
GSDMA	OT912R2E	Strong	Biomarker	[1591]
GSDMB	OTWA7P10	Strong	Altered Expression	[1592]
GSDMC	OTVM43E3	Strong	Genetic Variation	[1591]
GTF2A1	OTWW4PN0	Strong	Genetic Variation	[1593]
GTF2H1	OTCRXC6B	Strong	Altered Expression	[1500]
GTF2H4	OTPD1DIU	Strong	Altered Expression	[477]
GTSE1	OTPP742Z	Strong	Posttranslational Modification	[1594]
GZMA	OT43R33L	Strong	Genetic Variation	[1595]
H4C1	OTB71W46	Strong	Altered Expression	[1596]
HAND1	OTN4IPVV	Strong	Biomarker	[1597]
HAS1	OTJIAG1W	Strong	Altered Expression	[392]
HELLS	OTVVV668	Strong	Genetic Variation	[829]
HES2	OTMWY2KV	Strong	Altered Expression	[1598]
HHIP	OT77RQYS	Strong	Altered Expression	[1599]
HHLA2	OTYBTVQS	Strong	Altered Expression	[1600]
HIC1	OTI9TWY4	Strong	Altered Expression	[1601]
HLA-DOA	OTZE5Q7R	Strong	Altered Expression	[1602]
HLA-DQA2	OT1DH0N9	Strong	Genetic Variation	[1603]
HLA-F	OT76CM19	Strong	Biomarker	[1604]
HLTF	OTRX2OSF	Strong	Posttranslational Modification	[1605]
HMBOX1	OTPKTBVI	Strong	Altered Expression	[1606]
HMGN5	OTUUAHVQ	Strong	Biomarker	[1607]
HNRNPC	OT47AK4C	Strong	Biomarker	[395]
HNRNPD	OT5UO1FA	Strong	Biomarker	[1430]
HNRNPDL	OTB3BFCV	Strong	Biomarker	[395]
HNRNPL	OT0DJX74	Strong	Biomarker	[418]
HNRNPR	OT3FITK2	Strong	Biomarker	[395]
HOPX	OTBSR6C9	Strong	Altered Expression	[1608]
HORMAD1	OT7DR5T2	Strong	Altered Expression	[1492]
HOXA1	OTMSOJ7D	Strong	Biomarker	[1609]
HOXA2	OT6G6ZIK	Strong	Biomarker	[570]
HOXB5	OTU74TB8	Strong	Biomarker	[1610]
HOXB7	OTC7WYU8	Strong	Biomarker	[1611]
HOXB9	OTMVHQOU	Strong	Altered Expression	[1612]
HOXC10	OT5WF17M	Strong	Altered Expression	[1613]
HOXC6	OTBCRAZV	Strong	Biomarker	[1614]
HOXD10	OT0NOWU2	Strong	Biomarker	[1615]
HSPA12A	OTFOCDD6	Strong	Genetic Variation	[1616]
HSPA13	OTYXMC4G	Strong	Genetic Variation	[1617]
HSPA2	OTSDET7B	Strong	Genetic Variation	[1618]
HSPA4	OT5HR0AR	Strong	Biomarker	[1619]
HSPH1	OTVRR73T	Strong	Genetic Variation	[1620]
HTN3	OTEUXA81	Strong	Biomarker	[862]
ICAM2	OT3E070F	Strong	Biomarker	[44]
IDH3B	OTR89YF5	Strong	Biomarker	[418]
IFIT2	OTI4EOAR	Strong	Altered Expression	[1621]
IFITM1	OTECO1G8	Strong	Altered Expression	[1622]
IFRD1	OT4SQMLQ	Strong	Genetic Variation	[1623]
IGSF11	OTQEG2X1	Strong	Biomarker	[1624]
IHH	OT1DWGXC	Strong	Altered Expression	[1625]
IKBKE	OT5VYOSM	Strong	Biomarker	[793]
IL12RB1	OTM1IJO2	Strong	Genetic Variation	[559]
IL17RA	OTVVI8ER	Strong	Altered Expression	[1626]
IL17RB	OT0KDNSF	Strong	Biomarker	[1627]
IL36RN	OT5CO95A	Strong	Biomarker	[1628]
IMPACT	OTQ923OB	Strong	Biomarker	[1629]
INCENP	OT9HFRYK	Strong	Altered Expression	[1630]
ING4	OT0VVG4V	Strong	Biomarker	[1631]
INPPL1	OTCDAVBQ	Strong	Altered Expression	[1632]
INSIG1	OTZF5X1D	Strong	Altered Expression	[1391]
INSL3	OT7KUNTE	Strong	Genetic Variation	[1633]
IPO13	OT887N3O	Strong	Biomarker	[1634]
IPO4	OT2N5020	Strong	Altered Expression	[1635]
IQGAP2	OTX2UA7P	Strong	Biomarker	[1636]
IRF6	OTKJ44EV	Strong	Altered Expression	[1530]
ISL1	OTVNVKAX	Strong	Biomarker	[168]
ISM1	OTZTK2TV	Strong	Altered Expression	[1418]
ISYNA1	OT49ONSE	Strong	Genetic Variation	[1637]
ITGA3	OTBCH21D	Strong	Biomarker	[1638]
ITGAX	OTOGIMHE	Strong	Altered Expression	[1639]
ITGB4	OT28UK84	Strong	Biomarker	[1640]
ITGB5	OT21MF51	Strong	Genetic Variation	[1641]
ITIH5	OTP46PZM	Strong	Altered Expression	[1642]
ITLN1	OT7ZLJVV	Strong	Biomarker	[1643]
ITM2B	OTMXEPXB	Strong	Biomarker	[896]
JAG1	OT3LGT6K	Strong	Biomarker	[1644]
JRK	OTO8E77P	Strong	Biomarker	[1645]
KANK1	OT2E7A6W	Strong	Biomarker	[1646]
KANK2	OT3SZIWM	Strong	Biomarker	[1647]
KAT5	OTL7257A	Strong	Biomarker	[1648]
KCNE2	OTUO214Y	Strong	Biomarker	[1649]
KDM2B	OTDMCVW7	Strong	Biomarker	[1650]
KDM6A	OTZM3MJJ	Strong	Biomarker	[1651]
KHDRBS3	OTUG02U7	Strong	Altered Expression	[1652]
KIF14	OTXHT4JM	Strong	Biomarker	[1653]
KIF1B	OTI1XQTO	Strong	Altered Expression	[1654]
KIF20A	OTXOQHE0	Strong	Biomarker	[1655]
KIF23	OTY850JC	Strong	Biomarker	[678]
KIF2C	OTJ8G3NP	Strong	Altered Expression	[1656]
KLF11	OTKVQDJD	Strong	Altered Expression	[1657]
KLF6	OTQY9S7F	Strong	Altered Expression	[1658]
KLF9	OTBFEJRQ	Strong	Biomarker	[1659]
KLK10	OTD573EL	Strong	Biomarker	[1660]
KLK11	OT5PKX7Y	Strong	Altered Expression	[1661]
KLK12	OTNYK59J	Strong	Altered Expression	[1662]
KLK13	OT8LOD2U	Strong	Biomarker	[1663]
KMT2C	OTC59BCO	Strong	Genetic Variation	[1664]
KPNA2	OTU7FOE6	Strong	Altered Expression	[1665]
KRIT1	OT58AP1I	Strong	Genetic Variation	[1419]
KRR1	OTCMJ3K3	Strong	Altered Expression	[308]
KRT15	OTS6WLF7	Strong	Biomarker	[1666]
KRT20	OT4RB40L	Strong	Biomarker	[1667]
LAMTOR3	OTG93MCO	Strong	Genetic Variation	[1668]
LAT	OTZC1XZ1	Strong	Biomarker	[1669]
LAYN	OT9A9Q1X	Strong	Altered Expression	[1670]
LEF1	OTWS5I5H	Strong	Biomarker	[648]
LEMD1	OTII3FTO	Strong	Altered Expression	[1671]
LGALS3BP	OT9AGQKH	Strong	Altered Expression	[1672]
LGALS7	OTMSVI7R	Strong	Biomarker	[1673]
LGALS9	OT7MF91K	Strong	Altered Expression	[1674]
LIG3	OT48SKET	Strong	Genetic Variation	[1675]
LIMS2	OTZ7IIPM	Strong	Posttranslational Modification	[1676]
LLGL2	OTU8ZDC4	Strong	Biomarker	[1634]
LMLN	OTQF0JPY	Strong	Posttranslational Modification	[639]
LRATD2	OTEZBUUL	Strong	Biomarker	[1677]
LRIG1	OTY5HZN5	Strong	Altered Expression	[1678]
LRPAP1	OT6DVD2Q	Strong	Biomarker	[1679]
LXN	OTZQ2M6Y	Strong	Altered Expression	[1680]
LYPD4	OTYNO8BS	Strong	Genetic Variation	[1681]
LZTFL1	OTIEIOEW	Strong	Biomarker	[1682]
MACC1	OTV3DLX0	Strong	Biomarker	[1683]
MACROH2A1	OTV2DQDD	Strong	Biomarker	[1684]
MADD	OTUFYVGG	Strong	Posttranslational Modification	[1504]
MAGEA12	OT8ULELL	Strong	Posttranslational Modification	[1685]
MAGED2	OTMEWNSE	Strong	Altered Expression	[1686]
MAL	OTBM30SW	Strong	Altered Expression	[1687]
MAML3	OTZFV53Z	Strong	Altered Expression	[1688]
MAP1LC3B	OTUYHB84	Strong	Altered Expression	[175]
MAPK15	OT8SW0L7	Strong	Altered Expression	[1689]
MAPRE1	OTCVQD60	Strong	Biomarker	[1690]
MARCHF1	OTI2EYO6	Strong	Genetic Variation	[1691]
MARCHF6	OTBTA03N	Strong	Genetic Variation	[1692]
MARCKSL1	OT13J2FM	Strong	Biomarker	[1693]
MBD4	OTWR9YXE	Strong	Genetic Variation	[1694]
MCRS1	OT8K2X8P	Strong	Altered Expression	[333]
MDC1	OTEUQH4J	Strong	Biomarker	[1695]
MED1	OTOO24C4	Strong	Genetic Variation	[1696]
MED15	OT0D0JVD	Strong	Biomarker	[1304]
MED19	OTT9RT5N	Strong	Biomarker	[1697]
MEF2D	OT7CEIG0	Strong	Biomarker	[1698]
MEGF8	OT5G38CH	Strong	Biomarker	[1699]
MFAP2	OTMHVBTV	Strong	Biomarker	[1700]
MFSD2A	OTVG1VG0	Strong	Biomarker	[1701]
MFSD4A	OTUO018X	Strong	Altered Expression	[1702]
MGAT5	OTU4DD4G	Strong	Biomarker	[1703]
MICAL1	OTJEDVWA	Strong	Biomarker	[125]
MICAL2	OT04OQQJ	Strong	Altered Expression	[1704]
MICB	OTS2DVDW	Strong	Altered Expression	[1705]
MMP25	OT3BG37V	Strong	Biomarker	[1706]
MMUT	OTBBBV70	Strong	Genetic Variation	[1707]
MORC2	OT52A8BJ	Strong	Altered Expression	[1708]
MOS	OTNMQPFJ	Strong	Biomarker	[1709]
MPEG1	OT7DAO0F	Strong	Biomarker	[549]
MPHOSPH8	OTYI2WNS	Strong	Altered Expression	[1710]
MRE11	OTGU8TZM	Strong	Biomarker	[1695]
MRPL13	OT6D8Y9G	Strong	Biomarker	[418]
MRPL33	OTA3YDH0	Strong	Biomarker	[1711]
MRPL41	OTG5URO4	Strong	Biomarker	[1712]
MRPS11	OTEERNWQ	Strong	Biomarker	[418]
MRPS18B	OT1K9PFX	Strong	Biomarker	[418]
MSH3	OTD3YPVL	Strong	Biomarker	[1713]
MST1	OTOC4UNG	Strong	Posttranslational Modification	[639]
MSX2	OT1WDKE1	Strong	Genetic Variation	[677]
MTA2	OTCCYIQJ	Strong	Altered Expression	[1714]
MTMR3	OTBIT23O	Strong	Genetic Variation	[1715]
MTUS1	OTBPALMU	Strong	Biomarker	[1716]
MTX1	OTLSDNZO	Strong	Altered Expression	[1645]
MUC13	OTWKS9MF	Strong	Altered Expression	[1717]
MUC2	OT3X4QVX	Strong	Altered Expression	[1718]
MUC4	OTLT11V1	Strong	Biomarker	[1719]
MUL1	OT2JC9YR	Strong	Biomarker	[244]
MXD1	OTS5CTHX	Strong	Biomarker	[1720]
MYBL2	OTZ3JX8Q	Strong	Altered Expression	[1721]
MYH11	OTVNVWY3	Strong	Genetic Variation	[1722]
MYO5B	OTCKL3W3	Strong	Biomarker	[1723]
MYT1L	OTV45MAS	Strong	Genetic Variation	[1724]
MZB1	OT071TET	Strong	Altered Expression	[1505]
NAB1	OTEWHIZR	Strong	Altered Expression	[1465]
NAIF1	OT0B3H72	Strong	Altered Expression	[1725]
NANS	OTMQ2FUH	Strong	Genetic Variation	[1726]
NAXD	OTPO2GM2	Strong	Biomarker	[418]
NBN	OT73B5MD	Strong	Genetic Variation	[1727]
NCCRP1	OTJ9XP1Z	Strong	Altered Expression	[1728]
NCR3LG1	OT15YWU7	Strong	Biomarker	[1729]
NDC80	OTS7D306	Strong	Altered Expression	[1730]
NDRG2	OT5L6KD7	Strong	Altered Expression	[1731]
NDRG3	OTJTJCHD	Strong	Biomarker	[1732]
NDRG4	OTJBOTD8	Strong	Altered Expression	[1733]
NDUFA2	OTNSTATK	Strong	Biomarker	[418]
NDUFS1	OTTIZDFR	Strong	Biomarker	[418]
NDUFV1	OTEVK4WW	Strong	Biomarker	[418]
NEDD1	OTBD6X77	Strong	Biomarker	[1734]
NEIL1	OTHBU5DJ	Strong	Altered Expression	[1735]
NEIL2	OTV6JEON	Strong	Genetic Variation	[1736]
NEK3	OTKWD5FY	Strong	Altered Expression	[1737]
NEU2	OTW76T35	Strong	Altered Expression	[1575]
NFIA	OTDHQ9CG	Strong	Altered Expression	[1539]
NFIB	OTX94PD0	Strong	Altered Expression	[1539]
NFIC	OTLMCUIB	Strong	Altered Expression	[1539]
NFIX	OT1DPZAE	Strong	Altered Expression	[1539]
NFKBIB	OTY1ZJXH	Strong	Biomarker	[1738]
NID1	OTKLBLS6	Strong	Posttranslational Modification	[1739]
NID2	OTHC33FF	Strong	Biomarker	[925]
NKD2	OTCYT3I6	Strong	Posttranslational Modification	[1740]
NLRP6	OTEREN4W	Strong	Altered Expression	[1741]
NME2	OTCYGLHV	Strong	Biomarker	[850]
NMI	OTYVG3NM	Strong	Biomarker	[1742]
NOB1	OTW0YNSL	Strong	Altered Expression	[1743]
NOL3	OT1K0L0D	Strong	Biomarker	[1744]
NOL8	OT6RZLH3	Strong	Altered Expression	[1745]
NOP53	OTA2YKO6	Strong	Altered Expression	[1746]
NOP56	OTT67SRZ	Strong	Biomarker	[418]
NPC1	OTRIPICX	Strong	Biomarker	[1747]
NSD2	OTQ6SW4R	Strong	Altered Expression	[1688]
NTHL1	OTPQXPT1	Strong	Biomarker	[1748]
NUCB2	OTHO6JWN	Strong	Biomarker	[1749]
NUCKS1	OTL4VJC5	Strong	Altered Expression	[1750]
NUDT13	OT3004C1	Strong	Altered Expression	[1702]
NUP37	OTPZH72U	Strong	Biomarker	[1430]
NUP62	OTMN63DH	Strong	Altered Expression	[1500]
NUP98	OTNT12G2	Strong	Biomarker	[1364]
NUSAP1	OT85HIJ5	Strong	Altered Expression	[1751]
OAZ2	OTV1XSWG	Strong	Genetic Variation	[668]
OCLN	OTSUTVWL	Strong	Altered Expression	[1702]
ODAM	OTT666SJ	Strong	Biomarker	[1492]
OGT	OT1Z1ZXE	Strong	Altered Expression	[1752]
OIP5	OTI5C2DE	Strong	Biomarker	[1753]
OMP	OT7JH0DY	Strong	Genetic Variation	[1754]
OPCML	OT93PQ6Y	Strong	Altered Expression	[1755]
OSR1	OTB19LEQ	Strong	Biomarker	[1756]
OTP	OTS0JN6Y	Strong	Biomarker	[1757]
PA2G4	OT7IG7HT	Strong	Biomarker	[418]
PAEP	OTQA0NV4	Strong	Biomarker	[1758]
PAGR1	OTXR5PQ8	Strong	Altered Expression	[491]
PAQR3	OTTKJ9Y4	Strong	Biomarker	[1759]
PAX6	OTOC9876	Strong	Biomarker	[1760]
PBLD	OTI3A8RS	Strong	Altered Expression	[1761]
PBX3	OT8WMVM4	Strong	Biomarker	[1762]
PCDH17	OTRK0M05	Strong	Altered Expression	[1763]
PCDH8	OTDDOQM2	Strong	Altered Expression	[596]
PCGF2	OTIY1J5L	Strong	Altered Expression	[1764]
PDCD6	OT2YA5M8	Strong	Biomarker	[1765]
PDCL2	OTRNO6W3	Strong	Biomarker	[1766]
PDIA3	OTHPQ0Q3	Strong	Biomarker	[1767]
PDLIM7	OTAZVODU	Strong	Biomarker	[1768]
PDPN	OTBUV19I	Strong	Altered Expression	[1769]
PDSS2	OTEOQBMX	Strong	Altered Expression	[1770]
PELI2	OT7AFILK	Strong	Biomarker	[1771]
PELP1	OTVXQNOT	Strong	Altered Expression	[1772]
PENK	OT8P3HMP	Strong	Altered Expression	[1773]
PES1	OTMZK7XE	Strong	Genetic Variation	[1774]
PFKFB4	OTQYEXL2	Strong	Altered Expression	[1775]
PFN1	OTHTGA1H	Strong	Altered Expression	[1776]
PGA3	OT8EHCKQ	Strong	Genetic Variation	[1777]
PGAM1	OTZ5DB06	Strong	Biomarker	[381]
PGAP3	OTH9A75E	Strong	Biomarker	[689]
PGK1	OT6V1ICH	Strong	Biomarker	[1778]
PHF10	OTWDR4EX	Strong	Altered Expression	[1779]
PHF2	OTJCIQR2	Strong	Altered Expression	[1780]
PIAS3	OT3TWH9R	Strong	Altered Expression	[1781]
PIBF1	OTCBT1A1	Strong	Biomarker	[1782]
PIK3R3	OTXGJ8N1	Strong	Genetic Variation	[1783]
PIK3R4	OTRL8QP8	Strong	Altered Expression	[1487]
PITX1	OTA0UN4C	Strong	Altered Expression	[1784]
PIWIL1	OT7CRGZ3	Strong	Altered Expression	[1785]
PIWIL4	OTDA9MY0	Strong	Biomarker	[1786]
PKD1	OT5ALRZ5	Strong	Posttranslational Modification	[1787]
PLA1A	OT2IXYNX	Strong	Biomarker	[1788]
PLAGL1	OTZAO900	Strong	Biomarker	[1789]
PLCD1	OT6WFVXZ	Strong	Altered Expression	[1790]
PLCE1	OTJISZOX	Strong	Genetic Variation	[1791]
PLK3	OT19CT2Z	Strong	Biomarker	[1792]
PLXND1	OTNK9ALK	Strong	Biomarker	[1793]
PMS2	OTNLWTMI	Strong	Biomarker	[1794]
POLDIP3	OTTB5SV7	Strong	Altered Expression	[477]
POLE	OTFM3MMU	Strong	Genetic Variation	[417]
POLE3	OTOELRF6	Strong	Genetic Variation	[386]
POLR2A	OTHJQ1DZ	Strong	Genetic Variation	[1795]
POLR3K	OTZCSF6A	Strong	Biomarker	[418]
POPDC3	OTN4FJ5J	Strong	Altered Expression	[1796]
POT1	OTNBXJCQ	Strong	Biomarker	[765]
POU2F1	OTK7ELJ0	Strong	Biomarker	[731]
POU5F1B	OT0FKQ51	Strong	Biomarker	[1797]
PPFIA3	OTNPZ6HT	Strong	Biomarker	[1798]
PPIL1	OTS5S837	Strong	Biomarker	[1799]
PPP2R1A	OTYA3GB4	Strong	Biomarker	[418]
PRDM2	OT8L7CGX	Strong	Biomarker	[1800]
PRKAA2	OTU1KZPV	Strong	Biomarker	[1801]
PRKAB1	OT1OG4QZ	Strong	Biomarker	[1801]
PRKACB	OT6RMDCE	Strong	Biomarker	[1802]
PRKACG	OTKOQYF8	Strong	Altered Expression	[618]
PRKD3	OT987HJI	Strong	Biomarker	[681]
PRLHR	OT1THGOP	Strong	Genetic Variation	[1616]
PROCR	OTRHED17	Strong	Biomarker	[1803]
PRPF19	OTQ1STV3	Strong	Biomarker	[418]
PRPF31	OTSJ0Z1Y	Strong	Altered Expression	[575]
PRSS23	OT6DQAM1	Strong	Biomarker	[452]
PRSS55	OTXXWI5Y	Strong	Biomarker	[1099]
PRUNE1	OTQ3UHWQ	Strong	Altered Expression	[1508]
PRXL2C	OTI8ZAK8	Strong	Biomarker	[1804]
PSAP	OTUOEKY7	Strong	Biomarker	[438]
PSD	OTUZIXUZ	Strong	Biomarker	[1805]
PSG2	OT2EIXAI	Strong	Biomarker	[410]
PSMA1	OTNBVM2U	Strong	Biomarker	[1806]
PSMA7	OTPHI6ST	Strong	Biomarker	[1807]
PSMC3	OTSKT0JI	Strong	Altered Expression	[1808]
PSMD4	OTH1VZTM	Strong	Biomarker	[1393]
PSME2	OTYPP33T	Strong	Biomarker	[1809]
PTGR2	OTYPYOUM	Strong	Biomarker	[1810]
PTOV1	OT94WT5X	Strong	Biomarker	[418]
PTPN3	OTSLZBVY	Strong	Biomarker	[1811]
PTPN4	OT6SXU5Y	Strong	Biomarker	[1811]
PTPN9	OTNAR1I2	Strong	Altered Expression	[1812]
PTPRCAP	OT2YERNV	Strong	Genetic Variation	[1813]
PTPRF	OTH5KF2D	Strong	Biomarker	[418]
PTPRG	OT9N2WOF	Strong	Biomarker	[1814]
PTPRH	OTDUHQGF	Strong	Biomarker	[438]
PTTG1	OTIMYS4W	Strong	Biomarker	[1815]
PUS1	OTS2DQ0N	Strong	Biomarker	[418]
PXN	OTVMMUOF	Strong	Biomarker	[1816]
PYCARD	OT67RON3	Strong	Biomarker	[1817]
RAB14	OTF1J0TB	Strong	Biomarker	[1818]
RAB18	OTNMAQLS	Strong	Biomarker	[1819]
RAB27A	OT9SQRWY	Strong	Altered Expression	[1820]
RAB31	OTMLXQZ0	Strong	Altered Expression	[1372]
RAB3GAP2	OTQTE0GI	Strong	Altered Expression	[1487]
RAB40B	OTCA9ZF5	Strong	Biomarker	[1821]
RAB40C	OTM2V2R0	Strong	Biomarker	[1822]
RABEP1	OTQROTGT	Strong	Biomarker	[1823]
RABGEF1	OTWC3Z3R	Strong	Altered Expression	[1824]
RACGAP1	OTQE8IEH	Strong	Altered Expression	[1825]
RAD23A	OTBPAWHX	Strong	Biomarker	[418]
RANBP10	OT0ZNZ0B	Strong	Biomarker	[418]
RANGAP1	OTZGD3LJ	Strong	Biomarker	[1826]
RAP1A	OT5RH6TI	Strong	Biomarker	[1514]
RAP1B	OTHEIIMM	Strong	Altered Expression	[1827]
RAP1GAP	OTC31ONQ	Strong	Biomarker	[1828]
RAPGEF1	OTZ0TBN1	Strong	Genetic Variation	[1829]
RARRES2	OT1BJE8K	Strong	Biomarker	[1830]
RASAL2	OTGMMX6W	Strong	Altered Expression	[1831]
RASGRF1	OTNWJ7EN	Strong	Posttranslational Modification	[1832]
RASSF1	OTEZIPB7	Strong	Biomarker	[1833]
RASSF10	OTGB7EBG	Strong	Posttranslational Modification	[1834]
RASSF2	OT2JHDO4	Strong	Posttranslational Modification	[1835]
RASSF7	OT0V4EIZ	Strong	Altered Expression	[1836]
RBBP4	OTG3BT3M	Strong	Biomarker	[1329]
RBBP6	OTTVG4HU	Strong	Biomarker	[1837]
RBBP8	OTRHJ3GI	Strong	Altered Expression	[1409]
RBM14	OTO9GMBD	Strong	Biomarker	[1647]
RBM3	OTAJ7R31	Strong	Biomarker	[1838]
RBM4	OT5SFQA3	Strong	Biomarker	[1839]
RBP2	OTR8QG5V	Strong	Biomarker	[1840]
RBX1	OTYA1UIO	Strong	Biomarker	[1841]
RCAN2	OTGGWTWS	Strong	Biomarker	[1842]
RDX	OTNSYUN6	Strong	Biomarker	[1843]
RECQL4	OT59LSW7	Strong	Altered Expression	[1844]
REEP5	OTZU4TJI	Strong	Biomarker	[1553]
REG1A	OTMHUH1D	Strong	Altered Expression	[1845]
REV3L	OT0OP8EJ	Strong	Biomarker	[1846]
RFC3	OT1MS7AO	Strong	Genetic Variation	[1529]
RHBDF1	OTCQ7UDS	Strong	Altered Expression	[1847]
RHOBTB2	OT2DATFX	Strong	Genetic Variation	[1848]
RHOD	OTALMEIN	Strong	Altered Expression	[1849]
RIOX2	OT2YFPI2	Strong	Altered Expression	[1850]
RNASE1	OTKZ7CO9	Strong	Biomarker	[1851]
RNASE3	OTVE2XD1	Strong	Biomarker	[1852]
RNASEH2C	OTJL9ZRN	Strong	Biomarker	[1589]
RNF26	OTPXA60S	Strong	Altered Expression	[1853]
RNH1	OT6EC79B	Strong	Biomarker	[1854]
ROMO1	OTIEYVBW	Strong	Genetic Variation	[1855]
RPA3	OT8JAQGL	Strong	Altered Expression	[1856]
RPL10	OTBHOZGC	Strong	Altered Expression	[1428]
RPL11	OT3VZ6OE	Strong	Biomarker	[1746]
RPL13	OTFKNTD6	Strong	Biomarker	[418]
RPL18	OTJCH62J	Strong	Biomarker	[418]
RPL23	OTXI1YLM	Strong	Biomarker	[1857]
RPL34	OT0U9VMQ	Strong	Altered Expression	[1858]
RPN2	OTJ1SKOA	Strong	Biomarker	[22]
RPRM	OTNNBAS1	Strong	Posttranslational Modification	[1859]
RPS13	OTOMDIJ2	Strong	Biomarker	[1860]
RPS15	OT0WYZYG	Strong	Biomarker	[418]
RPS19	OTBKGP48	Strong	Biomarker	[418]
RPS21	OT6P58W6	Strong	Biomarker	[418]
RPS26	OTBYTA6A	Strong	Biomarker	[418]
RPS27	OTFXKY7P	Strong	Biomarker	[549]
RRAS	OTBBF28C	Strong	Altered Expression	[1861]
RRP9	OT97EAV4	Strong	Biomarker	[418]
RSPO2	OT3HHXU0	Strong	Biomarker	[1862]
RUFY1	OTIXX2TR	Strong	Biomarker	[1863]
S100A11	OTI57KDN	Strong	Biomarker	[1864]
S100A2	OTTGHJ1H	Strong	Altered Expression	[1865]
S100A7	OTJFVJRF	Strong	Altered Expression	[1866]
SAGE1	OT4H6FFA	Strong	Altered Expression	[1867]
SARM1	OTEP4I5O	Strong	Biomarker	[1868]
SATB2	OT2W80XC	Strong	Biomarker	[623]
SCAF11	OTX59D0X	Strong	Biomarker	[133]
SCGB2A1	OT9L87U9	Strong	Biomarker	[1869]
SCGB3A1	OTIR98RB	Strong	Altered Expression	[1870]
SCLT1	OT2ZSSP4	Strong	Biomarker	[438]
SCN7A	OTK05PXY	Strong	Genetic Variation	[649]
SCNN1B	OT61QQTL	Strong	Biomarker	[1871]
SCO2	OTJQQDRS	Strong	Biomarker	[195]
SDF4	OTQ7WFYW	Strong	Genetic Variation	[1446]
SDHC	OTC8G2MX	Strong	Genetic Variation	[1872]
SEC11A	OT06L834	Strong	Biomarker	[1873]
SELENBP1	OT3NZNTR	Strong	Biomarker	[361]
SELENOS	OTUEWIU9	Strong	Genetic Variation	[1874]
SEMA3B	OTCZCPMS	Strong	Altered Expression	[1875]
SEMA3C	OTEGUY7F	Strong	Biomarker	[1876]
SEMA3E	OTD4S36H	Strong	Biomarker	[1793]
SEMA5A	OTUOIOJV	Strong	Altered Expression	[1877]
SENP3	OTFQDOMC	Strong	Altered Expression	[482]
SERBP1	OTZVSU0X	Strong	Biomarker	[418]
SERPINA10	OTZ8OZ67	Strong	Biomarker	[1878]
SERPINA5	OTTZXPGD	Strong	Biomarker	[1879]
SERPINB2	OT72QLZB	Strong	Biomarker	[1880]
SERPINE2	OTYF5340	Strong	Biomarker	[1881]
SERPINI1	OTUJHIJW	Strong	Altered Expression	[1882]
SESN2	OT889IXY	Strong	Biomarker	[1883]
SETBP1	OTKGCOSR	Strong	Altered Expression	[1884]
SEZ6L2	OTUIKN2I	Strong	Biomarker	[752]
SFMBT2	OTZQT61Q	Strong	Biomarker	[1885]
SFN	OTLJCZ1U	Strong	Altered Expression	[1886]
SFRP2	OT8GZ0CA	Strong	Biomarker	[1887]
SFRP5	OTLCVVSH	Strong	Biomarker	[1887]
SH3GLB1	OTAZ5OP8	Strong	Altered Expression	[1888]
SINHCAF	OTHMZZ0A	Strong	Biomarker	[1889]
SKA1	OTDYJ12A	Strong	Biomarker	[1890]
SLC16A4	OT1YXBKC	Strong	Altered Expression	[170]
SLC66A1	OTUM63MK	Strong	Altered Expression	[1891]
SLIT3	OTU8MKEU	Strong	Biomarker	[1892]
SMAD2	OTC6VB4K	Strong	Altered Expression	[1893]
SMARCA1	OT0Y6PTU	Strong	Biomarker	[1894]
SMARCA2	OTSGJ8SV	Strong	Genetic Variation	[1895]
SMARCA5	OT5GR4Z2	Strong	Posttranslational Modification	[1896]
SMARCC1	OTUOMBE7	Strong	Altered Expression	[1805]
SMARCE1	OTAX4ITH	Strong	Biomarker	[1897]
SMR3B	OTL5HNM8	Strong	Biomarker	[1898]
SMURF1	OT5UIZR8	Strong	Altered Expression	[1899]
SND1	OTT734JN	Strong	Biomarker	[1900]
SNRPB	OT3UJ4ZU	Strong	Biomarker	[418]
SNX1	OTXQSJ1J	Strong	Altered Expression	[1901]
SNX5	OT6ZOWMU	Strong	Biomarker	[418]
SOCS4	OTIRULFZ	Strong	Altered Expression	[1902]
SOCS6	OT2O5ZBK	Strong	Biomarker	[1903]
SOSTDC1	OTAKDNSM	Strong	Altered Expression	[1904]
SOX1	OTVI1RAR	Strong	Biomarker	[1034]
SOX12	OT93P8C9	Strong	Biomarker	[1101]
SOX17	OT9H4WWE	Strong	Posttranslational Modification	[1905]
SOX7	OTOZOFAG	Strong	Altered Expression	[1906]
SOX9	OTVDJFGN	Strong	Biomarker	[691]
SPAG5	OTCLJ56M	Strong	Biomarker	[1907]
SPARCL1	OT74DWMV	Strong	Biomarker	[1908]
SPART	OTIVOS2I	Strong	Biomarker	[1909]
SPINT2	OTQV7BKQ	Strong	Posttranslational Modification	[1910]
SPPL2A	OTCVF6MM	Strong	Altered Expression	[1911]
SPTAN1	OT6VY3A3	Strong	Biomarker	[1912]
SRF	OTW18FQN	Strong	Biomarker	[1913]
SRI	OT4R3EAC	Strong	Altered Expression	[1914]
SRPX2	OT6A63TX	Strong	Altered Expression	[1915]
SRSF1	OTF61HOV	Strong	Altered Expression	[1916]
SRSF6	OTGLOSYE	Strong	Altered Expression	[1917]
SRSF7	OTRS4W4S	Strong	Altered Expression	[1917]
ST13	OTNML6UP	Strong	Altered Expression	[1608]
ST3GAL3	OTOORKUE	Strong	Biomarker	[1918]
ST6GALNAC1	OT3JQD99	Strong	Altered Expression	[1919]
STARD3	OTSTC5B5	Strong	Altered Expression	[1920]
STARD8	OTY9IAKW	Strong	Altered Expression	[1921]
STAT4	OTAK3VFR	Strong	Biomarker	[1922]
STAU1	OTTR5311	Strong	Biomarker	[1923]
STIM1	OT8CLQ1W	Strong	Biomarker	[1924]
STX1A	OTSBUZB4	Strong	Biomarker	[1925]
SUCLG1	OTDCSPXH	Strong	Biomarker	[418]
SUV39H2	OTU0F4LL	Strong	Altered Expression	[1926]
SYMPK	OTYAUDXV	Strong	Biomarker	[418]
SYT1	OTVTPOI6	Strong	Biomarker	[793]
TACC1	OTGX20TE	Strong	Biomarker	[1927]
TAF15	OTNE038N	Strong	Biomarker	[418]
TAFA5	OT2SWBT6	Strong	Biomarker	[1928]
TAOK2	OTNUMOZ1	Strong	Biomarker	[752]
TAPBP	OTL81AVZ	Strong	Biomarker	[1809]
TAS1R1	OTOGG3AH	Strong	Genetic Variation	[1929]
TAS2R38	OTX5MM36	Strong	Genetic Variation	[1930]
TBPL1	OT4I143E	Strong	Biomarker	[765]
TCAP	OTQQMJ94	Strong	Biomarker	[689]
TCEAL7	OTNPDZCN	Strong	Altered Expression	[1931]
TCF12	OTZVONNU	Strong	Biomarker	[1932]
TCF7L1	OTTUTF0O	Strong	Altered Expression	[1933]
TCIM	OTARUXQF	Strong	Biomarker	[1934]
TCN1	OTW6A49Y	Strong	Genetic Variation	[430]
TCTN1	OTG5KEV8	Strong	Biomarker	[1935]
TEAD4	OTJS0T2B	Strong	Biomarker	[1011]
TERF2IP	OT3M5P3G	Strong	Biomarker	[1514]
TET1	OTZDHT1D	Strong	Biomarker	[1936]
TFF3	OTJJDRTU	Strong	Altered Expression	[1937]
TFPI2	OTZCRWOR	Strong	Altered Expression	[657]
TGFBI	OTR443C5	Strong	Altered Expression	[1938]
TGIF2	OTMKKE3W	Strong	Biomarker	[1939]
THBS4	OTA1T9KK	Strong	Altered Expression	[1940]
TIMM8A	OTDX9687	Strong	Biomarker	[1537]
TIMP2	OT8S1RRP	Strong	Biomarker	[1941]
TIMP3	OTDGQAD1	Strong	Posttranslational Modification	[1942]
TINF2	OT861N2N	Strong	Altered Expression	[1943]
TLCD3B	OTM6EPUS	Strong	Biomarker	[1944]
TLK1	OTICTXI8	Strong	Altered Expression	[618]
TM7SF2	OTILU5S7	Strong	Biomarker	[357]
TM9SF3	OTBISJZQ	Strong	Altered Expression	[1515]
TMED6	OTLYX1ZZ	Strong	Altered Expression	[1470]
TMEFF2	OT1WZ2QO	Strong	Altered Expression	[661]
TMEM100	OTRJ6OHY	Strong	Altered Expression	[1945]
TMEM106A	OTHTBYDN	Strong	Posttranslational Modification	[1946]
TMEM52B	OTOC70IF	Strong	Biomarker	[54]
TMEM63A	OTIUZ0C7	Strong	Biomarker	[418]
TMEM8B	OTJZWPS6	Strong	Altered Expression	[1947]
TMPRSS13	OTMAOAP3	Strong	Posttranslational Modification	[639]
TMPRSS4	OTCCGY2K	Strong	Biomarker	[1948]
TNFAIP2	OTRZH80H	Strong	Genetic Variation	[1949]
TOX3	OTC9NR4W	Strong	Genetic Variation	[1950]
TP53I3	OTSCM68G	Strong	Biomarker	[1712]
TP53INP1	OT2363Z9	Strong	Altered Expression	[1951]
TPD52L2	OTTOG0NK	Strong	Altered Expression	[1952]
TPM3	OT5RU5G6	Strong	Biomarker	[381]
TRAF5	OTSBTLO0	Strong	Altered Expression	[1953]
TRAP1	OTNG0L8J	Strong	Biomarker	[418]
TRAPPC9	OTF0CVMC	Strong	Biomarker	[1954]
TRDMT1	OTAYQ8ZF	Strong	Biomarker	[1955]
TRIB3	OTG5OS7X	Strong	Altered Expression	[1956]
TRIM16	OTLRXYOZ	Strong	Biomarker	[1957]
TRIM17	OTUJZUOS	Strong	Altered Expression	[1958]
TRIM25	OT35SG1R	Strong	Biomarker	[1959]
TRIM31	OT7VW6RP	Strong	Altered Expression	[1958]
TRIM36	OT37JQ8Y	Strong	Biomarker	[1960]
TRIM44	OT0B1T2B	Strong	Altered Expression	[1961]
TRIM46	OTFE7WZW	Strong	Genetic Variation	[1645]
TRIM58	OT7OIIRH	Strong	Biomarker	[1962]
TRIT1	OTCU9FS5	Strong	Genetic Variation	[1963]
TSACC	OT3QW6PH	Strong	Biomarker	[1647]
TSPAN1	OTZQPIYK	Strong	Altered Expression	[1964]
TSPAN31	OT8WQ83R	Strong	Genetic Variation	[1726]
ABRACL	OT95T48Q	Definitive	Altered Expression	[1965]
ADAM19	OTH88TXU	Definitive	Biomarker	[965]
ALPG	OTCIM29R	Definitive	Biomarker	[1966]
APOC1	OTA58CED	Definitive	Altered Expression	[1967]
ARL6IP5	OTYZ6BEQ	Definitive	Altered Expression	[1081]
ARSI	OTIANNWW	Definitive	Altered Expression	[1968]
BATF2	OT4XBZC9	Definitive	Altered Expression	[1969]
BMPR1A	OTQOA4ZH	Definitive	Genetic Variation	[1970]
BRMS1L	OTJIW47U	Definitive	Altered Expression	[893]
CCDC62	OTTIAOBP	Definitive	Altered Expression	[1971]
CCNY	OTK1KG5W	Definitive	Biomarker	[1972]
CDC6	OTX93FE7	Definitive	Biomarker	[1973]
CLEC1B	OTO38TRG	Definitive	Altered Expression	[1974]
CNBP	OTTGM9NK	Definitive	Altered Expression	[1975]
COPS6	OTG9AAG0	Definitive	Biomarker	[1976]
CRTAP	OT53H5U6	Definitive	Biomarker	[934]
CSMD1	OTIVDSC4	Definitive	Altered Expression	[1977]
CSRP3	OTECBJMV	Definitive	Biomarker	[1978]
CXXC1	OTO10D1N	Definitive	Biomarker	[1972]
CYTIP	OTRJ3ZC5	Definitive	Biomarker	[934]
DERL2	OTI3TUUZ	Definitive	Altered Expression	[1979]
DSP	OTB2MOP8	Definitive	Biomarker	[1980]
EEF2	OTZ7SZ39	Definitive	Biomarker	[1981]
EIF3B	OTF67VPH	Definitive	Biomarker	[1982]
FBLN2	OTEHR7N7	Definitive	Altered Expression	[1983]
FBXO45	OTD4D2OP	Definitive	Biomarker	[1984]
GINS4	OTCVOO3S	Definitive	Biomarker	[1985]
GKN2	OTR9DOYG	Definitive	Biomarker	[544]
GLS2	OT08MSHL	Definitive	Biomarker	[1986]
HOXD9	OTZ4GVR1	Definitive	Biomarker	[1087]
IFNL2	OT4BMJF7	Definitive	Altered Expression	[1987]
IRF2BP2	OTSSRRCA	Definitive	Altered Expression	[1988]
KAT2A	OTN0W2SW	Definitive	Altered Expression	[462]
KIF2A	OT2WQ6QD	Definitive	Biomarker	[1989]
KNTC1	OTI2OOFN	Definitive	Genetic Variation	[1990]
KRT40	OT2ODDUR	Definitive	Biomarker	[854]
LDLRAD2	OTW8VKBZ	Definitive	Biomarker	[1991]
LMO4	OT5NDCT9	Definitive	Biomarker	[1978]
LRRC3B	OT9VDGPR	Definitive	Biomarker	[1992]
NCOA1	OTLIUJQD	Definitive	Biomarker	[462]
NLRP2	OTJA81JU	Definitive	Genetic Variation	[1990]
PAIP1	OTL2F5T5	Definitive	Biomarker	[1993]
PCLAF	OTMVIOUU	Definitive	Biomarker	[1994]
PEA15	OTKCKTSX	Definitive	Biomarker	[1995]
PRMT6	OT5V3XIN	Definitive	Biomarker	[1052]
PSMD1	OTW258OV	Definitive	Altered Expression	[1996]
PSME3	OTSTC4YY	Definitive	Altered Expression	[1997]
RAB13	OTIQ484I	Definitive	Altered Expression	[1998]
RASSF9	OTCY4KST	Definitive	Altered Expression	[1999]
RFC1	OT3L5PK3	Definitive	Genetic Variation	[2000]
RGS18	OTJ6ZOCN	Definitive	Altered Expression	[1064]
RIF1	OTPE49OE	Definitive	Genetic Variation	[1990]
RPS7	OTIK25WI	Definitive	Biomarker	[799]
RRS1	OTTNCZN6	Definitive	Biomarker	[2001]
S100A16	OT3ERKQI	Definitive	Biomarker	[2002]
SEC62	OTCWEL5F	Definitive	Biomarker	[2003]
SHC1	OT1J5IRN	Definitive	Altered Expression	[820]
SMYD5	OTE5VET6	Definitive	Altered Expression	[462]
STAMBPL1	OTI4CYTF	Definitive	Biomarker	[2004]
STK26	OTW4QE0D	Definitive	Biomarker	[466]
STRA6	OT2IDF27	Definitive	Altered Expression	[2005]
SYF2	OTY2ZW1H	Definitive	Biomarker	[2006]
TBX2	OTTOT7A9	Definitive	Biomarker	[2007]
TCHP	OTVDMHSY	Definitive	Posttranslational Modification	[2008]
TMPO	OTL68EL4	Definitive	Altered Expression	[2009]
TNFRSF19	OTTVT4MB	Definitive	Biomarker	[2010]
TOX	OTE8BL5Z	Definitive	Altered Expression	[146]
TSPYL5	OT7QEI2X	Definitive	Posttranslational Modification	[2011]

References

• [1] A standard database for drug repositioning. Sci Data. 2017 Mar 14;4:170029.
• [2] Bortezomib FDA Label
• [3] Capecitabine FDA Label
• [4] Assessment of a HER2 scoring system for colorectal cancer: results from a validation study. Mod Pathol. 2015 Nov;28(11):1481-91.
• [5] Cisplatin FDA Label
• [6] Citalopram FDA Label
• [7] Docetaxel FDA Label
• [8] Floxuridine FDA Label
• [9] Fludarabine FDA Label
• [10] Fluorouracil FDA Label
• [11] Irinotecan FDA Label
• [12] Levoleucovorin FDA Label
• [13] Oxaliplatin FDA Label
• [14] FDA Approved Drug Products from FDA Official Website. 2022. Application Number: 761228.
• [15] The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer. Nature. 2021 Dec;600(7890):727-730.
• [16] Vidarabine FDA Label
• [17] ClinicalTrials.gov (NCT05703555) INTRUSION: Unraveling the INTRatUmoral PK/PD relatION for SAR408701. U.S.National Institutes of Health.
• [18] ClinicalTrials.gov (NCT05002127) A Phase 2/3 Study of Evorpacept (ALX148) in Patients With Advanced HER2-Overexpressing Gastric/Gastroesophageal Junction Adenocarcinoma (ASPEN-06). U.S.National Institutes of Health.
• [19] ClinicalTrials.gov (NCT04683939) Phase I/IIa, First-in-human, Open-label, Dose Escalation Trial With Expansion Cohorts to Evaluate Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of BNT141 as a Monotherapy and in Combination With Other Anti-cancer Agents in Patients With CLDN18.2-positive Solid Tumors. U.S.National Institutes of Health.
• [20] ClinicalTrials.gov (NCT04404595) Open-label, Multicenter, Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of Autologous Anti-claudin 18.2 Chimeric Antigen Receptor T-cell Therapy in Subjects With Advanced Gastric, Pancreatic, or Other Specified Digestive System Cancers. U.S.National Institutes of Health.
• [21] Clinical pipeline report, company report or official report of Sanofi
• [22] Ribophorin II potentiates P-glycoprotein- and ABCG2-mediated multidrug resistance via activating ERK pathway in gastric cancer.Int J Biol Macromol. 2019 May 1;128:574-582. doi: 10.1016/j.ijbiomac.2019.01.195. Epub 2019 Jan 30.
• [23] A Disintegrin and Metalloproteinase 8 as a Potential Blood Biomarker for Early Diagnosis of Gastric Cancer.Yonsei Med J. 2019 Aug;60(8):713-719. doi: 10.3349/ymj.2019.60.8.713.
• [24] ADAMTS5 acts as a tumor suppressor by inhibiting migration, invasion and angiogenesis in human gastric cancer.Gastric Cancer. 2019 Mar;22(2):287-301. doi: 10.1007/s10120-018-0866-2. Epub 2018 Aug 13.
• [25] Prognostic value of alcohol dehydrogenase mRNA expression in gastric cancer.Oncol Lett. 2018 Apr;15(4):5505-5516. doi: 10.3892/ol.2018.8007. Epub 2018 Feb 9.
• [26] Adenosine interaction with adenosine receptor A2a promotes gastric cancer metastasis by enhancing PI3K-AKT-mTOR signaling.Mol Biol Cell. 2019 Sep 1;30(19):2527-2534. doi: 10.1091/mbc.E19-03-0136. Epub 2019 Jul 24.
• [27] Frequent reduced expression of alpha-1B-adrenergic receptor caused by aberrant promoter methylation in gastric cancers.Br J Cancer. 2007 Jan 29;96(2):383-90. doi: 10.1038/sj.bjc.6603555.
• [28] Functional role of beta-adrenergic receptors in the mitogenic action of nicotine on gastric cancer cells. Toxicol Sci. 2007 Mar;96(1):21-9.
• [29] Inhibition of apoptosis by miR?22?p in fetoproteinproducing gastric cancer.Oncol Rep. 2019 Apr;41(4):2595-2600. doi: 10.3892/or.2019.7023. Epub 2019 Feb 20.
• [30] Identification of serum proteins AHSG, FGA and APOA-I as diagnostic biomarkers for gastric cancer.Clin Proteomics. 2018 Apr 30;15:18. doi: 10.1186/s12014-018-9194-0. eCollection 2018.
• [31] ALKBH5 promotes invasion and metastasis of gastric cancer by decreasing methylation of the lncRNA NEAT1.J Physiol Biochem. 2019 Aug;75(3):379-389. doi: 10.1007/s13105-019-00690-8. Epub 2019 Jul 9.
• [32] Tepoxalin a dual 5-LOX-COX inhibitor and erlotinib an EGFR inhibitor halts progression of gastric cancer in tumor xenograft mice.Am J Transl Res. 2018 Nov 15;10(11):3847-3856. eCollection 2018.
• [33] The observation of angiogenin and basic fibroblast growth factor gene expression in human colonic adenocarcinomas, gastric adenocarcinomas, and hepatocellular carcinomas.J Pathol. 1994 Feb;172(2):171-5. doi: 10.1002/path.1711720203.
• [34] Capillary morphogenesis gene 2 maintains gastric cancer stem-like cell phenotype by activating a Wnt/-catenin pathway.Oncogene. 2018 Jul;37(29):3953-3966. doi: 10.1038/s41388-018-0226-z. Epub 2018 Apr 17.
• [35] Apoptosis of stomach cancer cell SGC-7901 and regulation of Akt signaling way induced by bovine lactoferrin.J Dairy Sci. 2010 Jun;93(6):2344-50. doi: 10.3168/jds.2009-2926.
• [36] Trastuzumab induces PUMA-dependent apoptosis and inhibits tumor growth in gastric cancer.FEBS Open Bio. 2018 Nov 19;8(12):1911-1919. doi: 10.1002/2211-5463.12522. eCollection 2018 Dec.
• [37] Overexpression of BCAT1 is a prognostic marker in gastric cancer.Hum Pathol. 2018 May;75:41-46. doi: 10.1016/j.humpath.2018.02.003. Epub 2018 Feb 13.
• [38] MicroRNA-424 regulates cisplatin resistance of gastric cancer by targeting SMURF1 based on GEO database and primary validation in human gastric cancer tissues.Onco Targets Ther. 2019 Sep 17;12:7623-7636. doi: 10.2147/OTT.S208275. eCollection 2019.
• [39] BioTarget: A Computational Framework Identifying Cancer Type Specific Transcriptional Targets of Immune Response Pathways.Sci Rep. 2019 Jun 21;9(1):9029. doi: 10.1038/s41598-019-45304-x.
• [40] Brain-derived neurotrophic factor downregulation in gastric cancer.J Cell Biochem. 2019 Oct;120(10):17831-17837. doi: 10.1002/jcb.29050. Epub 2019 Jun 6.
• [41] Dysregulation of miR-195-5p/-218-5p/BIRC5 axis predicts a poor prognosis in patients with gastric cancer.J Biol Regul Homeost Agents. 2019 Sep-Oct;33(5):1377-1385. doi: 10.23812/19-146-A.
• [42] Concomitant modulation of PTEN and Livin in gastric cancer treatment.Int J Mol Med. 2018 May;41(5):2901-2908. doi: 10.3892/ijmm.2018.3475. Epub 2018 Feb 8.
• [43] Upregulation of bone morphogenetic protein 1 is associated with poor prognosis of late-stage gastric Cancer patients.BMC Cancer. 2018 May 2;18(1):508. doi: 10.1186/s12885-018-4383-9.
• [44] Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2'-deoxycytidine treatment and oligonucleotide microarray. Cancer Sci. 2006 Jan;97(1):64-71.
• [45] Suppression of BMX-ARHGAP fusion gene inhibits epithelial-mesenchymal transition in gastric cancer cells via RhoA-mediated blockade of JAK/STAT axis.J Cell Biochem. 2019 Jan;120(1):439-451. doi: 10.1002/jcb.27400. Epub 2018 Sep 14.
• [46] Expression of BUB1 protein in gastric cancer correlates with the histological subtype, but not with DNA ploidy or microsatellite instability.J Pathol. 2004 Feb;202(2):208-14. doi: 10.1002/path.1499.
• [47] Upregulation of T-cadherin suppresses cell proliferation, migration and invasion of gastric cancer in vitro.Exp Ther Med. 2017 Nov;14(5):4194-4200. doi: 10.3892/etm.2017.5090. Epub 2017 Sep 1.
• [48] Efficacy and safety of intensity-modulated radiation therapy versus three-dimensional conformal radiation treatment for patients with gastric cancer: a systematic review and meta-analysis.Radiat Oncol. 2019 May 22;14(1):84. doi: 10.1186/s13014-019-1294-0.
• [49] Heterogeneous expression of cholecystokinin and gastrin receptor in stomach and pancreatic cancer: An immunohistochemical study.J Cancer Res Ther. 2016 Jan-Mar;12(1):411-6. doi: 10.4103/0973-1482.168970.
• [50] Identification of functional lncRNAs in gastric cancer by integrative analysis of GEO and TCGA data.J Cell Biochem. 2019 Oct;120(10):17898-17911. doi: 10.1002/jcb.29058. Epub 2019 May 28.
• [51] Expression of chemokine receptor CCR7 is a negative prognostic factor for patients with gastric cancer: a meta-analysis.Gastric Cancer. 2017 Mar;20(2):235-245. doi: 10.1007/s10120-016-0602-8. Epub 2016 Mar 16.
• [52] Surface CD200 and CD200R antigens on lymphocytes in advanced gastric cancer: a new potential target for immunotherapy.Arch Med Sci. 2018 Oct;14(6):1271-1280. doi: 10.5114/aoms.2018.73398. Epub 2018 May 21.
• [53] CD40 expression and its prognostic significance in human gastric carcinoma.Med Oncol. 2015 Mar;32(3):63. doi: 10.1007/s12032-014-0463-0. Epub 2015 Feb 10.
• [54] A positive feedback loop consisting of C12orf59/NF-B/CDH11 promotes gastric cancer invasion and metastasis.J Exp Clin Cancer Res. 2019 Apr 15;38(1):164. doi: 10.1186/s13046-019-1114-2.
• [55] Network Pharmacology-Based Approach to Investigate the Mechanisms of Hedyotis diffusa Willd. in the Treatment of Gastric Cancer.Evid Based Complement Alternat Med. 2018 May 2;2018:7802639. doi: 10.1155/2018/7802639. eCollection 2018.
• [56] MicroRNA-613 inhibits the progression of gastric cancer by targeting CDK9.Artif Cells Nanomed Biotechnol. 2018 Aug;46(5):980-984. doi: 10.1080/21691401.2017.1351983. Epub 2017 Jul 13.
• [57] Loss of cyclin-dependent kinase-like 2 predicts poor prognosis in gastric cancer, and its overexpression suppresses cells growth and invasion.Cancer Med. 2018 Jul;7(7):2993-3002. doi: 10.1002/cam4.1577. Epub 2018 May 23.
• [58] Analysis of key genes and signaling pathways involved in Helicobacter pylori-associated gastric cancer based on The Cancer Genome Atlas database and RNA sequencing data.Helicobacter. 2018 Oct;23(5):e12530. doi: 10.1111/hel.12530. Epub 2018 Sep 2.
• [59] Overexpression of CLC-3 is regulated by XRCC5 and is a poor prognostic biomarker for gastric cancer.J Hematol Oncol. 2018 Sep 14;11(1):115. doi: 10.1186/s13045-018-0660-y.
• [60] The expression of Claudin-4 in gastric cancer tissue: A single center experience.J BUON. 2017 Mar-Apr;22(2):403-409.
• [61] Exosome-mediated transfer of CLIC1 contributes to the vincristine-resistance in gastric cancer.Mol Cell Biochem. 2019 Dec;462(1-2):97-105. doi: 10.1007/s11010-019-03613-9. Epub 2019 Aug 31.
• [62] lncRNA CCAT1 contributes to the growth and invasion of gastric cancer via targeting miR-219-1.J Cell Biochem. 2019 Dec;120(12):19457-19468. doi: 10.1002/jcb.29239. Epub 2019 Sep 3.
• [63] Dysregulation of miR-126/Crk protein axis predicts poor prognosis in gastric cancer patients.Cancer Biomark. 2018 Feb 6;21(2):335-343. doi: 10.3233/CBM-170472.
• [64] Expression of CRYAB with the angiogenesis and poor prognosis for human gastric cancer.Medicine (Baltimore). 2019 Nov;98(45):e17799. doi: 10.1097/MD.0000000000017799.
• [65] Highly Expressed Granulocyte Colony-Stimulating Factor (G-CSF) and Granulocyte Colony-Stimulating Factor Receptor (G-CSFR) in Human Gastric Cancer Leads to Poor Survival.Med Sci Monit. 2018 Mar 23;24:1701-1711. doi: 10.12659/msm.909128.
• [66] The significance of scirrhous gastric cancer cell lines: the molecular characterization using cell lines and mouse models.Hum Cell. 2018 Oct;31(4):271-281. doi: 10.1007/s13577-018-0211-4. Epub 2018 Jun 6.
• [67] A C-X-C Chemokine Receptor Type 2-Dominated Cross-talk between Tumor Cells and Macrophages Drives Gastric Cancer Metastasis.Clin Cancer Res. 2019 Jun 1;25(11):3317-3328. doi: 10.1158/1078-0432.CCR-18-3567. Epub 2019 Feb 22.
• [68] MicroRNA-760 acts as a tumor suppressor in gastric cancer development via inhibiting G-protein-coupled receptor kinase interacting protein-1 transcription.World J Gastroenterol. 2019 Dec 7;25(45):6619-6633. doi: 10.3748/wjg.v25.i45.6619.
• [69] Whole Genome Messenger RNA Profiling Identifies a Novel Signature to Predict Gastric Cancer Survival.Clin Transl Gastroenterol. 2019 Jan;10(1):e00004. doi: 10.14309/ctg.0000000000000004.
• [70] Hypoxia decreases macrophage glycolysis and M1 percentage by targeting microRNA-30c and mTOR in human gastric cancer.Cancer Sci. 2019 Aug;110(8):2368-2377. doi: 10.1111/cas.14110. Epub 2019 Jul 12.
• [71] Silencing of Discoidin Domain Receptor-1 (DDR1) Concurrently Inhibits Multiple Steps of Metastasis Cascade in Gastric Cancer.Transl Oncol. 2018 Jun;11(3):575-584. doi: 10.1016/j.tranon.2018.02.003. Epub 2018 Mar 13.
• [72] Decreased RIG-I expression is associated with poor prognosis and promotes cell invasion in human gastric cancer.Cancer Cell Int. 2018 Sep 19;18:144. doi: 10.1186/s12935-018-0639-3. eCollection 2018.
• [73] Prognostic value of Dickkopf-1 and -catenin expression in advanced gastric cancer.BMC Cancer. 2018 May 2;18(1):506. doi: 10.1186/s12885-018-4420-8.
• [74] HLJ1 (DNAJB4) Gene Is a Novel Biomarker Candidate in Breast Cancer.OMICS. 2017 May;21(5):257-265. doi: 10.1089/omi.2017.0016.
• [75] EGR1 interacts with DNMT3L to inhibit the transcription of miR-195 and plays an anti-apoptotic role in the development of gastric cancer.J Cell Mol Med. 2019 Nov;23(11):7372-7381. doi: 10.1111/jcmm.14597. Epub 2019 Sep 12.
• [76] ceRNA network construction and comparison of gastric cancer with or without Helicobacter pylori infection.J Cell Physiol. 2019 May;234(5):7128-7140. doi: 10.1002/jcp.27467. Epub 2018 Oct 28.
• [77] G9A promotes gastric cancer metastasis by upregulating ITGB3 in a SET domain-independent manner.Cell Death Dis. 2018 Feb 15;9(3):278. doi: 10.1038/s41419-018-0322-6.
• [78] Prognostic Significance of High EphA1-4 Expression Levels in Locally Advanced Gastric Cancer.Anticancer Res. 2018 Mar;38(3):1685-1693. doi: 10.21873/anticanres.12402.
• [79] Identification of different gene expressions between diffuse- and intestinal-type spheroid-forming gastric cancer cells.Gastric Cancer. 2019 Sep;22(5):967-979. doi: 10.1007/s10120-019-00935-x. Epub 2019 Feb 6.
• [80] Long intergenic non-coding RNA 00324 promotes gastric cancer cell proliferation via binding with HuR and stabilizing FAM83B expression.Cell Death Dis. 2018 Jun 18;9(7):717. doi: 10.1038/s41419-018-0758-8.
• [81] Human HST1 (HSTF1) gene maps to chromosome band 11q13 and coamplifies with the INT2 gene in human cancer.Proc Natl Acad Sci U S A. 1988 Jul;85(13):4861-4. doi: 10.1073/pnas.85.13.4861.
• [82] Novel prognostic biomarkers of gastric cancer based on gene expression microarray: COL12A1, GSTA3, FGA and FGG.Mol Med Rep. 2018 Oct;18(4):3727-3736. doi: 10.3892/mmr.2018.9368. Epub 2018 Aug 9.
• [83] MicroRNA-345 inhibits metastasis and epithelial-mesenchymal transition of gastric cancer by targeting FOXQ1.Oncol Rep. 2017 Nov;38(5):2752-2760. doi: 10.3892/or.2017.6001. Epub 2017 Sep 26.
• [84] Frizzled-10 Extracellular Vesicles Plasma Concentration Is Associated with Tumoral Progression in Patients with Colorectal and Gastric Cancer.J Oncol. 2019 Jun 2;2019:2715968. doi: 10.1155/2019/2715968. eCollection 2019.
• [85] Stromal cells positively and negatively modulate the growth of cancer cells: stimulation via the PGE2-TNF-IL-6 pathway and inhibition via secreted GAPDH-E-cadherin interaction.PLoS One. 2015 Mar 18;10(3):e0119415. doi: 10.1371/journal.pone.0119415. eCollection 2015.
• [86] Long non-coding antisense RNA GAS6-AS1 supports gastric cancer progression via increasing GAS6 expression.Gene. 2019 May 15;696:1-9. doi: 10.1016/j.gene.2018.12.079. Epub 2019 Feb 5.
• [87] Key elements involved in Epstein-Barr virus-associated gastric cancer and their network regulation.Cancer Cell Int. 2018 Sep 21;18:146. doi: 10.1186/s12935-018-0637-5. eCollection 2018.
• [88] Targeting of glutamine transporter ASCT2 and glutamine synthetase suppresses gastric cancer cell growth.J Cancer Res Clin Oncol. 2018 May;144(5):821-833. doi: 10.1007/s00432-018-2605-9. Epub 2018 Feb 12.
• [89] The EGFR ligands amphiregulin and heparin-binding egf-like growth factor promote peritoneal carcinomatosis in CXCR4-expressing gastric cancer.Clin Cancer Res. 2011 Jun 1;17(11):3619-30. doi: 10.1158/1078-0432.CCR-10-2475. Epub 2011 Apr 11.
• [90] MicroRNA-222-3p associated with Helicobacter pylori targets HIPK2 to promote cell proliferation, invasion, and inhibits apoptosis in gastric cancer.J Cell Biochem. 2018 Jul;119(7):5153-5162. doi: 10.1002/jcb.26542. Epub 2018 Mar 25.
• [91] Quantitative Proteomics Analysis Revealed the Potential Role of lncRNA Ftx in Promoting Gastric Cancer Progression.Proteomics Clin Appl. 2020 Jan;14(1):e1900053. doi: 10.1002/prca.201900053. Epub 2019 Nov 25.
• [92] Elevated HOXA13 expression promotes the proliferation and metastasis of gastric cancer partly via activating Erk1/2.Onco Targets Ther. 2019 Mar 4;12:1803-1813. doi: 10.2147/OTT.S196986. eCollection 2019.
• [93] HOXA5 inhibits tumor growth of gastric cancer under the regulation of microRNA-196a.Gene. 2019 Jan 10;681:62-68. doi: 10.1016/j.gene.2018.09.051. Epub 2018 Sep 26.
• [94] HOXB13 expression and promoter methylation as a candidate biomarker in gastric cancer.Oncol Lett. 2018 Jun;15(6):8833-8840. doi: 10.3892/ol.2018.8371. Epub 2018 Mar 29.
• [95] Gene expression analysis in the lung of the rasH2 transgenic mouse at week 4 prior to induction of malignant tumor formation by urethane and N-methylolacrylamide.J Toxicol Sci. 2015 Dec;40(6):685-700. doi: 10.2131/jts.40.685.
• [96] Overexpression of HS6ST2 is associated with poor prognosis in patients with gastric cancer.Oncol Lett. 2017 Nov;14(5):6191-6197. doi: 10.3892/ol.2017.6944. Epub 2017 Sep 14.
• [97] Expression of 17-hydroxysteroid dehydrogenase type 2 is associated with some clinicopathological features in gastric cancer.Biomed Pharmacother. 2015 Mar;70:24-7. doi: 10.1016/j.biopha.2014.12.042. Epub 2015 Jan 9.
• [98] Heat shock protein 60 overexpression is associated with the progression and prognosis in gastric cancer.PLoS One. 2014 Sep 10;9(9):e107507. doi: 10.1371/journal.pone.0107507. eCollection 2014.
• [99] HTRA1 promotes transdifferentiation of normal fibroblasts to cancer-associated fibroblasts through activation of the NF-B/bFGF signaling pathway in gastric cancer.Biochem Biophys Res Commun. 2019 Jun 30;514(3):933-939. doi: 10.1016/j.bbrc.2019.05.076. Epub 2019 May 11.
• [100] Genetic polymorphisms in the 9p21 region associated with risk of multiple cancers.Carcinogenesis. 2014 Dec;35(12):2698-705. doi: 10.1093/carcin/bgu203. Epub 2014 Sep 19.
• [101] IGFBP1 Is a Predictive Factor for Haematogenous Metastasis in Patients With Gastric Cancer.Anticancer Res. 2019 Jun;39(6):2829-2837. doi: 10.21873/anticanres.13411.
• [102] The reciprocal interaction between tumor cells and activated fibroblasts mediated by TNF-/IL-33/ST2L signaling promotes gastric cancer metastasis.Oncogene. 2020 Feb;39(7):1414-1428. doi: 10.1038/s41388-019-1078-x. Epub 2019 Oct 28.
• [103] INHBA gene silencing inhibits gastric cancer cell migration and invasion by impeding activation of the TGF- signaling pathway.J Cell Physiol. 2019 Aug;234(10):18065-18074. doi: 10.1002/jcp.28439. Epub 2019 Apr 8.
• [104] Sophoridine suppresses macrophage-mediated immunosuppression through TLR4/IRF3 pathway and subsequently upregulates CD8(+) T cytotoxic function against gastric cancer.Biomed Pharmacother. 2020 Jan;121:109636. doi: 10.1016/j.biopha.2019.109636. Epub 2019 Nov 13.
• [105] Integrin subunit alpha V promotes growth, migration, and invasion of gastric cancer cells.Pathol Res Pract. 2019 Sep;215(9):152531. doi: 10.1016/j.prp.2019.152531. Epub 2019 Jul 10.
• [106] miR-200c inhibits TGF--induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer.Cancer Gene Ther. 2018 May;25(3-4):68-76. doi: 10.1038/s41417-017-0005-y. Epub 2018 Jan 4.
• [107] MicroRNA-4513 Promotes Gastric Cancer Cell Proliferation and Epithelial-Mesenchymal Transition Through Targeting KAT6B.Hum Gene Ther Clin Dev. 2019 Sep;30(3):142-148. doi: 10.1089/humc.2019.094.
• [108] NEK2 promotes proliferation, migration and tumor growth of gastric cancer cells via regulating KDM5B/H3K4me3.Am J Cancer Res. 2019 Nov 1;9(11):2364-2378. eCollection 2019.
• [109] Long non-coding RNA LINC01314 represses cell migration, invasion, and angiogenesis in gastric cancer via the Wnt/-catenin signaling pathway by down-regulating KLK4.Cancer Cell Int. 2019 Apr 11;19:94. doi: 10.1186/s12935-019-0799-9. eCollection 2019.
• [110] Expression levels of UL16 binding protein 1 and natural killer group 2 member D affect overall survival in patients with gastric cancer following gastrectomy.Oncol Lett. 2018 Jan;15(1):747-754. doi: 10.3892/ol.2017.7354. Epub 2017 Nov 6.
• [111] Soluble LAG3 acts as a potential prognostic marker of gastric cancer and its positive correlation with CD8+T cell frequency and secretion of IL-12 and INF- in peripheral blood.Cancer Biomark. 2018;23(3):341-351. doi: 10.3233/CBM-181278.
• [112] Leukemia inhibitory factor inhibits the proliferation of gastric cancer by inducing G1-phase arrest.J Cell Physiol. 2019 Apr;234(4):3613-3620. doi: 10.1002/jcp.27083. Epub 2018 Nov 22.
• [113] A novel scoring system for gastric cancer risk assessment based on the expression of three CLIP4 DNA methylation-associated genes.Int J Oncol. 2018 Aug;53(2):633-643. doi: 10.3892/ijo.2018.4433. Epub 2018 Jun 6.
• [114] A positive feedback between IDO1 metabolite and COL12A1 via MAPK pathway to promote gastric cancer metastasis.J Exp Clin Cancer Res. 2019 Jul 17;38(1):314. doi: 10.1186/s13046-019-1318-5.
• [115] MiR-122-5p suppresses the proliferation, migration, and invasion of gastric cancer cells by targeting LYN.Acta Biochim Biophys Sin (Shanghai). 2020 Jan 2;52(1):49-57. doi: 10.1093/abbs/gmz141.
• [116] Expression of the potential therapeutic target claudin-18.2 is frequently decreased in gastric cancer: results from a large Caucasian cohort study.Virchows Arch. 2019 Nov;475(5):563-571. doi: 10.1007/s00428-019-02624-7. Epub 2019 Jul 22.
• [117] Erratum: PLK1 as a potential prognostic marker of gastric cancer through MEK-ER K pathway on PDTX models [Corrigendum].Onco Targets Ther. 2019 Jan 3;12:413. doi: 10.2147/OTT.S199653. eCollection 2019.
• [118] The Gene Curation Coalition: A global effort to harmonize gene-disease evidence resources. Genet Med. 2022 Aug;24(8):1732-1742. doi: 10.1016/j.gim.2022.04.017. Epub 2022 May 4.
• [119] MDM4 genetic variants and risk of gastric cancer in an Eastern Chinese population.Oncotarget. 2017 Mar 21;8(12):19547-19555. doi: 10.18632/oncotarget.14666.
• [120] Macrophage migration inhibitory factor as a potential prognostic factor in gastric cancer.World J Gastroenterol. 2015 Sep 14;21(34):9916-26. doi: 10.3748/wjg.v21.i34.9916.
• [121] Overexpression of MMP21 and MMP28 is associated with gastric cancer progression and poor prognosis.Oncol Lett. 2018 May;15(5):7776-7782. doi: 10.3892/ol.2018.8328. Epub 2018 Mar 22.
• [122] Clinical Factors Associated With Gastric Cancer in Individuals With Lynch Syndrome.Clin Gastroenterol Hepatol. 2020 Apr;18(4):830-837.e1. doi: 10.1016/j.cgh.2019.07.012. Epub 2019 Jul 15.
• [123] Epigenetic downregulation of MUC17 by H. pylori infection facilitates NF-B-mediated expression of CEACAM1-3S in human gastric cancer.Gastric Cancer. 2019 Sep;22(5):941-954. doi: 10.1007/s10120-019-00932-0. Epub 2019 Feb 18.
• [124] Dietary n-3 and n-6 polyunsaturated fatty acids, the FADS gene, and the risk of gastric cancer in a Korean population.Sci Rep. 2018 Feb 28;8(1):3823. doi: 10.1038/s41598-018-21960-3.
• [125] NEDD9 Facilitates Hypoxia-Induced Gastric Cancer Cell Migration via MICAL1 Related Rac1 Activation.Front Pharmacol. 2019 Apr 4;10:291. doi: 10.3389/fphar.2019.00291. eCollection 2019.
• [126] Never-in-mitosis A-related kinase 8, a novel target of von-Hippel-Lindau tumor suppressor protein, promotes gastric cancer cell proliferation.Oncol Lett. 2018 Nov;16(5):5900-5906. doi: 10.3892/ol.2018.9328. Epub 2018 Aug 20.
• [127] High Expression of NLRC5 Is Associated with Prognosis of Gastric Cancer.Open Med (Wars). 2018 Oct 4;13:443-449. doi: 10.1515/med-2018-0066. eCollection 2018.
• [128] Downregulation of nicotinamide nucleotide transhydrogenase and its naturally occurring antisense RNA in gastric cancer.Asia Pac J Clin Oncol. 2019 Oct;15(5):e191-e196. doi: 10.1111/ajco.13230. Epub 2019 Jul 16.
• [129] The genetic association between iNOS and eNOS polymorphisms and gastric cancer risk: a meta-analysis.Onco Targets Ther. 2018 May 3;11:2497-2507. doi: 10.2147/OTT.S161925. eCollection 2018.
• [130] NADPH oxidase 4 is correlated with gastric cancer progression and predicts a poor prognosis.Am J Transl Res. 2019 Jun 15;11(6):3518-3530. eCollection 2019.
• [131] Association of nucleotide excision repair pathway gene polymorphisms with gastric cancer and atrophic gastritis risks.Oncotarget. 2016 Feb 9;7(6):6972-83. doi: 10.18632/oncotarget.6853.
• [132] NT5E is associated with unfavorable prognosis and regulates cell proliferation and motility in gastric cancer.Biosci Rep. 2019 May 17;39(5):BSR20190101. doi: 10.1042/BSR20190101. Print 2019 May 31.
• [133] Knockdown of ARK5 Expression Suppresses Invasion and Metastasis of Gastric Cancer.Cell Physiol Biochem. 2017;42(3):1025-1036. doi: 10.1159/000478685. Epub 2017 Jun 28.
• [134] Gastric cancer may share genetic predisposition with esophageal squamous cell carcinoma in Chinese populations.J Hum Genet. 2018 Nov;63(11):1159-1168. doi: 10.1038/s10038-018-0501-4. Epub 2018 Sep 10.
• [135] Hypomethylated gene NRP1 is co-expressed with PDGFRB and associated with poor overall survival in gastric cancer patients.Biomed Pharmacother. 2019 Mar;111:1334-1341. doi: 10.1016/j.biopha.2019.01.023. Epub 2019 Jan 16.
• [136] UFM1 suppresses invasive activities of gastric cancer cells by attenuating the expres7sion of PDK1 through PI3K/AKT signaling.J Exp Clin Cancer Res. 2019 Sep 18;38(1):410. doi: 10.1186/s13046-019-1416-4.
• [137] Exosomal miR-21-5p derived from gastric cancer promotes peritoneal metastasis via mesothelial-to-mesenchymal transition.Cell Death Dis. 2018 Aug 28;9(9):854. doi: 10.1038/s41419-018-0928-8.
• [138] Association of 758 G/A polymorphism of 3'untranslated region of prohibitin with risk of gastric cancer.J Clin Lab Anal. 2018 Jan;32(1):e22182. doi: 10.1002/jcla.22182. Epub 2017 Mar 13.
• [139] Proviral insertion in murine lymphomas 2 promotes stomach cancer progression by regulating apoptosis via reactive oxygen species-triggered endoplasmic reticulum stress.Biochem Biophys Res Commun. 2018 Nov 17;506(1):145-152. doi: 10.1016/j.bbrc.2018.09.062. Epub 2018 Oct 16.
• [140] Bufothionine exerts anti-cancer activities in gastric cancer through Pim3.Life Sci. 2019 Sep 1;232:116615. doi: 10.1016/j.lfs.2019.116615. Epub 2019 Jun 28.
• [141] PLOD2 as a potential regulator of peritoneal dissemination in gastric cancer.Int J Cancer. 2018 Sep 1;143(5):1202-1211. doi: 10.1002/ijc.31410. Epub 2018 Apr 20.
• [142] Cyclophilin A Enhances Cell Proliferation and Xenografted Tumor Growth of Early Gastric Cancer.Dig Dis Sci. 2015 Sep;60(9):2700-11. doi: 10.1007/s10620-015-3694-9. Epub 2015 May 26.
• [143] Plasma activity of Thioredoxin Reductase as a Novel Biomarker in Gastric Cancer.Sci Rep. 2019 Dec 13;9(1):19084. doi: 10.1038/s41598-019-55641-6.
• [144] Monoclonal antibody 3H11 chimeric antigen receptors enhance T cell effector function and exhibit efficacy against gastric cancer.Oncol Lett. 2018 May;15(5):6887-6894. doi: 10.3892/ol.2018.8255. Epub 2018 Mar 13.
• [145] Clinical Significance of PRKCI Gene Expression in Cancerous Tissue in Patients With Gastric Cancer.Anticancer Res. 2019 Oct;39(10):5715-5720. doi: 10.21873/anticanres.13771.
• [146] Sanguinarine inhibits the tumorigenesis of gastric cancer by regulating the TOX/DNA-PKcs/ KU70/80 pathway.Pathol Res Pract. 2019 Nov;215(11):152677. doi: 10.1016/j.prp.2019.152677. Epub 2019 Sep 27.
• [147] Circ-PRMT5 promotes gastric cancer progression by sponging miR-145 and miR-1304 to upregulate MYC.Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):4120-4130. doi: 10.1080/21691401.2019.1671857.
• [148] MicroRNA-133a inhibits gastric cancer cells growth, migration, and epithelial-mesenchymal transition process by targeting presenilin 1.J Cell Biochem. 2019 Jan;120(1):470-480. doi: 10.1002/jcb.27403. Epub 2018 Aug 30.
• [149] PGD2/PTGDR2 Signaling Restricts the Self-Renewal and Tumorigenesis of Gastric Cancer.Stem Cells. 2018 Jul;36(7):990-1003. doi: 10.1002/stem.2821. Epub 2018 Apr 4.
• [150] Evidence for PTGER4, PSCA, and MBOAT7 as risk genes for gastric cancer on the genome and transcriptome level.Cancer Med. 2018 Oct;7(10):5057-5065. doi: 10.1002/cam4.1719. Epub 2018 Sep 6.
• [151] Apatinib suppresses the Proliferation and Apoptosis of Gastric Cancer Cells via the PI3K/Akt Signaling Pathway.J BUON. 2019 Sep-Oct;24(5):1985-1991.
• [152] Therapeutic silence of pleiotrophin by targeted delivery of siRNA and its effect on the inhibition of tumor growth and metastasis.PLoS One. 2017 May 31;12(5):e0177964. doi: 10.1371/journal.pone.0177964. eCollection 2017.
• [153] miR-146b Regulates Cell Proliferation and Apoptosis in Gastric Cancer by Targeting PTP1B.Dig Dis Sci. 2020 Feb;65(2):457-463. doi: 10.1007/s10620-019-05771-8. Epub 2019 Aug 22.
• [154] The chemopreventive effect of -cryptoxanthin from mandarin on human stomach cells (BGC-823).Food Chem. 2013 Feb 15;136(3-4):1122-9. doi: 10.1016/j.foodchem.2012.09.073. Epub 2012 Sep 28.
• [155] REG3A overexpression suppresses gastric cancer cell invasion, proliferation and promotes apoptosis through PI3K/Akt signaling pathway.Int J Mol Med. 2018 Jun;41(6):3167-3174. doi: 10.3892/ijmm.2018.3520. Epub 2018 Feb 28.
• [156] SYT7 acts as a driver of hepatic metastasis formation of gastric cancer cells.Oncogene. 2018 Sep;37(39):5355-5366. doi: 10.1038/s41388-018-0335-8. Epub 2018 Jun 1.
• [157] Rapamycin-insensitive companion of mTOR (RICTOR) amplification defines a subset of advanced gastric cancer and is sensitive to AZD2014-mediated mTORC1/2 inhibition.Ann Oncol. 2017 Mar 1;28(3):547-554. doi: 10.1093/annonc/mdw669.
• [158] Association between receptor interacting serine/threonine kinase 2 polymorphisms and gastric cancer susceptibility.Oncol Lett. 2018 Mar;15(3):3772-3778. doi: 10.3892/ol.2018.7785. Epub 2018 Jan 12.
• [159] Ring finger protein 43 associates with gastric cancer progression and attenuates the stemness of gastric cancer stem-like cells via the Wnt-/catenin signaling pathway.Stem Cell Res Ther. 2017 Apr 26;8(1):98. doi: 10.1186/s13287-017-0548-8.
• [160] Knockdown of RNF6 inhibits gastric cancer cell growth by suppressing STAT3 signaling.Onco Targets Ther. 2018 Oct 5;11:6579-6587. doi: 10.2147/OTT.S174846. eCollection 2018.
• [161] WNT/PCP signaling pathway and human cancer (review).Oncol Rep. 2005 Dec;14(6):1583-8.
• [162] Nuclear receptor retinoid-related orphan receptor alpha promotes apoptosis but is reduced in human gastric cancer.Oncotarget. 2017 Feb 14;8(7):11105-11113. doi: 10.18632/oncotarget.14364.
• [163] MGr1-Antigen/37 kDa laminin receptor precursor promotes cellular prion protein induced multi-drug-resistance of gastric cancer.Oncotarget. 2017 May 11;8(42):71630-71641. doi: 10.18632/oncotarget.17795. eCollection 2017 Sep 22.
• [164] S100A6 as a potential serum prognostic biomarker and therapeutic target in gastric cancer.Dig Dis Sci. 2014 Sep;59(9):2136-44. doi: 10.1007/s10620-014-3137-z. Epub 2014 Apr 5.
• [165] Distinct prognostic roles of S100 mRNA expression in gastric cancer.Pathol Res Pract. 2019 Jan;215(1):127-136. doi: 10.1016/j.prp.2018.10.034. Epub 2018 Nov 2.
• [166] Reduced expression and loss of heterozygosity of the SDHD gene in colorectal and gastric cancer.Oncol Rep. 2003 Sep-Oct;10(5):1375-80.
• [167] Serpin peptidase inhibitor clade A member 1 is a biomarker of poor prognosis in gastric cancer.Br J Cancer. 2014 Nov 11;111(10):1993-2002. doi: 10.1038/bjc.2014.490. Epub 2014 Sep 11.
• [168] ISL1 predicts poor outcomes for patients with gastric cancer and drives tumor progression through binding to the ZEB1 promoter together with SETD7.Cell Death Dis. 2019 Jan 15;10(2):33. doi: 10.1038/s41419-018-1278-2.
• [169] Phosphorylation by mTORC1 stablizes Skp2 and regulates its oncogenic function in gastric cancer.Mol Cancer. 2017 Apr 26;16(1):83. doi: 10.1186/s12943-017-0649-0.
• [170] MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis.Oncotarget. 2016 Jul 12;7(28):43492-43503. doi: 10.18632/oncotarget.9523.
• [171] Topotecan induces apoptosis via ASCT2 mediated oxidative stress in gastric cancer.Phytomedicine. 2019 Apr;57:117-128. doi: 10.1016/j.phymed.2018.12.011. Epub 2018 Dec 11.
• [172] SLC22A16 upregulation is an independent unfavorable prognostic indicator in gastric cancer.Future Oncol. 2018 Sep;14(21):2139-2148. doi: 10.2217/fon-2018-0207. Epub 2018 Apr 26.
• [173] Functional analysis and clinical significance of sodium iodide symporter expression in gastric cancer.Gastric Cancer. 2019 May;22(3):473-485. doi: 10.1007/s10120-018-0874-2. Epub 2018 Sep 6.
• [174] SOX5 promotes cell invasion and metastasis via activation of Twist-mediated epithelial-mesenchymal transition in gastric cancer.Onco Targets Ther. 2019 Apr 3;12:2465-2476. doi: 10.2147/OTT.S197087. eCollection 2019.
• [175] SPHK1-induced autophagy in peritoneal mesothelial cell enhances gastric cancer peritoneal dissemination.Cancer Med. 2019 Apr;8(4):1731-1743. doi: 10.1002/cam4.2041. Epub 2019 Feb 21.
• [176] Autophagy inhibition enhances PD-L1 expression in gastric cancer.J Exp Clin Cancer Res. 2019 Mar 29;38(1):140. doi: 10.1186/s13046-019-1148-5.
• [177] Micheliolide inhibits gastric cancer growth in vitro and in vivo via blockade of the IL-6/STAT3 pathway.Pharmazie. 2019 Mar 1;74(3):175-178. doi: 10.1691/ph.2019.8816.
• [178] Krppel-like Factor 4 Suppresses Serine/Threonine Kinase 33 Activation and Metastasis of Gastric Cancer through Reversing Epithelial-Mesenchymal Transition.Clin Cancer Res. 2018 May 15;24(10):2440-2451. doi: 10.1158/1078-0432.CCR-17-3346. Epub 2018 Jan 24.
• [179] Low STYK1 expression indicates poor prognosis in gastric cancer.Cancer Manag Res. 2018 Dec 6;10:6669-6676. doi: 10.2147/CMAR.S181910. eCollection 2018.
• [180] Epigenetic silenced miR-125a-5p could be self-activated through targeting Suv39H1 in gastric cancer.J Cell Mol Med. 2018 Oct;22(10):4721-4731. doi: 10.1111/jcmm.13716. Epub 2018 Aug 17.
• [181] LASSObased CoxPH model identifies an 11lncRNA signature for prognosis prediction in gastric cancer.Mol Med Rep. 2018 Dec;18(6):5579-5593. doi: 10.3892/mmr.2018.9567. Epub 2018 Oct 22.
• [182] Role of Helicobacter pylori infection in aberrant DNA methylation along multistep gastric carcinogenesis.Cancer Sci. 2010 Jun;101(6):1337-46. doi: 10.1111/j.1349-7006.2010.01535.x. Epub 2010 Feb 18.
• [183] Clinical significance of CD8(+) T cell immunoreceptor with Ig and ITIM domains(+) in locally advanced gastric cancer treated with SOX regimen after D2 gastrectomy.Oncoimmunology. 2019 Apr 1;8(6):e1593807. doi: 10.1080/2162402X.2019.1593807. eCollection 2019.
• [184] Clinical significance and diagnostic capacity of serum TK1, CEA, CA 19-9 and CA 72-4 levels in gastric and colorectal cancer patients.J Cancer. 2018 Jan 1;9(3):494-501. doi: 10.7150/jca.21562. eCollection 2018.
• [185] Evaluation of toll-like receptors as prognostic biomarkers in gastric cancer: high tissue TLR5 predicts a better outcome.Sci Rep. 2019 Aug 29;9(1):12553. doi: 10.1038/s41598-019-49111-2.
• [186] Could OX40 agonist antibody promote activation of the anti-tumor immune response in gastric cancer?.J Surg Oncol. 2018 Apr;117(5):840-844. doi: 10.1002/jso.25001. Epub 2018 Mar 12.
• [187] Stimulation of natural killer cells with rhCD137 ligand enhances tumor-targeting antibody efficacy in gastric cancer.PLoS One. 2018 Oct 15;13(10):e0204880. doi: 10.1371/journal.pone.0204880. eCollection 2018.
• [188] High TREM2 expression correlates with poor prognosis in gastric cancer.Hum Pathol. 2018 Feb;72:91-99. doi: 10.1016/j.humpath.2017.10.026. Epub 2017 Nov 2.
• [189] TRIM59 Is a Novel Marker of Poor Prognosis and Promotes Malignant Progression of Ovarian Cancer by Inducing Annexin A2 Expression.Int J Biol Sci. 2018 Nov 3;14(14):2073-2082. doi: 10.7150/ijbs.28757. eCollection 2018.
• [190] TRPC1/3/6 inhibition attenuates the TGF-1-induced epithelial-mesenchymal transition in gastric cancer via the Ras/Raf1/ERK signaling pathway.Cell Biol Int. 2018 Aug;42(8):975-984. doi: 10.1002/cbin.10963. Epub 2018 May 10.
• [191] TRPM2 channel-mediated regulation of autophagy maintains mitochondrial function and promotes gastric cancer cell survival via the JNK-signaling pathway.J Biol Chem. 2018 Mar 9;293(10):3637-3650. doi: 10.1074/jbc.M117.817635. Epub 2018 Jan 17.
• [192] Biomarkers of gastric cancer-related ischemic stroke and its underlying pathogenesis.Medicine (Baltimore). 2018 Apr;97(17):e0493. doi: 10.1097/MD.0000000000010493.
• [193] Clinical significance of UGT1A1 polymorphism and expression of ERCC1, BRCA1, TYMS, RRM1, TUBB3, STMN1 and TOP2A in gastric cancer.BMC Gastroenterol. 2017 Jan 5;17(1):2. doi: 10.1186/s12876-016-0561-x.
• [194] Targeting autophagy potentiates antitumor activity of Met-TKIs against Met-amplified gastric cancer.Cell Death Dis. 2019 Feb 13;10(2):139. doi: 10.1038/s41419-019-1314-x.
• [195] Impact of intratumoral expression levels of fluoropyrimidine-metabolizing enzymes on treatment outcomes of adjuvant S-1 therapy in gastric cancer.PLoS One. 2015 Mar 20;10(3):e0120324. doi: 10.1371/journal.pone.0120324. eCollection 2015.
• [196] USP14 as a novel prognostic marker promotes cisplatin resistance via Akt/ERK signaling pathways in gastric cancer.Cancer Med. 2018 Nov;7(11):5577-5588. doi: 10.1002/cam4.1770. Epub 2018 Sep 17.
• [197] circHECTD1 facilitates glutaminolysis to promote gastric cancer progression by targeting miR-1256 and activating -catenin/c-Myc signaling.Cell Death Dis. 2019 Aug 2;10(8):576. doi: 10.1038/s41419-019-1814-8.
• [198] Indomethacin impairs mitochondrial dynamics by activating the PKC-p38-DRP1 pathway and inducing apoptosis in gastric cancer and normal mucosal cells.J Biol Chem. 2019 May 17;294(20):8238-8258. doi: 10.1074/jbc.RA118.004415. Epub 2019 Apr 2.
• [199] Long non-coding RNA CASC15 regulates gastric cancer cell proliferation, migration and epithelial mesenchymal transition by targeting CDKN1A and ZEB1.Mol Oncol. 2018 Jun;12(6):799-813. doi: 10.1002/1878-0261.12187. Epub 2018 May 9.
• [200] miR-127 suppresses gastric cancer cell migration and invasion via targeting Wnt7a.Oncol Lett. 2019 Mar;17(3):3219-3226. doi: 10.3892/ol.2019.9955. Epub 2019 Jan 21.
• [201] Genetic variants in XDH are associated with prognosis for gastric cancer in a Chinese population.Gene. 2018 Jul 15;663:196-202. doi: 10.1016/j.gene.2018.03.043. Epub 2018 Mar 15.
• [202] Exosomal transfer of miR-501 confers doxorubicin resistance and tumorigenesis via targeting of BLID in gastric cancer.Cancer Lett. 2019 Sep 10;459:122-134. doi: 10.1016/j.canlet.2019.05.035. Epub 2019 Jun 5.
• [203] KLF8 is associated with poor prognosis and regulates glycolysis by targeting GLUT4 in gastric cancer.J Cell Mol Med. 2019 Aug;23(8):5087-5097. doi: 10.1111/jcmm.14378. Epub 2019 May 24.
• [204] ADAM17 promotes lymph node metastasis in gastric cancer via activation of the Notch and Wnt signaling pathways.Int J Mol Med. 2019 Feb;43(2):914-926. doi: 10.3892/ijmm.2018.4028. Epub 2018 Dec 17.
• [205] Lower Sympathetic Nervous System Density and -adrenoreceptor Expression Are Involved in Gastric Cancer Progression.Anticancer Res. 2019 Jan;39(1):231-236. doi: 10.21873/anticanres.13102.
• [206] Long noncoding RNA SOX2OT contributes to gastric cancer progression by sponging miR-194-5p from AKT2.Exp Cell Res. 2018 Aug 15;369(2):187-196. doi: 10.1016/j.yexcr.2018.05.017. Epub 2018 May 18.
• [207] Prognostic importance of the preoperative modified systemic inflammation score for patients with gastric cancer.Gastric Cancer. 2019 Mar;22(2):403-412. doi: 10.1007/s10120-018-0854-6. Epub 2018 Jul 7.
• [208] Low angiomotin-p130 with concomitant high Yes-associated protein 1 expression is associated with adverse prognosis of advanced gastric cancer.APMIS. 2017 Nov;125(11):996-1006. doi: 10.1111/apm.12750. Epub 2017 Sep 8.
• [209] Expression profiles of Annexin A1, formylated peptide receptors and cyclooxigenase-2 in gastroesophageal inflammations and neoplasias.Pathol Res Pract. 2018 Feb;214(2):181-186. doi: 10.1016/j.prp.2017.12.003. Epub 2017 Dec 7.
• [210] Discovery and validation of methylated-differentially expressed genes in Helicobacter pylori-induced gastric cancer.Cancer Gene Ther. 2020 Jun;27(6):473-485. doi: 10.1038/s41417-019-0125-7. Epub 2019 Jul 16.
• [211] Long-term use of proton-pump inhibitors and risk of gastric cancer: a review of the current evidence.Therap Adv Gastroenterol. 2019 Mar 11;12:1756284819834511. doi: 10.1177/1756284819834511. eCollection 2019.
• [212] Heterozygous ATR mutations in mismatch repair-deficient cancer cells have functional significance.Cancer Res. 2005 Aug 15;65(16):7091-5. doi: 10.1158/0008-5472.CAN-05-1019.
• [213] High BIM mRNA levels are associated with longer survival in advanced gastric cancer.Oncol Lett. 2017 Mar;13(3):1826-1834. doi: 10.3892/ol.2017.5660. Epub 2017 Feb 1.
• [214] Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of Cancer.Cancer Res. 2016 Jan 15;76(2):206-15. doi: 10.1158/0008-5472.CAN-15-0295. Epub 2015 Dec 30.
• [215] Relevance of DNA repair gene polymorphisms to gastric cancer risk and phenotype.Oncotarget. 2017 May 30;8(22):35848-35862. doi: 10.18632/oncotarget.16261.
• [216] Increased BTLA and HVEM in gastric cancer are associated with progression and poor prognosis.Onco Targets Ther. 2017 Feb 16;10:919-926. doi: 10.2147/OTT.S128825. eCollection 2017.
• [217] Complement C5a/C5aR pathway potentiates the pathogenesis ofgastric cancer by down-regulating p21 expression.Cancer Lett. 2018 Jan 1;412:30-36. doi: 10.1016/j.canlet.2017.10.003. Epub 2017 Oct 12.
• [218] Comparison of the protein expression of calpain-1, calpain-2, calpastatin and calmodulin between gastric cancer and normal gastric mucosa.Oncol Lett. 2017 Sep;14(3):3705-3710. doi: 10.3892/ol.2017.6617. Epub 2017 Jul 20.
• [219] Correlation of Caveolin-1 Expression with Prognosis in Patients with Gastric Cancer after Gastrectomy.Oncol Res Treat. 2017;40(4):185-190. doi: 10.1159/000456620. Epub 2017 Mar 3.
• [220] CBX7 regulates stem cell-like properties of gastric cancer cells via p16 and AKT-NF-B-miR-21 pathways.J Hematol Oncol. 2018 Feb 8;11(1):17. doi: 10.1186/s13045-018-0562-z.
• [221] Identification of An mtDNA Setpoint Associated with Highest Levels of CD44 Positivity and Chemoresistance in HGC-27 and MKN-45 Gastric Cancer Cell Lines.Cell J. 2018 Oct;20(3):312-317. doi: 10.22074/cellj.2018.5309. Epub 2018 May 15.
• [222] B7-H3 promotes gastric cancer cell migration and invasion.Oncotarget. 2017 May 13;8(42):71725-71735. doi: 10.18632/oncotarget.17847. eCollection 2017 Sep 22.
• [223] CD36 mediates palmitate acid-induced metastasis of gastric cancer via AKT/GSK-3/-catenin pathway.J Exp Clin Cancer Res. 2019 Feb 4;38(1):52. doi: 10.1186/s13046-019-1049-7.
• [224] Cadherin 5 expression correlates with poor survival in human gastric cancer.J Clin Pathol. 2017 Mar;70(3):217-221. doi: 10.1136/jclinpath-2016-203640. Epub 2016 Jul 26.
• [225] LncRNA CASC11 promoted gastric cancer cell proliferation, migration and invasion in vitro by regulating cell cycle pathway.Cell Cycle. 2018;17(15):1886-1900. doi: 10.1080/15384101.2018.1502574. Epub 2018 Sep 10.
• [226] CDK5 suppresses the metastasis of gastric cancer cells by interacting with and regulating PP2A.Oncol Rep. 2019 Feb;41(2):779-788. doi: 10.3892/or.2018.6860. Epub 2018 Nov 9.
• [227] Dual role of carcinoembryonic antigen-related cell adhesion molecule 6 expression in predicting the overall survival of gastric cancer patients.Sci Rep. 2017 Sep 7;7(1):10773. doi: 10.1038/s41598-017-11482-9.
• [228] Enrichment of CLDN18-ARHGAP fusion gene in gastric cancers in young adults.Cancer Sci. 2019 Apr;110(4):1352-1363. doi: 10.1111/cas.13967.
• [229] MACC1 mediates chemotherapy sensitivity of 5-FU and cisplatin via regulating MCT1 expression in gastric cancer.Biochem Biophys Res Commun. 2017 Apr 8;485(3):665-671. doi: 10.1016/j.bbrc.2017.02.096. Epub 2017 Feb 21.
• [230] Effects of vascular endothelial growth factor and epidermal growth factor on biological properties of gastric cancer cells.Arch Med Sci. 2019 Oct;15(6):1498-1509. doi: 10.5114/aoms.2019.88443. Epub 2019 Oct 7.
• [231] GATA6 suppresses migration and metastasis by regulating the miR-520b/CREB1 axis in gastric cancer.Cell Death Dis. 2019 Jan 15;10(2):35. doi: 10.1038/s41419-018-1270-x.
• [232] Tumor antigen-specific CD8(+) T cells are negatively regulated by PD-1 and Tim-3 in human gastric cancer.Cell Immunol. 2017 Mar;313:43-51. doi: 10.1016/j.cellimm.2017.01.001. Epub 2017 Jan 5.
• [233] Chemokine Receptor CXCR3 Correlates with Decreased M2 Macrophage Infiltration and Favorable Prognosis in Gastric Cancer.Biomed Res Int. 2019 May 21;2019:6832867. doi: 10.1155/2019/6832867. eCollection 2019.
• [234] Circular RNA and gene expression profiles in gastric cancer based on microarray chip technology.Oncol Rep. 2017 Mar;37(3):1804-1814. doi: 10.3892/or.2017.5415. Epub 2017 Feb 1.
• [235] A Serological Biopsy Using Five Stomach-Specific Circulating Biomarkers for Gastric Cancer Risk Assessment: A Multi-Phase Study.Am J Gastroenterol. 2017 May;112(5):704-715. doi: 10.1038/ajg.2017.55. Epub 2017 Mar 21.
• [236] DDR2 Induces Gastric Cancer Cell Activities via Activating mTORC2 Signaling and Is Associated with Clinicopathological Characteristics of Gastric Cancer.Dig Dis Sci. 2016 Aug;61(8):2272-2283. doi: 10.1007/s10620-016-4116-3. Epub 2016 Mar 24.
• [237] miR-5590-3p inhibited tumor growth in gastric cancer by targeting DDX5/AKT/m-TOR pathway.Biochem Biophys Res Commun. 2018 Sep 10;503(3):1491-1497. doi: 10.1016/j.bbrc.2018.07.068. Epub 2018 Jul 17.
• [238] LncRNA SNHG16 promotes epithelial- mesenchymal transition via down-regulation of DKK3 in gastric cancer.Cancer Biomark. 2019;26(4):393-401. doi: 10.3233/CBM-190497.
• [239] The Impact of the Expression Level of Intratumoral Dihydropyrimidine Dehydrogenase on Chemotherapy Sensitivity and Survival of Patients in Gastric Cancer: A Meta-Analysis.Dis Markers. 2017;2017:9202676. doi: 10.1155/2017/9202676. Epub 2017 Jan 31.
• [240] The significance of ENAH in carcinogenesis and prognosis in gastric cancer.Oncotarget. 2017 Aug 2;8(42):72466-72479. doi: 10.18632/oncotarget.19801. eCollection 2017 Sep 22.
• [241] EphA3 contributes to tumor growth and angiogenesis in human gastric cancer cells.Oncol Rep. 2018 Oct;40(4):2408-2416. doi: 10.3892/or.2018.6586. Epub 2018 Jul 20.
• [242] Epidermal Growth Factor Receptor Family and its Role in Gastric Cancer.Front Oncol. 2019 Nov 26;9:1308. doi: 10.3389/fonc.2019.01308. eCollection 2019.
• [243] Thrombin conducts epithelialmesenchymal transition via proteaseactivated receptor? in human gastric cancer.Int J Oncol. 2014 Dec;45(6):2287-94. doi: 10.3892/ijo.2014.2651. Epub 2014 Sep 15.
• [244] ASPP2 suppresses invasion and TGF-1-induced epithelial-mesenchymal transition by inhibiting Smad7 degradation mediated by E3 ubiquitin ligase ITCH in gastric cancer.Cancer Lett. 2017 Jul 10;398:52-61. doi: 10.1016/j.canlet.2017.04.002. Epub 2017 Apr 9.
• [245] Stromal fibroblast activation protein alpha promotes gastric cancer progression via epithelial-mesenchymal transition through Wnt/ -catenin pathway.BMC Cancer. 2018 Nov 12;18(1):1099. doi: 10.1186/s12885-018-5035-9.
• [246] Small interfering RNA-mediated knockdown of fatty acid synthase attenuates the proliferation and metastasis of human gastric cancer cells via the mTOR/Gli1 signaling pathway.Oncol Lett. 2018 Jul;16(1):594-602. doi: 10.3892/ol.2018.8648. Epub 2018 May 7.
• [247] Verteporfin inhibits gastric cancer cell growth by suppressing adhesion molecule FAT1.Oncotarget. 2017 Oct 19;8(58):98887-98897. doi: 10.18632/oncotarget.21946. eCollection 2017 Nov 17.
• [248] Abnormal FHIT protein expression may be correlated with poor prognosis in gastric cancer: a meta-analysis.Tumour Biol. 2014 Jul;35(7):6815-21. doi: 10.1007/s13277-014-1936-7. Epub 2014 Apr 12.
• [249] Folate receptor 1 (FOLR1) targeted chimeric antigen receptor (CAR) T cells for the treatment of gastric cancer.PLoS One. 2018 Jun 6;13(6):e0198347. doi: 10.1371/journal.pone.0198347. eCollection 2018.
• [250] Fucosyltransferase-4 and Oligosaccharide Lewis Y Antigen as potentially Correlative Biomarkers of Helicobacter pylori CagA Associated Gastric Cancer.Pathol Oncol Res. 2017 Jan;23(1):173-179. doi: 10.1007/s12253-016-0122-1. Epub 2016 Oct 18.
• [251] MicroRNA-144 functions as a tumor suppressor in gastric cancer by targeting cyclooxygenase-2.Exp Ther Med. 2018 Mar;15(3):3088-3095. doi: 10.3892/etm.2018.5763. Epub 2018 Jan 17.
• [252] Utility of GDF-15 as a diagnostic biomarker in gastric cancer: an investigation combining GEO, TCGA and meta-analysis.FEBS Open Bio. 2018 Nov 28;9(1):35-42. doi: 10.1002/2211-5463.12537. eCollection 2019 Jan.
• [253] Tumor and serum gamma-glutamyl transpeptidase, new prognostic and molecular interpretation of an old biomarker in gastric cancer.Oncotarget. 2017 May 30;8(22):36171-36184. doi: 10.18632/oncotarget.15609.
• [254] Grhl2 reduces invasion and migration through inhibition of TGF-induced EMT in gastric cancer.Oncogenesis. 2017 Jan 9;6(1):e284. doi: 10.1038/oncsis.2016.83.
• [255] Long noncoding RNA UCA1 promotes tumour metastasis by inducing GRK2 degradation in gastric cancer.Cancer Lett. 2017 Nov 1;408:10-21. doi: 10.1016/j.canlet.2017.08.013. Epub 2017 Aug 23.
• [256] HDAC is indispensable for IFN--induced B7-H1 expression in gastric cancer.Clin Epigenetics. 2018 Dec 11;10(1):153. doi: 10.1186/s13148-018-0589-6.
• [257] Expression profiles of histone modification genes in gastric cancer progression.Mol Biol Rep. 2018 Dec;45(6):2275-2282. doi: 10.1007/s11033-018-4389-z. Epub 2018 Sep 24.
• [258] A novel HDAC6 inhibitor exerts an anti-cancer effect by triggering cell cycle arrest and apoptosis in gastric cancer.Eur J Pharmacol. 2018 Jun 5;828:67-79. doi: 10.1016/j.ejphar.2018.03.026. Epub 2018 Mar 19.
• [259] The expression of HDAC7 in cancerous gastric tissues is positively associated with distant metastasis and poor patient prognosis.Clin Transl Oncol. 2017 Aug;19(8):1045-1054. doi: 10.1007/s12094-017-1639-9. Epub 2017 Mar 15.
• [260] HNF4 pathway mapping identifies wild-type IDH1 as a targetable metabolic node in gastric cancer.Gut. 2020 Feb;69(2):231-242. doi: 10.1136/gutjnl-2018-318025. Epub 2019 May 8.
• [261] Endoplasmic reticulum chaperone glucose-regulated protein 78 in gastric cancer: An emerging biomarker.Oncol Lett. 2018 May;15(5):6087-6093. doi: 10.3892/ol.2018.8114. Epub 2018 Feb 26.
• [262] Clinicopathological significance of HSP27 in gastric cancer: a meta-analysis.Onco Targets Ther. 2017 Sep 13;10:4543-4551. doi: 10.2147/OTT.S146590. eCollection 2017.
• [263] miR-93-5p/IFNAR1 axis promotes gastric cancer metastasis through activating the STAT3 signaling pathway.Cancer Lett. 2017 Nov 1;408:23-32. doi: 10.1016/j.canlet.2017.08.017. Epub 2017 Aug 24.
• [264] Antitumor activity of pan-HER inhibitors in HER2-positive gastric cancer.Cancer Sci. 2018 Apr;109(4):1166-1176. doi: 10.1111/cas.13546. Epub 2018 Mar 25.
• [265] MAL and TMEM220 are novel DNA methylation markers in human gastric cancer.Biomarkers. 2017 Feb;22(1):35-44. doi: 10.1080/1354750X.2016.1201542. Epub 2016 Sep 22.
• [266] Expression of microRNAs and IRAK1 pathway genes are altered in gastric cancer patients with Helicobacter pylori infection.J Cell Biochem. 2018 Sep;119(9):7570-7576. doi: 10.1002/jcb.27067. Epub 2018 May 24.
• [267] HMGA2-FOXL2 Axis Regulates Metastases and Epithelial-to-Mesenchymal Transition of Chemoresistant Gastric Cancer.Clin Cancer Res. 2017 Jul 1;23(13):3461-3473. doi: 10.1158/1078-0432.CCR-16-2180. Epub 2017 Jan 24.
• [268] In silico analyses for potential key genes associated with gastric cancer.PeerJ. 2018 Dec 7;6:e6092. doi: 10.7717/peerj.6092. eCollection 2018.
• [269] KCND2 upregulation might be an independent indicator of poor survival in gastric cancer.Future Oncol. 2018 Nov;14(27):2811-2820. doi: 10.2217/fon-2018-0418. Epub 2018 Jul 27.
• [270] KCNMA1 cooperating with PTK2 is a novel tumor suppressor in gastric cancer and is associated with disease outcome.Mol Cancer. 2017 Feb 23;16(1):46. doi: 10.1186/s12943-017-0613-z.
• [271] LINC00460 modulates KDM2A to promote cell proliferation and migration by targeting miR-342-3p in gastric cancer.Onco Targets Ther. 2018 Oct 2;11:6383-6394. doi: 10.2147/OTT.S169307. eCollection 2018.
• [272] Enhancement of Proliferation and Invasion of Gastric Cancer Cell by KDM5C Via Decrease in p53 Expression.Technol Cancer Res Treat. 2017 Apr;16(2):141-149. doi: 10.1177/1533034616629261. Epub 2016 Jul 8.
• [273] Acquired JHDM1D-BRAF Fusion Confers Resistance to FGFR Inhibition in FGFR2-Amplified Gastric Cancer.Mol Cancer Ther. 2018 Oct;17(10):2217-2225. doi: 10.1158/1535-7163.MCT-17-1022. Epub 2018 Jul 25.
• [274] Keratin17 Promotes Tumor Growth and is Associated with Poor Prognosis in Gastric Cancer.J Cancer. 2018 Jan 1;9(2):346-357. doi: 10.7150/jca.19838. eCollection 2018.
• [275] Helicobacter pylori infection promotes epithelial-to-mesenchymal transition of gastric cells by upregulating LAPTM4B.Biochem Biophys Res Commun. 2019 Jun 30;514(3):893-900. doi: 10.1016/j.bbrc.2019.05.036. Epub 2019 May 10.
• [276] Asparaginyl endopeptidase improves the resistance of microtubule-targeting drugs in gastric cancer through IQGAP1 modulating the EGFR/JNK/ERK signaling pathway.Onco Targets Ther. 2017 Feb 3;10:627-643. doi: 10.2147/OTT.S125579. eCollection 2017.
• [277] Diallyl disulfide suppresses epithelial-mesenchymal transition, invasion and proliferation by downregulation of LIMK1 in gastric cancer.Oncotarget. 2016 Mar 1;7(9):10498-512. doi: 10.18632/oncotarget.7252.
• [278] Epigenetic silencing of miR-1271 enhances MEK1 and TEAD4 expression in gastric cancer.Cancer Med. 2018 Jul;7(7):3411-3424. doi: 10.1002/cam4.1605. Epub 2018 Jun 4.
• [279] The Elevated ASK1 Expression Inhibits Proliferation and Invasion in Gastric Cancer HGC-27 Cells.Anat Rec (Hoboken). 2018 Nov;301(11):1815-1819. doi: 10.1002/ar.23906. Epub 2018 Oct 15.
• [280] Gimatecan exerts potent antitumor activity against gastric cancer in vitro and in vivo via AKT and MAPK signaling pathways.J Transl Med. 2017 Dec 13;15(1):253. doi: 10.1186/s12967-017-1360-z.
• [281] Long non-coding RNA MYOSLID functions as a competing endogenous RNA to regulate MCL-1 expression by sponging miR-29c-3p in gastric cancer.Cell Prolif. 2019 Nov;52(6):e12678. doi: 10.1111/cpr.12678. Epub 2019 Sep 9.
• [282] miR-19a/b and MeCP2 repress reciprocally to regulate multidrug resistance in gastric cancer cells.Int J Mol Med. 2018 Jul;42(1):228-236. doi: 10.3892/ijmm.2018.3581. Epub 2018 Mar 22.
• [283] MerTK inhibition by RXDX-106 in MerTK activated gastric cancer cell lines.Oncotarget. 2017 Nov 11;8(62):105727-105734. doi: 10.18632/oncotarget.22394. eCollection 2017 Dec 1.
• [284] Correlation of COX-2 and MMP-13 expressions with gastric cancer and their effects on prognosis.J BUON. 2019 Jan-Feb;24(1):187-193.
• [285] A polymorphism within the mismatch repair gene predicts prognosis and adjuvant chemotherapy benefit in gastric cancer.Gastric Cancer. 2019 Nov;22(6):1121-1129. doi: 10.1007/s10120-019-00962-8. Epub 2019 Apr 15.
• [286] MicroRNA-331 inhibits development of gastric cancer through targeting musashi1.World J Gastrointest Oncol. 2019 Sep 15;11(9):705-716. doi: 10.4251/wjgo.v11.i9.705.
• [287] Downregulation of methylthioadenosin phosphorylase by homozygous deletion in gastric carcinoma.Genes Chromosomes Cancer. 2011 Jun;50(6):421-33. doi: 10.1002/gcc.20867. Epub 2011 Mar 15.
• [288] Fluctuations of epigenetic regulations in human gastric Adenocarcinoma: How does it affect?.Biomed Pharmacother. 2019 Jan;109:144-156. doi: 10.1016/j.biopha.2018.10.094. Epub 2018 Nov 2.
• [289] Nectin-4 promotes gastric cancer progression via the PI3K/AKT signaling pathway.Hum Pathol. 2018 Feb;72:107-116. doi: 10.1016/j.humpath.2017.10.034. Epub 2017 Dec 5.
• [290] RNA binding protein Lin28B confers gastric cancer cells stemness via directly binding to NRP-1.Biomed Pharmacother. 2018 Aug;104:383-389. doi: 10.1016/j.biopha.2018.05.064. Epub 2018 May 25.
• [291] REV-ERB reduction is associated with clinicopathological features and prognosis in human gastric cancer.Oncol Lett. 2018 Aug;16(2):1499-1506. doi: 10.3892/ol.2018.8809. Epub 2018 May 25.
• [292] Liver X receptor (LXR) promoted invasion and EMT of gastric cancer cells by regulation of NF-B activity.Hum Cell. 2017 Apr;30(2):124-132. doi: 10.1007/s13577-016-0157-3. Epub 2017 Jan 16.
• [293] CircRNA_001569 promotes cell proliferation through absorbing miR-145 in gastric cancer.J Biochem. 2019 Jan 1;165(1):27-36. doi: 10.1093/jb/mvy079.
• [294] Validation of Neurotensin Receptor 1 as a Therapeutic Target for Gastric Cancer.Mol Cells. 2018 Jun;41(6):591-602. doi: 10.14348/molcells.2018.0025. Epub 2018 May 24.
• [295] Expression of NUAK2 in gastric cancer tissue and its effects on the proliferation of gastric cancer cells.Exp Ther Med. 2017 Feb;13(2):676-680. doi: 10.3892/etm.2016.3983. Epub 2016 Dec 19.
• [296] PDCD2 and NCoR1 as putative tumor suppressors in gastric gastrointestinal stromal tumors.Cell Oncol (Dordr). 2016 Apr;39(2):129-37. doi: 10.1007/s13402-015-0258-0. Epub 2015 Nov 20.
• [297] 3-Phosphoinositide Dependent Protein Kinase-1 (PDK-1) Promotes Migration and Invasion in Gastric Cancer Cells Through Activating the NF-B Pathway.Oncol Res. 2017 Aug 7;25(7):1153-1159. doi: 10.3727/096504017X14845839228545. Epub 2017 Jan 20.
• [298] RKIP and peroxiredoxin 2 expression predicts the proliferative potential of gastric cancer stem cells.Oncol Lett. 2018 Mar;15(3):3173-3177. doi: 10.3892/ol.2017.7700. Epub 2017 Dec 28.
• [299] Histone demethylase PHF8 promotes progression and metastasis of gastric cancer.Am J Cancer Res. 2017 Mar 1;7(3):448-461. eCollection 2017.
• [300] Global transcriptomic analysis identifies SERPINE1 as a prognostic biomarker associated with epithelial-to-mesenchymal transition in gastric cancer.PeerJ. 2019 Jun 10;7:e7091. doi: 10.7717/peerj.7091. eCollection 2019.
• [301] Effect of PLK1 inhibition on cisplatin-resistant gastric cancer cells.J Cell Physiol. 2019 May;234(5):5904-5914. doi: 10.1002/jcp.26777. Epub 2018 Nov 29.
• [302] Low periostin expression predicts poor survival in intestinal type gastric cancer patients.Cancer Manag Res. 2018 Dec 18;11:25-36. doi: 10.2147/CMAR.S175596. eCollection 2019.
• [303] Constitutive expression of PPAR inhibits proliferation and migration of gastric cancer cells and down-regulates Wnt/-Catenin signaling pathway downstream target genes TERT and ENAH.Gene. 2016 Jun 10;584(1):31-37. doi: 10.1016/j.gene.2016.03.003. Epub 2016 Mar 5.
• [304] Genetic amplification of PPME1 in gastric and lung cancer and its potential as a novel therapeutic target.Cancer Biol Ther. 2014 Jan;15(1):128-34. doi: 10.4161/cbt.27146. Epub 2013 Nov 19.
• [305] Genetic variants in PPP2CA are associated with gastric cancer risk in a Chinese population.Sci Rep. 2017 Sep 13;7(1):11499. doi: 10.1038/s41598-017-12040-z.
• [306] Genome-Wide Association of Genetic Variation in the PSCA Gene with Gastric Cancer Susceptibility in a Korean Population.Cancer Res Treat. 2019 Apr;51(2):748-757. doi: 10.4143/crt.2018.162. Epub 2018 Sep 5.
• [307] PSMB8 and PBK as potential gastric cancer subtype-specific biomarkers associated with prognosis.Oncotarget. 2016 Apr 19;7(16):21454-68. doi: 10.18632/oncotarget.7411.
• [308] Receptor-interacting protein-1 promotes the growth and invasion in gastric cancer.Int J Oncol. 2016 Jun;48(6):2387-98. doi: 10.3892/ijo.2016.3455. Epub 2016 Mar 24.
• [309] EPAC1 overexpression is a prognostic marker and its inhibition shows promising therapeutic potential for gastric cancer.Oncol Rep. 2017 Apr;37(4):1953-1960. doi: 10.3892/or.2017.5442. Epub 2017 Feb 14.
• [310] Silencing the long noncoding RNA NORAD inhibits gastric cancer cell proliferation and invasion by the RhoA/ROCK1 pathway.Eur Rev Med Pharmacol Sci. 2019 May;23(9):3760-3770. doi: 10.26355/eurrev_201905_17802.
• [311] Upregulation of ROCK2 in gastric cancer cell promotes tumor cell proliferation, metastasis and invasion.Clin Exp Med. 2017 Nov;17(4):519-529. doi: 10.1007/s10238-016-0444-z. Epub 2016 Dec 5.
• [312] 18-glycyrrhetinic acid inhibited mitochondrial energy metabolism and gastric carcinogenesis through methylation-regulated TLR2 signaling pathway.Carcinogenesis. 2019 Apr 29;40(2):234-245. doi: 10.1093/carcin/bgy150.
• [313] Identification of hub genes correlated with the pathogenesis and prognosis of gastric cancer via bioinformatics methods.Minerva Med. 2020 Jun;111(3):213-225. doi: 10.23736/S0026-4806.19.06166-4. Epub 2019 Oct 14.
• [314] Heat shock protein 47 regulated by miR-29a to enhance glioma tumor growth and invasion.J Neurooncol. 2014 May;118(1):39-47. doi: 10.1007/s11060-014-1412-7. Epub 2014 Mar 5.
• [315] Quantitative analysis and diagnostic significance of methylated SLC19A3 DNA in the plasma of breast and gastric cancer patients. PLoS One. 2011;6(7):e22233.
• [316] Prognostic Significance of the Expression of CD98 (4F2hc) in Gastric Cancer.Anticancer Res. 2017 Feb;37(2):631-636. doi: 10.21873/anticanres.11357.
• [317] NHE1 is upregulated in gastric cancer and regulates gastric cancer cell proliferation, migration and invasion.Oncol Rep. 2017 Mar;37(3):1451-1460. doi: 10.3892/or.2017.5386. Epub 2017 Jan 18.
• [318] SRPK1 facilitates tumor cell growth via modulating the small nucleolar RNA expression in gastric cancer.J Cell Physiol. 2019 Aug;234(8):13582-13591. doi: 10.1002/jcp.28036. Epub 2019 Jan 11.
• [319] A Positive Feedback Loop of SLP2 Activates MAPK Signaling Pathway to Promote Gastric Cancer Progression.Theranostics. 2018 Nov 10;8(20):5744-5757. doi: 10.7150/thno.28898. eCollection 2018.
• [320] SGT1 regulates Akt signaling by promoting beta-TrCP-dependent PHLPP1 degradation in gastric cancer cells.Mol Biol Rep. 2013 Apr;40(4):2947-53. doi: 10.1007/s11033-012-2363-8. Epub 2013 Feb 26.
• [321] Increased nuclear localization of substance P in human gastric tumor cells.Acta Histochem. 2017 Apr;119(3):337-342. doi: 10.1016/j.acthis.2017.03.003. Epub 2017 Mar 18.
• [322] IKK and TBK1 expression in gastric cancer.Oncotarget. 2017 Mar 7;8(10):16233-16242. doi: 10.18632/oncotarget.9069.
• [323] miR-632 promotes gastric cancer progression by accelerating angiogenesis in a TFF1-dependent manner.BMC Cancer. 2019 Jan 7;19(1):14. doi: 10.1186/s12885-018-5247-z.
• [324] miR-618 Suppresses Metastasis in Gastric Cancer by Downregulating the Expression of TGF-2.Anat Rec (Hoboken). 2019 Jun;302(6):931-940. doi: 10.1002/ar.24083. Epub 2019 Feb 25.
• [325] Circular RNA CircCACTIN Promotes Gastric Cancer Progression by Sponging MiR-331-3p and Regulating TGFBR1 Expression.Int J Biol Sci. 2019 Apr 22;15(5):1091-1103. doi: 10.7150/ijbs.31533. eCollection 2019.
• [326] Tissue transglutaminase-1 promotes stemness and chemoresistance in gastric cancer cells by regulating Wnt/-catenin signaling.Exp Biol Med (Maywood). 2017 Jan;242(2):194-202. doi: 10.1177/1535370216670541. Epub 2016 Oct 4.
• [327] Toll-like receptor 9 polymorphisms and Helicobacter pylori influence gene expression and risk of gastric carcinogenesis in the Brazilian population.World J Gastrointest Oncol. 2019 Nov 15;11(11):998-1010. doi: 10.4251/wjgo.v11.i11.998.
• [328] The prognostic role of MAC30 in advanced gastric cancer patients receiving platinum-based chemotherapy.Future Oncol. 2017 Dec;13(29):2691-2696. doi: 10.2217/fon-2017-0426. Epub 2017 Oct 3.
• [329] Dasatinib promotes TRAIL-mediated apoptosis by upregulating CHOP-dependent death receptor 5 in gastric cancer.FEBS Open Bio. 2018 Mar 23;8(5):732-742. doi: 10.1002/2211-5463.12404. eCollection 2018 May.
• [330] TRIM37 promotes cell invasion and metastasis by regulating SIP1-mediated epithelial-mesenchymal transition in gastric cancer.Onco Targets Ther. 2018 Dec 10;11:8803-8813. doi: 10.2147/OTT.S178446. eCollection 2018.
• [331] UBE2T knockdown inhibits gastric cancer progression.Oncotarget. 2017 May 16;8(20):32639-32654. doi: 10.18632/oncotarget.15947.
• [332] The novel negative checkpoint regulator VISTA is expressed in gastric carcinoma and associated with PD-L1/PD-1: A future perspective for a combined gastric cancer therapy?.Oncoimmunology. 2017 Feb 21;6(4):e1293215. doi: 10.1080/2162402X.2017.1293215. eCollection 2017.
• [333] Effects of MCRS1 on proliferation, migration, invasion, and epithelial mesenchymal transition of gastric cancer cells by interacting with Pkmyt1 protein kinase.Cell Signal. 2019 Jul;59:171-181. doi: 10.1016/j.cellsig.2019.04.002. Epub 2019 Apr 3.
• [334] miR-129-5p and -3p co-target WWP1 to suppress gastric cancer proliferation and migration.J Cell Biochem. 2019 May;120(5):7527-7538. doi: 10.1002/jcb.28027. Epub 2018 Nov 11.
• [335] Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.J BUON. 2019 Mar-Apr;24(2):663-671.
• [336] CagA and vacA allelic combination of Helicobacter pylori in gastroduodenal disorders.Microb Pathog. 2018 Sep;122:144-150. doi: 10.1016/j.micpath.2018.06.023. Epub 2018 Jun 20.
• [337] Silencing of the ABCC4 gene by RNA interference reverses multidrug resistance in human gastric cancer.Oncol Rep. 2015 Mar;33(3):1147-54. doi: 10.3892/or.2014.3702. Epub 2014 Dec 30.
• [338] High Expression of ABL2 Suppresses Apoptosis in Gastric Cancer.Dig Dis Sci. 2018 Sep;63(9):2294-2300. doi: 10.1007/s10620-018-5111-7. Epub 2018 May 16.
• [339] Long non-coding RNA FLJ22763 is involved in the progression and prognosis of gastric cancer.Gene. 2019 Apr 20;693:84-91. doi: 10.1016/j.gene.2019.01.028. Epub 2019 Feb 1.
• [340] Decreased expression of the mitochondrial metabolic enzyme aconitase (ACO2) is associated with poor prognosis in gastric cancer.Med Oncol. 2013 Jun;30(2):552. doi: 10.1007/s12032-013-0552-5. Epub 2013 Apr 2.
• [341] EphA8 acts as an oncogene and contributes to poor prognosis in gastric cancer via regulation of ADAM10.J Cell Physiol. 2019 Nov;234(11):20408-20419. doi: 10.1002/jcp.28642. Epub 2019 Apr 26.
• [342] Expression of ADAM33 is a novel regulatory mechanism in IL-18-secreted process in gastric cancer.J Immunol. 2009 Mar 15;182(6):3548-55. doi: 10.4049/jimmunol.0801695.
• [343] ADAM9 functions as a promoter of gastric cancer growth which is negatively and post-transcriptionally regulated by miR-126.Oncol Rep. 2017 Apr;37(4):2033-2040. doi: 10.3892/or.2017.5460. Epub 2017 Feb 16.
• [344] Downregulation of A disintegrin and metallopeptidase with thrombospondin motif type 1 by DNA hypermethylation in human gastric cancer.Mol Med Rep. 2015 Aug;12(2):2487-94. doi: 10.3892/mmr.2015.3667. Epub 2015 Apr 23.
• [345] ALDH2 and ADH1 genetic polymorphisms may contribute to the risk of gastric cancer: a meta-analysis.PLoS One. 2014 Mar 14;9(3):e88779. doi: 10.1371/journal.pone.0088779. eCollection 2014.
• [346] Degranulation of mast cells induced by gastric cancer-derived adrenomedullin prompts gastric cancer progression.Cell Death Dis. 2018 Oct 10;9(10):1034. doi: 10.1038/s41419-018-1100-1.
• [347] Omega-3 PUFAs induce apoptosis of gastric cancer cells via ADORA1.Front Biosci (Landmark Ed). 2014 Jun 1;19(6):854-61. doi: 10.2741/4252.
• [348] Correlation between protein kinase catalytic subunit alpha-1 gene rs13361707 polymorphism and gastric cancer susceptibility in asian populations.Oncotarget. 2017 Jul 18;8(40):68354-68364. doi: 10.18632/oncotarget.19355. eCollection 2017 Sep 15.
• [349] Expression of the local angiotensin II system in gastric cancer may facilitate lymphatic invasion and nodal spread.Cancer Biol Ther. 2007 Aug;6(8):1218-26. doi: 10.4161/cbt.6.8.4412. Epub 2007 Aug 10.
• [350] Multiple genetic mutations caused by NKX6.3 depletion contribute to gastric tumorigenesis.Sci Rep. 2018 Dec 4;8(1):17609. doi: 10.1038/s41598-018-35733-5.
• [351] Allograft inflammatory factor-1 is an independent prognostic indicator that regulates -catenin in gastric cancer.Oncol Rep. 2014 Feb;31(2):828-34. doi: 10.3892/or.2013.2915. Epub 2013 Dec 12.
• [352] Transcript level of AKR1C3 is down-regulated in gastric cancer. Biochem Cell Biol. 2016 Apr;94(2):138-46.
• [353] Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression.Mol Cancer. 2019 Mar 30;18(1):71. doi: 10.1186/s12943-019-0969-3.
• [354] Overexpression of activated leukocute cell adhesion molecule in gastric cancer is associated with advanced stages and poor prognosis and miR-9 deregulation.Mol Med Rep. 2015 Mar;11(3):2004-12. doi: 10.3892/mmr.2014.2933. Epub 2014 Nov 12.
• [355] 12-Lipoxygenase promotes epithelial-mesenchymal transition via the Wnt/-catenin signaling pathway in gastric cancer cells.Onco Targets Ther. 2019 Jul 11;12:5551-5561. doi: 10.2147/OTT.S201373. eCollection 2019.
• [356] Polyamine synthesis enzyme AMD1 is closely associated with tumorigenesis and prognosis of human gastric cancers.Carcinogenesis. 2020 Apr 22;41(2):214-222. doi: 10.1093/carcin/bgz098.
• [357] Expression of angiopoietin 1, 2 and their common receptor Tie2 in human gastric carcinoma: implication for angiogenesis.J Korean Med Sci. 2006 Apr;21(2):272-8. doi: 10.3346/jkms.2006.21.2.272.
• [358] Knockdown of angiopoietin-like 4 inhibits the development of human gastric cancer.Oncol Rep. 2018 Apr;39(4):1739-1746. doi: 10.3892/or.2018.6253. Epub 2018 Feb 7.
• [359] Transcriptional activation of ANO1 promotes gastric cancer progression.Biochem Biophys Res Commun. 2019 Apr 23;512(1):131-136. doi: 10.1016/j.bbrc.2019.03.001. Epub 2019 Mar 12.
• [360] PARP1: A potential biomarker for gastric cancer.Pathol Res Pract. 2019 Aug;215(8):152472. doi: 10.1016/j.prp.2019.152472. Epub 2019 May 31.
• [361] Two-dimensional differential in-gel electrophoresis for identification of gastric cancer-specific protein markers.Oncol Rep. 2009 Jun;21(6):1429-37. doi: 10.3892/or_00000371.
• [362] Silencing of AQP3 induces apoptosis of gastric cancer cells via downregulation of glycerol intake and downstream inhibition of lipogenesis and autophagy.Onco Targets Ther. 2017 Jun 1;10:2791-2804. doi: 10.2147/OTT.S134016. eCollection 2017.
• [363] Over expression of amphiregulin promoted malignant progression in gastric cancer.Pathol Res Pract. 2019 Oct;215(10):152576. doi: 10.1016/j.prp.2019.152576. Epub 2019 Aug 10.
• [364] Overexpression of ADP-ribosylation factor 1 in human gastric carcinoma and its clinicopathological significance.Cancer Sci. 2012 Jun;103(6):1136-44. doi: 10.1111/j.1349-7006.2012.02243.x. Epub 2012 Mar 28.
• [365] Analysis of Polymorphism and Expression Profile of ASIC1 and IL-6 Genes in Patients with Gastric Cancer.Asian Pac J Cancer Prev. 2018 Dec 25;19(12):3451-3455. doi: 10.31557/APJCP.2018.19.12.3451.
• [366] Activating transcription factor 4 confers a multidrug resistance phenotype to gastric cancer cells through transactivation of SIRT1 expression.PLoS One. 2012;7(2):e31431. doi: 10.1371/journal.pone.0031431. Epub 2012 Feb 17.
• [367] PD-L1 and immune infiltrates are differentially expressed in distinct subgroups of gastric cancer.Oncoimmunology. 2018 Dec 10;8(2):e1544442. doi: 10.1080/2162402X.2018.1544442. eCollection 2019.
• [368] Expression and Transcriptional Regulation of Human ATP6V1A Gene in Gastric Cancers.Sci Rep. 2017 Jun 7;7(1):3015. doi: 10.1038/s41598-017-03021-3.
• [369] Characterization and risk association of polymorphisms in Aurora kinases A, B and C with genetic susceptibility to gastric cancer development.BMC Cancer. 2019 Sep 14;19(1):919. doi: 10.1186/s12885-019-6133-z.
• [370] Decreased expression of AZGP1 is associated with poor prognosis in primary gastric cancer.PLoS One. 2013 Jul 23;8(7):e69155. doi: 10.1371/journal.pone.0069155. Print 2013.
• [371] BAK overexpression mediates p53-independent apoptosis inducing effects on human gastric cancer cells.BMC Cancer. 2004 Jul 12;4:33. doi: 10.1186/1471-2407-4-33.
• [372] A novel Bcl-2 related gene, Bfl-1, is overexpressed in stomach cancer and preferentially expressed in bone marrow.Oncogene. 1995 Nov 2;11(9):1693-8.
• [373] miR-129-1-3p inhibits cell migration by targeting BDKRB2 in gastric cancer.Med Oncol. 2014 Aug;31(8):98. doi: 10.1007/s12032-014-0098-1. Epub 2014 Jul 10.
• [374] Identification of core genes and outcome in gastric cancer using bioinformatics analysis.Oncotarget. 2017 Aug 9;8(41):70271-70280. doi: 10.18632/oncotarget.20082. eCollection 2017 Sep 19.
• [375] Upregulation of heme oxygenase-1 and p21 confers resistance to apoptosis in human gastric cancer cells. Oncogene. 2004 Jan 15;23(2):503-13. doi: 10.1038/sj.onc.1207173.
• [376] Huaier n-butanol extract suppresses proliferation and metastasis of gastric cancer via c-Myc-Bmi1 axis.Sci Rep. 2019 Jan 24;9(1):447. doi: 10.1038/s41598-018-36940-w.
• [377] CD147 overexpression may serve as a promising diagnostic and prognostic marker for gastric cancer: evidence from original research and literature.Oncotarget. 2017 May 9;8(19):30888-30899. doi: 10.18632/oncotarget.15737.
• [378] Molecular carcinogenesis of gastric cancer: Lauren classification, mucin phenotype expression, and cancer stem cells.Int J Clin Oncol. 2019 Jul;24(7):771-778. doi: 10.1007/s10147-019-01443-9. Epub 2019 Apr 12.
• [379] Diversity of clinical implication of B-cell translocation gene 1 expression by histopathologic and anatomic subtypes of gastric cancer.Dig Dis Sci. 2015 May;60(5):1256-64. doi: 10.1007/s10620-014-3477-8. Epub 2014 Dec 9.
• [380] A peptide derivative serves as a fibroblast growth factor 2 antagonist in human gastric cancer.Tumour Biol. 2015 Sep;36(9):7233-41. doi: 10.1007/s13277-015-3435-x. Epub 2015 Apr 19.
• [381] Diverse proteomic alterations in gastric adenocarcinoma.Proteomics. 2004 Oct;4(10):3276-87. doi: 10.1002/pmic.200300916.
• [382] CREB is a key negative regulator of carbonic anhydrase IX (CA9) in gastric cancer.Cell Signal. 2015 Jul;27(7):1369-79. doi: 10.1016/j.cellsig.2015.03.019. Epub 2015 Apr 2.
• [383] Methylation of the calcium channel-related gene, CACNA2D3, is frequent and a poor prognostic factor in gastric cancer.Gastroenterology. 2008 Aug;135(2):580-90. doi: 10.1053/j.gastro.2008.05.041. Epub 2008 May 16.
• [384] Calreticulin regulates vascular endothelial growth factor-A mRNA stability in gastric cancer cells.PLoS One. 2019 Nov 14;14(11):e0225107. doi: 10.1371/journal.pone.0225107. eCollection 2019.
• [385] Calcium calmodulin dependent kinase kinase 2 - a novel therapeutic target for gastric adenocarcinoma.Cancer Biol Ther. 2015;16(2):336-45. doi: 10.4161/15384047.2014.972264.
• [386] Inactivating mutations of the caspase-10 gene in gastric cancer.Oncogene. 2002 Apr 25;21(18):2919-25. doi: 10.1038/sj.onc.1205394.
• [387] The effect of direct translocation across endosomes on the cytotoxicity of the recombinant protein e23sFv-Fdt-casp6 to HER2 positive gastric cancer cells.Biomaterials. 2011 Oct;32(30):7641-50. doi: 10.1016/j.biomaterials.2011.06.071. Epub 2011 Jul 20.
• [388] Potentially functional polymorphisms in the CASP7 gene contribute to gastric adenocarcinoma susceptibility in an eastern Chinese population.PLoS One. 2013 Sep 10;8(9):e74041. doi: 10.1371/journal.pone.0074041. eCollection 2013.
• [389] Prognostic significance of microsatellite instabilityassociated pathways and genes in gastric cancer.Int J Mol Med. 2018 Jul;42(1):149-160. doi: 10.3892/ijmm.2018.3643. Epub 2018 Apr 26.
• [390] Caffeine induces sustained apoptosis of human gastric cancer cells by activating the caspase?/caspase? signalling pathway.Mol Med Rep. 2017 Sep;16(3):2445-2454. doi: 10.3892/mmr.2017.6894. Epub 2017 Jun 30.
• [391] 15-hydroxyprostaglandin dehydrogenase is downregulated and exhibits tumor suppressor activity in gastric cancer.Cancer Invest. 2011 May;29(4):257-65. doi: 10.3109/07357907.2011.568562.
• [392] miR-125a restrains cell migration and invasion by targeting STAT3 in gastric cancer cells.Onco Targets Ther. 2018 Dec 24;12:205-215. doi: 10.2147/OTT.S168454. eCollection 2019.
• [393] Expression of the Cholecystokinin-B Receptor in Neoplastic Gastric Cells.Horm Cancer. 2018 Feb;9(1):40-54. doi: 10.1007/s12672-017-0311-8. Epub 2017 Oct 4.
• [394] C-C motif chemokine 22 predicts postoperative prognosis and adjuvant chemotherapeutic benefits in patients with stage II/III gastric cancer.Oncoimmunology. 2018 Mar 6;7(6):e1433517. doi: 10.1080/2162402X.2018.1433517. eCollection 2018.
• [395] HnRNPR-CCNB1/CENPF axis contributes to gastric cancer proliferation and metastasis.Aging (Albany NY). 2019 Sep 16;11(18):7473-7491. doi: 10.18632/aging.102254. Epub 2019 Sep 16.
• [396] Aberrant CCR4 expression is involved in tumor invasion of lymph node-negative human gastric cancer.PLoS One. 2015 Mar 19;10(3):e0120059. doi: 10.1371/journal.pone.0120059. eCollection 2015.
• [397] CrkL meditates CCL20/CCR6-induced EMT in gastric cancer.Cytokine. 2015 Dec;76(2):163-169. doi: 10.1016/j.cyto.2015.05.009. Epub 2015 Jun 1.
• [398] TEM1 expression in cancer-associated fibroblasts is correlated with a poor prognosis in patients with gastric cancer.Cancer Med. 2015 Nov;4(11):1667-78. doi: 10.1002/cam4.515. Epub 2015 Sep 4.
• [399] CD33+ Immature Myeloid Cells Critically Predict Recurrence in Advanced Gastric Cancer.J Surg Res. 2020 Jan;245:552-563. doi: 10.1016/j.jss.2019.07.095. Epub 2019 Aug 28.
• [400] CD47 expression in Epstein-Barr virus-associated gastric carcinoma: coexistence with tumor immunity lowering the ratio of CD8(+)/Foxp3(+) T cells.Virchows Arch. 2018 Apr;472(4):643-651. doi: 10.1007/s00428-018-2332-2. Epub 2018 Mar 13.
• [401] The tag SNP rs10746463 in decay-accelerating factor is associated with the susceptibility to gastric cancer.Mol Immunol. 2015 Feb;63(2):473-8. doi: 10.1016/j.molimm.2014.10.006.
• [402] Prognostic significance of CD44 in human colon cancer and gastric cancer: Evidence from bioinformatic analyses.Oncotarget. 2016 Jul 19;7(29):45538-45546. doi: 10.18632/oncotarget.9998.
• [403] A functional variant at miR-132-3p, miR-212-3p, and miR-361-5p binding site in CD80 gene alters susceptibility to gastric cancer in a Chinese Han population.Med Oncol. 2014 Aug;31(8):60. doi: 10.1007/s12032-014-0060-2. Epub 2014 Jul 1.
• [404] Tumor suppressor gene Runx3 sensitizes gastric cancer cells to chemotherapeutic drugs by downregulating Bcl-2, MDR-1 and MRP-1. Int J Cancer. 2005 Aug 10;116(1):155-60. doi: 10.1002/ijc.20919.
• [405] Spindle assembly checkpoint MAD2 and CDC20 overexpressions and cell-in-cell formation in gastric cancer and its precursor lesions.Hum Pathol. 2019 Mar;85:174-183. doi: 10.1016/j.humpath.2018.10.029. Epub 2018 Nov 15.
• [406] hsa_circ_0081143 promotes cisplatin resistance in gastric cancer by targeting miR-646/CDK6 pathway.Cancer Cell Int. 2019 Feb 1;19:25. doi: 10.1186/s12935-019-0737-x. eCollection 2019.
• [407] Upregulation of cyclin-dependent kinase 7 and matrix metalloproteinase-14 expression contribute to metastatic properties of gastric cancer.IUBMB Life. 2016 Oct;68(10):799-805. doi: 10.1002/iub.1543. Epub 2016 Aug 25.
• [408] A role for Cdkl1 in the development of gastric cancer.Acta Oncol. 2012 Jul;51(6):790-6. doi: 10.3109/0284186X.2012.665611. Epub 2012 Feb 27.
• [409] Stem cell associated genes working with one miRNA cluster have different clinic pathologic values in gastric cancer.Pathol Oncol Res. 2011 Dec;17(4):939-46. doi: 10.1007/s12253-011-9407-6. Epub 2011 May 10.
• [410] Prognostic Biomarkers for Gastric Cancer: An Umbrella Review of the Evidence.Front Oncol. 2019 Nov 29;9:1321. doi: 10.3389/fonc.2019.01321. eCollection 2019.
• [411] Melatonin set out to ER stress signaling thwarts epithelial mesenchymal transition and peritoneal dissemination via calpain-mediated C/EBP and NFB cleavage.J Pineal Res. 2016 Mar;60(2):142-54. doi: 10.1111/jpi.12295. Epub 2015 Dec 16.
• [412] Effects of selected genetic polymorphisms in xeroderma pigmentosum complementary group D on gastric cancer.Mol Biol Rep. 2011 Mar;38(3):1507-13. doi: 10.1007/s11033-010-0258-0. Epub 2010 Sep 15.
• [413] CHK1 expression in Gastric Cancer is modulated by p53 and RB1/E2F1: implications in chemo/radiotherapy response.Sci Rep. 2016 Feb 12;6:21519. doi: 10.1038/srep21519.
• [414] Hypermethylated FAM5C and MYLK in serum as diagnosis and pre-warning markers for gastric cancer.Dis Markers. 2012;32(3):195-202. doi: 10.3233/DMA-2011-0877.
• [415] MACC1 mediates acetylcholine-induced invasion and migration by human gastric cancer cells.Oncotarget. 2016 Apr 5;7(14):18085-94. doi: 10.18632/oncotarget.7634.
• [416] Migration of gastric cancer is suppressed by recombinant Newcastle disease virus (rL-RVG) via regulating 7-nicotinic acetylcholine receptors/ERK- EMT.BMC Cancer. 2019 Oct 22;19(1):976. doi: 10.1186/s12885-019-6225-9.
• [417] Genetic variants in DNA repair pathway genes and risk of esophageal squamous cell carcinoma and gastric adenocarcinoma in a Chinese population.Carcinogenesis. 2013 Jul;34(7):1536-42. doi: 10.1093/carcin/bgt094. Epub 2013 Mar 15.
• [418] A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients.PLoS One. 2011 Feb 18;6(2):e16694. doi: 10.1371/journal.pone.0016694.
• [419] Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells.J Cancer Res Clin Oncol. 2015 Dec;141(12):2109-20. doi: 10.1007/s00432-015-1973-7. Epub 2015 May 8.
• [420] Distinct Involvement of the Sonic Hedgehog Signaling Pathway in Gastric Adenocarcinoma of Fundic Gland Type and Conventional Gastric Adenocarcinoma.Digestion. 2017;96(2):81-91. doi: 10.1159/000478999. Epub 2017 Jul 22.
• [421] COL1A2 is a Novel Biomarker to Improve Clinical Prediction in Human Gastric Cancer: Integrating Bioinformatics and Meta-Analysis.Pathol Oncol Res. 2018 Jan;24(1):129-134. doi: 10.1007/s12253-017-0223-5. Epub 2017 Apr 11.
• [422] A circular RNA derived from COL6A3 functions as a ceRNA in gastric cancer development.Biochem Biophys Res Commun. 2019 Jul 12;515(1):16-23. doi: 10.1016/j.bbrc.2019.05.079. Epub 2019 May 20.
• [423] The NAD(P)H: quinine oxidoreductase 1 (NQO1) gene 609 C>T polymorphism is associated with gastric cancer risk: evidence from a case-control study and a meta-analysis.Asian Pac J Cancer Prev. 2014;15(5):2363-7. doi: 10.7314/apjcp.2014.15.5.2363.
• [424] CSE1L silence inhibits the growth and metastasis in gastric cancer by repressing GPNMB via positively regulating transcription factor MITF.J Cell Physiol. 2020 Mar;235(3):2071-2079. doi: 10.1002/jcp.29107. Epub 2019 Jul 25.
• [425] Destabilized adhesion in the gastric proliferative zone and c-Src kinase activation mark the development of early diffuse gastric cancer.Cancer Res. 2007 Mar 15;67(6):2480-9. doi: 10.1158/0008-5472.CAN-06-3021.
• [426] Analysis of promoter methylation and polymorphic minisatellites of BORIS and lack of association with gastric cancer.DNA Cell Biol. 2011 Sep;30(9):691-8. doi: 10.1089/dna.2011.1248. Epub 2011 Apr 15.
• [427] Estimation of associations between 10 common gene polymorphisms and gastric cancer: evidence from a meta-analysis.J Clin Pathol. 2020 Jun;73(6):318-321. doi: 10.1136/jclinpath-2019-206189. Epub 2019 Nov 25.
• [428] Cathepsin E is a marker of gastric differentiation and signet-ring cell carcinoma of stomach: a novel suggestion on gastric tumorigenesis.PLoS One. 2013;8(2):e56766. doi: 10.1371/journal.pone.0056766. Epub 2013 Feb 22.
• [429] Cathepsin F Knockdown Induces Proliferation and Inhibits Apoptosis in Gastric Cancer Cells.Oncol Res. 2018 Jan 19;26(1):83-93. doi: 10.3727/096504017X14928634401204. Epub 2017 Apr 25.
• [430] Association study between genome-wide significant variants of vitamin B12 metabolism and gastric cancer in a han Chinese population.IUBMB Life. 2016 Apr;68(4):303-10. doi: 10.1002/iub.1485. Epub 2016 Mar 9.
• [431] LncRNA COL1A1-014 is involved in the progression of gastric cancer via regulating CXCL12-CXCR4 axis.Gastric Cancer. 2020 Mar;23(2):260-272. doi: 10.1007/s10120-019-01011-0. Epub 2019 Oct 24.
• [432] CXCL13 expression is prognostic and predictive for postoperative adjuvant chemotherapy benefit in patients with gastric cancer.Cancer Immunol Immunother. 2018 Feb;67(2):261-269. doi: 10.1007/s00262-017-2083-y. Epub 2017 Oct 31.
• [433] CD40 controls CXCR5-induced recruitment of myeloid-derived suppressor cells to gastric cancer.Oncotarget. 2015 Nov 17;6(36):38901-11. doi: 10.18632/oncotarget.5644.
• [434] CYP2A6 and ERCC1 polymorphisms correlate with efficacy of S-1 plus cisplatin in metastatic gastric cancer patients.Br J Cancer. 2011 Mar 29;104(7):1126-34. doi: 10.1038/bjc.2011.24. Epub 2011 Mar 1.
• [435] Effects of the CYP2C19 genetic polymorphism on gastritis, peptic ulcer disease, peptic ulcer bleeding and gastric cancer.Asian Pac J Cancer Prev. 2014;15(24):10957-60. doi: 10.7314/apjcp.2014.15.24.10957.
• [436] Zipper-interacting protein kinase promotes epithelial-mesenchymal transition, invasion and metastasis through AKT and NF-kB signaling and is associated with metastasis and poor prognosis in gastric cancer patients.Oncotarget. 2015 Apr 10;6(10):8323-38. doi: 10.18632/oncotarget.3200.
• [437] DCTPP1 attenuates the sensitivity of human gastric cancer cells to 5-fluorouracil by up-regulating MDR1 expression epigenetically.Oncotarget. 2016 Oct 18;7(42):68623-68637. doi: 10.18632/oncotarget.11864.
• [438] Molecular cloning of a human transmembrane-type protein tyrosine phosphatase and its expression in gastrointestinal cancers.J Biol Chem. 1994 Jan 21;269(3):2075-81.
• [439] Bidirectional regulation between WDR83 and its natural antisense transcript DHPS in gastric cancer.Cell Res. 2012 Sep;22(9):1374-89. doi: 10.1038/cr.2012.57. Epub 2012 Apr 10.
• [440] The regulatory mechanism of CCR7 gene expression and its involvement in the metastasis and progression of gastric cancer.Tumour Biol. 2013 Jun;34(3):1865-71. doi: 10.1007/s13277-013-0728-9. Epub 2013 Mar 22.
• [441] Ethnic differences in serum pepsinogen levels among Japanese and non-Japanese Brazilian gastric cancer patients and controls.Cancer Detect Prev. 2000;24(6):564-71.
• [442] Delta-like 3 localizes to neuroendocrine cells and plays a pivotal role in gastrointestinal neuroendocrine malignancy.Cancer Sci. 2019 Oct;110(10):3122-3131. doi: 10.1111/cas.14157. Epub 2019 Aug 14.
• [443] Exome sequencing reveals three novel candidate predisposition genes for diffuse gastric cancer.Fam Cancer. 2015 Jun;14(2):241-6. doi: 10.1007/s10689-015-9778-z.
• [444] Overexpression of denticleless E3 ubiquitin protein ligase homolog (DTL) is related to poor outcome in gastric carcinoma.Oncotarget. 2015 Nov 3;6(34):36615-24. doi: 10.18632/oncotarget.5620.
• [445] microRNA-95 knockdown inhibits epithelial-mesenchymal transition and cancer stem cell phenotype in gastric cancer cells through MAPK pathway by upregulating DUSP5.J Cell Physiol. 2020 Feb;235(2):944-956. doi: 10.1002/jcp.29010. Epub 2019 Jul 15.
• [446] Epigenetic silencing of DUSP9 induces the proliferation of human gastric cancer by activating JNK signaling.Oncol Rep. 2015 Jul;34(1):121-8. doi: 10.3892/or.2015.3998. Epub 2015 May 20.
• [447] TFAP2E methylation promotes 5fluorouracil resistance via exosomal miR?06a?p and miR?21 in gastric cancer MGC?03 cells.Mol Med Rep. 2019 Jul;20(1):323-331. doi: 10.3892/mmr.2019.10237. Epub 2019 May 14.
• [448] MiR-26a enhances the sensitivity of gastric cancer cells to cisplatin by targeting NRAS and E2F2.Saudi J Gastroenterol. 2015 Sep-Oct;21(5):313-9. doi: 10.4103/1319-3767.166206.
• [449] Association of endothelin-converting enzyme-1b C-338A polymorphism with gastric cancer risk: a case-control study.Eur J Cancer. 2008 Jun;44(9):1253-8. doi: 10.1016/j.ejca.2007.09.013. Epub 2007 Oct 30.
• [450] An insertion/deletion polymorphism within the proximal promoter of EGLN2 is associated with susceptibility for gastric cancer in the Chinese population.Genet Test Mol Biomarkers. 2014 Apr;18(4):269-73. doi: 10.1089/gtmb.2013.0438. Epub 2014 Feb 11.
• [451] BAG3 contributes to HGF-mediated cell proliferation, migration, and invasion via the Egr1 pathway in gastric cancer.Tumori. 2019 Feb;105(1):63-75. doi: 10.1177/0300891618811274. Epub 2018 Dec 4.
• [452] PRSS23 knockdown inhibits gastric tumorigenesis through EIF2 signaling.Pharmacol Res. 2019 Apr;142:50-57. doi: 10.1016/j.phrs.2019.02.008. Epub 2019 Feb 12.
• [453] Thermo-chemotherapy inhibits the proliferation and metastasis of gastric cancer cells via suppression of EIF5A2 expression.Onco Targets Ther. 2019 Aug 9;12:6275-6284. doi: 10.2147/OTT.S215590. eCollection 2019.
• [454] Update on a tumor-associated NADH oxidase in gastric cancer cell growth. World J Gastroenterol. 2016 Mar 14;22(10):2900-5.
• [455] The tumor promoting roles of HSP60 and HIF2 in gastric cancer cells.Tumour Biol. 2016 Jul;37(7):9849-54. doi: 10.1007/s13277-015-4783-2. Epub 2016 Jan 26.
• [456] EphA2-to-YAP pathway drives gastric cancer growth and therapy resistance.Int J Cancer. 2020 Apr 1;146(7):1937-1949. doi: 10.1002/ijc.32609. Epub 2019 Aug 23.
• [457] Overexpression of the receptor tyrosine kinase EphA4 in human gastric cancers.World J Gastroenterol. 2008 Oct 7;14(37):5650-6. doi: 10.3748/wjg.14.5650.
• [458] Increased expression of P2RY2, CD248 and EphB1 in gastric cancers from Chilean patients.Asian Pac J Cancer Prev. 2014;15(5):1931-6. doi: 10.7314/apjcp.2014.15.5.1931.
• [459] EZH2-mediated epigenetic suppression of EphB3 inhibits gastric cancer proliferation and metastasis by affecting E-cadherin and vimentin expression.Gene. 2019 Feb 20;686:118-124. doi: 10.1016/j.gene.2018.11.015. Epub 2018 Nov 6.
• [460] Long noncoding RNA BC005927 upregulates EPHB4 and promotes gastric cancer metastasis under hypoxia.Cancer Sci. 2018 Apr;109(4):988-1000. doi: 10.1111/cas.13519. Epub 2018 Mar 5.
• [461] Elevated epiregulin expression predicts poor prognosis in gastric cancer.Pathol Res Pract. 2019 May;215(5):873-879. doi: 10.1016/j.prp.2019.01.030. Epub 2019 Jan 28.
• [462] Comprehensive analysis of histone modification-associated genes on differential gene expression and prognosis in gastric cancer.Exp Ther Med. 2019 Sep;18(3):2219-2230. doi: 10.3892/etm.2019.7808. Epub 2019 Jul 24.
• [463] Estrogen-related receptor gamma functions as a tumor suppressor in gastric cancer.Nat Commun. 2018 May 15;9(1):1920. doi: 10.1038/s41467-018-04244-2.
• [464] Membrane-bound -catenin degradation is enhanced by ETS2-mediated Siah1 induction in Helicobacter pylori-infected gastric cancer cells.Oncogenesis. 2017 May 8;6(5):e327. doi: 10.1038/oncsis.2017.26.
• [465] Upregulation of nuclear-enriched abundant transcript 1 confers oxaliplatin resistance to gastric cancer.Cell Biol Int. 2020 Feb;44(2):446-455. doi: 10.1002/cbin.11245. Epub 2019 Oct 31.
• [466] MST4 Predicts Poor Prognosis And Promotes Metastasis By Facilitating Epithelial-Mesenchymal Transition In Gastric Cancer.Cancer Manag Res. 2019 Nov 5;11:9353-9369. doi: 10.2147/CMAR.S219689. eCollection 2019.
• [467] Analysis for the combination expression of CK20, FABP1 and MUC2 is sensitive for the prediction of peritoneal recurrence in gastric cancer.Jpn J Clin Oncol. 2012 Feb;42(2):148-52. doi: 10.1093/jjco/hyr179. Epub 2011 Dec 15.
• [468] Palmitate acid promotes gastric cancer metastasis via FABP5/SP1/UCA1 pathway.Cancer Cell Int. 2019 Mar 22;19:69. doi: 10.1186/s12935-019-0787-0. eCollection 2019.
• [469] Genetic variants in fas signaling pathway genes and risk of gastric cancer.Int J Cancer. 2014 Feb 15;134(4):822-31. doi: 10.1002/ijc.28415. Epub 2013 Sep 11.
• [470] LINC01436, regulating miR-585 and FBXO11, is an oncogenic lncRNA in the progression of gastric cancer.Cell Biol Int. 2020 Mar;44(3):882-893. doi: 10.1002/cbin.11287. Epub 2020 Jan 8.
• [471] LncRNA MT1JP functions as a ceRNA in regulating FBXW7 through competitively binding to miR-92a-3p in gastric cancer.Mol Cancer. 2018 May 2;17(1):87. doi: 10.1186/s12943-018-0829-6.
• [472] FGF18, a prominent player in FGF signaling, promotes gastric tumorigenesis through autocrine manner and is negatively regulated by miR-590-5p.Oncogene. 2019 Jan;38(1):33-46. doi: 10.1038/s41388-018-0430-x. Epub 2018 Aug 6.
• [473] Differential gene expression in growth factors, epithelial mesenchymal transition and chemotaxis in the diffuse type compared with the intestinal type of gastric cancer.Oncol Lett. 2019 Jul;18(1):674-686. doi: 10.3892/ol.2019.10392. Epub 2019 May 21.
• [474] Identification of a novel oncogenic mutation of FGFR4 in gastric cancer.Sci Rep. 2019 Oct 10;9(1):14627. doi: 10.1038/s41598-019-51217-6.
• [475] Expression of FHL1 in gastric cancer tissue and its correlation with the invasion and metastasis of gastric cancer.Mol Cell Biochem. 2012 Apr;363(1-2):93-9. doi: 10.1007/s11010-011-1161-2. Epub 2011 Dec 6.
• [476] Comprehensive evaluation of FKBP10 expression and its prognostic potential in gastric cancer.Oncol Rep. 2019 Aug;42(2):615-628. doi: 10.3892/or.2019.7195. Epub 2019 Jun 11.
• [477] Enhanced expression of p46 Shc in the nucleus and p52 Shc in the cytoplasm of human gastric cancer.Int J Oncol. 2005 Apr;26(4):905-11.
• [478] FKBP5 polymorphisms as vulnerability to anxiety and depression in patients with advanced gastric cancer: a controlled and prospective study.Psychoneuroendocrinology. 2012 Sep;37(9):1569-76. doi: 10.1016/j.psyneuen.2012.02.017. Epub 2012 Mar 28.
• [479] Overexpression of FNDC1 Relates to Poor Prognosis and Its Knockdown Impairs Cell Invasion and Migration in Gastric Cancer.Technol Cancer Res Treat. 2019 Jan 1;18:1533033819869928. doi: 10.1177/1533033819869928.
• [480] Polymorphisms and mutations of the folate receptor-alpha gene and risk of gastric cancer in a Chinese population.Int J Mol Med. 2005 Apr;15(4):627-32.
• [481] Expression and clinical significance of FOS-like antigen 1 in gastric adenocarcinoma.Pathol Res Pract. 2019 Jun;215(6):152394. doi: 10.1016/j.prp.2019.03.022. Epub 2019 Mar 19.
• [482] De-SUMOylation of FOXC2 by SENP3 promotes the epithelial-mesenchymal transition in gastric cancer cells.Oncotarget. 2014 Aug 30;5(16):7093-104. doi: 10.18632/oncotarget.2197.
• [483] METase/lncRNA HULC/FoxM1 reduced cisplatin resistance in gastric cancer by suppressing autophagy.J Cancer Res Clin Oncol. 2019 Oct;145(10):2507-2517. doi: 10.1007/s00432-019-03015-w. Epub 2019 Sep 4.
• [484] RETRACTED: miR-135b Delivered by Gastric Tumor Exosomes Inhibits FOXO1 Expression in Endothelial Cells and Promotes Angiogenesis.Mol Ther. 2019 Oct 2;27(10):1772-1783. doi: 10.1016/j.ymthe.2019.06.018. Epub 2019 Jul 25.
• [485] Formyl peptide receptor 1 suppresses gastric cancer angiogenesis and growth by exploiting inflammation resolution pathways.Oncoimmunology. 2017 Feb 21;6(4):e1293213. doi: 10.1080/2162402X.2017.1293213. eCollection 2017.
• [486] FPR2 promotes invasion and metastasis of gastric cancer cells and predicts the prognosis of patients.Sci Rep. 2017 Jun 9;7(1):3153. doi: 10.1038/s41598-017-03368-7.
• [487] Smad4/Fascin index is highly prognostic in patients with diffuse type EBV-associated gastric cancer.Pathol Res Pract. 2018 Apr;214(4):475-481. doi: 10.1016/j.prp.2018.03.017. Epub 2018 Mar 15.
• [488] Expression of Demethylase Genes, FTO and ALKBH1, Is Associated with Prognosis of Gastric Cancer.Dig Dis Sci. 2019 Jun;64(6):1503-1513. doi: 10.1007/s10620-018-5452-2. Epub 2019 Jan 14.
• [489] Variation at ABO histo-blood group and FUT loci and diffuse and intestinal gastric cancer risk in a European population.Int J Cancer. 2015 Feb 15;136(4):880-93. doi: 10.1002/ijc.29034. Epub 2014 Jul 1.
• [490] Galanin expression is down-regulated in patients with gastric cancer.J Int Med Res. 2019 Mar;47(3):1241-1249. doi: 10.1177/0300060518819382. Epub 2019 Jan 7.
• [491] Mice that express human interleukin-8 have increased mobilization of immature myeloid cells, which exacerbates inflammation and accelerates colon carcinogenesis.Gastroenterology. 2013 Jan;144(1):155-66. doi: 10.1053/j.gastro.2012.09.057. Epub 2012 Oct 3.
• [492] Inactivation of the phosphatidylinositol 3-kinase/Akt pathway is involved in BMP9-mediated tumor-suppressive effects in gastric cancer cells.J Cell Biochem. 2015 Jun;116(6):1080-9. doi: 10.1002/jcb.25063.
• [493] High gamma-glutamyl hydrolase and low folylpolyglutamate synthetase expression as prognostic biomarkers in patients with locally advanced gastric cancer who were administrated postoperative adjuvant chemotherapy with S-1.J Cancer Res Clin Oncol. 2020 Jan;146(1):75-86. doi: 10.1007/s00432-019-03087-8. Epub 2019 Nov 21.
• [494] Ghrelin induces gastric cancer cell proliferation, migration, and invasion through GHS-R/NF-B signaling pathway.Mol Cell Biochem. 2013 Oct;382(1-2):163-72. doi: 10.1007/s11010-013-1731-6. Epub 2013 Jun 27.
• [495] Association between C1019T polymorphism in the connexin 37 gene and Helicobacter pylori infection in patients with gastric cancer.Asian Pac J Cancer Prev. 2012;13(5):2363-7. doi: 10.7314/apjcp.2012.13.5.2363.
• [496] Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer.J Clin Oncol. 2007 Nov 1;25(31):4887-94. doi: 10.1200/JCO.2006.09.8921.
• [497] Connexin32 inhibits gastric carcinogenesis through cell cycle arrest and altered expression of p21Cip1 and p27Kip1.BMB Rep. 2013 Jan;46(1):25-30. doi: 10.5483/bmbrep.2013.46.1.078.
• [498] Upregulation of connexin 30 in intestinal phenotype gastric cancer and its reduction during tumor progression.Pathobiology. 2010;77(5):241-8. doi: 10.1159/000314966. Epub 2010 Nov 29.
• [499] GLI1 overexpression promotes gastric cancer cell proliferation and migration and induces drug resistance by combining with the AKT-mTOR pathway.Biomed Pharmacother. 2019 Mar;111:993-1004. doi: 10.1016/j.biopha.2019.01.018. Epub 2019 Jan 10.
• [500] GLI2 induces PDGFRB expression and modulates cancer stem cell properties of gastric cancer.Eur Rev Med Pharmacol Sci. 2017 Oct;21(17):3857-3865.
• [501] Integrated genomic and functional analyses reveal glyoxalase I as a novel metabolic oncogene in human gastric cancer.Oncogene. 2015 Feb 26;34(9):1196-206. doi: 10.1038/onc.2014.57. Epub 2014 Mar 24.
• [502] Exosomal long noncoding RNA lnc-GNAQ-6:1 may serve as a diagnostic marker for gastric cancer.Clin Chim Acta. 2020 Feb;501:252-257. doi: 10.1016/j.cca.2019.10.047. Epub 2019 Nov 12.
• [503] The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines.Oncotarget. 2016 Sep 20;7(38):61021-61035. doi: 10.18632/oncotarget.10477.
• [504] Downregulation of G Protein-Coupled Estrogen Receptor (GPER) is Associated with Reduced Prognosis in Patients with Gastric Cancer.Med Sci Monit. 2019 Apr 27;25:3115-3126. doi: 10.12659/MSM.913634.
• [505] GPAA1 promotes gastric cancer progression via upregulation of GPI-anchored protein and enhancement of ERBB signalling pathway.J Exp Clin Cancer Res. 2019 May 22;38(1):214. doi: 10.1186/s13046-019-1218-8.
• [506] Transcriptome analysis reveals GPNMB as a potential therapeutic target for gastric cancer.J Cell Physiol. 2020 Mar;235(3):2738-2752. doi: 10.1002/jcp.29177. Epub 2019 Sep 9.
• [507] Cloning of a G-protein-coupled receptor that shows an activity to transform NIH3T3 cells and is expressed in gastric cancer cells.Cancer Sci. 2004 Feb;95(2):131-5. doi: 10.1111/j.1349-7006.2004.tb03193.x.
• [508] Involvement of genetic factors and lifestyle on the occurrence of colorectal and gastric cancer.Crit Rev Oncol Hematol. 2016 Nov;107:72-81. doi: 10.1016/j.critrevonc.2016.08.014. Epub 2016 Sep 2.
• [509] Glutamate receptor, ionotropic, kainate 2 silencing by DNA hypermethylation possesses tumor suppressor function in gastric cancer.Int J Cancer. 2010 Jun 1;126(11):2542-52. doi: 10.1002/ijc.24958.
• [510] GRIK3: A novel oncogenic protein related to tumor TNM stage, lymph node metastasis, and poor prognosis of GC.Tumour Biol. 2017 Jun;39(6):1010428317704364. doi: 10.1177/1010428317704364.
• [511] Quantitative hypermethylation of NMDAR2B in human gastric cancer.Int J Cancer. 2007 Nov 1;121(9):1994-2000. doi: 10.1002/ijc.22934.
• [512] Elevated O-GlcNAcylation stabilizes FOXM1 by its reduced degradation through GSK-3 inactivation in a human gastric carcinoma cell line, MKN45cells.Biochem Biophys Res Commun. 2018 Jan 8;495(2):1681-1687. doi: 10.1016/j.bbrc.2017.11.179. Epub 2017 Dec 2.
• [513] Genetic polymorphisms in GSTA1, GSTP1, GSTT1, and GSTM1 and gastric cancer risk in a Vietnamese population.Oncol Res. 2010;18(7):349-55. doi: 10.3727/096504010x12626118080064.
• [514] Ectopic expression of guanylyl cyclase C in gastric cancer as a potential biomarker and therapeutic target.J Dig Dis. 2009 Nov;10(4):272-85. doi: 10.1111/j.1751-2980.2009.00396.x.
• [515] miRNA-558 promotes gastric cancer progression through attenuating Smad4-mediated repression of heparanase expression. Cell Death Dis. 2016 Sep 29;7(9):e2382.
• [516] Resequencing and copy number analysis of the human tyrosine kinase gene family in poorly differentiated gastric cancer.Carcinogenesis. 2009 Nov;30(11):1857-64. doi: 10.1093/carcin/bgp206. Epub 2009 Sep 4.
• [517] Effect of orexin A on apoptosis in BGC-823 gastric cancer cells via OX1R through the AKT signaling pathway.Mol Med Rep. 2015 May;11(5):3439-44. doi: 10.3892/mmr.2015.3190. Epub 2015 Jan 13.
• [518] Expression and biological function of rhotekin in gastric cancer through regulating p53 pathway.Cancer Manag Res. 2019 Jan 25;11:1069-1080. doi: 10.2147/CMAR.S185345. eCollection 2019.
• [519] Weighted gene co-expression network analysis and connectivity map identifies lovastatin as a treatment option of gastric cancer by inhibiting HDAC2.Gene. 2019 Jan 10;681:15-25. doi: 10.1016/j.gene.2018.09.040. Epub 2018 Sep 25.
• [520] lncRNA-MIAT regulates cell biological behaviors in gastric cancer through a mechanism involving the miR-29a-3p/HDAC4 axis.Oncol Rep. 2017 Dec;38(6):3465-3472. doi: 10.3892/or.2017.6020. Epub 2017 Oct 10.
• [521] The inhibition of histone deacetylase 8 suppresses proliferation and inhibits apoptosis in gastric adenocarcinoma.Int J Oncol. 2015 Nov;47(5):1819-28. doi: 10.3892/ijo.2015.3182. Epub 2015 Sep 24.
• [522] Oxidative stress activates the human histidine decarboxylase promoter in AGS gastric cancer cells.J Biol Chem. 1998 Sep 4;273(36):23046-54. doi: 10.1074/jbc.273.36.23046.
• [523] miR-141 suppresses proliferation and motility of gastric cancer cells by targeting HDGF.Mol Cell Biochem. 2014 Mar;388(1-2):211-8. doi: 10.1007/s11010-013-1912-3. Epub 2013 Nov 26.
• [524] Roles of Fibroblast Activation Protein and Hepatocyte Growth Factor Expressions in Angiogenesis and Metastasis of Gastric Cancer.Pathol Oncol Res. 2019 Jan;25(1):369-376. doi: 10.1007/s12253-017-0359-3. Epub 2017 Nov 13.
• [525] TGF- induces HLA-G expression through inhibiting miR-152 in gastric cancer cells.J Biomed Sci. 2015 Dec 2;22:107. doi: 10.1186/s12929-015-0177-4.
• [526] Circ_0000267 promotes gastric cancer progression via sponging MiR-503-5p and regulating HMGA2 expression.Mol Genet Genomic Med. 2020 Feb;8(2):e1093. doi: 10.1002/mgg3.1093. Epub 2019 Dec 17.
• [527] Bioinformatics analysis of the prognosis and biological significance of HMGB1, HMGB2, and HMGB3 in gastric cancer.J Cell Physiol. 2020 Apr;235(4):3438-3446. doi: 10.1002/jcp.29233. Epub 2019 Oct 16.
• [528] HMGCR is up-regulated in gastric cancer and promotes the growth and migration of the cancer cells.Gene. 2016 Aug 1;587(1):42-7. doi: 10.1016/j.gene.2016.04.029. Epub 2016 Apr 13.
• [529] Clinicopathological and prognostic significance of heme oxygenase-1 expression in small intestinal adenocarcinomas.Pathol Int. 2018 May;68(5):294-300. doi: 10.1111/pin.12657. Epub 2018 Mar 14.
• [530] High expression of hnRNPA1 promotes cell invasion by inducing EMT in gastric cancer.Oncol Rep. 2018 Apr;39(4):1693-1701. doi: 10.3892/or.2018.6273. Epub 2018 Feb 16.
• [531] Aberrant expression and localization of hnRNP-A2/B1 is a common event in human gastric adenocarcinoma.J Gastroenterol Hepatol. 2011 Jan;26(1):108-15. doi: 10.1111/j.1440-1746.2010.06482.x.
• [532] Epigenetic changes and functional study of HOXA11 in human gastric cancer.Epigenomics. 2015;7(2):201-13. doi: 10.2217/epi.14.92. Epub 2015 Jan 15.
• [533] Antitumor activity of ginseng sapogenins, 25-OH-PPD and 25-OCH3-PPD, on gastric cancer cells.Biotechnol Lett. 2016 Jan;38(1):43-50. doi: 10.1007/s10529-015-1964-4. Epub 2015 Oct 1.
• [534] High Hepsin expression predicts poor prognosis in Gastric Cancer.Sci Rep. 2016 Nov 14;6:36902. doi: 10.1038/srep36902.
• [535] Tumorsuppressive miR?99?p inhibits gastric cancer cell invasion by targeting heparanase.Mol Med Rep. 2019 Sep;20(3):2151-2158. doi: 10.3892/mmr.2019.10436. Epub 2019 Jun 27.
• [536] Association between common genetic variant of HRH2 and gastric cancer risk.Int J Oncol. 2012 Aug;41(2):497-503. doi: 10.3892/ijo.2012.1482. Epub 2012 May 17.
• [537] Deletion and down-regulation of HRH4 gene in gastric carcinomas: a potential correlation with tumor progression. PLoS One. 2012;7(2):e31207. doi: 10.1371/journal.pone.0031207. Epub 2012 Feb 20.
• [538] c-Met expression in a gastric cancer cell line producing alpha-fetoprotein.Surg Today. 2004;34(2):115-22. doi: 10.1007/s00595-003-2668-2.
• [539] Genetic susceptibility factors on genes involved in the steroid hormone biosynthesis pathway and progesterone receptor for gastric cancer risk.PLoS One. 2012;7(10):e47603. doi: 10.1371/journal.pone.0047603. Epub 2012 Oct 23.
• [540] mRNA expression of steroidogenic enzymes, steroid hormone receptors and their coregulators in gastric cancer.Oncol Lett. 2017 May;13(5):3369-3378. doi: 10.3892/ol.2017.5881. Epub 2017 Mar 21.
• [541] Increased expression of heat shock factor 1 (HSF1) is associated with poor survival in gastric cancer patients.Diagn Pathol. 2018 Oct 17;13(1):80. doi: 10.1186/s13000-018-0755-3.
• [542] Tailoring subtractive cell biopanning to identify diffuse gastric adenocarcinoma-associated antigens via human scFv antibodies.Immunology. 2020 Jan;159(1):96-108. doi: 10.1111/imm.13129. Epub 2019 Nov 8.
• [543] Phase II Trial of Adjuvant Immunotherapy with Autologous Tumor-derived Gp96 Vaccination in Patients with Gastric Cancer.J Cancer. 2017 Jul 2;8(10):1826-1832. doi: 10.7150/jca.18946. eCollection 2017.
• [544] GKN2 promotes oxidative stress-induced gastric cancer cell apoptosis via the Hsc70 pathway.J Exp Clin Cancer Res. 2019 Aug 5;38(1):338. doi: 10.1186/s13046-019-1336-3.
• [545] Mortalin is a prognostic factor of gastric cancer with normal p53 function.Gastric Cancer. 2014 Apr;17(2):255-62. doi: 10.1007/s10120-013-0279-1. Epub 2013 Jul 5.
• [546] HtrA1, a potential predictor of response to cisplatin-based combination chemotherapy in gastric cancer.Histopathology. 2011 Apr;58(5):669-78. doi: 10.1111/j.1365-2559.2011.03818.x. Epub 2011 Mar 30.
• [547] A functional variant at miR-24 binding site in B7-H2 alters susceptibility to gastric cancer in a Chinese Han population.Mol Immunol. 2013 Nov;56(1-2):98-103. doi: 10.1016/j.molimm.2013.04.010. Epub 2013 May 18.
• [548] siRNA-mediated knockdown of ID1 disrupts Nanog- and Oct-4-mediated cancer stem cell-likeness and resistance to chemotherapy in gastric cancer cells.Oncol Lett. 2017 May;13(5):3014-3024. doi: 10.3892/ol.2017.5828. Epub 2017 Mar 8.
• [549] Metallopanstimulin-1 regulates invasion and migration of gastric cancer cells partially through integrin 4.Carcinogenesis. 2013 Dec;34(12):2851-60. doi: 10.1093/carcin/bgt226. Epub 2013 Jun 26.
• [550] Polymorphisms in Th1-type cell-mediated response genes and risk of gastric cancer.Carcinogenesis. 2007 Jan;28(1):118-23. doi: 10.1093/carcin/bgl130. Epub 2006 Aug 2.
• [551] Upregulation of autophagy-related gene-5 (ATG-5) is associated with chemoresistance in human gastric cancer.PLoS One. 2014 Oct 17;9(10):e110293. doi: 10.1371/journal.pone.0110293. eCollection 2014.
• [552] Immunohistochemical expression and localization of cytokines/chemokines/growth factors in gastric cancer.Cytokine. 2017 Jan;89:82-90. doi: 10.1016/j.cyto.2016.08.032. Epub 2016 Oct 25.
• [553] PKNOX2 suppresses gastric cancer through the transcriptional activation of IGFBP5 and p53.Oncogene. 2019 Jun;38(23):4590-4604. doi: 10.1038/s41388-019-0743-4. Epub 2019 Feb 11.
• [554] The transcribed-ultraconserved regions in prostate and gastric cancer: DNA hypermethylation and microRNA-associated regulation.Oncogene. 2016 Jul 7;35(27):3598-606. doi: 10.1038/onc.2015.445. Epub 2015 Dec 7.
• [555] RPS15A promotes gastric cancer progression via activation of the Akt/IKK-/NF-B signalling pathway.J Cell Mol Med. 2019 Mar;23(3):2207-2218. doi: 10.1111/jcmm.14141. Epub 2019 Jan 19.
• [556] Association analysis of ERBB2 amplicon genetic polymorphisms and STARD3 expression with risk of gastric cancer in the Chinese population.Gene. 2014 Feb 10;535(2):225-32. doi: 10.1016/j.gene.2013.11.030. Epub 2013 Nov 28.
• [557] Cancer-Associated Fibroblasts Promote the Chemo-resistance in Gastric Cancer through Secreting IL-11 Targeting JAK/STAT3/Bcl2 Pathway.Cancer Res Treat. 2019 Jan;51(1):194-210. doi: 10.4143/crt.2018.031. Epub 2018 Apr 20.
• [558] Golgi phosphoprotein 2 down-regulates the Th1 response in human gastric cancer cells by suppressing IL-12A.Asian Pac J Cancer Prev. 2013;14(10):5747-51. doi: 10.7314/apjcp.2013.14.10.5747.
• [559] Gastric cancer in three relatives of a patient with a biallelic IL12RB1 mutation.Fam Cancer. 2015 Mar;14(1):89-94. doi: 10.1007/s10689-014-9764-x.
• [560] Serum IL-17 levels can be diagnostic for gastric cancer.J BUON. 2019 Jul-Aug;24(4):1601-1609.
• [561] Distribution of circulating follicular helper T cells and expression of interleukin-21 and chemokine C-X-C ligand 13 in gastric cancer.Oncol Lett. 2018 Sep;16(3):3917-3922. doi: 10.3892/ol.2018.9112. Epub 2018 Jul 10.
• [562] IL-21R functions as an oncogenic factor and is regulated by the lncRNA MALAT1/miR-125a-3p axis in gastric cancer.Int J Oncol. 2019 Jan;54(1):7-16. doi: 10.3892/ijo.2018.4612. Epub 2018 Oct 31.
• [563] Polymorphisms of IL-23R predict survival of gastric cancer patients in a Chinese population.Cytokine. 2019 May;117:79-83. doi: 10.1016/j.cyto.2019.01.014. Epub 2019 Mar 1.
• [564] Diverse Expression of IL-32 in Diffuse and Intestinal Types of Gastric Cancer.Gastroenterol Res Pract. 2018 Oct 4;2018:6578273. doi: 10.1155/2018/6578273. eCollection 2018.
• [565] E-selectin rs5361 and FCGR2A rs1801274 variants were associated with increased risk of gastric cancer in a Chinese population.Mol Carcinog. 2012 Aug;51(8):597-607. doi: 10.1002/mc.20828. Epub 2011 Jul 20.
• [566] High expression of integrin-linked kinase predicts aggressiveness and poor prognosis in patients with gastric cancer.Acta Histochem. 2014 Jun;116(5):758-62. doi: 10.1016/j.acthis.2014.01.005. Epub 2014 Feb 3.
• [567] IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor features: A tissue microarray study on 8,877 human cancers and normal tissues.Oncol Rep. 2018 Jan;39(1):3-12. doi: 10.3892/or.2017.6072. Epub 2017 Nov 2.
• [568] MIR17HG-miR-18a/19a axis, regulated by interferon regulatory factor-1, promotes gastric cancer metastasis via Wnt/-catenin signalling.Cell Death Dis. 2019 Jun 11;10(6):454. doi: 10.1038/s41419-019-1685-z.
• [569] ITGA1 polymorphisms and haplotypes are associated with gastric cancer risk in a Korean population.World J Gastroenterol. 2013 Sep 21;19(35):5870-6. doi: 10.3748/wjg.v19.i35.5870.
• [570] Quantitative expression of the homeobox and integrin genes in human gastric carcinoma.Int J Mol Med. 2007 Oct;20(4):621-9.
• [571] CXCL1 from tumor-associated lymphatic endothelial cells drives gastric cancer cell into lymphatic system via activating integrin 1/FAK/AKT signaling.Cancer Lett. 2017 Jan 28;385:28-38. doi: 10.1016/j.canlet.2016.10.043. Epub 2016 Nov 8.
• [572] MiR-124-3p inhibits the migration and invasion of Gastric cancer by targeting ITGB3.Pathol Res Pract. 2020 Jan;216(1):152762. doi: 10.1016/j.prp.2019.152762. Epub 2019 Nov 30.
• [573] Clinical significance of integrin v6 expression effects on gastric carcinoma invasiveness and progression via cancer-associated fibroblasts.Med Oncol. 2013;30(3):580. doi: 10.1007/s12032-013-0580-1. Epub 2013 May 15.
• [574] Possible involvement of inositol 1,4,5-trisphosphate receptor type 3 (IP3R3) in the peritoneal dissemination of gastric cancers.Anticancer Res. 2003 Sep-Oct;23(5A):3691-7.
• [575] DC-SIGN mediates gastric cancer progression by regulating the JAK2/STAT3 signaling pathway and affecting LncRNA RP11-181G12.2 expression.Biomed Pharmacother. 2020 Jan;121:109644. doi: 10.1016/j.biopha.2019.109644. Epub 2019 Nov 19.
• [576] Aberrant expression of Eag1 potassium channels in gastric cancer patients and cell lines.Med Oncol. 2007;24(3):345-50. doi: 10.1007/s12032-007-0015-y.
• [577] The hERG1 Potassium Channel Behaves As Prognostic Factor In Gastric Dysplasia Endoscopic Samples.Onco Targets Ther. 2019 Nov 7;12:9377-9384. doi: 10.2147/OTT.S226257. eCollection 2019.
• [578] The carcinogenic complex lncRNA FOXP4-AS1/EZH2/LSD1 accelerates proliferation, migration and invasion of gastric cancer.Eur Rev Med Pharmacol Sci. 2019 Oct;23(19):8371-8376. doi: 10.26355/eurrev_201910_19148.
• [579] Upregulation of the long noncoding RNA ADPGK-AS1 promotes carcinogenesis and predicts poor prognosis in gastric cancer.Biochem Biophys Res Commun. 2019 May 21;513(1):127-134. doi: 10.1016/j.bbrc.2019.03.140. Epub 2019 Mar 31.
• [580] Elevated JMJD1A is a novel predictor for prognosis and a potential therapeutic target for gastric cancer.Int J Clin Exp Pathol. 2015 Sep 1;8(9):11092-9. eCollection 2015.
• [581] JMJD2A sensitizes gastric cancer to chemotherapy by cooperating with CCDC8.Gastric Cancer. 2020 May;23(3):426-436. doi: 10.1007/s10120-019-01024-9. Epub 2019 Nov 1.
• [582] Histone demethylase retinoblastoma binding protein 2 is overexpressed in hepatocellular carcinoma and negatively regulated by hsa-miR-212.PLoS One. 2013 Jul 29;8(7):e69784. doi: 10.1371/journal.pone.0069784. Print 2013.
• [583] Comprehensive profiling of JMJD3 in gastric cancer and its influence on patient survival.Sci Rep. 2019 Jan 29;9(1):868. doi: 10.1038/s41598-018-37340-w.
• [584] Clinical significance and effect of Sam68 expression in gastric cancer. Oncol Lett. 2018 Apr;15(4):4745-4752.
• [585] KIF26B, a novel oncogene, promotes proliferation and metastasis by activating the VEGF pathway in gastric cancer. Oncogene. 2017 Oct 5;36(40):5609-5619.
• [586] KISS1 and KISS1R expression in gastric cancer.J BUON. 2018 Jan-Feb;23(1):79-84.
• [587] Comparison of tissue kallikrein and kinin receptor expression in gastric ulcers and neoplasms.Int Immunopharmacol. 2001 Nov;1(12):2063-80. doi: 10.1016/s1567-5769(01)00118-7.
• [588] Kallikrein-related peptidase 6 induces chemotherapeutic resistance by attenuating auranofin-induced cell death through activation of autophagy in gastric cancer.Oncotarget. 2016 Dec 20;7(51):85332-85348. doi: 10.18632/oncotarget.13352.
• [589] An updated review of gastric cancer in the next-generation sequencing era: insights from bench to bedside and vice versa.World J Gastroenterol. 2014 Apr 14;20(14):3927-37. doi: 10.3748/wjg.v20.i14.3927.
• [590] SET8 expression is associated with overall survival in gastric cancer.Genet Mol Res. 2015 Dec 2;14(4):15609-15. doi: 10.4238/2015.December.1.12.
• [591] KRAS Mutation in Gastric Cancer and Prognostication Associated with Microsatellite Instability Status.Pathol Oncol Res. 2019 Jan;25(1):333-340. doi: 10.1007/s12253-017-0348-6. Epub 2017 Nov 8.
• [592] Development of a high-throughput membrane-array method for molecular diagnosis of circulating tumor cells in patients with gastric cancers.Int J Cancer. 2006 Jul 15;119(2):373-9. doi: 10.1002/ijc.21856.
• [593] Gastric cancers overexpress S100A calcium-binding proteins.Cancer Res. 2002 Dec 1;62(23):6823-6.
• [594] Overexpression of L1CAM is associated with tumor progression and prognosis via ERK signaling in gastric cancer.Ann Surg Oncol. 2014 Feb;21(2):560-8. doi: 10.1245/s10434-013-3246-5. Epub 2013 Sep 18.
• [595] Aberrant up-regulation of LAMB3 and LAMC2 by promoter demethylation in gastric cancer.Biochem Biophys Res Commun. 2011 Mar 25;406(4):539-45. doi: 10.1016/j.bbrc.2011.02.082. Epub 2011 Feb 21.
• [596] Protocadherin-8 promotes invasion and metastasis via laminin subunit 2 in gastric cancer.Cancer Sci. 2018 Mar;109(3):732-740. doi: 10.1111/cas.13502. Epub 2018 Feb 20.
• [597] MicroRNA-218 inhibits the proliferation, migration, and invasion and promotes apoptosis of gastric cancer cells by targeting LASP1.Tumour Biol. 2016 Nov;37(11):15241-15252. doi: 10.1007/s13277-016-5388-0. Epub 2016 Sep 30.
• [598] miR-372 regulates cell cycle and apoptosis of ags human gastric cancer cell line through direct regulation of LATS2.Mol Cells. 2009 Dec 31;28(6):521-7. doi: 10.1007/s10059-009-0158-0. Epub 2009 Nov 19.
• [599] Genetic polymorphisms in the Toll-like receptor signalling pathway in Helicobacter pylori infection and related gastric cancer.Hum Immunol. 2014 Aug;75(8):808-15. doi: 10.1016/j.humimm.2014.06.001. Epub 2014 Jun 11.
• [600] The molecular mechanism and clinical significance of LDHA in HER2-mediated progression of gastric cancer.Am J Transl Res. 2018 Jul 15;10(7):2055-2067. eCollection 2018.
• [601] Lowered expression of galectin-2 is associated with lymph node metastasis in gastric cancer.J Gastroenterol. 2012 Jan;47(1):37-48. doi: 10.1007/s00535-011-0463-1. Epub 2011 Oct 21.
• [602] Ablation of human telomerase reverse transcriptase (hTERT) induces cellular senescence in gastric cancer through a galectin-3 dependent mechanism.Oncotarget. 2016 Aug 30;7(35):57117-57130. doi: 10.18632/oncotarget.10986.
• [603] GPR48, a poor prognostic factor, promotes tumor metastasis and activates -catenin/TCF signaling in colorectal cancer.Carcinogenesis. 2013 Dec;34(12):2861-9. doi: 10.1093/carcin/bgt229. Epub 2013 Jun 26.
• [604] Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer.Stem Cells. 2019 Feb;37(2):176-189. doi: 10.1002/stem.2942. Epub 2018 Nov 23.
• [605] A novel long noncoding RNA-LOWEG is low expressed in gastric cancer and acts as a tumor suppressor by inhibiting cell invasion.J Cancer Res Clin Oncol. 2016 Mar;142(3):601-9. doi: 10.1007/s00432-015-2071-6. Epub 2015 Nov 4.
• [606] MicroRNA-7 as a potential therapeutic target for aberrant NF-B-driven distant metastasis of gastric cancer.J Exp Clin Cancer Res. 2019 Feb 6;38(1):55. doi: 10.1186/s13046-019-1074-6.
• [607] Expression of immunoglobulin-like transcript (ILT)2 and ILT3 in human gastric cancer and its clinical significance.Mol Med Rep. 2012 Apr;5(4):910-6. doi: 10.3892/mmr.2012.744. Epub 2012 Jan 9.
• [608] Overexpression of Lin28 inhibits the proliferation, migration and cell cycle progression and induces apoptosis of BGC-823 gastric cancer cells.Oncol Rep. 2015 Feb;33(2):997-1003. doi: 10.3892/or.2014.3674. Epub 2014 Dec 15.
• [609] An 8-gene signature, including methylated and down-regulated glutathione peroxidase 3, of gastric cancer.Int J Oncol. 2010 Feb;36(2):405-14.
• [610] Lysyl oxidase and hypoxia-inducible factor 1: biomarkers of gastric cancer.World J Gastroenterol. 2019 Apr 21;25(15):1828-1839. doi: 10.3748/wjg.v25.i15.1828.
• [611] microRNA-501-5p promotes cell proliferation and migration in gastric cancer by downregulating LPAR1.J Cell Biochem. 2020 Feb;121(2):1911-1922. doi: 10.1002/jcb.29426. Epub 2019 Nov 20.
• [612] Hsp90ab1 stabilizes LRP5 to promote epithelial-mesenchymal transition via activating of AKT and Wnt/-catenin signaling pathways in gastric cancer progression.Oncogene. 2019 Feb;38(9):1489-1507. doi: 10.1038/s41388-018-0532-5. Epub 2018 Oct 10.
• [613] Effects of diphyllin as a novel V-ATPase inhibitor on gastric adenocarcinoma.Eur J Pharmacol. 2011 Sep 30;667(1-3):330-8. doi: 10.1016/j.ejphar.2011.05.042. Epub 2011 Jun 2.
• [614] PinX1 inhibits telomerase activity in gastric cancer cells through Mad1/c-Myc pathway.J Gastrointest Surg. 2010 Aug;14(8):1227-34. doi: 10.1007/s11605-010-1253-4. Epub 2010 Jun 11.
• [615] Expression of MAGE-1, MAGE-2 and MAGE-3 genes in human gastric carcinomas; lack of evidence for cytotoxic effects in cases with simultaneous expression of MAGE-3 and HLA-A2.Anticancer Res. 1998 Sep-Oct;18(5B):3639-44.
• [616] Evaluation of the diagnostic value of 64 simultaneously measured autoantibodies for early detection of gastric cancer.Sci Rep. 2016 May 3;6:25467. doi: 10.1038/srep25467.
• [617] MAP3K1 rs889312 genotypes influence survival outcomes of Chinese gastric cancer patients who received adjuvant chemotherapy based on platinum and fluorouracil regimes.Onco Targets Ther. 2019 Aug 22;12:6843-6855. doi: 10.2147/OTT.S205438. eCollection 2019.
• [618] High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.Mol Med Rep. 2017 Jul;16(1):224-230. doi: 10.3892/mmr.2017.6560. Epub 2017 May 10.
• [619] Integrated exome and transcriptome sequencing reveals ZAK isoform usage in gastric cancer.Nat Commun. 2014 May 8;5:3830. doi: 10.1038/ncomms4830.
• [620] Gene expression profiles in human gastric cancer: expression of maspin correlates with lymph node metastasis.Br J Cancer. 2005 Mar 28;92(6):1130-6. doi: 10.1038/sj.bjc.6602429.
• [621] DLX6-AS1 promotes cell proliferation, migration and EMT of gastric cancer through FUS-regulated MAP4K1.Cancer Biol Ther. 2020;21(1):17-25. doi: 10.1080/15384047.2019.1647050. Epub 2019 Oct 8.
• [622] Silencing of MAP4K4 by short hairpin RNA suppresses proliferation, induces G1 cell cycle arrest and induces apoptosis in gastric cancer cells.Mol Med Rep. 2016 Jan;13(1):41-8. doi: 10.3892/mmr.2015.4510. Epub 2015 Nov 6.
• [623] SATB2 suppresses gastric cancer cell proliferation and migration.Tumour Biol. 2016 Apr;37(4):4597-602. doi: 10.1007/s13277-015-4282-5. Epub 2015 Oct 27.
• [624] Direct targeting of MAPK8IP1 by miR-10a-5p is a major mechanism for gastric cancer metastasis.Oncol Lett. 2017 Mar;13(3):1131-1136. doi: 10.3892/ol.2016.5544. Epub 2016 Dec 28.
• [625] Prognostic Value of Upregulation of Myristoylated Alanine-Rich C-Kinase Substrate in Gastric Cancer.Med Sci Monit. 2019 Jan 9;25:279-287. doi: 10.12659/MSM.913558.
• [626] PAR-1 polymorphisms and risk of Helicobacter pylori-related gastric cancer in a Chinese population.Anticancer Res. 2012 Sep;32(9):3715-21.
• [627] Overexpression of methionine adenosyltransferase II alpha (MAT2A) in gastric cancer and induction of cell cycle arrest and apoptosis in SGC-7901 cells by shRNA-mediated silencing of MAT2A gene.Acta Histochem. 2013 Jan;115(1):48-55. doi: 10.1016/j.acthis.2012.03.006. Epub 2012 Apr 26.
• [628] Sphingosine 1-phosphate receptor expression profile in human gastric cancer cells: differential regulation on the migration and proliferation.J Surg Res. 2006 Jan;130(1):80-7. doi: 10.1016/j.jss.2005.08.004. Epub 2005 Sep 23.
• [629] CD146 promotes metastasis and predicts poor prognosis of hepatocellular carcinoma.J Exp Clin Cancer Res. 2016 Feb 29;35:38. doi: 10.1186/s13046-016-0313-3.
• [630] Suppression of midkine gene promotes the antitumoral effect of cisplatin on human gastric cancer cell line AGS in vitro and in vivo via the modulation of Notch signaling pathway.Oncol Rep. 2017 Aug;38(2):745-754. doi: 10.3892/or.2017.5743. Epub 2017 Jun 22.
• [631] Maternal embryonic leucine zipper kinase serves as a poor prognosis marker and therapeutic target in gastric cancer.Oncotarget. 2016 Feb 2;7(5):6266-80. doi: 10.18632/oncotarget.6673.
• [632] The Association Between MGMT Promoter Methylation and Patients with Gastric Cancer: A Meta-Analysis.Genet Test Mol Biomarkers. 2017 Apr;21(4):213-221. doi: 10.1089/gtmb.2016.0284. Epub 2017 Feb 23.
• [633] Eicosapentaenoic acid and docosahexaenoic acid inhibit macrophage-induced gastric cancer cell migration by attenuating the expression of matrix metalloproteinase 10. J Nutr Biochem. 2012 Nov;23(11):1434-9. doi: 10.1016/j.jnutbio.2011.09.004. Epub 2012 Jan 27.
• [634] Exosomal miRNA-139 in cancer-associated fibroblasts inhibits gastric cancer progression by repressing MMP11 expression.Int J Biol Sci. 2019 Aug 22;15(11):2320-2329. doi: 10.7150/ijbs.33750. eCollection 2019.
• [635] Identification of potential serum biomarkers for gastric cancer by a novel computational method, multiple normal tissues corrected differential analysis.Clin Chim Acta. 2012 Feb 18;413(3-4):428-33. doi: 10.1016/j.cca.2011.10.026. Epub 2011 Oct 25.
• [636] beta-Catenin/Wnt signaling regulates expression of the membrane type 3 matrix metalloproteinase in gastric cancer.Cancer Res. 2006 May 1;66(9):4734-41. doi: 10.1158/0008-5472.CAN-05-4268.
• [637] The Role of MMP8 in Cancer: A Systematic Review.Int J Mol Sci. 2019 Sep 11;20(18):4506. doi: 10.3390/ijms20184506.
• [638] Increased musashi 2 expression indicates a poor prognosis and promotes malignant phenotypes in gastric cancer.Oncol Lett. 2019 Mar;17(3):2599-2606. doi: 10.3892/ol.2019.9889. Epub 2019 Jan 4.
• [639] DNA diagnosis of peritoneal fluid cytology test by CDO1 promoter DNA hypermethylation in gastric cancer.Gastric Cancer. 2017 Sep;20(5):784-792. doi: 10.1007/s10120-017-0697-6. Epub 2017 Feb 27.
• [640] Oncogenic MST1R activity in pancreatic and gastric cancer represents a valid target of HSP90 inhibitors.Anticancer Res. 2012 Feb;32(2):427-37.
• [641] Metastasis-associated protein 1 (MTA1) in gastric cancer tissues is positively associated with poorer prognosis.Pathol Res Pract. 2018 Apr;214(4):536-541. doi: 10.1016/j.prp.2018.02.011. Epub 2018 Feb 21.
• [642] miR?664?P suppresses the proliferation and metastasis of gastric cancer by attenuating the NFB signaling pathway through targeting MTDH.Int J Oncol. 2019 Mar;54(3):845-858. doi: 10.3892/ijo.2019.4680. Epub 2019 Jan 8.
• [643] Dietary folate, one-carbon metabolism-related genes, and gastric cancer risk in Korea.Mol Nutr Food Res. 2016 Feb;60(2):337-45. doi: 10.1002/mnfr.201500384. Epub 2015 Nov 17.
• [644] Development of the Tumor-Specific Antigen-Derived Synthetic Peptides as Potential Candidates for Targeting Breast and Other Possible Human Carcinomas.Molecules. 2019 Aug 29;24(17):3142. doi: 10.3390/molecules24173142.
• [645] Clinical Significance of Serum CA125, CA19-9, CA72-4, and Fibrinogen-to-Lymphocyte Ratio in Gastric Cancer With Peritoneal Dissemination.Front Oncol. 2019 Nov 5;9:1159. doi: 10.3389/fonc.2019.01159. eCollection 2019.
• [646] Differentially expressed genes ASPN, COL1A1, FN1, VCAN and MUC5AC are potential prognostic biomarkers for gastric cancer.Oncol Lett. 2019 Mar;17(3):3191-3202. doi: 10.3892/ol.2019.9952. Epub 2019 Jan 21.
• [647] Reduced expression of MUTYH with suppressive activity against mutations caused by 8-hydroxyguanine is a novel predictor of a poor prognosis in human gastric cancer.J Pathol. 2011 Nov;225(3):414-23. doi: 10.1002/path.2953. Epub 2011 Aug 8.
• [648] Overexpression of MYC binding protein promotes invasion and migration in gastric cancer.Oncol Lett. 2018 Apr;15(4):5243-5249. doi: 10.3892/ol.2018.7944. Epub 2018 Feb 2.
• [649] Helicobacter pylori babA2 Positivity Predicts Risk of Gastric Cancer in Ardabil, a Very High-Risk Area in Iran.Asian Pac J Cancer Prev. 2016;17(2):733-8. doi: 10.7314/apjcp.2016.17.2.733.
• [650] Preliminary study on the effect of nucleolin specific aptamer-miRNA let-7d chimera on Janus kinase-2 expression level and activity in gastric cancer (MKN-45) cells.Mol Biol Rep. 2019 Feb;46(1):207-215. doi: 10.1007/s11033-018-4462-7. Epub 2018 Nov 10.
• [651] Retracted: AIB1 induces epithelial-mesenchymal transition in gastric cancer via the PI3K/AKT signaling.J Cell Biochem. 2021 Sep;122(9):926-933. doi: 10.1002/jcb.29530. Epub 2019 Nov 6.
• [652] Mitochondrial GRIM-19 as a potential therapeutic target for STAT3-dependent carcinogenesis of gastric cancer.Oncotarget. 2016 Jul 5;7(27):41404-41420. doi: 10.18632/oncotarget.9167.
• [653] CircRNA circPDSS1 promotes the gastric cancer progression by sponging miR-186-5p and modulating NEK2.J Cell Physiol. 2019 Jul;234(7):10458-10469. doi: 10.1002/jcp.27714. Epub 2018 Nov 11.
• [654] Palliative Role of Aqueous Ginger Extract on N-Nitroso-N-Methylurea-Induced Gastric Cancer.Nutr Cancer. 2020;72(1):157-169. doi: 10.1080/01635581.2019.1619784. Epub 2019 Jun 1.
• [655] Nucleotide-binding oligomerization domain 1 and Helicobacter pylori infection: A review.World J Gastroenterol. 2018 Apr 28;24(16):1725-1733. doi: 10.3748/wjg.v24.i16.1725.
• [656] NOD1 and NOD2 Genetic Variants in Association with Risk of Gastric Cancer and Its Precursors in a Chinese Population.PLoS One. 2015 May 1;10(5):e0124949. doi: 10.1371/journal.pone.0124949. eCollection 2015.
• [657] Function and diagnostic value of Anosmin-1 in gastric cancer progression.Int J Cancer. 2016 Feb 1;138(3):721-30. doi: 10.1002/ijc.29803. Epub 2015 Sep 1.
• [658] Notch signaling pathway regulates CD4(+)CD25(+)CD127(dim/-) regulatory T cells and T helper 17 cells function in gastric cancer patients.Biosci Rep. 2019 May 14;39(5):BSR20182044. doi: 10.1042/BSR20182044. Print 2019 May 31.
• [659] Natriuretic peptide receptor A inhibition suppresses gastric cancer development through reactive oxygen species-mediated G2/M cell cycle arrest and cell death.Free Radic Biol Med. 2016 Oct;99:593-607. doi: 10.1016/j.freeradbiomed.2016.08.019. Epub 2016 Sep 12.
• [660] Role of NQO1 609C>T and NQO2-3423G>A polymorphisms in susceptibility to gastric cancer in Kashmir valley.DNA Cell Biol. 2011 May;30(5):297-303. doi: 10.1089/dna.2010.1115. Epub 2011 Feb 7.
• [661] TMEFF2 deregulation contributes to gastric carcinogenesis and indicates poor survival outcome.Clin Cancer Res. 2014 Sep 1;20(17):4689-704. doi: 10.1158/1078-0432.CCR-14-0315. Epub 2014 Jul 1.
• [662] Epigenetic silencing of the NR4A3 tumor suppressor, by aberrant JAK/STAT signaling, predicts prognosis in gastric cancer.Sci Rep. 2016 Aug 16;6:31690. doi: 10.1038/srep31690.
• [663] Nr5a2 promotes tumor growth and metastasis of gastric cancer AGS cells by Wnt/beta-catenin signaling.Onco Targets Ther. 2019 Apr 17;12:2891-2902. doi: 10.2147/OTT.S201228. eCollection 2019.
• [664] Clinical significance of overexpression of NRG1 and its receptors, HER3 and HER4, in gastric cancer patients.Gastric Cancer. 2018 Mar;21(2):225-236. doi: 10.1007/s10120-017-0732-7. Epub 2017 Jun 1.
• [665] Expression of the EGF family in gastric cancer: downregulation of HER4 and its activating ligand NRG4.PLoS One. 2014 Apr 11;9(4):e94606. doi: 10.1371/journal.pone.0094606. eCollection 2014.
• [666] Netrin-1 promotes cell neural invasion in gastric cancer via its receptor neogenin.J Cancer. 2019 Jun 2;10(14):3197-3207. doi: 10.7150/jca.30230. eCollection 2019.
• [667] RETRACTED: Long non-coding RNA LINC00978 promotes cell proliferation and tumorigenesis via regulating microRNA-497/NTRK3 axis in gastric cancer.Int J Biol Macromol. 2019 Feb 15;123:1106-1114. doi: 10.1016/j.ijbiomac.2018.11.162. Epub 2018 Nov 17.
• [668] Gene polymorphisms in the ornithine decarboxylase-polyamine pathway modify gastric cancer risk by interaction with isoflavone concentrations.Gastric Cancer. 2015 Jul;18(3):495-503. doi: 10.1007/s10120-014-0396-5. Epub 2014 Jul 31.
• [669] Olfactomedin-4 in digestive diseases: A mini-review.World J Gastroenterol. 2018 May 7;24(17):1881-1887. doi: 10.3748/wjg.v24.i17.1881.
• [670] High frequency occurrence of 1-OPRD variant of PRNP gene in gastric cancer cell lines and Chinese population with gastric cancer.Cell Biol Int. 2006 Nov;30(11):920-3. doi: 10.1016/j.cellbi.2006.05.015. Epub 2006 Jul 7.
• [671] Oncostatin M receptor, positively regulated by SP1, promotes gastric cancer growth and metastasis upon treatment with Oncostatin M.Gastric Cancer. 2019 Sep;22(5):955-966. doi: 10.1007/s10120-019-00934-y. Epub 2019 Feb 18.
• [672] Anti-proliferative Effects of Nucleotides on Gastric Cancer via a Novel P2Y6/SOCE/Ca(2+)/-catenin Pathway.Sci Rep. 2017 May 26;7(1):2459. doi: 10.1038/s41598-017-02562-x.
• [673] Whole genome gene copy number profiling of gastric cancer identifies PAK1 and KRAS gene amplification as therapy targets.Genes Chromosomes Cancer. 2014 Nov;53(11):883-94. doi: 10.1002/gcc.22196. Epub 2014 Jun 17.
• [674] P21 activated kinase 4 binds translation elongation factor eEF1A1 to promote gastric cancer cell migration and invasion.Oncol Rep. 2017 May;37(5):2857-2864. doi: 10.3892/or.2017.5543. Epub 2017 Mar 31.
• [675] Aberrant expression of AID and AID activators of NF-B and PAX5 is irrelevant to EBV-associated gastric cancers, but is associated with carcinogenesis in certain EBV-non-associated gastric cancers.Oncol Lett. 2017 Jun;13(6):4133-4140. doi: 10.3892/ol.2017.5978. Epub 2017 Apr 3.
• [676] Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma.Br J Cancer. 2017 Jan 17;116(2):218-226. doi: 10.1038/bjc.2016.394. Epub 2016 Nov 29.
• [677] Frameshift mutations of OGDH, PPAT and PCCA genes in gastric and colorectal cancers.Neoplasma. 2016;63(5):681-6. doi: 10.4149/neo_2016_504.
• [678] KIF23 Promotes Gastric Cancer by Stimulating Cell Proliferation.Dis Markers. 2019 Mar 17;2019:9751923. doi: 10.1155/2019/9751923. eCollection 2019.
• [679] A Novel Strategy for Targeted Lipidomics Based on LC-Tandem-MS Parameters Prediction, Quantification, and Multiple Statistical Data Mining: Evaluation of Lysophosphatidylcholines as Potential Cancer Biomarkers.Anal Chem. 2019 Mar 5;91(5):3389-3396. doi: 10.1021/acs.analchem.8b04715. Epub 2019 Feb 12.
• [680] Polymorphism of the programmed death-ligand 1 gene is associated with its protein expression and prognosis in gastric cancer.J Gastroenterol Hepatol. 2019 Jul;34(7):1201-1207. doi: 10.1111/jgh.14520. Epub 2018 Nov 18.
• [681] Protein kinase D3 promotes gastric cancer development through p65/6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 activation of glycolysis.Exp Cell Res. 2019 Jul 15;380(2):188-197. doi: 10.1016/j.yexcr.2019.04.022. Epub 2019 Apr 24.
• [682] SNP interactions of PGC with its neighbor lncRNAs enhance the susceptibility to gastric cancer/atrophic gastritis and influence the expression of involved molecules.Cancer Med. 2018 Oct;7(10):5252-5271. doi: 10.1002/cam4.1743. Epub 2018 Aug 28.
• [683] MiR-144 functions as tumor suppressor by targeting PIM1 in gastric cancer.Eur Rev Med Pharmacol Sci. 2017 Jul;21(13):3028-3037.
• [684] Expression of group IIA phospholipase A2 is an independent predictor of favorable outcome for patients with gastric cancer.Hum Pathol. 2013 Oct;44(10):2020-7. doi: 10.1016/j.humpath.2013.01.027. Epub 2013 May 10.
• [685] Overexpression of forkhead box M1 and urokinase-type plasminogen activator in gastric cancer is associated with cancer progression and poor prognosis.Oncol Lett. 2017 Dec;14(6):7288-7296. doi: 10.3892/ol.2017.7136. Epub 2017 Oct 4.
• [686] Rebamipide abolishes Helicobacter pylori CagA-induced phospholipase D1 expression via inhibition of NFB and suppresses invasion of gastric cancer cells.Oncogene. 2013 Jul 25;32(30):3531-42. doi: 10.1038/onc.2012.358. Epub 2012 Aug 13.
• [687] Silencing of polo-like kinase 2 increases cell proliferation and decreases apoptosis in SGC-7901 gastric cancer cells.Mol Med Rep. 2015 Apr;11(4):3033-8. doi: 10.3892/mmr.2014.3077. Epub 2014 Dec 11.
• [688] PLK4 overexpression and its effect on centrosome regulation and chromosome stability in human gastric cancer.Mol Biol Rep. 2014 Oct;41(10):6635-44. doi: 10.1007/s11033-014-3546-2. Epub 2014 Jul 1.
• [689] Evolutionary recombination hotspot around GSDML-GSDM locus is closely linked to the oncogenomic recombination hotspot around the PPP1R1B-ERBB2-GRB7 amplicon.Int J Oncol. 2004 Apr;24(4):757-63.
• [690] Clinical significance of a point mutation in DNA polymerase beta (POLB) gene in gastric cancer.Int J Biol Sci. 2015 Jan 1;11(2):144-55. doi: 10.7150/ijbs.10692. eCollection 2015.
• [691] PPAR Interacts with the Hippo Coactivator YAP1 to Promote SOX9 Expression and Gastric Cancer Progression.Mol Cancer Res. 2020 Mar;18(3):390-402. doi: 10.1158/1541-7786.MCR-19-0895. Epub 2019 Dec 3.
• [692] Expression and role of cyclophilin B in stomach cancer.Genet Mol Res. 2015 May 22;14(2):5346-54. doi: 10.4238/2015.May.22.5.
• [693] Increased wild-type p53-induced phosphatase 1 (Wip1 or PPM1D) expression correlated with downregulation of checkpoint kinase 2 in human gastric carcinoma.Pathol Int. 2007 Sep;57(9):566-71. doi: 10.1111/j.1440-1827.2007.02140.x.
• [694] MiR-125b promotes cell migration and invasion by targeting PPP1CA-Rb signal pathways in gastric cancer, resulting in a poor prognosis.Gastric Cancer. 2015 Oct;18(4):729-39. doi: 10.1007/s10120-014-0421-8. Epub 2014 Sep 21.
• [695] hsa_circ_0092306 Targeting miR-197-3p Promotes Gastric Cancer Development by Regulating PRKCB in MKN-45 Cells.Mol Ther Nucleic Acids. 2019 Dec 6;18:617-626. doi: 10.1016/j.omtn.2019.08.012. Epub 2019 Aug 16.
• [696] PRKCH gene polymorphism is associated with the risk of severe gastric atrophy.Gastric Cancer. 2010 Jun;13(2):90-4. doi: 10.1007/s10120-009-0542-7. Epub 2010 Jul 3.
• [697] Lipid insertion enables targeted functionalization of paclitaxel-loaded erythrocyte membrane nanosystem by tumor-penetrating bispecific recombinant protein.Int J Nanomedicine. 2018 Sep 11;13:5347-5359. doi: 10.2147/IJN.S165109. eCollection 2018.
• [698] Glycosylation of ascites-derived exosomal CD133: a potential prognostic biomarker in patients with advanced pancreatic cancer.Med Mol Morphol. 2019 Dec;52(4):198-208. doi: 10.1007/s00795-019-00218-5. Epub 2019 Feb 25.
• [699] Gankyrin Drives Malignant Transformation of Gastric Cancer and Alleviates Oxidative Stress via mTORC1 Activation.Oxid Med Cell Longev. 2018 Oct 21;2018:9480316. doi: 10.1155/2018/9480316. eCollection 2018.
• [700] MINT31 methylation in gastric noninvasive neoplasia: potential role in the secondary prevention of gastric cancer.Eur J Cancer Prev. 2012 Sep;21(5):442-8. doi: 10.1097/CEJ.0b013e32834f7536.
• [701] Signature of positive selection of PTK6 gene in East Asian populations: a cross talk for Helicobacter pylori invasion and gastric cancer endemicity.Mol Genet Genomics. 2015 Oct;290(5):1741-52. doi: 10.1007/s00438-015-1032-8. Epub 2015 Apr 3.
• [702] PTK-7 Expression in Gastric Cancer: A Prognostic Determinant.Balkan Med J. 2020 Feb 28;37(2):91-97. doi: 10.4274/balkanmedj.galenos.2019.2019.8.12. Epub 2019 Dec 10.
• [703] The miR-29c-KIAA1199 axis regulates gastric cancer migration by binding with WBP11 and PTP4A3.Oncogene. 2019 Apr;38(17):3134-3150. doi: 10.1038/s41388-018-0642-0. Epub 2019 Jan 9.
• [704] MicroRNA-204-5p inhibits gastric cancer cell proliferation by downregulating USP47 and RAB22A.Med Oncol. 2015 Jan;32(1):331. doi: 10.1007/s12032-014-0331-y. Epub 2014 Nov 28.
• [705] RAD51 G135C genetic polymorphism and their potential role in gastric cancer induced by Helicobacter pylori infection in Bhutan.Epidemiol Infect. 2016 Jan;144(2):234-40. doi: 10.1017/S0950268815001430. Epub 2015 Jun 29.
• [706] Expression of two types of neurofibromatosis type 1 gene transcripts in gastric cancers and comparison of GAP activities.Biochem Biophys Res Commun. 1992 Aug 31;187(1):332-9. doi: 10.1016/s0006-291x(05)81497-4.
• [707] The AKT1/NF-kappaB/Notch1/PTEN axis has an important role in chemoresistance of gastric cancer cells.Cell Death Dis. 2013 Oct 10;4(10):e847. doi: 10.1038/cddis.2013.375.
• [708] miR-221 and miR-222 Simultaneously Target RECK and Regulate Growth and Invasion of Gastric Cancer Cells.Med Sci Monit. 2015 Sep 13;21:2718-25. doi: 10.12659/MSM.894324.
• [709] Expression of Reg IV and SOX9 and their correlation in human gastric cancer.BMC Cancer. 2018 Mar 27;18(1):344. doi: 10.1186/s12885-018-4285-x.
• [710] Gain-of-Function RHOA Mutations Promote Focal Adhesion Kinase Activation and Dependency in Diffuse Gastric Cancer.Cancer Discov. 2020 Feb;10(2):288-305. doi: 10.1158/2159-8290.CD-19-0811. Epub 2019 Nov 26.
• [711] Systematic approach identifies RHOA as a potential biomarker therapeutic target for Asian gastric cancer.Oncotarget. 2016 Dec 6;7(49):81435-81451. doi: 10.18632/oncotarget.12963.
• [712] Reduced USP33 expression in gastric cancer decreases inhibitory effects of Slit2-Robo1 signalling on cell migration and EMT.Cell Prolif. 2019 May;52(3):e12606. doi: 10.1111/cpr.12606. Epub 2019 Mar 21.
• [713] miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer.J Exp Clin Cancer Res. 2015 Nov 14;34:139. doi: 10.1186/s13046-015-0253-3.
• [714] RPS12-specific shRNA inhibits the proliferation, migration of BGC823 gastric cancer cells with S100A4 as a downstream effector.Int J Oncol. 2013 May;42(5):1763-9. doi: 10.3892/ijo.2013.1872. Epub 2013 Mar 28.
• [715] Gene amplification of ribosomal protein S6 kinase-1 and -2 in gastric cancer.Anticancer Res. 2013 Feb;33(2):469-75.
• [716] Ribonucleotide reductase large subunit M1 predicts poor survival due to modulation of proliferative and invasive ability of gastric cancer.PLoS One. 2013 Jul 29;8(7):e70191. doi: 10.1371/journal.pone.0070191. Print 2013.
• [717] Overexpression of RRM2 in gastric cancer cell promotes their invasiveness via AKT/NF-B signaling pathway.Pharmazie. 2016 May;71(5):280-4.
• [718] In silico analysis and verification of S100 gene expression in gastric cancer.BMC Cancer. 2008 Sep 16;8:261. doi: 10.1186/1471-2407-8-261.
• [719] A selective sphingosine-1-phosphate receptor 1 agonist SEW-2871 aggravates gastric cancer by recruiting myeloid-derived suppressor cells.J Biochem. 2018 Jan 1;163(1):77-83. doi: 10.1093/jb/mvx064.
• [720] SATB1 3'-UTR and lncRNA-UCA1 competitively bind to miR-495-3p and together regulate the proliferation and invasion of gastric cancer.J Cell Biochem. 2019 Apr;120(4):6671-6682. doi: 10.1002/jcb.27963. Epub 2018 Oct 28.
• [721] Voltage-gated sodium channel Nav 1.7 promotes gastric cancer progression through MACC1-mediated upregulation of NHE1.Int J Cancer. 2016 Dec 1;139(11):2553-69. doi: 10.1002/ijc.30381. Epub 2016 Aug 26.
• [722] E-Selectin S128R gene polymorphism in gastric cancer.Int J Biol Markers. 2013 Apr 23;28(1):38-42. doi: 10.5301/JBM.2012.9582.
• [723] Maspin genetically and functionally associates with gastric cancer by regulating cell cycle progression.Carcinogenesis. 2012 Dec;33(12):2344-50. doi: 10.1093/carcin/bgs280. Epub 2012 Sep 7.
• [724] SETD2 indicates favourable prognosis in gastric cancer and suppresses cancer cell proliferation, migration, and invasion.Biochem Biophys Res Commun. 2018 Apr 6;498(3):579-585. doi: 10.1016/j.bbrc.2018.03.022. Epub 2018 Mar 9.
• [725] Penicillinbinding protein 1A mutationpositive Helicobacterpylori promotes epithelialmesenchymal transition in gastric cancer via the suppression of microRNA?34.Int J Oncol. 2019 Mar;54(3):916-928. doi: 10.3892/ijo.2018.4665. Epub 2018 Dec 12.
• [726] Lnc-SGK1 induced by Helicobacter pylori infection and highsalt diet promote Th2 and Th17 differentiation in human gastric cancer by SGK1/Jun B signaling.Oncotarget. 2016 Apr 12;7(15):20549-60. doi: 10.18632/oncotarget.7823.
• [727] Shugoshin1 enhances multidrug resistance of gastric cancer cells by regulating MRP1, Bcl-2, and Bax genes.Tumour Biol. 2013 Aug;34(4):2205-14. doi: 10.1007/s13277-013-0758-3. Epub 2013 Apr 6.
• [728] Inhibition of sphingosine-1-phosphate phosphatase 1 promotes cancer cells migration in gastric cancer: Clinical implications. Oncol Rep. 2015 Oct;34(4):1977-87.
• [729] Identification of transporters associated with Etoposide sensitivity of stomach cancer cell lines and methotrexate sensitivity of breast cancer cell lines by quantitative targeted absolute proteomics.Mol Pharmacol. 2013 Feb;83(2):490-500. doi: 10.1124/mol.112.081083. Epub 2012 Nov 29.
• [730] CD44-SLC1A2 gene fusions in gastric cancer. Sci Transl Med. 2011 Apr 6;3(77):77ra30. doi: 10.1126/scitranslmed.3001423.
• [731] DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial-mesenchymal transition in gastric cancer.Gastric Cancer. 2020 Mar;23(2):212-227. doi: 10.1007/s10120-019-01002-1. Epub 2019 Aug 28.
• [732] Genetic variation in sodium-dependent ascorbic acid transporters and risk of gastric cancer in Poland.Eur J Cancer. 2009 Jul;45(10):1824-30. doi: 10.1016/j.ejca.2009.01.027. Epub 2009 Feb 23.
• [733] SLC34A2 regulates miR-25-Gsk3 signaling pathway to affect tumor progression in gastric cancer stem cell-like cells.Mol Carcinog. 2018 Mar;57(3):440-450. doi: 10.1002/mc.22768. Epub 2017 Dec 12.
• [734] Overexpression of SLC38A1 is associated with poorer prognosis in Chinese patients with gastric cancer.BMC Gastroenterol. 2014 Apr 9;14:70. doi: 10.1186/1471-230X-14-70.
• [735] Epigenetic silencing of BTB and CNC homology 2 and concerted promoter CpG methylation in gastric cancer.Cancer Lett. 2014 Sep 1;351(2):206-14. doi: 10.1016/j.canlet.2014.05.009. Epub 2014 May 23.
• [736] A crucial role for bone morphogenetic protein-Smad1 signalling in the DNA damage response.Nat Commun. 2012 May 15;3:836. doi: 10.1038/ncomms1832.
• [737] Transcription factor KLF4 modulates microRNA-106a that targets Smad7 in gastric cancer.Pathol Res Pract. 2019 Aug;215(8):152467. doi: 10.1016/j.prp.2019.152467. Epub 2019 May 23.
• [738] SCF(FBW7)-mediated degradation of Brg1 suppresses gastric cancer metastasis.Nat Commun. 2018 Sep 3;9(1):3569. doi: 10.1038/s41467-018-06038-y.
• [739] Mutational and expressional analysis of SMC2 gene in gastric and colorectal cancers with microsatellite instability.APMIS. 2014 Jun;122(6):499-504. doi: 10.1111/apm.12193. Epub 2014 Feb 1.
• [740] Overexpression of SMYD2 contributes to malignant outcome in gastric cancer.Br J Cancer. 2015 Jan 20;112(2):357-64. doi: 10.1038/bjc.2014.543. Epub 2014 Oct 16.
• [741] Upregulated SMYD3 promotes bladder cancer progression by targeting BCLAF1 and activating autophagy.Tumour Biol. 2016 Jun;37(6):7371-81. doi: 10.1007/s13277-015-4410-2. Epub 2015 Dec 16.
• [742] siRNA Targeting of the SNCG Gene Inhibits the Growth of Gastric Carcinoma SGC7901 Cells in vitro and in vivo by Downregulating the Phosphorylation of AKT/ERK.Cytogenet Genome Res. 2018;154(4):209-216. doi: 10.1159/000488571. Epub 2018 Jun 15.
• [743] miR-922 regulates apoptosis, migration, and invasion by targeting SOCS1 in gastric cancer.Kaohsiung J Med Sci. 2020 Mar;36(3):178-185. doi: 10.1002/kjm2.12155. Epub 2019 Nov 11.
• [744] MiR-221 affects proliferation and apoptosis of gastric cancer cells through targeting SOCS3.Eur Rev Med Pharmacol Sci. 2019 Nov;23(21):9427-9435. doi: 10.26355/eurrev_201911_19436.
• [745] Association between Genetic Polymorphisms in Superoxide Dismutase Gene Family and Risk of Gastric Cancer.Pathol Oncol Res. 2020 Jan;26(1):335-339. doi: 10.1007/s12253-018-0470-0. Epub 2018 Sep 21.
• [746] Effect of mitomycin C on X-ray repair cross complementing group 1 expression and consequent cytotoxicity regulation in human gastric cancer cells.J Cell Biochem. 2019 May;120(5):8333-8342. doi: 10.1002/jcb.28116. Epub 2019 Jan 6.
• [747] SPOCK1 promotes the invasion and metastasis of gastric cancer through Slug-induced epithelial-mesenchymal transition.J Cell Mol Med. 2018 Feb;22(2):797-807. doi: 10.1111/jcmm.13357. Epub 2017 Sep 22.
• [748] Deregulated Expression of SRC, LYN and CKB Kinases by DNA Methylation and Its Potential Role in Gastric Cancer Invasiveness and Metastasis.PLoS One. 2015 Oct 13;10(10):e0140492. doi: 10.1371/journal.pone.0140492. eCollection 2015.
• [749] Somatostatin receptor 1, a novel EBV-associated CpG hypermethylated gene, contributes to the pathogenesis of EBV-associated gastric cancer.Br J Cancer. 2013 Jun 25;108(12):2557-64. doi: 10.1038/bjc.2013.263. Epub 2013 May 30.
• [750] Expression of somatostatin receptor subtype 3 in the gastric mucosa of dyspeptic patients in relation to Helicobacter pylori infection and a family history of gastric cancer.J Gastroenterol Hepatol. 2008 Mar;23(3):424-9. doi: 10.1111/j.1440-1746.2007.05094.x. Epub 2007 Aug 7.
• [751] Stanniocalcin? promotes cell proliferation, chemoresistance and metastasis in hypoxic gastric cancer cells via Bcl?.Oncol Rep. 2019 Mar;41(3):1998-2008. doi: 10.3892/or.2019.6980. Epub 2019 Jan 23.
• [752] A protein-bound polysaccharide, PSK, enhances tumor suppression induced by docetaxel in a gastric cancer xenograft model.Anticancer Res. 2009 Mar;29(3):843-50.
• [753] Stathmin gene silencing suppresses proliferation, migration and invasion of gastric cancer cells via AKT/sCLU and STAT3 signaling.Int J Oncol. 2019 Mar;54(3):1086-1098. doi: 10.3892/ijo.2019.4674. Epub 2019 Jan 3.
• [754] Correlation between the methylation of SULF2 and WRN promoter and the irinotecan chemosensitivity in gastric cancer.BMC Gastroenterol. 2013 Dec 23;13:173. doi: 10.1186/1471-230X-13-173.
• [755] High expression of transforming acidic coiled coil-containing protein 3 strongly correlates with aggressive characteristics and poor prognosis of gastric cancer.Oncol Rep. 2015 Sep;34(3):1397-405. doi: 10.3892/or.2015.4093. Epub 2015 Jun 30.
• [756] The role and molecular mechanism of Trop2 induced epithelial-mesenchymal transition through mediated -catenin in gastric cancer.Cancer Med. 2019 Mar;8(3):1135-1147. doi: 10.1002/cam4.1934. Epub 2019 Jan 11.
• [757] MicroRNA-133a functions as a tumor suppressor in gastric cancer.J Biol Regul Homeost Agents. 2014 Oct-Dec;28(4):615-24.
• [758] TBL1XR1 is involved in c-Met-mediated tumorigenesis of human nonsmall cell lung cancer.Cancer Gene Ther. 2020 Apr;27(3-4):136-146. doi: 10.1038/s41417-019-0111-0. Epub 2019 Jun 27.
• [759] Association between gastric cancer and -1993 polymorphism of TBX21 gene.World J Gastroenterol. 2012 Mar 14;18(10):1117-22. doi: 10.3748/wjg.v18.i10.1117.
• [760] Lineage-specific RUNX3 hypomethylation marks the preneoplastic immune component of gastric cancer.Oncogene. 2015 May 28;34(22):2856-66. doi: 10.1038/onc.2014.233. Epub 2014 Aug 4.
• [761] Robust quantitative assessments of cytosine modifications and changes in the expressions of related enzymes in gastric cancer.Gastric Cancer. 2015 Jul;18(3):516-25. doi: 10.1007/s10120-014-0409-4. Epub 2014 Aug 7.
• [762] Down-regulation of P-cadherin with PF-03732010 inhibits cell migration and tumor growth in gastric cancer.Invest New Drugs. 2012 Aug;30(4):1404-12. doi: 10.1007/s10637-011-9710-9. Epub 2011 Jul 1.
• [763] Two genetic variants in telomerase-associated protein 1 are associated with stomach cancer risk.J Hum Genet. 2016 Oct;61(10):885-889. doi: 10.1038/jhg.2016.71. Epub 2016 Jun 16.
• [764] Identification of Serum Biomarkers for Gastric Cancer Diagnosis Using a Human Proteome Microarray.Mol Cell Proteomics. 2016 Feb;15(2):614-23. doi: 10.1074/mcp.M115.051250. Epub 2015 Nov 23.
• [765] Expression of telomere binding proteins in gastric cancer and correlation with clinicopathological parameters.Asia Pac J Clin Oncol. 2011 Dec;7(4):339-45. doi: 10.1111/j.1743-7563.2011.01437.x.
• [766] Zinc-finger protein 471 suppresses gastric cancer through transcriptionally repressing downstream oncogenic PLS3 and TFAP2A.Oncogene. 2018 Jun;37(26):3601-3616. doi: 10.1038/s41388-018-0220-5. Epub 2018 Apr 3.
• [767] Alterations of thyroid hormone receptor alpha gene: frequency and association with Nm23 protein expression and metastasis in gastric cancer.Cancer Lett. 2002 Jan 25;175(2):121-7. doi: 10.1016/s0304-3835(01)00722-4.
• [768] Association between promoter methylation and expression of thyroid hormone receptor beta (THR) gene in patients with gastric cancer in an Iranian population.J Gastroenterol Hepatol. 2015 Mar;30(3):485-9. doi: 10.1111/jgh.12808.
• [769] By downregulating TIAM1 expression, microRNA-329 suppresses gastric cancer invasion and growth.Oncotarget. 2015 Jul 10;6(19):17559-69. doi: 10.18632/oncotarget.2755.
• [770] Expression of the mutated transketolase TKTL1, a molecular marker in gastric cancer.Oncol Rep. 2006 Oct;16(4):657-61.
• [771] Genomic Profiling of HER2-Positive Gastric Cancer: PI3K/Akt/mTOR Pathway as Predictor of Outcomes in HER2-Positive Advanced Gastric Cancer Treated with Trastuzumab.Oncologist. 2018 Sep;23(9):1092-1102. doi: 10.1634/theoncologist.2017-0379. Epub 2018 Apr 26.
• [772] TLR1 and PRKAA1 Gene Polymorphisms in the Development of Atrophic Gastritis and Gastric Cancer.J Gastrointestin Liver Dis. 2018 Dec;27(4):363-369. doi: 10.15403/jgld.2014.1121.274.tlr.
• [773] Expression patterns of Thymosin 4 and cancer stem cell marker CD133 in ovarian cancers.Pathol Oncol Res. 2013 Apr;19(2):237-45. doi: 10.1007/s12253-012-9574-0. Epub 2012 Oct 10.
• [774] TWEAK/Fn14 signaling mediates gastric cancer cell resistance to 5-fluorouracil via NF-B activation.Int J Oncol. 2014 Feb;44(2):583-90. doi: 10.3892/ijo.2013.2211. Epub 2013 Dec 9.
• [775] APRIL induces cisplatin resistance in gastric cancer cells via activation of the NF-B pathway.Cell Physiol Biochem. 2015;35(2):571-85. doi: 10.1159/000369720. Epub 2015 Jan 27.
• [776] Gene therapy of gastric cancer using LIGHT-secreting human umbilical cord blood-derived mesenchymal stem cells.Gastric Cancer. 2013 Apr;16(2):155-66. doi: 10.1007/s10120-012-0166-1. Epub 2012 Aug 1.
• [777] Amplification of ACK1 promotes gastric tumorigenesis via ECD-dependent p53 ubiquitination degradation.Oncotarget. 2017 Feb 21;8(8):12705-12716. doi: 10.18632/oncotarget.6194.
• [778] Expression of tankyrase 1 in gastric cancer and its correlation with telomerase activity.Pathol Oncol Res. 2011 Sep;17(3):685-90. doi: 10.1007/s12253-011-9369-8. Epub 2011 Apr 1.
• [779] Clinical Significance of Tensin 4 Gene Expression in Patients with Gastric Cancer. In Vivo. 2017 Nov-Dec;31(6):1065-1071.
• [780] Overexpressed targeting protein for Xklp2 (TPX2) serves as a promising prognostic marker and therapeutic target for gastric cancer. Cancer Biol Ther. 2016 Aug 2;17(8):824-32.
• [781] Regulation of TRIM24 by miR-511 modulates cell proliferation in gastric cancer.J Exp Clin Cancer Res. 2017 Jan 23;36(1):17. doi: 10.1186/s13046-017-0489-1.
• [782] Clinical utility of measuring expression levels of KAP1, TIMP1 and STC2 in peripheral blood of patients with gastric cancer.World J Surg Oncol. 2013 Apr 2;11:81. doi: 10.1186/1477-7819-11-81.
• [783] Helicobacter pylori upregulates TRPC6 via Wnt/-catenin signaling to promote gastric cancer migration and invasion.Onco Targets Ther. 2019 Jul 3;12:5269-5279. doi: 10.2147/OTT.S201025. eCollection 2019.
• [784] Oncogenic role and therapeutic target of transient receptor potential melastatin 7 channel in malignancy.Expert Opin Ther Targets. 2014 Oct;18(10):1177-96. doi: 10.1517/14728222.2014.940894. Epub 2014 Jul 29.
• [785] Pharmacogenomics on gastric cancer.Cancer Biol Ther. 2004 Jun;3(6):566-7. doi: 10.4161/cbt.3.6.936. Epub 2004 Jun 24.
• [786] Evaluation of thymic stromal lymphopoietin (TSLP) and its correlation with lymphatic metastasis in human gastric cancer.Med Oncol. 2015 Aug;32(8):217. doi: 10.1007/s12032-015-0653-4. Epub 2015 Jul 15.
• [787] Vitamin D3 up-regulated protein 1 (VDUP1) expression in gastrointestinal cancer and its relation to stage of disease.Anticancer Res. 2002 Nov-Dec;22(6C):4045-8.
• [788] The diagnosis value of promoter methylation of UCHL1 in the serum for progression of gastric cancer.Biomed Res Int. 2015;2015:741030. doi: 10.1155/2015/741030. Epub 2015 Oct 15.
• [789] High ubiquitin-specific protease 44 expression induces DNA aneuploidy and provides independent prognostic information in gastric cancer.Cancer Med. 2017 Jun;6(6):1453-1464. doi: 10.1002/cam4.1090. Epub 2017 May 23.
• [790] Strabismus (STB)/Vang-like (VANGL) gene family (Review).Int J Mol Med. 2002 Jul;10(1):11-5.
• [791] Curcumin inhibits the lymphangiogenesis of gastric cancer cells by inhibiton of HMGB1/VEGF-D signaling.Int J Immunopathol Pharmacol. 2019 Jan-Dec;33:2058738419861600. doi: 10.1177/2058738419861600.
• [792] VPAC1 couples with TRPV4 channel to promote calcium-dependent gastric cancer progression via a novel autocrine mechanism.Oncogene. 2019 May;38(20):3946-3961. doi: 10.1038/s41388-019-0709-6. Epub 2019 Jan 28.
• [793] miR-155-5p inhibition promotes the transition of bone marrow mesenchymal stem cells to gastric cancer tissue derived MSC-like cells via NF-B p65 activation.Oncotarget. 2016 Mar 29;7(13):16567-80. doi: 10.18632/oncotarget.7767.
• [794] HEF1 regulates differentiation through the Wnt5a/-catenin signaling pathway in human gastric cancer.Biochem Biophys Res Commun. 2019 Jan 29;509(1):201-208. doi: 10.1016/j.bbrc.2018.12.104. Epub 2018 Dec 19.
• [795] WWP2 regulates proliferation of gastric cancer cells in a PTEN-dependent manner.Biochem Biophys Res Commun. 2020 Jan 15;521(3):652-659. doi: 10.1016/j.bbrc.2019.10.179. Epub 2019 Oct 31.
• [796] Targeting Nuclear Exporter Protein XPO1/CRM1 in Gastric Cancer.Int J Mol Sci. 2019 Sep 28;20(19):4826. doi: 10.3390/ijms20194826.
• [797] miR-140-5p suppresses the proliferation, migration and invasion of gastric cancer by regulating YES1.Mol Cancer. 2017 Aug 17;16(1):139. doi: 10.1186/s12943-017-0708-6.
• [798] Prognostic significance of ZNF217 expression in gastric carcinoma.Anticancer Res. 2014 Sep;34(9):4813-7.
• [799] Aurora kinase B inhibitor barasertib (AZD1152) inhibits glucose metabolism in gastric cancer cells.Anticancer Drugs. 2019 Jan;30(1):19-26. doi: 10.1097/CAD.0000000000000684.
• [800] Effects of microRNA-378 on epithelial-mesenchymal transition, migration, invasion and prognosis in gastric carcinoma by targeting BMP2.Eur Rev Med Pharmacol Sci. 2019 Jun;23(12):5176-5186. doi: 10.26355/eurrev_201906_18182.
• [801] Downregulation of miR-142-5p promotes tumor metastasis through directly regulating CYR61 expression in gastric cancer.Gastric Cancer. 2019 Mar;22(2):302-313. doi: 10.1007/s10120-018-0872-4. Epub 2018 Sep 3.
• [802] Expression pattern of CDK12 protein in gastric cancer and its positive correlation with CD8(+) cell density and CCL12 expression.Int J Med Sci. 2019 Aug 6;16(8):1142-1148. doi: 10.7150/ijms.34541. eCollection 2019.
• [803] Loss of CEACAM1 is associated with poor prognosis and peritoneal dissemination of patients with gastric cancer.Sci Rep. 2019 Sep 3;9(1):12702. doi: 10.1038/s41598-019-49230-w.
• [804] Claudin-6 is a single prognostic marker and functions as a tumor-promoting gene in a subgroup of intestinal type gastric cancer.Gastric Cancer. 2020 May;23(3):403-417. doi: 10.1007/s10120-019-01014-x. Epub 2019 Oct 25.
• [805] CSNK2A1 Promotes Gastric Cancer Invasion Through the PI3K-Akt-mTOR Signaling Pathway.Cancer Manag Res. 2019 Dec 2;11:10135-10143. doi: 10.2147/CMAR.S222620. eCollection 2019.
• [806] DEK Is a Potential Biomarker Associated with Malignant Phenotype in Gastric Cancer Tissues and Plasma.Int J Mol Sci. 2019 Nov 13;20(22):5689. doi: 10.3390/ijms20225689.
• [807] Overexpressed MALAT1 promotes invasion and metastasis of gastric cancer cells via increasing EGFL7 expression.Life Sci. 2016 Jul 15;157:38-44. doi: 10.1016/j.lfs.2016.05.041. Epub 2016 May 31.
• [808] Upregulation of family with sequence similarity 83 member D expression enhances cell proliferation and motility via activation of Wnt/-catenin signaling and predicts poor prognosis in gastric cancer.Cancer Manag Res. 2019 Jul 22;11:6775-6791. doi: 10.2147/CMAR.S203082. eCollection 2019.
• [809] G3BP1 activates the TGF-/Smad signaling pathway to promote gastric cancer.Onco Targets Ther. 2019 Sep 2;12:7149-7156. doi: 10.2147/OTT.S213728. eCollection 2019.
• [810] Overexpression of UDP-Glucose 4-Epimerase Is Associated with Differentiation Grade of Gastric Cancer.Dis Markers. 2019 Nov 20;2019:6325326. doi: 10.1155/2019/6325326. eCollection 2019.
• [811] GJB4 promotes gastric cancer cell proliferation and migration via Wnt/CTNNB1 pathway.Onco Targets Ther. 2019 Aug 20;12:6745-6755. doi: 10.2147/OTT.S205601. eCollection 2019.
• [812] Plasmacytoid Dendritic Cells and ICOS(+) Regulatory T Cells Predict Poor Prognosis in Gastric Cancer: A Pilot Study.J Cancer. 2019 Oct 22;10(26):6711-6715. doi: 10.7150/jca.34826. eCollection 2019.
• [813] NIMA related kinase 2 promotes gastric cancer cell proliferation via ERK/MAPK signaling.World J Gastroenterol. 2019 Jun 21;25(23):2898-2910. doi: 10.3748/wjg.v25.i23.2898.
• [814] Tissue Expression of Melanoma-associated Antigen A6 and Clinical Characteristics of Gastric Cancer.Anticancer Res. 2019 Nov;39(11):5903-5910. doi: 10.21873/anticanres.13794.
• [815] Diallyl trisulfide suppresses tumor growth through the attenuation of Nrf2/Akt and activation of p38/JNK and potentiates cisplatin efficacy in gastric cancer treatment.Acta Pharmacol Sin. 2017 Jul;38(7):1048-1058. doi: 10.1038/aps.2016.176. Epub 2017 Mar 27.
• [816] Level of Melanotransferrin in Tissue and Sera Serves as a Prognostic Marker of Gastric Cancer.Anticancer Res. 2019 Nov;39(11):6125-6133. doi: 10.21873/anticanres.13820.
• [817] Using a panel of multiple tumor-associated antigens to enhance autoantibody detection for immunodiagnosis of gastric cancer.Oncoimmunology. 2018 Apr 18;7(8):e1452582. doi: 10.1080/2162402X.2018.1452582. eCollection 2018.
• [818] Serum Exosomal Long Noncoding RNA pcsk2-2:1 As A Potential Novel Diagnostic Biomarker For Gastric Cancer.Onco Targets Ther. 2019 Nov 25;12:10035-10041. doi: 10.2147/OTT.S229033. eCollection 2019.
• [819] miR-497-5p inhibits gastric cancer cell proliferation and growth through targeting PDK3.Biosci Rep. 2019 Sep 6;39(9):BSR20190654. doi: 10.1042/BSR20190654. Print 2019 Sep 30.
• [820] SHCBP1 is a novel target and exhibits tumorpromoting effects in gastric cancer.Oncol Rep. 2019 Mar;41(3):1649-1657. doi: 10.3892/or.2018.6952. Epub 2018 Dec 21.
• [821] CRISPR/Cas9-mediated knockout of the PDEF gene inhibits migration and invasion of human gastric cancer AGS cells.Biomed Pharmacother. 2019 Mar;111:76-85. doi: 10.1016/j.biopha.2018.12.048. Epub 2018 Dec 19.
• [822] TGF- gene variations and increased susceptibility of gastric cancer in an Eastern Chinese Han population.Biomarkers. 2014 Feb;19(1):9-15. doi: 10.3109/1354750X.2013.859736. Epub 2013 Nov 18.
• [823] TNF-like ligand 1A is associated with progression and prognosis of human gastric cancer.Onco Targets Ther. 2019 Sep 19;12:7715-7723. doi: 10.2147/OTT.S210939. eCollection 2019.
• [824] Mutational analysis of mononucleotide repeats in dual specificity tyrosine phosphatase genes in gastric and colon carcinomas with microsatellite instability.APMIS. 2010 May;118(5):389-93. doi: 10.1111/j.1600-0463.2010.02612.x.
• [825] A novel YAP1/SLC35B4 regulatory axis contributes to proliferation and progression of gastric carcinoma.Cell Death Dis. 2019 Jun 7;10(6):452. doi: 10.1038/s41419-019-1674-2.
• [826] Environmental factors, seven GWAS-identified susceptibility loci, and risk of gastric cancer and its precursors in a Chinese population.Cancer Med. 2017 Mar;6(3):708-720. doi: 10.1002/cam4.1038. Epub 2017 Feb 21.
• [827] Downregulation of Annexin A11 (ANXA11) Inhibits Cell Proliferation, Invasion, and Migration via the AKT/GSK-3 Pathway in Gastric Cancer.Med Sci Monit. 2018 Jan 7;24:149-160. doi: 10.12659/msm.905372.
• [828] Effect of bevacizumab, a humanized monoclonal antibody to vascular endothelial growth factor, on peritoneal metastasis of MNK-45P human gastric cancer in mice.J Surg Res. 2009 Jun 15;154(2):196-202. doi: 10.1016/j.jss.2008.08.017. Epub 2008 Sep 16.
• [829] TP53 in gastric cancer: mutations in the l3 loop and LSH motif DNA-binding domains of TP53 predict poor outcome.J Cell Physiol. 2004 Sep;200(3):476-85. doi: 10.1002/jcp.20053.
• [830] Exosomes derived from human mesenchymal stem cells confer drug resistance in gastric cancer.Cell Cycle. 2015 Aug 3;14(15):2473-83. doi: 10.1080/15384101.2015.1005530. Epub 2015 Jun 19.
• [831] Mitomycin C resistance induced by TCF-3 overexpression in gastric cancer cell line MKN28 is associated with DT-diaphorase down-regulation.Cancer Res. 2000 Nov 1;60(21):5959-62.
• [832] Anti-tumour effects of small interfering RNA targeting anion exchanger 1 in experimental gastric cancer.Br J Pharmacol. 2012 Jan;165(1):135-47. doi: 10.1111/j.1476-5381.2011.01521.x.
• [833] Aberrant methylation and histone deacetylation associated with silencing of SLC5A8 in gastric cancer.Tumour Biol. 2004 May-Jun;25(3):134-40. doi: 10.1159/000079145.
• [834] Elevated SLC6A6 expression drives tumorigenesis and affects clinical outcomes in gastric cancer.Biomark Med. 2019 Feb;13(2):95-104. doi: 10.2217/bmm-2018-0256. Epub 2019 Feb 15.
• [835] AKR1B10 expression predicts response of gastric cancer to neoadjuvant chemotherapy.Oncol Lett. 2019 Jan;17(1):773-780. doi: 10.3892/ol.2018.9705. Epub 2018 Nov 15.
• [836] iTRAQ-Based Quantitative Proteomics Approach Identifies Novel Diagnostic Biomarkers That Were Essential for Glutamine Metabolism and Redox Homeostasis for Gastric Cancer.Proteomics Clin Appl. 2019 Jul;13(4):e1800038. doi: 10.1002/prca.201800038. Epub 2019 Jan 4.
• [837] MicroRNA-21 induces loss of 15-hydroxyprostaglandin dehydrogenase in early gastric tubular adenocarcinoma.Sci Rep. 2018 Dec 7;8(1):17717. doi: 10.1038/s41598-018-36139-z.
• [838] The clinical and prognostic significance of paraoxonase-2 in gastric cancer patients: immunohistochemical analysis.Hum Cell. 2019 Oct;32(4):487-494. doi: 10.1007/s13577-019-00263-3. Epub 2019 Jul 23.
• [839] PHD3 affects gastric cancer progression by negatively regulating HIF1A.Mol Med Rep. 2017 Nov;16(5):6882-6889. doi: 10.3892/mmr.2017.7455. Epub 2017 Sep 11.
• [840] Hint1 expression inhibits proliferation and promotes radiosensitivity of human SGC7901 gastric cancer cells.Oncol Lett. 2018 Aug;16(2):2135-2142. doi: 10.3892/ol.2018.8900. Epub 2018 Jun 5.
• [841] Aldolase A as a prognostic factor and mediator of progression via inducing epithelial-mesenchymal transition in gastric cancer.J Cell Mol Med. 2018 Sep;22(9):4377-4386. doi: 10.1111/jcmm.13732. Epub 2018 Jul 11.
• [842] Bioinformatic analysis suggests that UGT2B15 activates the HippoYAP signaling pathway leading to the pathogenesis of gastric cancer.Oncol Rep. 2018 Oct;40(4):1855-1862. doi: 10.3892/or.2018.6604. Epub 2018 Jul 26.
• [843] Blood groups A and AB are associated with increased gastric cancer risk: evidence from a large genetic study and systematic review.BMC Cancer. 2019 Feb 21;19(1):164. doi: 10.1186/s12885-019-5355-4.
• [844] Clinical significance of tartrate-resistant acid phosphatase type-5 expression in human gastric cancer.Anticancer Res. 2014 Jul;34(7):3425-9.
• [845] Mitochondrial Acetyl-CoA Synthetase 3 is Biosignature of Gastric Cancer Progression.Cancer Med. 2018 Apr;7(4):1240-1252. doi: 10.1002/cam4.1295. Epub 2018 Mar 1.
• [846] Genetic polymorphisms of ADH1B, ADH1C and ALDH2, alcohol consumption, and the risk of gastric cancer: the Japan Public Health Center-based prospective study.Carcinogenesis. 2015 Feb;36(2):223-31. doi: 10.1093/carcin/bgu244. Epub 2014 Dec 18.
• [847] Knockdown of asparagine synthetase (ASNS) suppresses cell proliferation and inhibits tumor growth in gastric cancer cells.Scand J Gastroenterol. 2016 Oct;51(10):1220-6. doi: 10.1080/00365521.2016.1190399. Epub 2016 Jun 2.
• [848] Altered expression of DNA-dependent protein kinase catalytic subunit (DNA-PKcs) during gastric carcinogenesis and its clinical implications on gastric cancer.Int J Oncol. 2007 Oct;31(4):859-66.
• [849] A summary of meat intakes and health burdens.Eur J Clin Nutr. 2018 Jan;72(1):18-29. doi: 10.1038/ejcn.2017.117. Epub 2017 Aug 9.
• [850] Nucleoside diphosphate kinase 2 confers acquired 5-fluorouracil resistance in colorectal cancer cells.Artif Cells Nanomed Biotechnol. 2018;46(sup1):896-905. doi: 10.1080/21691401.2018.1439835. Epub 2018 Feb 23.
• [851] Interaction between cytochrome P-450 2E1 polymorphisms and environmental factors with risk of esophageal and stomach cancers in Chinese.Cancer Epidemiol Biomarkers Prev. 2002 Jan;11(1):29-34.
• [852] DDAH1 mediates gastric cancer cell invasion and metastasis via Wnt/-catenin signaling pathway.Mol Oncol. 2017 Sep;11(9):1208-1224. doi: 10.1002/1878-0261.12089. Epub 2017 Jun 22.
• [853] Polymorphisms in metabolic genes related to tobacco smoke and the risk of gastric cancer in the European prospective investigation into cancer and nutrition.Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2427-34. doi: 10.1158/1055-9965.EPI-06-0072.
• [854] Identification of biomarkers associated with histological grade and prognosis of gastric cancer by co-expression network analysis.Oncol Lett. 2019 Nov;18(5):5499-5507. doi: 10.3892/ol.2019.10869. Epub 2019 Sep 13.
• [855] Genetic polymorphisms of GSTO2, GSTM1, and GSTT1 and risk of gastric cancer.Mol Biol Rep. 2009 Apr;36(4):781-4. doi: 10.1007/s11033-008-9245-0. Epub 2008 Apr 9.
• [856] Single nucleotide polymorphisms of one-carbon metabolism and cancers of the esophagus, stomach, and liver in a Chinese population.PLoS One. 2014 Oct 22;9(10):e109235. doi: 10.1371/journal.pone.0109235. eCollection 2014.
• [857] Genetic susceptibility and gastric cancer risk.Int J Cancer. 2002 Jul 20;100(3):249-60. doi: 10.1002/ijc.10466.
• [858] P4HA3 is Epigenetically Activated by Slug in Gastric Cancer and its Deregulation is Associated With Enhanced Metastasis and Poor Survival.Technol Cancer Res Treat. 2018 Jan 1;17:1533033818796485. doi: 10.1177/1533033818796485.
• [859] Combinatory low methylation statuses of SAT- and L1 are associated with shortened survival time in patients with advanced gastric cancer.Gastric Cancer. 2019 Jan;22(1):37-47. doi: 10.1007/s10120-018-0852-8. Epub 2018 Jun 20.
• [860] Epigenetic silencing of miR-124 prevents spermine oxidase regulation: implications for Helicobacter pylori-induced gastric cancer. Oncogene. 2016 Oct 20;35(42):5480-5488.
• [861] Polymorphisms in metabolic genes, their combination and interaction with tobacco smoke and alcohol consumption and risk of gastric cancer: a case-control study in an Italian population.BMC Cancer. 2007 Nov 8;7:206. doi: 10.1186/1471-2407-7-206.
• [862] Cloned hst gene from normal human leukocyte DNA transforms NIH3T3 cells.Biochem Biophys Res Commun. 1988 Mar 30;151(3):965-72. doi: 10.1016/s0006-291x(88)80460-1.
• [863] Polymorphisms of the UDP-glucuronosyl transferase 1A genes are associated with adverse events in cancer patients receiving irinotecan-based chemotherapy.Tohoku J Exp Med. 2013 Feb;229(2):107-14. doi: 10.1620/tjem.229.107.
• [864] Up-regulated expression of the uridine phosphorylase gene in human gastric tumors is correlated with a favorable prognosis.Anticancer Res. 2006 Nov-Dec;26(6C):4647-51.
• [865] Transcription Factor Myeloid Zinc-Finger 1 Suppresses Human Gastric Carcinogenesis by Interacting with Metallothionein 2A.Clin Cancer Res. 2019 Feb 1;25(3):1050-1062. doi: 10.1158/1078-0432.CCR-18-1281. Epub 2018 Oct 9.
• [866] -Actinin-4 promotes metastasis in gastric cancer.Lab Invest. 2017 Sep;97(9):1084-1094. doi: 10.1038/labinvest.2017.28. Epub 2017 Jun 5.
• [867] LINC00319 acts as a microRNA-335-5p sponge to accelerate tumor growth and metastasis in gastric cancer by upregulating ADCY3.Am J Physiol Gastrointest Liver Physiol. 2020 Jan 1;318(1):G10-G22. doi: 10.1152/ajpgi.00405.2018. Epub 2019 Aug 21.
• [868] CD97 promotion of gastric carcinoma lymphatic metastasis is exosome dependent.Gastric Cancer. 2016 Jul;19(3):754-66. doi: 10.1007/s10120-015-0523-y. Epub 2015 Aug 2.
• [869] AEBP1 promotes epithelial-mesenchymal transition of gastric cancer cells by activating the NF-B pathway and predicts poor outcome of the patients.Sci Rep. 2018 Aug 10;8(1):11955. doi: 10.1038/s41598-018-29878-6.
• [870] Involvement of Aryl Hydrocarbon Receptor and Aryl Hydrocarbon Receptor Repressor in Helicobacter Pylori-related Gastric Pathogenesis.J Cancer. 2018 Jul 1;9(15):2757-2764. doi: 10.7150/jca.26083. eCollection 2018.
• [871] Knockdown of A-kinase anchor protein 4 inhibits hypoxia-induced epithelial-to-mesenchymal transition via suppression of the Wnt/-catenin pathway in human gastric cancer cells.J Cell Biochem. 2018 Dec;119(12):10013-10020. doi: 10.1002/jcb.27331. Epub 2018 Aug 26.
• [872] High expression of the ANKRD49 protein is associated with progression and poor prognosis of gastric cancer.Cancer Biomark. 2018;22(4):649-656. doi: 10.3233/CBM-171074.
• [873] Serum levels of ANOS1 serve as a diagnostic biomarker of gastric cancer: a prospective multicenter observational study.Gastric Cancer. 2020 Mar;23(2):203-211. doi: 10.1007/s10120-019-00995-z. Epub 2019 Aug 3.
• [874] miR-203 Inhibits the Invasion and EMT of Gastric Cancer Cells by Directly Targeting Annexin A4.Oncol Res. 2019 Jul 12;27(7):789-799. doi: 10.3727/096504018X15444387696532. Epub 2019 Mar 5.
• [875] AP-2 reverses vincristine-induced multidrug resistance of SGC7901 gastric cancer cells by inhibiting the Notch pathway.Apoptosis. 2017 Jul;22(7):933-941. doi: 10.1007/s10495-017-1379-x.
• [876] Knockdown of Arf6 increases drug sensitivity and inhibits proliferation, migration and invasion in gastric cancer SGC-7901 cells.Oncol Lett. 2018 Feb;15(2):2147-2152. doi: 10.3892/ol.2017.7558. Epub 2017 Dec 8.
• [877] CircRNA microarray profiling identifies a novel circulating biomarker for detection of gastric cancer.Mol Cancer. 2018 Sep 20;17(1):137. doi: 10.1186/s12943-018-0888-8.
• [878] Impaired autophagic degradation of lncRNA ARHGAP5-AS1 promotes chemoresistance in gastric cancer.Cell Death Dis. 2019 May 16;10(6):383. doi: 10.1038/s41419-019-1585-2.
• [879] miR-148b-3p inhibits gastric cancer metastasis by inhibiting the Dock6/Rac1/Cdc42 axis.J Exp Clin Cancer Res. 2018 Mar 27;37(1):71. doi: 10.1186/s13046-018-0729-z.
• [880] ARHGEF39 promotes gastric cancer cell proliferation and migration via Akt signaling pathway.Mol Cell Biochem. 2018 Mar;440(1-2):33-42. doi: 10.1007/s11010-017-3153-3. Epub 2017 Sep 4.
• [881] Efficacy of glutathione inhibitors for the treatment of ARID1A-deficient diffuse-type gastric cancers.Biochem Biophys Res Commun. 2020 Feb 5;522(2):342-347. doi: 10.1016/j.bbrc.2019.11.078. Epub 2019 Nov 22.
• [882] Identification of ARL4C as a Peritoneal Dissemination-Associated Gene and Its Clinical Significance in Gastric Cancer.Ann Surg Oncol. 2018 Mar;25(3):745-753. doi: 10.1245/s10434-017-6292-6. Epub 2017 Dec 21.
• [883] ALEX1, a novel tumor suppressor gene, inhibits gastric cancer metastasis via the PAR-1/Rho GTPase signaling pathway.J Gastroenterol. 2018 Jan;53(1):71-83. doi: 10.1007/s00535-017-1329-y. Epub 2017 Mar 17.
• [884] Argininosuccinate synthetase 1 contributes to gastric cancer invasion and progression by modulating autophagy.FASEB J. 2018 May;32(5):2601-2614. doi: 10.1096/fj.201700094R. Epub 2018 Jan 10.
• [885] miRNA-103a-3p Promotes Human Gastric Cancer Cell Proliferation by Targeting and Suppressing ATF7 in vitro.Mol Cells. 2018 May 31;41(5):390-400. doi: 10.14348/molcells.2018.2078. Epub 2018 May 10.
• [886] MIR-1265 regulates cellular proliferation and apoptosis by targeting calcium binding protein 39 in gastric cancer and, thereby, impairing oncogenic autophagy.Cancer Lett. 2019 May 1;449:226-236. doi: 10.1016/j.canlet.2019.02.026. Epub 2019 Feb 16.
• [887] Frameshift mutations of Wnt pathway genes AXIN2 and TCF7L2 in gastric carcinomas with high microsatellite instability.Hum Pathol. 2009 Jan;40(1):58-64. doi: 10.1016/j.humpath.2008.06.006. Epub 2008 Aug 27.
• [888] Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme ADAR1 are important prognostic biomarkers in gastric cancer.J Transl Med. 2018 Dec 18;16(1):366. doi: 10.1186/s12967-018-1740-z.
• [889] Barrier-to-autointegration factor 1: A novel biomarker for gastric cancer.Oncol Lett. 2018 Nov;16(5):6488-6494. doi: 10.3892/ol.2018.9432. Epub 2018 Sep 11.
• [890] A Novel Mechanism of Doxorubicin Resistance and Tumorigenesis Mediated by MicroRNA-501-5p-Suppressed BLID.Mol Ther Nucleic Acids. 2018 Sep 7;12:578-590. doi: 10.1016/j.omtn.2018.06.011. Epub 2018 Jul 5.
• [891] Avicularin reversed multidrug-resistance in human gastric cancer through enhancing Bax and BOK expressions.Biomed Pharmacother. 2018 Jul;103:67-74. doi: 10.1016/j.biopha.2018.03.110. Epub 2018 Apr 7.
• [892] HCCR-1 is a Novel Prognostic Indicator for Gastric Cancer and Promotes Cell Proliferation.J Cancer. 2019 Jun 9;10(15):3533-3542. doi: 10.7150/jca.22462. eCollection 2019.
• [893] Epigenetics mechanisms mediate the miR-125a/BRMS1 axis to regulate invasion and metastasis in gastric cancer.Onco Targets Ther. 2019 Sep 12;12:7513-7525. doi: 10.2147/OTT.S210376. eCollection 2019.
• [894] Inhibition of TNF-interacting protein (Tip)-associated gastric carcinogenesis by BTG2(/TIS21) via downregulating cytoplasmic nucleolin expression.Exp Mol Med. 2018 Feb 23;50(2):e449. doi: 10.1038/emm.2017.281.
• [895] Single nucleotide polymorphisms rs911160 in AURKA and rs2289590 in AURKB mitotic checkpoint genes contribute to gastric cancer susceptibility.Environ Mol Mutagen. 2017 Dec;58(9):701-711. doi: 10.1002/em.22129. Epub 2017 Aug 26.
• [896] BRICHOS: a conserved domain in proteins associated with dementia, respiratory distress and cancer.Trends Biochem Sci. 2002 Jul;27(7):329-32. doi: 10.1016/s0968-0004(02)02134-5.
• [897] CAP2 is a Valuable Biomarker for Diagnosis and Prognostic in Patients with Gastric Cancer.Pathol Oncol Res. 2020 Jan;26(1):273-279. doi: 10.1007/s12253-018-0450-4. Epub 2018 Jul 26.
• [898] MicroRNA-181a Functions as an Oncogene in Gastric Cancer by Targeting Caprin-1.Front Pharmacol. 2019 Jan 10;9:1565. doi: 10.3389/fphar.2018.01565. eCollection 2018.
• [899] Prognostic value of CAPZA1 overexpression in gastric cancer.Int J Oncol. 2013 May;42(5):1569-77. doi: 10.3892/ijo.2013.1867. Epub 2013 Mar 27.
• [900] Identification of miR-758-3p as Potential Modulator of CBX5 Expression in Gastric Cancer.Technol Cancer Res Treat. 2018 Jan 1;17:1533033818816061. doi: 10.1177/1533033818816061.
• [901] NANOGP8 expression regulates gastric cancer cell progression by transactivating DBC1 in gastric cancer MKN-45 cells.Oncol Lett. 2019 Jan;17(1):555-563. doi: 10.3892/ol.2018.9595. Epub 2018 Oct 18.
• [902] Genome-wide expression profiling and bioinformatics analysis of deregulated genes in human gastric cancer tissue after gastroscopy.Asia Pac J Clin Oncol. 2018 Apr;14(2):e29-e36. doi: 10.1111/ajco.12688. Epub 2017 Apr 4.
• [903] Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.World J Gastroenterol. 2019 Oct 14;25(38):5814-5825. doi: 10.3748/wjg.v25.i38.5814.
• [904] Prognostic role of cyclin D2/D3 in multiple human malignant neoplasms: A systematic review and meta-analysis.Cancer Med. 2019 Jun;8(6):2717-2729. doi: 10.1002/cam4.2152. Epub 2019 Apr 5.
• [905] Cyclin G2 suppresses Wnt/-catenin signaling and inhibits gastric cancer cell growth and migration through Dapper1.J Exp Clin Cancer Res. 2018 Dec 14;37(1):317. doi: 10.1186/s13046-018-0973-2.
• [906] Clinico-pathological significance of exosome marker CD63 expression on cancer cells and stromal cells in gastric cancer.PLoS One. 2018 Sep 17;13(9):e0202956. doi: 10.1371/journal.pone.0202956. eCollection 2018.
• [907] Tumor-infiltrating CD8+ T cells combined with tumor-associated CD68+ macrophages predict postoperative prognosis and adjuvant chemotherapy benefit in resected gastric cancer.BMC Cancer. 2019 Sep 14;19(1):920. doi: 10.1186/s12885-019-6089-z.
• [908] Nuclear Drosha enhances cell invasion via an EGFR-ERK1/2-MMP7 signaling pathway induced by dysregulated miRNA-622/197 and their targets LAMC2 and CD82 in gastric cancer.Cell Death Dis. 2017 Mar 2;8(3):e2642. doi: 10.1038/cddis.2017.5.
• [909] CDC27 Facilitates Gastric Cancer Cell Proliferation, Invasion and Metastasis via Twist-Induced Epithelial-Mesenchymal Transition.Cell Physiol Biochem. 2018;50(2):501-511. doi: 10.1159/000494164. Epub 2018 Oct 11.
• [910] DNA hypomethylation promotes invasion and metastasis of gastric cancer cells by regulating the binding of SP1 to the CDCA3 promoter.J Cell Biochem. 2020 Jan;121(1):142-151. doi: 10.1002/jcb.28993. Epub 2019 Jun 18.
• [911] (111)In-labeled anti-cadherin17 antibody D2101 has potential as a noninvasive imaging probe for diagnosing gastric cancer and lymph-node metastasis.Ann Nucl Med. 2020 Jan;34(1):13-23. doi: 10.1007/s12149-019-01408-y. Epub 2019 Oct 12.
• [912] Knockdown of Cyclin-Dependent Kinase Inhibitor 3 Inhibits Proliferation and Invasion in Human Gastric Cancer Cells.Oncol Res. 2017 May 24;25(5):721-731. doi: 10.3727/096504016X14772375848616. Epub 2016 Oct 27.
• [913] Cancer-specific promoter DNA methylation of Cysteine dioxygenase type 1 (CDO1) gene as an important prognostic biomarker of gastric cancer.PLoS One. 2019 Apr 1;14(4):e0214872. doi: 10.1371/journal.pone.0214872. eCollection 2019.
• [914] Transduced caudal-type homeobox (CDX) 2/CDX1 can induce growth inhibition on CDX-deficient gastric cancer by rapid intestinal differentiation.Cancer Sci. 2018 Dec;109(12):3853-3864. doi: 10.1111/cas.13821. Epub 2018 Oct 26.
• [915] Knockdown of CEACAM19 suppresses human gastric cancer through inhibition of PI3K/Akt and NF-B.Surg Oncol. 2018 Sep;27(3):495-502. doi: 10.1016/j.suronc.2018.05.003. Epub 2018 May 3.
• [916] miR-615-3p promotes proliferation and migration and inhibits apoptosis through its potential target CELF2 in gastric cancer.Biomed Pharmacother. 2018 May;101:406-413. doi: 10.1016/j.biopha.2018.02.104. Epub 2018 Mar 22.
• [917] Ceramide synthase 6 predicts the prognosis of human gastric cancer: It functions as an oncoprotein by dysregulating the SOCS2/JAK2/STAT3 pathway.Mol Carcinog. 2018 Dec;57(12):1675-1689. doi: 10.1002/mc.22888. Epub 2018 Aug 29.
• [918] Knockdown of Cbp/P300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 inhibits cell division and increases apoptosis in gastric cancer.J Surg Res. 2017 May 1;211:1-7. doi: 10.1016/j.jss.2016.11.049. Epub 2016 Dec 5.
• [919] Claudin-7 (CLDN7) is overexpressed in gastric cancer and promotes gastric cancer cell proliferation, invasion and maintains mesenchymal state.Neoplasma. 2018 Mar 14;65(3):349-359. doi: 10.4149/neo_2018_170320N200.
• [920] Expression and clinical significance of autophagic protein LC3B and EMT markers in gastric cancer.Cancer Manag Res. 2018 Jun 11;10:1479-1486. doi: 10.2147/CMAR.S164842. eCollection 2018.
• [921] CMIP promotes Herceptin resistance of HER2 positive gastric cancer cells.Pathol Res Pract. 2020 Feb;216(2):152776. doi: 10.1016/j.prp.2019.152776. Epub 2019 Dec 2.
• [922] SOX10-dependent CMTM7 expression inhibits cell proliferation and tumor growth in gastric carcinoma.Biochem Biophys Res Commun. 2018 Dec 9;507(1-4):91-99. doi: 10.1016/j.bbrc.2018.10.172. Epub 2018 Nov 2.
• [923] TGF-1-SOX9 axis-inducible COL10A1 promotes invasion and metastasis in gastric cancer via epithelial-to-mesenchymal transition.Cell Death Dis. 2018 Aug 28;9(9):849. doi: 10.1038/s41419-018-0877-2.
• [924] COL12A1, a novel potential prognostic factor and therapeutic target in gastric cancer.Mol Med Rep. 2019 Oct;20(4):3103-3112. doi: 10.3892/mmr.2019.10548. Epub 2019 Aug 1.
• [925] Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.Pathol Res Pract. 2019 May;215(5):1038-1048. doi: 10.1016/j.prp.2019.02.012. Epub 2019 Feb 28.
• [926] Long non-coding RNA KRT19P3 suppresses proliferation and metastasis through COPS7A-mediated NF-B pathway in gastric cancer.Oncogene. 2019 Nov;38(45):7073-7088. doi: 10.1038/s41388-019-0934-z. Epub 2019 Aug 13.
• [927] CORO1C expression is associated with poor survival rates in gastric cancer and promotes metastasis invitro.FEBS Open Bio. 2019 Jun;9(6):1097-1108. doi: 10.1002/2211-5463.12639. Epub 2019 Apr 29.
• [928] Safety of early oral feeding after total laparoscopic radical gastrectomy for gastric cancer (SOFTLY): Study protocol for a randomized controlled trial.Trials. 2019 Jun 26;20(1):384. doi: 10.1186/s13063-019-3493-2.
• [929] CPEB4 promotes growth and metastasis of gastric cancer cells via ZEB1-mediated epithelial- mesenchymal transition.Onco Targets Ther. 2018 Sep 21;11:6153-6165. doi: 10.2147/OTT.S175428. eCollection 2018.
• [930] Overexpression of CPXM2 predicts an unfavorable prognosis and promotes the proliferation and migration of gastric cancer.Oncol Rep. 2019 Oct;42(4):1283-1294. doi: 10.3892/or.2019.7254. Epub 2019 Jul 30.
• [931] Upregulation of the cysteine protease inhibitor, cystatin SN, contributes to cell proliferation and cathepsin inhibition in gastric cancer.Clin Chim Acta. 2009 Aug;406(1-2):45-51. doi: 10.1016/j.cca.2009.05.008. Epub 2009 May 19.
• [932] C-terminal of E1A binding protein 1 enhances the migration of gastric epithelial cells and has a clinicopathologic significance in human gastric carcinoma.Onco Targets Ther. 2019 Jul 2;12:5189-5200. doi: 10.2147/OTT.S203479. eCollection 2019.
• [933] KDM5D inhibit epithelial-mesenchymal transition of gastric cancer through demethylation in the promoter of Cul4A in male.J Cell Biochem. 2019 Aug;120(8):12247-12258. doi: 10.1002/jcb.27308. Epub 2019 Mar 12.
• [934] Prognostic significance of mRNA expression of CASPs in gastric cancer.Oncol Lett. 2019 Nov;18(5):4535-4554. doi: 10.3892/ol.2019.10816. Epub 2019 Sep 5.
• [935] CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition.Oncol Rep. 2017 Jun;37(6):3279-3286. doi: 10.3892/or.2017.5598. Epub 2017 Apr 25.
• [936] Epigenetic down-regulation and suppressive role of DCBLD2 in gastric cancer cell proliferation and invasion.Mol Cancer Res. 2008 Feb;6(2):222-30. doi: 10.1158/1541-7786.MCR-07-0142.
• [937] Dermcidin as a novel binding protein of lncRNA STCAT3 and its effect on prognosis in gastric cancer.Oncol Rep. 2018 Nov;40(5):2854-2863. doi: 10.3892/or.2018.6673. Epub 2018 Aug 24.
• [938] Low expression of CDK5RAP3 and DDRGK1 indicates a poor prognosis in patients with gastric cancer.World J Gastroenterol. 2018 Sep 14;24(34):3898-3907. doi: 10.3748/wjg.v24.i34.3898.
• [939] DDX21 promotes gastric cancer proliferation by regulating cell cycle.Biochem Biophys Res Commun. 2018 Nov 10;505(4):1189-1194. doi: 10.1016/j.bbrc.2018.10.060. Epub 2018 Oct 12.
• [940] EGF Stimulates Rab35 Activation and Gastric Cancer Cell Migration by Regulating DENND1A-Grb2 Complex Formation.Front Pharmacol. 2018 Nov 22;9:1343. doi: 10.3389/fphar.2018.01343. eCollection 2018.
• [941] MicroRNA-154 Inhibits the Growth and Invasion of Gastric Cancer Cells by Targeting DIXDC1/WNT Signaling.Oncol Res. 2018 Jul 5;26(6):847-856. doi: 10.3727/096504017X15016337254632. Epub 2017 Aug 11.
• [942] MDGA2 is a novel tumour suppressor cooperating with DMAP1 in gastric cancer and is associated with disease outcome.Gut. 2016 Oct;65(10):1619-31. doi: 10.1136/gutjnl-2015-309276. Epub 2015 Jul 23.
• [943] Docking protein-1 promotes inflammatory macrophage signaling in gastric cancer.Oncoimmunology. 2019 Aug 21;8(11):e1649961. doi: 10.1080/2162402X.2019.1649961. eCollection 2019.
• [944] Transcriptome profiling of cancer tissues in Chinese patients with gastric cancer by high-throughput sequencing.Oncol Lett. 2018 Feb;15(2):2057-2064. doi: 10.3892/ol.2017.7548. Epub 2017 Dec 8.
• [945] c-FLIP is a target of the E3 ligase deltex1 in gastric cancer.Cell Death Dis. 2018 Jan 26;9(2):135. doi: 10.1038/s41419-017-0165-6.
• [946] Gene expression and prognosis of NOX family members in gastric cancer.Onco Targets Ther. 2018 May 24;11:3065-3074. doi: 10.2147/OTT.S161287. eCollection 2018.
• [947] TNPO2 operates downstream of DYNC1I1 and promotes gastric cancer cell proliferation and inhibits apoptosis.Cancer Med. 2019 Dec;8(17):7299-7312. doi: 10.1002/cam4.2582. Epub 2019 Oct 11.
• [948] Attenuation of enoyl coenzyme A hydratase short chain 1 expression in gastric cancer cells inhibits cell proliferation and migration in vitro.Cell Mol Biol Lett. 2014 Dec;19(4):576-89. doi: 10.2478/s11658-014-0213-5. Epub 2014 Oct 23.
• [949] MiR-92a antagonized the facilitation effect of extracellular matrix protein 1 in GC metastasis through targeting its 3'UTR region.Food Chem Toxicol. 2019 Nov;133:110779. doi: 10.1016/j.fct.2019.110779. Epub 2019 Aug 28.
• [950] Overexpression of eukaryotic elongation factor 1 alpha-2 is associated with poorer prognosis in patients with gastric cancer.J Cancer Res Clin Oncol. 2015 Jul;141(7):1265-75. doi: 10.1007/s00432-014-1897-7. Epub 2015 Jan 20.
• [951] High serum Ephrin-B2 levels predict poor prognosis for patients with gastric cancer.Oncol Lett. 2018 Oct;16(4):4455-4461. doi: 10.3892/ol.2018.9202. Epub 2018 Jul 24.
• [952] Circ-EIF4G3 promotes the development of gastric cancer by sponging miR-335.Pathol Res Pract. 2019 Sep;215(9):152507. doi: 10.1016/j.prp.2019.152507. Epub 2019 Jun 20.
• [953] TSPAN9 and EMILIN1 synergistically inhibit the migration and invasion of gastric cancer cells by increasing TSPAN9 expression.BMC Cancer. 2019 Jun 26;19(1):630. doi: 10.1186/s12885-019-5810-2.
• [954] Decreased expression levels of DAL-1 and TOB1 are associated with clinicopathological features and poor prognosis in gastric cancer.Pathol Res Pract. 2019 Jun;215(6):152403. doi: 10.1016/j.prp.2019.03.031. Epub 2019 Apr 2.
• [955] EPB41L5 Mediates TGF-Induced Metastasis of Gastric Cancer.Clin Cancer Res. 2019 Jun 15;25(12):3617-3629. doi: 10.1158/1078-0432.CCR-18-2959. Epub 2019 Feb 27.
• [956] Differential Expression and Significance of Endoplasmic Reticulum Golgi Intermediate Compartment 1 in Precancerous Gastric Lesions and Gastric Cancer.Am J Med Sci. 2018 Mar;355(3):228-234. doi: 10.1016/j.amjms.2017.11.001. Epub 2017 Nov 9.
• [957] ESCO2 knockdown inhibits cell proliferation and induces apoptosis in human gastric cancer cells.Biochem Biophys Res Commun. 2018 Feb 5;496(2):475-481. doi: 10.1016/j.bbrc.2018.01.048. Epub 2018 Jan 9.
• [958] Fatty acid 2-hydroxylation inhibits tumor growth and increases sensitivity to cisplatin in gastric cancer.EBioMedicine. 2019 Mar;41:256-267. doi: 10.1016/j.ebiom.2019.01.066. Epub 2019 Feb 7.
• [959] FAM107B is regulated by S100A4 and mediates the effect of S100A4 on the proliferation and migration of MGC803 gastric cancer cells.Cell Biol Int. 2017 Oct;41(10):1103-1109. doi: 10.1002/cbin.10816. Epub 2017 Aug 29.
• [960] Elevated FAM3C promotes cell epithelial- mesenchymal transition and cell migration in gastric cancer.Onco Targets Ther. 2018 Dec 5;11:8491-8505. doi: 10.2147/OTT.S178455. eCollection 2018.
• [961] FBXO2, a novel marker for metastasis in human gastric cancer.Biochem Biophys Res Commun. 2018 Jan 15;495(3):2158-2164. doi: 10.1016/j.bbrc.2017.12.097. Epub 2017 Dec 18.
• [962] FBXW5 Promotes Tumorigenesis and Metastasis in Gastric Cancer via Activation of the FAK-Src Signaling Pathway.Cancers (Basel). 2019 Jun 17;11(6):836. doi: 10.3390/cancers11060836.
• [963] Quantitative Proteomic Approach Targeted to Fibrinogen Chain in Tissue Gastric Carcinoma.Int J Mol Sci. 2018 Mar 7;19(3):759. doi: 10.3390/ijms19030759.
• [964] Overexpression of FIBCD1 Is Predictive of Poor Prognosis in Gastric Cancer.Am J Clin Pathol. 2018 Apr 25;149(6):474-483. doi: 10.1093/ajcp/aqy013.
• [965] Analysis of the clinical significance of DNA methylation in gastric cancer based on a genome-wide high-resolution array.Clin Epigenetics. 2019 Nov 1;11(1):154. doi: 10.1186/s13148-019-0747-5.
• [966] Forkhead Box F2 Suppresses Gastric Cancer through a Novel FOXF2-IRF2BPL--Catenin Signaling Axis.Cancer Res. 2018 Apr 1;78(7):1643-1656. doi: 10.1158/0008-5472.CAN-17-2403. Epub 2018 Jan 26.
• [967] Coexpression of FOXK1 and vimentin promotes EMT, migration, and invasion in gastric cancer cells.J Mol Med (Berl). 2019 Feb;97(2):163-176. doi: 10.1007/s00109-018-1720-z. Epub 2018 Nov 27.
• [968] Downregulation of FOXK2 is associated with poor prognosis in patients with gastric cancer.Mol Med Rep. 2018 Nov;18(5):4356-4364. doi: 10.3892/mmr.2018.9466. Epub 2018 Sep 7.
• [969] FOXS1 is regulated by GLI1 and miR-125a-5p and promotes cell proliferation and EMT in gastric cancer.Sci Rep. 2019 Mar 27;9(1):5281. doi: 10.1038/s41598-019-41717-w.
• [970] Integrated Analysis Identifies Molecular Signatures and Specific Prognostic Factors for Different Gastric Cancer Subtypes.Transl Oncol. 2017 Feb;10(1):99-107. doi: 10.1016/j.tranon.2016.11.003. Epub 2016 Dec 22.
• [971] Aberrant GATA2 epigenetic dysregulation induces a GATA2/GATA6 switch in human gastric cancer.Oncogene. 2018 Feb 22;37(8):993-1004. doi: 10.1038/onc.2017.397. Epub 2017 Nov 6.
• [972] Overexpression of TWA1 predicts poor prognosis in patients with gastric cancer.Pathol Res Pract. 2019 Nov;215(11):152594. doi: 10.1016/j.prp.2019.152594. Epub 2019 Aug 16.
• [973] The role and diagnostic potential of gastrokine 1 in gastric cancer.Cancer Manag Res. 2019 Mar 1;11:1921-1931. doi: 10.2147/CMAR.S194949. eCollection 2019.
• [974] ACOT1 expression is associated with poor prognosis in gastric adenocarcinoma.Hum Pathol. 2018 Jul;77:35-44. doi: 10.1016/j.humpath.2018.03.013. Epub 2018 Mar 17.
• [975] GLIS2 redundancy causes chemoresistance and poor prognosis of gastric cancer based on coexpression network analysis.Oncol Rep. 2019 Jan;41(1):191-201. doi: 10.3892/or.2018.6794. Epub 2018 Oct 15.
• [976] Long noncoding RNA lncGNAT1? inhibits gastric cancer cell proliferation and invasion through the Wnt/catenin pathway in Helicobacterpylori infection.Mol Med Rep. 2018 Oct;18(4):4009-4015. doi: 10.3892/mmr.2018.9405. Epub 2018 Aug 20.
• [977] GREM2 maintains stem cell-like phenotypes in gastric cancer cells by regulating the JNK signaling pathway.Cell Cycle. 2019 Oct;18(19):2414-2431. doi: 10.1080/15384101.2019.1646561. Epub 2019 Aug 25.
• [978] Transmembrane protein GRINA modulates aerobic glycolysis and promotes tumor progression in gastric cancer.J Exp Clin Cancer Res. 2018 Dec 12;37(1):308. doi: 10.1186/s13046-018-0974-1.
• [979] GSE1 predicts poor survival outcome in gastric cancer patients by SLC7A5 enhancement of tumor growth and metastasis.J Biol Chem. 2018 Mar 16;293(11):3949-3964. doi: 10.1074/jbc.RA117.001103. Epub 2018 Jan 24.
• [980] Combination of TNM staging and pathway based risk score models in patients with gastric cancer.J Cell Biochem. 2018 Apr;119(4):3608-3617. doi: 10.1002/jcb.26563. Epub 2018 Jan 9.
• [981] GTPBP4 Promotes Gastric Cancer Progression via Regulating P53 Activity.Cell Physiol Biochem. 2018;45(2):667-676. doi: 10.1159/000487160. Epub 2018 Jan 31.
• [982] Overexpression of HACE1 in gastric cancer inhibits tumor aggressiveness by impeding cell proliferation and migration.Cancer Med. 2018 Jun;7(6):2472-2484. doi: 10.1002/cam4.1496. Epub 2018 Apr 19.
• [983] Heat shock-induced HIKESHI protects cell viability via nuclear translocation of heat shock protein 70.Oncol Rep. 2017 Sep;38(3):1500-1506. doi: 10.3892/or.2017.5844. Epub 2017 Jul 21.
• [984] In vitro and in vivo effects of miRNA-19b/20a/92a on gastric cancer stem cells and the related mechanism.Int J Med Sci. 2018 Jan 1;15(1):86-94. doi: 10.7150/ijms.21164. eCollection 2018.
• [985] SPP1 rs4754 and its epistatic interactions with SPARC polymorphisms in gastric cancer susceptibility.Gene. 2018 Jan 15;640:43-50. doi: 10.1016/j.gene.2017.09.053. Epub 2017 Sep 28.
• [986] Hyaluronan-mediated motility receptor confers resistance to chemotherapy via TGF/Smad2-induced epithelial-mesenchymal transition in gastric cancer.FASEB J. 2019 May;33(5):6365-6377. doi: 10.1096/fj.201802186R. Epub 2019 Feb 25.
• [987] miR-26a/HOXC9 Dysregulation Promotes Metastasis and Stem Cell-Like Phenotype of Gastric Cancer.Cell Physiol Biochem. 2018;49(4):1659-1676. doi: 10.1159/000493502. Epub 2018 Sep 11.
• [988] miR-99b-3p is induced by vitamin D3 and contributes to its antiproliferative effects in gastric cancer cells by targeting HoxD3.Biol Chem. 2019 Jul 9;400(8):1079-1086. doi: 10.1515/hsz-2019-0102. Print 2019 Jul 26.
• [989] Identification of HRK as a target of epigenetic inactivation in colorectal and gastric cancer.Clin Cancer Res. 2003 Dec 15;9(17):6410-8.
• [990] Knockdown of IARS2 suppressed growth of gastric cancer cells by regulating the phosphorylation of cell cycle-related proteins.Mol Cell Biochem. 2018 Jun;443(1-2):93-100. doi: 10.1007/s11010-017-3213-8. Epub 2017 Oct 25.
• [991] Mechanism and biological significance of the overexpression of IFITM3 in gastric cancer.Oncol Rep. 2014 Dec;32(6):2648-56. doi: 10.3892/or.2014.3522. Epub 2014 Oct 1.
• [992] IFT80 Improves Invasion Ability in Gastric Cancer Cell Line via ift80/p75NGFR/MMP9 Signaling.Int J Mol Sci. 2018 Nov 16;19(11):3616. doi: 10.3390/ijms19113616.
• [993] Investigation on correlations of serum IL-26 with diagnosis and staging of gastric cancer.J BUON. 2019 Jan-Feb;24(1):215-220.
• [994] Inhibitor of growth 3 induces cell death by regulating cell proliferation, apoptosis and cell cycle arrest by blocking the PI3K/AKT pathway.Cancer Gene Ther. 2018 Oct;25(9-10):240-247. doi: 10.1038/s41417-018-0023-4. Epub 2018 Jun 1.
• [995] Evaluation of MT Family Isoforms as Potential Biomarker for Predicting Progression and Prognosis in Gastric Cancer.Biomed Res Int. 2019 Jul 17;2019:2957821. doi: 10.1155/2019/2957821. eCollection 2019.
• [996] Overexpression of the Transmembrane Protein IQGAP3 Is Associated with Poor Survival of Patients with Gastric Cancer.Pathobiology. 2018;85(3):192-200. doi: 10.1159/000481890. Epub 2017 Nov 1.
• [997] IRF-2 Inhibits Gastric Cancer Invasion and Migration by Down-Regulating MMP-1.Dig Dis Sci. 2020 Jan;65(1):168-177. doi: 10.1007/s10620-019-05739-8. Epub 2019 Jul 26.
• [998] Intestine-specific homeobox (ISX) induces intestinal metaplasia and cell proliferation to contribute to gastric carcinogenesis.J Gastroenterol. 2016 Oct;51(10):949-60. doi: 10.1007/s00535-016-1176-2. Epub 2016 Feb 12.
• [999] MicroRNA-1275 inhibits cell migration and invasion in gastric cancer by regulating vimentin and E-cadherin via JAZF1.BMC Cancer. 2019 Jul 29;19(1):740. doi: 10.1186/s12885-019-5929-1.
• [1000] High-Expression HBO1 Predicts Poor Prognosis in Gastric Cancer.Am J Clin Pathol. 2019 Sep 9;152(4):517-526. doi: 10.1093/ajcp/aqz065.
• [1001] Overexpression of Kin of IRRE-Like Protein 1 (KIRREL) in Gastric Cancer and Its Clinical Prognostic Significance.Med Sci Monit. 2018 May 2;24:2711-2719. doi: 10.12659/MSM.910386.
• [1002] KLF16 promotes proliferation in gastric cancer cells via regulating p21 and CDK4.Am J Transl Res. 2017 Jun 15;9(6):3027-3036. eCollection 2017.
• [1003] microRNA-32-5p targets KLF2 to promote gastric cancer by activating PI3K/AKT signaling pathway.Am J Transl Res. 2019 Aug 15;11(8):4895-4908. eCollection 2019.
• [1004] Crocin inhibits the migration, invasion, and epithelial-mesenchymal transition of gastric cancer cells via miR-320/KLF5/HIF-1 signaling.J Cell Physiol. 2019 Aug;234(10):17876-17885. doi: 10.1002/jcp.28418. Epub 2019 Mar 9.
• [1005] Prognostic value of the cancer oncogene Kelch-like 6 in gastric cancer.Br J Surg. 2017 Dec;104(13):1847-1856. doi: 10.1002/bjs.10628. Epub 2017 Oct 17.
• [1006] Dysregulation of NCAPG, KNL1, miR-148a-3p, miR-193b-3p, and miR-1179 may contribute to the progression of gastric cancer.Biol Res. 2018 Nov 3;51(1):44. doi: 10.1186/s40659-018-0192-5.
• [1007] Cytokeratin-18 fragments predict treatment response and overall survival in gastric cancer in a randomized controlled trial.Tumour Biol. 2018 Mar;40(3):1010428318764007. doi: 10.1177/1010428318764007.
• [1008] High KRT8 expression promotes tumor progression and metastasis of gastric cancer.Cancer Sci. 2017 Feb;108(2):178-186. doi: 10.1111/cas.13120.
• [1009] Mitochondrial NADH Dehydrogenase Subunit 3 (MTND3) Polymorphisms are Associated with Gastric Cancer Susceptibility.Int J Med Sci. 2018 Aug 10;15(12):1329-1333. doi: 10.7150/ijms.26881. eCollection 2018.
• [1010] Alazami syndrome: the first case of papillary thyroid carcinoma.J Hum Genet. 2020 Jan;65(2):133-141. doi: 10.1038/s10038-019-0682-5. Epub 2019 Oct 28.
• [1011] High Yes-associated protein 1 with concomitant negative LATS1/2 expression is associated with poor prognosis of advanced gastric cancer.Pathology. 2019 Apr;51(3):261-267. doi: 10.1016/j.pathol.2019.01.001. Epub 2019 Feb 25.
• [1012] LGR6 promotes the progression of gastric cancer through PI3K/AKT/mTOR pathway.Onco Targets Ther. 2018 May 22;11:3025-3033. doi: 10.2147/OTT.S149303. eCollection 2018.
• [1013] LIMD1 is a survival prognostic marker of gastric cancer and hinders tumor progression by suppressing activation of YAP1.Cancer Manag Res. 2018 Oct 9;10:4349-4361. doi: 10.2147/CMAR.S174856. eCollection 2018.
• [1014] Combining multi-dimensional data to identify a key signature (gene and miRNA) of cisplatin-resistant gastric cancer.J Cell Biochem. 2018 Aug;119(8):6997-7008. doi: 10.1002/jcb.26908. Epub 2018 Apr 25.
• [1015] LMO3 promotes gastric cancer cell invasion and proliferation through Akt-mTOR and Akt-GSK3 signaling.Int J Mol Med. 2018 May;41(5):2755-2763. doi: 10.3892/ijmm.2018.3476. Epub 2018 Feb 8.
• [1016] LMX1A inhibits C-Myc expression through ANGPTL4 to exert tumor suppressive role in gastric cancer.PLoS One. 2019 Sep 26;14(9):e0221640. doi: 10.1371/journal.pone.0221640. eCollection 2019.
• [1017] Multifocal gastric adenocarcinoma in a patient with LRBA deficiency.Orphanet J Rare Dis. 2017 Jul 18;12(1):131. doi: 10.1186/s13023-017-0682-5.
• [1018] Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer.Oncotarget. 2018 Aug 31;9(68):32917-32928. doi: 10.18632/oncotarget.25952. eCollection 2018 Aug 31.
• [1019] LTBP2 promotes the migration and invasion of gastric cancer cells and predicts poor outcome of patients with gastric cancer.Int J Oncol. 2018 Jun;52(6):1886-1898. doi: 10.3892/ijo.2018.4356. Epub 2018 Apr 4.
• [1020] Overexpression of Lymphocyte Antigen 6 Complex, Locus E in Gastric Cancer Promotes Cancer Cell Growth and Metastasis.Cell Physiol Biochem. 2018;45(3):1219-1229. doi: 10.1159/000487453. Epub 2018 Feb 9.
• [1021] Evaluation of PET and laparoscopy in STagIng advanced gastric cancer: a multicenter prospective study (PLASTIC-study).BMC Cancer. 2018 Apr 20;18(1):450. doi: 10.1186/s12885-018-4367-9.
• [1022] LC3A, LC3B and Beclin-1 Expression in Gastric Cancer.Anticancer Res. 2018 Dec;38(12):6827-6833. doi: 10.21873/anticanres.13056.
• [1023] Sh-MARCH8 Inhibits Tumorigenesis via PI3K Pathway in Gastric Cancer.Cell Physiol Biochem. 2018;49(1):306-321. doi: 10.1159/000492882. Epub 2018 Aug 23.
• [1024] Magnesium-dependent Phosphatase (MDP) 1 is a Potential Suppressor of Gastric Cancer.Curr Cancer Drug Targets. 2019;19(10):817-827. doi: 10.2174/1568009619666190620112546.
• [1025] Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer.Cancer Med. 2019 Aug;8(10):4766-4781. doi: 10.1002/cam4.2360. Epub 2019 Jun 26.
• [1026] Dysregulated N6-methyladenosinemethylation writer METTL3 contributes to the proliferation and migration of gastric cancer.J Cell Physiol. 2020 Jan;235(1):548-562. doi: 10.1002/jcp.28994. Epub 2019 Jun 24.
• [1027] Human fused NKG2D-IL-15 protein controls xenografted human gastric cancer through the recruitment and activation of NK cells.Cell Mol Immunol. 2017 Mar;14(3):293-307. doi: 10.1038/cmi.2015.81. Epub 2015 Sep 14.
• [1028] MIIP is downregulated in gastric cancer and its forced expression inhibits proliferation and invasion of gastric cancer cells in vitro and in vivo.Onco Targets Ther. 2018 Dec 11;11:8951-8964. doi: 10.2147/OTT.S173393. eCollection 2018.
• [1029] Sensitive and specific detection of early gastric cancer with DNA methylation analysis of gastric washes.Gastroenterology. 2009 Jun;136(7):2149-58. doi: 10.1053/j.gastro.2009.02.085. Epub 2009 Apr 16.
• [1030] MLKL is a potential prognostic marker in gastric cancer.Oncol Lett. 2019 Oct;18(4):3830-3836. doi: 10.3892/ol.2019.10687. Epub 2019 Jul 29.
• [1031] Overexpression of MPC1 inhibits the proliferation, migration, invasion, and stem cell-like properties of gastric cancer cells.Onco Targets Ther. 2017 Oct 24;10:5151-5163. doi: 10.2147/OTT.S148681. eCollection 2017.
• [1032] MRFAP1 plays a protective role in neddylation inhibitor MLN4924-mediated gastric cancer cell death.Eur Rev Med Pharmacol Sci. 2018 Dec;22(23):8273-8280. doi: 10.26355/eurrev_201812_16524.
• [1033] Long Noncoding RNA MRPL39 Inhibits Gastric Cancer Proliferation and Progression by Directly Targeting miR-130.Genet Test Mol Biomarkers. 2018 Nov;22(11):656-663. doi: 10.1089/gtmb.2018.0151.
• [1034] Identifying novel biomarkers of gastric cancer through integration analysis of single nucleotide polymorphisms and gene expression profile.Int J Biol Markers. 2015 Jul 22;30(3):e321-6. doi: 10.5301/jbm.5000145.
• [1035] MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFN/STAT1 signaling.J Exp Clin Cancer Res. 2019 May 21;38(1):206. doi: 10.1186/s13046-019-1186-z.
• [1036] The DNA Endonuclease Mus81 Regulates ZEB1 Expression and Serves as a Target of BET4 Inhibitors in Gastric Cancer.Mol Cancer Ther. 2019 Aug;18(8):1439-1450. doi: 10.1158/1535-7163.MCT-18-0833. Epub 2019 May 29.
• [1037] miR-143 and miR-145 inhibit gastric cancer cell migration and metastasis by suppressing MYO6. Cell Death Dis. 2017 Oct 12;8(10):e3101.
• [1038] Expression and prognosis of MYOZ2 in gastric cancer.Eur Rev Med Pharmacol Sci. 2018 Sep;22(18):5920-5927. doi: 10.26355/eurrev_201809_15921.
• [1039] LINC01410-miR-532-NCF2-NF-kB feedback loop promotes gastric cancer angiogenesis and metastasis.Oncogene. 2018 May;37(20):2660-2675. doi: 10.1038/s41388-018-0162-y. Epub 2018 Feb 27.
• [1040] Nectin1 expression is frequently decreased in gastric cancers.Pathol Int. 2018 Oct;68(10):557-562. doi: 10.1111/pin.12721. Epub 2018 Sep 17.
• [1041] Long non-coding RNA TOB1-AS1 modulates cell proliferation, apoptosis, migration and invasion through miR-23a/NEU1 axis via Wnt/b-catenin pathway in gastric cancer.Eur Rev Med Pharmacol Sci. 2019 Nov;23(22):9890-9899. doi: 10.26355/eurrev_201911_19554.
• [1042] miR-374a-5p: A New Target for Diagnosis and Drug Resistance Therapy in Gastric Cancer.Mol Ther Nucleic Acids. 2019 Dec 6;18:320-331. doi: 10.1016/j.omtn.2019.07.025. Epub 2019 Aug 27.
• [1043] Identification of N- and O-linked glycans recognized by AAL in saliva of patients with atrophic gastritis and gastric cancer.Cancer Biomark. 2018;22(4):669-681. doi: 10.3233/CBM-171087.
• [1044] Ets-1 promoter-associated noncoding RNA regulates the NONO/ERG/Ets-1 axis to drive gastric cancer progression.Oncogene. 2018 Aug;37(35):4871-4886. doi: 10.1038/s41388-018-0302-4. Epub 2018 May 18.
• [1045] Cross-Database Analysis Reveals Sensitive Biomarkers for Combined Therapy for ERBB2+ Gastric Cancer.Front Pharmacol. 2018 Aug 3;9:861. doi: 10.3389/fphar.2018.00861. eCollection 2018.
• [1046] Potent and specific MTH1 inhibitors targeting gastric cancer.Cell Death Dis. 2019 Jun 4;10(6):434. doi: 10.1038/s41419-019-1665-3.
• [1047] Bioinformatic exploration of OLFML2B overexpression in gastric cancer base on multiple analyzing tools.BMC Cancer. 2019 Mar 13;19(1):227. doi: 10.1186/s12885-019-5406-x.
• [1048] Down-regulation of a pro-apoptotic pathway regulated by PCAF/ADA3 in early stage gastric cancer.Cell Death Dis. 2018 May 1;9(5):442. doi: 10.1038/s41419-018-0470-8.
• [1049] MicroRNA-370 inhibits the proliferation, invasion and EMT of gastric cancer cells by directly targeting PAQR4.J Pharmacol Sci. 2018 Oct;138(2):96-106. doi: 10.1016/j.jphs.2018.08.004. Epub 2018 Aug 25.
• [1050] PARI functions as a new transcriptional target of FOXM1 involved in gastric cancer development.Int J Biol Sci. 2018 Apr 5;14(5):531-541. doi: 10.7150/ijbs.23945. eCollection 2018.
• [1051] Evaluating the clinical feasibility: The direct bisulfite genomic sequencing for examination of methylated status of protocadherin10 (PCDH10) promoter to predict the prognosis of gastric cancer.Cancer Biomark. 2015;15(5):567-73. doi: 10.3233/CBM-150496.
• [1052] Asymmetric dimethylation at histone H3 arginine 2 by PRMT6 in gastric cancer progression.Carcinogenesis. 2019 Mar 12;40(1):15-26. doi: 10.1093/carcin/bgy147.
• [1053] Loss of PCDH9 is associated with the differentiation of tumor cells and metastasis and predicts poor survival in gastric cancer.Clin Exp Metastasis. 2015 Jun;32(5):417-28. doi: 10.1007/s10585-015-9712-7. Epub 2015 Apr 14.
• [1054] PCDHGA9 acts as a tumor suppressor to induce tumor cell apoptosis and autophagy and inhibit the EMT process in human gastric cancer.Cell Death Dis. 2018 Jan 18;9(2):27. doi: 10.1038/s41419-017-0189-y.
• [1055] Low expression of PDHA1 predicts poor prognosis in gastric cancer.Pathol Res Pract. 2019 Mar;215(3):478-482. doi: 10.1016/j.prp.2018.12.038. Epub 2018 Dec 31.
• [1056] Inhibiting casein kinase 2 overcomes paclitaxel resistance in gastric cancer.Gastric Cancer. 2019 Nov;22(6):1153-1163. doi: 10.1007/s10120-019-00971-7. Epub 2019 May 16.
• [1057] PDRG1 gene silencing contributes to inhibit the growth and induce apoptosis of gastric cancer cells.Pathol Res Pract. 2019 Oct;215(10):152567. doi: 10.1016/j.prp.2019.152567. Epub 2019 Jul 27.
• [1058] Knockdown of long non-coding RNA PEG10 inhibits growth, migration and invasion of gastric carcinoma cells via up-regulating miR-3200.Neoplasma. 2018 Sep 19;65(5):769-778. doi: 10.4149/neo_2018_171204N794. Epub 2018 Jun 17.
• [1059] Circ_0027599/PHDLA1 suppresses gastric cancer progression by sponging miR-101-3p.1.Cell Biosci. 2018 Nov 6;8:58. doi: 10.1186/s13578-018-0252-0. eCollection 2018.
• [1060] PIAS1 inhibited the metastasis of gastric cancer cell by epithelial-mesenchymal transition regulation within the inflammatory microenvironment.Oncol Lett. 2018 Mar;15(3):3828-3837. doi: 10.3892/ol.2018.7811. Epub 2018 Jan 16.
• [1061] PIEZO1 functions as a potential oncogene by promoting cell proliferation and migration in gastric carcinogenesis.Mol Carcinog. 2018 Sep;57(9):1144-1155. doi: 10.1002/mc.22831. Epub 2018 May 2.
• [1062] Adipocytes fuel gastric cancer omental metastasis via PITPNC1-mediated fatty acid metabolic reprogramming.Theranostics. 2018 Oct 29;8(19):5452-5468. doi: 10.7150/thno.28219. eCollection 2018.
• [1063] Development of Novel Monoclonal Antibodies for Evaluation of Transmembrane Prostate Androgen-Induced Protein 1 (TMEPAI) Expression Patterns in Gastric Cancer.Pathol Oncol Res. 2018 Apr;24(2):427-438. doi: 10.1007/s12253-017-0247-x. Epub 2017 Jun 5.
• [1064] Identification of plasma RGS18 and PPBP mRNAs as potential biomarkers for gastric cancer using transcriptome arrays.Oncol Lett. 2019 Jan;17(1):247-255. doi: 10.3892/ol.2018.9608. Epub 2018 Oct 23.
• [1065] Overexpression of Myosin Phosphatase Target Subunit 1 (MYPT1) Inhibits Tumor Progression and Metastasis of Gastric Cancer.Med Sci Monit. 2018 Apr 24;24:2508-2517. doi: 10.12659/msm.906852.
• [1066] pRb2/p130 localizes to the cytoplasm in diffuse gastric cancer.J Cell Physiol. 2015 Apr;230(4):802-5. doi: 10.1002/jcp.24805.
• [1067] MicroRNA-596 acts as a tumor suppressor in gastric cancer and is upregulated by promotor demethylation.World J Gastroenterol. 2019 Mar 14;25(10):1224-1237. doi: 10.3748/wjg.v25.i10.1224.
• [1068] PRDX2 protects against oxidative stress induced by H. pylori and promotes resistance to cisplatin in gastric cancer.Redox Biol. 2020 Jan;28:101319. doi: 10.1016/j.redox.2019.101319. Epub 2019 Sep 5.
• [1069] High tissue MMP14 expression predicts worse survival in gastric cancer, particularly with a low PROX1.Cancer Med. 2019 Nov;8(16):6995-7005. doi: 10.1002/cam4.2576. Epub 2019 Sep 27.
• [1070] Downregulation of peroxiredoxin II suppresses the proliferation and metastasis of gastric cancer cells.Oncol Lett. 2018 Oct;16(4):4551-4560. doi: 10.3892/ol.2018.9208. Epub 2018 Jul 25.
• [1071] Testes-specific protease 50 (TSP50) promotes invasion and metastasis by inducing EMT in gastric cancer.BMC Cancer. 2018 Jan 23;18(1):94. doi: 10.1186/s12885-018-4000-y.
• [1072] Peroxiredoxin V Inhibits Emodin-induced Gastric Cancer Cell Apoptosis via the ROS/Bcl2 Pathway.In Vivo. 2019 Jul-Aug;33(4):1183-1192. doi: 10.21873/invivo.11589.
• [1073] Combination of L-3-phosphoserine phosphatase and CEA using real-time RT-PCR improves accuracy in detection of peritoneal micrometastasis of gastric cancer.Anticancer Res. 2004 Mar-Apr;24(2C):1113-20.
• [1074] MicroRNA-4268 inhibits cell proliferation via AKT/JNK signalling pathways by targeting Rab6B in human gastric cancer.Cancer Gene Ther. 2020 Jun;27(6):461-472. doi: 10.1038/s41417-019-0118-6. Epub 2019 Jul 15.
• [1075] RAD51B as a potential biomarker for early detection and poor prognostic evaluation contributes to tumorigenesis of gastric cancer.Tumour Biol. 2016 Nov;37(11):14969-14978. doi: 10.1007/s13277-016-5340-3. Epub 2016 Sep 20.
• [1076] High Expression of Retinoic Acid Induced 14 (RAI14) in Gastric Cancer and Its Prognostic Value.Med Sci Monit. 2018 Apr 14;24:2244-2251. doi: 10.12659/msm.910133.
• [1077] The regulation and function of microRNA-377/RASSF8 signaling axis in gastric cancer.Oncol Lett. 2018 Mar;15(3):3630-3638. doi: 10.3892/ol.2018.7740. Epub 2018 Jan 8.
• [1078] RNA-binding motif protein 47 inhibits Nrf2 activity to suppress tumor growth in lung adenocarcinoma.Oncogene. 2016 Sep 22;35(38):5000-9. doi: 10.1038/onc.2016.35. Epub 2016 Feb 29.
• [1079] RNF138 confers cisplatin resistance in gastric cancer cells via activating Chk1 signaling pathway.Cancer Biol Ther. 2018;19(12):1128-1138. doi: 10.1080/15384047.2018.1480293. Epub 2018 Sep 27.
• [1080] Promoter methylation of RNF180 is associated with H.pylori infection and serves as a marker for gastric cancer and atrophic gastritis.Oncotarget. 2016 Apr 26;7(17):24800-9. doi: 10.18632/oncotarget.8523.
• [1081] RNF185 modulates JWA ubiquitination and promotes gastric cancer metastasis.Biochim Biophys Acta Mol Basis Dis. 2018 May;1864(5 Pt A):1552-1561. doi: 10.1016/j.bbadis.2018.02.013. Epub 2018 Feb 23.
• [1082] Long non-coding RNA LINC00665 gastric cancer tumorigenesis by regulation miR-149-3p/RNF2 axis.Onco Targets Ther. 2019 Aug 28;12:6981-6990. doi: 10.2147/OTT.S214588. eCollection 2019.
• [1083] Ring finger protein 31-mediated atypical ubiquitination stabilizes forkhead box P3 and thereby stimulates regulatory T-cell function.J Biol Chem. 2018 Dec 28;293(52):20099-20111. doi: 10.1074/jbc.RA118.005802. Epub 2018 Nov 2.
• [1084] Circular RNA hsa_circ_0006848 Related to Ribosomal Protein L6 Acts as a Novel Biomarker for Early Gastric Cancer.Dis Markers. 2019 Sep 2;2019:3863458. doi: 10.1155/2019/3863458. eCollection 2019.
• [1085] NRF2 through RPS6 Activation Is Related to Anti-HER2 Drug Resistance in HER2-Amplified Gastric Cancer.Clin Cancer Res. 2019 Mar 1;25(5):1639-1649. doi: 10.1158/1078-0432.CCR-18-2421. Epub 2018 Nov 30.
• [1086] RSRC1 suppresses gastric cancer cell proliferation and migration by regulating PTEN expression.Mol Med Rep. 2019 Aug;20(2):1747-1753. doi: 10.3892/mmr.2019.10409. Epub 2019 Jun 21.
• [1087] HOXD9 promotes the growth, invasion and metastasis of gastric cancer cells by transcriptional activation of RUFY3.J Exp Clin Cancer Res. 2019 Sep 23;38(1):412. doi: 10.1186/s13046-019-1399-1.
• [1088] CPT1A-mediated succinylation of S100A10 increases human gastric cancer invasion.J Cell Mol Med. 2019 Jan;23(1):293-305. doi: 10.1111/jcmm.13920. Epub 2018 Nov 5.
• [1089] A genetic variant of miR-148a binding site in the SCRN1 3'-UTR is associated with susceptibility and prognosis of gastric cancer.Sci Rep. 2014 Nov 17;4:7080. doi: 10.1038/srep07080.
• [1090] LncRNA TP73-AS1 accelerates tumor progression in gastric cancer through regulating miR-194-5p/SDAD1 axis.Pathol Res Pract. 2018 Dec;214(12):1993-1999. doi: 10.1016/j.prp.2018.09.006. Epub 2018 Sep 13.
• [1091] Analysis of succinate dehydrogenase subunit B gene alterations in gastric cancers.Pathol Int. 2010 Aug;60(8):559-65. doi: 10.1111/j.1440-1827.2010.02558.x.
• [1092] Stemness Is Enhanced in Gastric Cancer by a SET/PP2A/E2F1 Axis.Mol Cancer Res. 2018 Mar;16(3):554-563. doi: 10.1158/1541-7786.MCR-17-0393. Epub 2018 Jan 12.
• [1093] High-definition CpG methylation of novel genes in gastric carcinogenesis identified by next-generation sequencing.Mod Pathol. 2016 Feb;29(2):182-93. doi: 10.1038/modpathol.2015.144. Epub 2016 Jan 15.
• [1094] Circulating SH2B1 is associated with an increased risk of gastric cancer.Oncol Lett. 2018 May;15(5):7305-7311. doi: 10.3892/ol.2018.8196. Epub 2018 Mar 7.
• [1095] High Expression of Serine Hydroxymethyltransferase 2 Indicates Poor Prognosis of Gastric Cancer Patients.Med Sci Monit. 2019 Oct 3;25:7430-7438. doi: 10.12659/MSM.917435.
• [1096] Plasma long noncoding RNAs PANDAR, FOXD2-AS1, and SMARCC2 as potential novel diagnostic biomarkers for gastric cancer.Cancer Manag Res. 2019 Jul 4;11:6175-6184. doi: 10.2147/CMAR.S201935. eCollection 2019.
• [1097] Serum SOX11 promoter methylation is a novel biomarker for the diagnosis of Hepatitis B virus-related hepatocellular carcinoma.Neoplasma. 2016;63(3):419-26. doi: 10.4149/311_151029N552.
• [1098] Circ_SPECC1 enhances the inhibition of miR-526b on downstream KDM4A/YAP1 pathway to regulate the growth and invasion of gastric cancer cells.Biochem Biophys Res Commun. 2019 Sep 17;517(2):253-259. doi: 10.1016/j.bbrc.2019.07.065. Epub 2019 Jul 23.
• [1099] IL-18 enhances thrombospondin-1 production in human gastric cancer via JNK pathway.Biochem Biophys Res Commun. 2006 Jun 16;344(4):1284-9. doi: 10.1016/j.bbrc.2006.04.016. Epub 2006 Apr 21.
• [1100] MicroRNA-150-5p and SRC kinase signaling inhibitor 1 involvement in the pathological development of gastric cancer.Exp Ther Med. 2019 Oct;18(4):2667-2674. doi: 10.3892/etm.2019.7828. Epub 2019 Jul 30.
• [1101] Sex determining region Y-box 12 (SOX12) promotes gastric cancer metastasis by upregulating MMP7 and IGF1.Cancer Lett. 2019 Jun 28;452:103-118. doi: 10.1016/j.canlet.2019.03.035. Epub 2019 Mar 25.
• [1102] SSH1 expression is associated with gastric cancer progression and predicts a poor prognosis.BMC Gastroenterol. 2018 Jan 16;18(1):12. doi: 10.1186/s12876-018-0739-5.
• [1103] Impact of liver kinase B1 on p53 and survivin and its correlation with prognosis in gastric cancer.Onco Targets Ther. 2019 Feb 22;12:1439-1445. doi: 10.2147/OTT.S199138. eCollection 2019.
• [1104] The oncogenic role of MST3 in human gastric cancer.Am J Cancer Res. 2018 Oct 1;8(10):2130-2139. eCollection 2018.
• [1105] STUB1 suppresseses tumorigenesis and chemoresistance through antagonizing YAP1 signaling.Cancer Sci. 2019 Oct;110(10):3145-3156. doi: 10.1111/cas.14166. Epub 2019 Aug 28.
• [1106] Expression of sushi domain containing two reflects the malignant potential of gastric cancer.Cancer Med. 2018 Oct;7(10):5194-5204. doi: 10.1002/cam4.1793. Epub 2018 Sep 27.
• [1107] The levels of SYT13 and CEA mRNAs in peritoneal lavages predict the peritoneal recurrence of gastric cancer.Gastric Cancer. 2019 Nov;22(6):1143-1152. doi: 10.1007/s10120-019-00967-3. Epub 2019 May 4.
• [1108] Significance of SYT8 For the Detection, Prediction, and Treatment of Peritoneal Metastasis From Gastric Cancer.Ann Surg. 2018 Mar;267(3):495-503. doi: 10.1097/SLA.0000000000002096.
• [1109] Tbx3 overexpression in human gastric cancer is correlated with advanced tumor stage and nodal status and promotes cancer cell growth and invasion.Virchows Arch. 2016 Nov;469(5):505-513. doi: 10.1007/s00428-016-2007-9. Epub 2016 Aug 24.
• [1110] FAM46C suppresses gastric cancer by inhibition of Wnt/beta-catenin.Front Biosci (Landmark Ed). 2020 Jan 1;25(3):549-563. doi: 10.2741/4820.
• [1111] miR-487a promotes progression of gastric cancer by targeting TIA1.Biochimie. 2018 Nov;154:119-126. doi: 10.1016/j.biochi.2018.08.006. Epub 2018 Aug 23.
• [1112] TIGAR Promotes Tumorigenesis and Protects Tumor Cells From Oxidative and Metabolic Stresses in Gastric Cancer.Front Oncol. 2019 Nov 19;9:1258. doi: 10.3389/fonc.2019.01258. eCollection 2019.
• [1113] TIMMDC1 Knockdown Inhibits Growth and Metastasis of Gastric Cancer Cells through Metabolic Inhibition and AKT/GSK3/-Catenin Signaling Pathway.Int J Biol Sci. 2018 Jul 27;14(10):1256-1267. doi: 10.7150/ijbs.27100. eCollection 2018.
• [1114] Gene regulatory network construction identified NFYA as a diffuse subtype-specific prognostic factor in gastric cancer.Int J Oncol. 2018 Nov;53(5):1857-1868. doi: 10.3892/ijo.2018.4519. Epub 2018 Aug 9.
• [1115] Expression of transmembrane protein 41A is associated with metastasis via the modulation of Ecadherin in radically resected gastric cancer.Mol Med Rep. 2018 Sep;18(3):2963-2972. doi: 10.3892/mmr.2018.9241. Epub 2018 Jul 3.
• [1116] Knockdown of TMEM45B inhibits cell proliferation and invasion in gastric cancer.Biomed Pharmacother. 2018 Aug;104:576-581. doi: 10.1016/j.biopha.2018.05.016. Epub 2018 May 25.
• [1117] Knockdown of TMPRSS3 inhibits gastric cancer cell proliferation, invasion and EMT via regulation of the ERK1/2 and PI3K/Akt pathways.Biomed Pharmacother. 2018 Nov;107:841-848. doi: 10.1016/j.biopha.2018.08.023. Epub 2018 Aug 22.
• [1118] TIPE1 suppresses invasion and migration through down-regulating Wnt/-catenin pathway in gastric cancer.J Cell Mol Med. 2018 Feb;22(2):1103-1117. doi: 10.1111/jcmm.13362. Epub 2017 Oct 10.
• [1119] Troponin I2 as a Specific Biomarker for Prediction of Peritoneal Metastasis in Gastric Cancer.Ann Surg Oncol. 2018 Jul;25(7):2083-2090. doi: 10.1245/s10434-018-6480-z. Epub 2018 Apr 16.
• [1120] Somatic mutations and losses of expression of microRNA regulation-related genes AGO2 and TNRC6A in gastric and colorectal cancers.J Pathol. 2010 Jun;221(2):139-46. doi: 10.1002/path.2683.
• [1121] TRP channels in gastric cancer: New hopes and clinical perspectives.Cell Calcium. 2019 Sep;82:102053. doi: 10.1016/j.ceca.2019.06.007. Epub 2019 Jun 17.
• [1122] miR-17-92 functions as an oncogene and modulates NF-B signaling by targeting TRAF3 in MGC-803 human gastric cancer cells.Int J Oncol. 2018 Nov;53(5):2241-2257. doi: 10.3892/ijo.2018.4543. Epub 2018 Aug 28.
• [1123] TRIM14 promotes the migration and invasion of gastric cancer by regulating epithelialtomesenchymal transition via activation of AKT signaling regulated by miR?95?p.Oncol Rep. 2018 Dec;40(6):3273-3284. doi: 10.3892/or.2018.6750. Epub 2018 Sep 28.
• [1124] Elevated TRIM23 expression predicts poor prognosis in Chinese gastric cancer.Pathol Res Pract. 2018 Dec;214(12):2062-2068. doi: 10.1016/j.prp.2018.10.010. Epub 2018 Oct 19.
• [1125] Prognostic value of tripartite motif containing 29 expression in patients with gastric cancer following surgical resection.Oncol Lett. 2018 Apr;15(4):5792-5798. doi: 10.3892/ol.2018.8059. Epub 2018 Feb 15.
• [1126] A targeted proteomics approach reveals a serum protein signature as diagnostic biomarker for resectable gastric cancer.EBioMedicine. 2019 Jun;44:322-333. doi: 10.1016/j.ebiom.2019.05.044. Epub 2019 May 28.
• [1127] K-ras-ERK1/2 down-regulates H2A.X(Y142ph) through WSTF to promote the progress of gastric cancer.BMC Cancer. 2019 May 31;19(1):530. doi: 10.1186/s12885-019-5750-x.
• [1128] Circ-CCDC66 accelerates proliferation and invasion of gastric cancer via binding to miRNA-1238-3p.Eur Rev Med Pharmacol Sci. 2019 May;23(10):4164-4172. doi: 10.26355/eurrev_201905_17919.
• [1129] Enhanced expression of circular RNA circ-DCAF6 predicts adverse prognosis and promotes cell progression via sponging miR-1231 and miR-1256 in gastric cancer.Exp Mol Pathol. 2019 Oct;110:104273. doi: 10.1016/j.yexmp.2019.104273. Epub 2019 Jun 19.
• [1130] LINC00339 promotes gastric cancer progression by elevating DCP1A expression via inhibiting miR-377-3p.J Cell Physiol. 2019 Dec;234(12):23667-23674. doi: 10.1002/jcp.28934. Epub 2019 Jun 12.
• [1131] Down-regulation of EGFL8: a novel biomarker for advanced gastric cancer.Anticancer Res. 2011 Oct;31(10):3377-80.
• [1132] ELK1-induced upregulation of lncRNA TRPM2-AS promotes tumor progression in gastric cancer by regulating miR-195/ HMGA1 axis.J Cell Biochem. 2019 Oct;120(10):16921-16933. doi: 10.1002/jcb.28951. Epub 2019 May 19.
• [1133] Suppression of fumarate hydratase activity increases the efficacy of cisplatin-mediated chemotherapy in gastric cancer.Cell Death Dis. 2019 May 28;10(6):413. doi: 10.1038/s41419-019-1652-8.
• [1134] GAGE7B promotes tumor metastasis and growth via activating the p38/pMAPKAPK2/pHSP27 pathway in gastric cancer.J Exp Clin Cancer Res. 2019 Mar 11;38(1):124. doi: 10.1186/s13046-019-1125-z.
• [1135] ILF3 promotes gastric cancer proliferation and may be used as a prognostic marker.Mol Med Rep. 2019 Jul;20(1):125-134. doi: 10.3892/mmr.2019.10229. Epub 2019 May 9.
• [1136] LBX2-AS1/miR-219a-2-3p/FUS/LBX2 positive feedback loop contributes to the proliferation of gastric cancer.Gastric Cancer. 2020 May;23(3):449-463. doi: 10.1007/s10120-019-01019-6. Epub 2019 Oct 31.
• [1137] High SALM3 Expression in Tumor Cells and Fibroblasts Is Correlated with Poor Prognosis in Gastric Cancer Patients.Dis Markers. 2019 Apr 4;2019:8282414. doi: 10.1155/2019/8282414. eCollection 2019.
• [1138] Leucine-rich repeat neuronal protein-1 suppresses apoptosis of gastric cancer cells through regulation of Fas/FasL.Cancer Sci. 2019 Jul;110(7):2145-2155. doi: 10.1111/cas.14042. Epub 2019 Jun 10.
• [1139] The correlation between NEDD4L and HIF-1 levels as a gastric cancer prognostic marker.Int J Med Sci. 2019 Oct 21;16(11):1517-1524. doi: 10.7150/ijms.34646. eCollection 2019.
• [1140] Significant association of YAP1 and HSPC111 proteins with poor prognosis in Chinese gastric cancer patients.Oncotarget. 2017 May 17;8(46):80303-80314. doi: 10.18632/oncotarget.17932. eCollection 2017 Oct 6.
• [1141] NPTX1 promotes metastasis via integrin/FAK signaling in gastric cancer.Cancer Manag Res. 2019 Apr 15;11:3237-3251. doi: 10.2147/CMAR.S196509. eCollection 2019.
• [1142] PALB2 c.2257C>T truncating variant is a Greek founder and is associated with high breast cancer risk.J Hum Genet. 2019 Aug;64(8):767-773. doi: 10.1038/s10038-019-0612-6. Epub 2019 May 14.
• [1143] A miR-567-PIK3AP1-PI3K/AKT-c-Myc feedback loop regulates tumour growth and chemoresistance in gastric cancer.EBioMedicine. 2019 Jun;44:311-321. doi: 10.1016/j.ebiom.2019.05.003. Epub 2019 May 9.
• [1144] Lysyl oxidase is a tumor suppressor gene inactivated by methylation and loss of heterozygosity in human gastric cancers.Cancer Res. 2004 Sep 15;64(18):6410-5. doi: 10.1158/0008-5472.CAN-04-1543.
• [1145] High-level expression of PRSS3 correlates with metastasis and poor prognosis in patients with gastric cancer.J Surg Oncol. 2019 Jun;119(8):1108-1121. doi: 10.1002/jso.25448. Epub 2019 Mar 25.
• [1146] Asporin promotes cell proliferation via interacting with PSMD2 in gastric cancer.Front Biosci (Landmark Ed). 2019 Jun 1;24(6):1178-1189. doi: 10.2741/4774.
• [1147] Knockdown of STIL suppresses the progression of gastric cancer by down-regulating the IGF-1/PI3K/AKT pathway.J Cell Mol Med. 2019 Aug;23(8):5566-5575. doi: 10.1111/jcmm.14440. Epub 2019 Jun 11.
• [1148] Clinical Significance of Transcription Factor 7 (TCF7) as a Prognostic Factor in Gastric Cancer.Med Sci Monit. 2019 May 28;25:3957-3963. doi: 10.12659/MSM.913913.
• [1149] Lnc-GIHCG promotes cell proliferation and migration in gastric cancer through miR- 1281 adsorption.Mol Genet Genomic Med. 2019 Jun;7(6):e711. doi: 10.1002/mgg3.711. Epub 2019 May 2.
• [1150] Usefulness of the real-time reverse transcription-polymerase chain reaction assay targeted to alpha1,4-N-acetylglucosaminyltransferase for the detection of gastric cancer.Lab Invest. 2003 Feb;83(2):187-97. doi: 10.1097/01.lab.0000057001.21187.a0.
• [1151] Association of IL10 gene promoter polymorphisms with risks of gastric cancer and atrophic gastritis.J Int Med Res. 2018 Dec;46(12):5155-5166. doi: 10.1177/0300060518792785. Epub 2018 Sep 11.
• [1152] Clinicopathological and prognostic significance of aberrant Arpin expression in gastric cancer.World J Gastroenterol. 2017 Feb 28;23(8):1450-1457. doi: 10.3748/wjg.v23.i8.1450.
• [1153] Association analysis of telomere length related gene ACYP2 with the gastric cancer risk in the northwest Chinese Han population.Oncotarget. 2017 May 9;8(19):31144-31152. doi: 10.18632/oncotarget.16097.
• [1154] Clinical significance of ADAM29 promoting the invasion and growth of gastric cancer cells in vitro.Oncol Lett. 2018 Aug;16(2):1483-1490. doi: 10.3892/ol.2018.8838. Epub 2018 May 30.
• [1155] High-resolution melting analysis of ADAMTS18 methylation levels in gastric, colorectal and pancreatic cancers.Med Oncol. 2010 Sep;27(3):998-1004. doi: 10.1007/s12032-009-9323-8. Epub 2009 Oct 6.
• [1156] MicroRNA-148a-3p enhances cisplatin cytotoxicity in gastric cancer through mitochondrial fission induction and cyto-protective autophagy suppression.Cancer Lett. 2017 Dec 1;410:212-227. doi: 10.1016/j.canlet.2017.09.035. Epub 2017 Sep 28.
• [1157] Molecular heterogeneity in the novel fusion gene APIP-FGFR2: Diversity of genomic breakpoints in gastric cancer with high-level amplifications at 11p13 and 10q26.Oncol Lett. 2017 Jan;13(1):215-221. doi: 10.3892/ol.2016.5386. Epub 2016 Nov 15.
• [1158] ASCL2 expression contributes to gastric tumor migration and invasion by downregulating miR223 and inducing EMT.Mol Med Rep. 2018 Oct;18(4):3751-3759. doi: 10.3892/mmr.2018.9363. Epub 2018 Aug 8.
• [1159] miR-874 regulates multiple-drug resistance in gastric cancer by targeting ATG16L1.Int J Oncol. 2018 Dec;53(6):2769-2779. doi: 10.3892/ijo.2018.4593. Epub 2018 Oct 11.
• [1160] ATG4A promotes tumor metastasis by inducing the epithelial-mesenchymal transition and stem-like properties in gastric cells.Oncotarget. 2016 Jun 28;7(26):39279-39292. doi: 10.18632/oncotarget.9827.
• [1161] Identification of significant biomarkers and pathways associated with gastric carcinogenesis by whole genome-wide expression profiling analysis.Int J Oncol. 2018 Mar;52(3):955-966. doi: 10.3892/ijo.2018.4243. Epub 2018 Jan 11.
• [1162] miR?94BAG? axis is involved in cinobufaciniinduced cell proliferation and apoptosis in gastric cancer.Mol Med Rep. 2018 May;17(5):7435-7441. doi: 10.3892/mmr.2018.8788. Epub 2018 Mar 20.
• [1163] Bcl? associated athanogene 4 promotes proliferation, migration and invasion of gastric cancer cells.Mol Med Rep. 2017 Oct;16(4):3753-3760. doi: 10.3892/mmr.2017.7073. Epub 2017 Jul 21.
• [1164] BMP8B Is a Tumor Suppressor Gene Regulated by Histone Acetylation in Gastric Cancer.J Cell Biochem. 2017 Apr;118(4):869-877. doi: 10.1002/jcb.25766. Epub 2016 Nov 10.
• [1165] The microRNA-423-3p-Bim Axis Promotes Cancer Progression and Activates Oncogenic Autophagy in Gastric Cancer.Mol Ther. 2017 Apr 5;25(4):1027-1037. doi: 10.1016/j.ymthe.2017.01.013. Epub 2017 Feb 21.
• [1166] Inhibition of Bcl6b promotes gastric cancer by amplifying inflammation in mice.Cell Commun Signal. 2019 Jul 9;17(1):72. doi: 10.1186/s12964-019-0387-6.
• [1167] Expression of miR-30c and BCL-9 in gastric carcinoma tissues and their function in the development of gastric cancer.Oncol Lett. 2018 Aug;16(2):2416-2426. doi: 10.3892/ol.2018.8934. Epub 2018 Jun 8.
• [1168] The unfolded protein response is activated in Helicobacter-induced gastric carcinogenesis in a non-cell autonomous manner.Lab Invest. 2013 Jan;93(1):112-22. doi: 10.1038/labinvest.2012.131. Epub 2012 Oct 29.
• [1169] Expression of the ERBB Family of Ligands and Receptors in Gastric Cancer.Pathobiology. 2017;84(4):210-217. doi: 10.1159/000464250. Epub 2017 Apr 12.
• [1170] Basic Transcription Factor 3 Is Required for Proliferation and Epithelial-Mesenchymal Transition via Regulation of FOXM1 and JAK2/STAT3 Signaling in Gastric Cancer.Oncol Res. 2017 Nov 2;25(9):1453-1462. doi: 10.3727/096504017X14886494526344. Epub 2017 Mar 8.
• [1171] Exome Array Analysis Identifies Variants in SPOCD1 and BTN3A2 That Affect Risk for Gastric Cancer.Gastroenterology. 2017 Jun;152(8):2011-2021. doi: 10.1053/j.gastro.2017.02.017. Epub 2017 Feb 27.
• [1172] CAB39L elicited an anti-Warburg effect via a LKB1-AMPK-PGC1 axis to inhibit gastric tumorigenesis.Oncogene. 2018 Dec;37(50):6383-6398. doi: 10.1038/s41388-018-0402-1. Epub 2018 Jul 27.
• [1173] Quantitative global proteome and lysine succinylome analyses provide insights into metabolic regulation and lymph node metastasis in gastric cancer.Sci Rep. 2017 Feb 6;7:42053. doi: 10.1038/srep42053.
• [1174] Combination of platelet count and neutrophil-lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival in metastatic advanced gastric cancer.Biomark Med. 2017 Oct 26. doi: 10.2217/bmm-2016-0288. Online ahead of print.
• [1175] Association between Sumoylation-Related Gene rs77447679 Polymorphism and Risk of Gastric Cancer (GC) in a Chinese Population.J Cancer. 2017 Sep 15;8(16):3226-3231. doi: 10.7150/jca.20587. eCollection 2017.
• [1176] Inhibition of CCAR1, a Coactivator of -Catenin, Suppresses the Proliferation and Migration of Gastric Cancer Cells.Int J Mol Sci. 2017 Feb 21;18(2):460. doi: 10.3390/ijms18020460.
• [1177] Clinical Correlation Between WISP2 and -Catenin in Gastric Cancer.Anticancer Res. 2017 Aug;37(8):4469-4473. doi: 10.21873/anticanres.11842.
• [1178] Clinical significance and biological roles of cyclins in gastric cancer.Onco Targets Ther. 2018 Oct 9;11:6673-6685. doi: 10.2147/OTT.S171716. eCollection 2018.
• [1179] Utilization of invariant natural killer T cells for gastric cancer treatment.Future Oncol. 2018 Aug;14(20):2053-2066. doi: 10.2217/fon-2017-0724. Epub 2018 Jul 27.
• [1180] Altered NKp30, NKp46, NKG2D, and DNAM-1 Expression on Circulating NK Cells Is Associated with Tumor Progression in Human Gastric Cancer.J Immunol Res. 2018 Sep 3;2018:6248590. doi: 10.1155/2018/6248590. eCollection 2018.
• [1181] Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer.J Hematol Oncol. 2019 Feb 18;12(1):18. doi: 10.1186/s13045-019-0704-y.
• [1182] Targeting claudin-4 enhances CDDP-chemosensitivity in gastric cancer.Oncotarget. 2019 Mar 15;10(22):2189-2202. doi: 10.18632/oncotarget.26758. eCollection 2019 Mar 15.
• [1183] Development of a novel gene signature in patients without Helicobacter pylori infection gastric cancer.J Cell Biochem. 2020 Feb;121(2):1842-1854. doi: 10.1002/jcb.29419. Epub 2019 Oct 21.
• [1184] Hypermethylation of the CHRDL1 promoter induces proliferation and metastasis by activating Akt and Erk in gastric cancer.Oncotarget. 2017 Apr 4;8(14):23155-23166. doi: 10.18632/oncotarget.15513.
• [1185] CISD2 enhances the chemosensitivity of gastric cancer through the enhancement of 5-FU-induced apoptosis and the inhibition of autophagy by AKT/mTOR pathway.Cancer Med. 2017 Oct;6(10):2331-2346. doi: 10.1002/cam4.1169. Epub 2017 Aug 31.
• [1186] High Intratumoral Expression of Tetranectin Associates with Poor Prognosis of Patients with Gastric Cancer after Gastrectomy.J Cancer. 2017 Oct 9;8(17):3623-3630. doi: 10.7150/jca.19438. eCollection 2017.
• [1187] Prediction of three lipid derivatives for postoperative gastric cancer mortality: the Fujian prospective investigation of cancer (FIESTA) study.BMC Cancer. 2018 Aug 6;18(1):785. doi: 10.1186/s12885-018-4596-y.
• [1188] Transcriptional Regulatory Network Analysis for Gastric Cancer Based on mRNA Microarray.Pathol Oncol Res. 2017 Oct;23(4):785-791. doi: 10.1007/s12253-016-0159-1. Epub 2017 Jan 11.
• [1189] CREBRF promotes the proliferation of human gastric cancer cells via the AKT signaling pathway.Cell Mol Biol (Noisy-le-grand). 2018 Apr 30;64(5):40-45.
• [1190] Antibody-sandwich ELISA analysis of a novel blood biomarker of CST4 in gastrointestinal cancers.Onco Targets Ther. 2018 Mar 28;11:1743-1756. doi: 10.2147/OTT.S149204. eCollection 2018.
• [1191] CtBP2 overexpression promotes tumor cell proliferation and invasion in gastric cancer and is associated with poor prognosis.Oncotarget. 2017 Apr 25;8(17):28736-28749. doi: 10.18632/oncotarget.15661.
• [1192] Gastric Cancer Associated Genes Identified by an Integrative Analysis of Gene Expression Data.Biomed Res Int. 2017;2017:7259097. doi: 10.1155/2017/7259097. Epub 2017 Jan 23.
• [1193] miR-92b promotes gastric cancer growth by activating the DAB2IP-mediated PI3K/AKT signalling pathway.Cell Prolif. 2020 Jan;53(1):e12630. doi: 10.1111/cpr.12630. Epub 2019 Nov 12.
• [1194] Prognostic significance of Daxx NCR (Nuclear/Cytoplasmic Ratio) in gastric cancer.Cancer Med. 2017 Sep;6(9):2063-2075. doi: 10.1002/cam4.1144. Epub 2017 Aug 15.
• [1195] MicroRNA-17 inhibition overcomes chemoresistance and suppresses epithelial-mesenchymal transition through a DEDD-dependent mechanism in gastric cancer.Int J Biochem Cell Biol. 2018 Sep;102:59-70. doi: 10.1016/j.biocel.2018.06.007. Epub 2018 Jun 25.
• [1196] Distinct subgroup of the Ras family member 3 (DIRAS3) expression impairs metastasis and induces autophagy of gastric cancer cells in mice.J Cancer Res Clin Oncol. 2018 Oct;144(10):1869-1886. doi: 10.1007/s00432-018-2708-3. Epub 2018 Jul 24.
• [1197] Genomic alterations in BCL2L1 and DLC1 contribute to drug sensitivity in gastric cancer.Proc Natl Acad Sci U S A. 2015 Oct 6;112(40):12492-7. doi: 10.1073/pnas.1507491112. Epub 2015 Sep 23.
• [1198] Region-Specific Dok2 Overexpression Associates with Poor Prognosis in Human Astrocytoma.Mol Neurobiol. 2018 Jan;55(1):402-408. doi: 10.1007/s12035-016-0324-2. Epub 2016 Dec 14.
• [1199] DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia.Cancer Med. 2019 Oct;8(14):6393-6402. doi: 10.1002/cam4.2540. Epub 2019 Sep 4.
• [1200] Pharmacological inhibition of DUSP6 suppresses gastric cancer growth and metastasis and overcomes cisplatin resistance.Cancer Lett. 2018 Jan 1;412:243-255. doi: 10.1016/j.canlet.2017.10.007. Epub 2017 Oct 16.
• [1201] miRNA-34a enhances the sensitivity of gastric cancer cells to treatment with paclitaxel by targeting E2F5.Oncol Lett. 2017 Jun;13(6):4837-4842. doi: 10.3892/ol.2017.6041. Epub 2017 Apr 18.
• [1202] Trastuzumab-Based Photoimmunotherapy Integrated with Viral HER2 Transduction Inhibits Peritoneally Disseminated HER2-Negative Cancer.Mol Cancer Ther. 2016 Mar;15(3):402-11. doi: 10.1158/1535-7163.MCT-15-0644. Epub 2016 Feb 1.
• [1203] miR?06 inhibits cancer initiating cells by targeting EHF in gastric cancer.Oncol Rep. 2017 Sep;38(3):1688-1694. doi: 10.3892/or.2017.5794. Epub 2017 Jul 6.
• [1204] High expression of eIF3d is associated with poor prognosis in patients with gastric cancer.Cancer Manag Res. 2017 Oct 25;9:539-544. doi: 10.2147/CMAR.S142324. eCollection 2017.
• [1205] Eukaryotic translation initiation factor EIF3H potentiates gastric carcinoma cell proliferation.Tissue Cell. 2018 Aug;53:23-29. doi: 10.1016/j.tice.2018.05.006. Epub 2018 May 8.
• [1206] Impact of a Eukaryotic Translation Initiation Factor 3a Polymorphism on Susceptibility to Gastric Cancer.Med Princ Pract. 2016;25(5):461-5. doi: 10.1159/000447741. Epub 2016 Jun 22.
• [1207] Pharmacogenetic variants associated with outcome in patients with advanced gastric cancer treated with fluoropyrimidine and platinum-based triplet combinations: a pooled analysis of three prospective studies.Pharmacogenomics J. 2017 Oct;17(5):441-451. doi: 10.1038/tpj.2016.81. Epub 2016 Dec 20.
• [1208] Prognostic Value of Excision Repair Cross-Complementing mRNA Expression in Gastric Cancer.Biomed Res Int. 2018 Oct 17;2018:6204684. doi: 10.1155/2018/6204684. eCollection 2018.
• [1209] Detection and clinical significance of DNA repair gene ERCC8 tag SNPs in gastric cancer.Turk J Gastroenterol. 2018 Jul;29(4):392-396. doi: 10.5152/tjg.2018.17662.
• [1210] Expression of ERO1L in gastric cancer and its association with patient prognosis.Exp Ther Med. 2017 Sep;14(3):2298-2302. doi: 10.3892/etm.2017.4782. Epub 2017 Jul 11.
• [1211] ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway.BMC Cancer. 2017 Sep 6;17(1):626. doi: 10.1186/s12885-017-3613-x.
• [1212] Aurora kinase A regulates Survivin stability through targeting FBXL7 in gastric cancer drug resistance and prognosis.Oncogenesis. 2017 Feb 20;6(2):e298. doi: 10.1038/oncsis.2016.80.
• [1213] EZH2 contributes to 5-FU resistance in gastric cancer by epigenetically suppressing FBXO32 expression.Onco Targets Ther. 2018 Nov 5;11:7853-7864. doi: 10.2147/OTT.S180131. eCollection 2018.
• [1214] Fibrinogenlikeprotein 1 promotes the invasion and metastasis of gastric cancer and is associated with poor prognosis.Mol Med Rep. 2018 Aug;18(2):1465-1472. doi: 10.3892/mmr.2018.9097. Epub 2018 May 29.
• [1215] Characteristic expression of fukutin in gastric cancer among atomic bomb survivors.Oncol Lett. 2017 Feb;13(2):937-941. doi: 10.3892/ol.2016.5520. Epub 2016 Dec 20.
• [1216] Testin and filamin-C downregulation by acetylated Siah2 increases invasiveness of Helicobacter pylori-infected gastric cancer cells.Int J Biochem Cell Biol. 2018 Oct;103:14-24. doi: 10.1016/j.biocel.2018.07.012. Epub 2018 Jul 29.
• [1217] MicroRNA-187 promotes growth and metastasis of gastric cancer by inhibiting FOXA2.Oncol Rep. 2017 Mar;37(3):1747-1755. doi: 10.3892/or.2017.5370. Epub 2017 Jan 16.
• [1218] Prognostic impact of FOXF1 polymorphisms in gastric cancer patients.Pharmacogenomics J. 2018 Apr;18(2):262-269. doi: 10.1038/tpj.2017.9. Epub 2017 Apr 11.
• [1219] miR-491-5p, mediated by Foxi1, functions as a tumor suppressor by targeting Wnt3a/-catenin signaling in the development of gastric cancer.Cell Death Dis. 2017 Mar 30;8(3):e2714. doi: 10.1038/cddis.2017.134.
• [1220] MicroRNA-6852 suppresses cell proliferation and invasion via targeting forkhead box J1 in gastric cancer.Exp Ther Med. 2018 Oct;16(4):3249-3255. doi: 10.3892/etm.2018.6569. Epub 2018 Aug 2.
• [1221] MiR-1-3p suppresses cell proliferation and invasion and targets STC2 in gastric cancer.Eur Rev Med Pharmacol Sci. 2019 Oct;23(20):8870-8877. doi: 10.26355/eurrev_201910_19282.
• [1222] MiR-16-1 Targeted Silences Far Upstream Element Binding Protein 1 to Advance the Chemosensitivity to Adriamycin in Gastric Cancer.Pathol Oncol Res. 2018 Jul;24(3):483-488. doi: 10.1007/s12253-017-0263-x. Epub 2017 Jun 30.
• [1223] Digital PCR identifies changes in CDH1 (E-cadherin) transcription pattern in intestinal-type gastric cancer.Oncotarget. 2017 Mar 21;8(12):18811-18820. doi: 10.18632/oncotarget.13401.
• [1224] GALNT5 uaRNA promotes gastric cancer progression through its interaction with HSP90.Oncogene. 2018 Aug;37(33):4505-4517. doi: 10.1038/s41388-018-0266-4. Epub 2018 May 10.
• [1225] Loss of GFAT1 promotes epithelial-to-mesenchymal transition and predicts unfavorable prognosis in gastric cancer.Oncotarget. 2016 Jun 21;7(25):38427-39. doi: 10.18632/oncotarget.9538.
• [1226] GPR155 Serves as a Predictive Biomarker for Hematogenous Metastasis in Patients with Gastric Cancer.Sci Rep. 2017 Feb 6;7:42089. doi: 10.1038/srep42089.
• [1227] GPX3 hypermethylation in gastric cancer and its prognostic value in patients aged over 60.Future Oncol. 2019 Apr;15(11):1279-1289. doi: 10.2217/fon-2018-0674. Epub 2019 Mar 29.
• [1228] GRAM domain-containing protein 1B (GRAMD1B), a novel component of the JAK/STAT signaling pathway, functions in gastric carcinogenesis.Oncotarget. 2017 Dec 15;8(70):115370-115383. doi: 10.18632/oncotarget.23265. eCollection 2017 Dec 29.
• [1229] Downregulation of gasdermin D promotes gastric cancer proliferation by regulating cell cycle-related proteins.J Dig Dis. 2018 Feb;19(2):74-83. doi: 10.1111/1751-2980.12576.
• [1230] GSDME mediates caspase-3-dependent pyroptosis in gastric cancer.Biochem Biophys Res Commun. 2018 Jan 1;495(1):1418-1425. doi: 10.1016/j.bbrc.2017.11.156. Epub 2017 Nov 26.
• [1231] The role of miR-144/GSPT1 axis in gastric cancer.Eur Rev Med Pharmacol Sci. 2018 Jul;22(13):4138-4145. doi: 10.26355/eurrev_201807_15406.
• [1232] Glutathione S-transferase M1 null genotype meta-analysis on gastric cancer risk.Diagn Pathol. 2014 Jun 19;9:122. doi: 10.1186/1746-1596-9-122.
• [1233] HNRNPK inhibits gastric cancer cell proliferation through p53/p21/CCND1 pathway.Oncotarget. 2017 Oct 17;8(61):103364-103374. doi: 10.18632/oncotarget.21873. eCollection 2017 Nov 28.
• [1234] HOXA10 deteriorates gastric cancer through activating JAK1/STAT3 signaling pathway.Cancer Manag Res. 2019 Jul 15;11:6625-6635. doi: 10.2147/CMAR.S201342. eCollection 2019.
• [1235] IGF1/IGF1R/STAT3 signaling-inducible IFITM2 promotes gastric cancer growth and metastasis.Cancer Lett. 2017 May 1;393:76-85. doi: 10.1016/j.canlet.2017.02.014. Epub 2017 Feb 20.
• [1236] IGF2BP3 functions as a potential oncogene and is a crucial target of miR-34a in gastric carcinogenesis.Mol Cancer. 2017 Apr 11;16(1):77. doi: 10.1186/s12943-017-0647-2.
• [1237] IL-17B activated mesenchymal stem cells enhance proliferation and migration of gastric cancer cells.Oncotarget. 2017 Mar 21;8(12):18914-18923. doi: 10.18632/oncotarget.14835.
• [1238] Expression and Clinical Significance of ILF2 in Gastric Cancer.Dis Markers. 2017;2017:4387081. doi: 10.1155/2017/4387081. Epub 2017 Jul 31.
• [1239] MAEL contributes to gastric cancer progression by promoting ILKAP degradation.Oncotarget. 2017 Dec 6;8(69):113331-113344. doi: 10.18632/oncotarget.22970. eCollection 2017 Dec 26.
• [1240] FAM196B acts as oncogene and promotes proliferation of gastric cancer cells through AKT signaling pathway.Cell Mol Biol (Noisy-le-grand). 2017 Sep 30;63(9):18-23. doi: 10.14715/cmb/2017.63.9.4.
• [1241] Protein arginine methyltransferase 5-mediated epigenetic silencing of IRX1 contributes to tumorigenicity and metastasis of gastric cancer.Biochim Biophys Acta Mol Basis Dis. 2018 Sep;1864(9 Pt B):2835-2844. doi: 10.1016/j.bbadis.2018.05.015. Epub 2018 May 23.
• [1242] ITGBL1 Predicts a Poor Prognosis and Correlates EMT Phenotype in Gastric Cancer.J Cancer. 2017 Oct 17;8(18):3764-3773. doi: 10.7150/jca.20900. eCollection 2017.
• [1243] Overexpression of KIFC1 and its association with spheroid formation in esophageal squamous cell carcinoma.Pathol Res Pract. 2017 Nov;213(11):1388-1393. doi: 10.1016/j.prp.2017.09.009. Epub 2017 Sep 12.
• [1244] LncRNA TTN-AS1 contributes to gastric cancer progression by acting as a competing endogenous RNA of miR-376b-3p.Neoplasma. 2019 Jul 23;66(4):564-575. doi: 10.4149/neo_2018_180927N721. Epub 2019 Mar 30.
• [1245] KLF15 Inhibits Cell Proliferation in Gastric Cancer Cells via Up-Regulating CDKN1A/p21 and CDKN1C/p57 Expression.Dig Dis Sci. 2017 Jun;62(6):1518-1526. doi: 10.1007/s10620-017-4558-2. Epub 2017 Apr 18.
• [1246] Krppel-Like Factor 7 is a Marker of Aggressive Gastric Cancer and Poor Prognosis.Cell Physiol Biochem. 2017;43(3):1090-1099. doi: 10.1159/000481748. Epub 2017 Oct 5.
• [1247] Downregulation of KMT2D suppresses proliferation and induces apoptosis of gastric cancer.Biochem Biophys Res Commun. 2018 Sep 26;504(1):129-136. doi: 10.1016/j.bbrc.2018.08.143. Epub 2018 Sep 1.
• [1248] LAMA4 expression is activated by zinc finger Eboxbinding homeobox1 and independently predicts poor overall survival in gastric cancer.Oncol Rep. 2018 Sep;40(3):1725-1733. doi: 10.3892/or.2018.6564. Epub 2018 Jul 12.
• [1249] Clinical significance of LMO1 in gastric cancer tissue and its association with apoptosis of cancer cells.Oncol Lett. 2017 Dec;14(6):6511-6518. doi: 10.3892/ol.2017.7102. Epub 2017 Sep 28.
• [1250] Significance of the Lysyl Oxidase Members Lysyl Oxidase Like 1, 3, and 4 in Gastric Cancer.Digestion. 2018;98(4):238-248. doi: 10.1159/000489558. Epub 2018 Jul 25.
• [1251] Lumican expression in gastric cancer and its association with biological behavior and prognosis.Oncol Lett. 2017 Nov;14(5):5235-5240. doi: 10.3892/ol.2017.6842. Epub 2017 Aug 28.
• [1252] MiR-30c-5p suppresses migration, invasion and epithelial to mesenchymal transition of gastric cancer via targeting MTA1.Biomed Pharmacother. 2017 Sep;93:554-560. doi: 10.1016/j.biopha.2017.06.084. Epub 2017 Jul 4.
• [1253] Mastl overexpression is associated with epithelial to mesenchymal transition and predicts a poor clinical outcome in gastric cancer.Oncol Lett. 2017 Dec;14(6):7283-7287. doi: 10.3892/ol.2017.7155. Epub 2017 Oct 10.
• [1254] Flavonoids and the Risk of Gastric Cancer: An Exploratory Case-Control Study in the MCC-Spain Study.Nutrients. 2019 Apr 27;11(5):967. doi: 10.3390/nu11050967.
• [1255] MED30 Regulates the Proliferation and Motility of Gastric Cancer Cells.PLoS One. 2015 Jun 25;10(6):e0130826. doi: 10.1371/journal.pone.0130826. eCollection 2015.
• [1256] Overexpression of Mitochondrial GTPase MFN2 Represents a Negative Prognostic Marker in Human Gastric Cancer and Its Inhibition Exerts Anti-Cancer Effects.J Cancer. 2017 Apr 9;8(7):1153-1161. doi: 10.7150/jca.17986. eCollection 2017.
• [1257] Inactivation of Capicua drives cancer metastasis.Nat Genet. 2017 Jan;49(1):87-96. doi: 10.1038/ng.3728. Epub 2016 Nov 21.
• [1258] Muscle RAS oncogene homolog (MRAS) recurrent mutation in Borrmann type IV gastric cancer.Cancer Med. 2017 Jan;6(1):235-244. doi: 10.1002/cam4.959. Epub 2016 Nov 28.
• [1259] LncRNA SNHG17 promotes gastric cancer progression by epigenetically silencing of p15 and p57.J Cell Physiol. 2019 Apr;234(4):5163-5174. doi: 10.1002/jcp.27320. Epub 2018 Sep 6.
• [1260] miR-205 regulation of ICT1 has an oncogenic potential via promoting the migration and invasion of gastric cancer cells.Biomed Pharmacother. 2017 Dec;96:191-197. doi: 10.1016/j.biopha.2017.09.147. Epub 2017 Oct 6.
• [1261] Decreased long non-coding RNA MTM contributes to gastric cancer cell migration and invasion via modulating MT1F.Oncotarget. 2017 Oct 26;8(57):97371-97383. doi: 10.18632/oncotarget.22126. eCollection 2017 Nov 14.
• [1262] MDM2 binding protein as a predictor of metastasis and a novel prognostic biomarker in patients with gastric cancer.Oncol Lett. 2017 Dec;14(6):6409-6416. doi: 10.3892/ol.2017.7031. Epub 2017 Sep 22.
• [1263] Metastasis suppressor protein 1 regulated by PTEN suppresses invasion, migration, and EMT of gastric carcinoma by inactivating PI3K/AKT signaling.J Cell Biochem. 2019 Mar;120(3):3447-3454. doi: 10.1002/jcb.27618. Epub 2018 Sep 23.
• [1264] Overexpression of KIF11 in Gastric Cancer with Intestinal Mucin Phenotype.Pathobiology. 2017;84(1):16-24. doi: 10.1159/000447303. Epub 2016 Jul 27.
• [1265] Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer.Nat Genet. 2014 Jun;46(6):573-82. doi: 10.1038/ng.2983. Epub 2014 May 11.
• [1266] LncRNA HULC promotes the progression of gastric cancer by regulating miR-9-5p/MYH9 axis.Biomed Pharmacother. 2020 Jan;121:109607. doi: 10.1016/j.biopha.2019.109607. Epub 2019 Nov 11.
• [1267] microRNA-29c inhibits cell proliferation by targeting NASP in human gastric cancer.BMC Cancer. 2017 Feb 7;17(1):109. doi: 10.1186/s12885-017-3096-9.
• [1268] Identification and functional annotation of metabolism-associated lncRNAs and their related protein-coding genes in gastric cancer.Mol Genet Genomic Med. 2018 Sep;6(5):728-738. doi: 10.1002/mgg3.427. Epub 2018 Jul 10.
• [1269] LncRNA CTC-497E21.4 promotes the progression of gastric cancer via modulating miR-22/NET1 axis through RhoA signaling pathway.Gastric Cancer. 2020 Mar;23(2):228-240. doi: 10.1007/s10120-019-00998-w. Epub 2019 Aug 26.
• [1270] NETO2 promotes invasion and metastasis of gastric cancer cells via activation of PI3K/Akt/NF-B/Snail axis and predicts outcome of the patients.Cell Death Dis. 2019 Feb 15;10(3):162. doi: 10.1038/s41419-019-1388-5.
• [1271] Bapx1 mediates transforming growth factor-- induced epithelial-mesenchymal transition and promotes a malignancy phenotype of gastric cancer cells.Biochem Biophys Res Commun. 2017 Apr 29;486(2):285-292. doi: 10.1016/j.bbrc.2017.03.029. Epub 2017 Mar 14.
• [1272] Probabilistic natural mapping of gene-level tests for genome-wide association studies.Brief Bioinform. 2018 Jul 20;19(4):545-553. doi: 10.1093/bib/bbx002.
• [1273] Implications of NOVA1 suppression within the microenvironment of gastric cancer: association with immune cell dysregulation.Gastric Cancer. 2017 May;20(3):438-447. doi: 10.1007/s10120-016-0623-3. Epub 2016 Jun 18.
• [1274] Identification and Characterization of a Novel NADPH Oxidase 1 (Nox1) Inhibitor That Suppresses Proliferation of Colon and Stomach Cancer Cells.Biol Pharm Bull. 2018 Mar 1;41(3):419-426. doi: 10.1248/bpb.b17-00804. Epub 2017 Dec 22.
• [1275] Oxysterol-Binding Protein-Related Protein 8 Inhibits Gastric Cancer Growth Through Induction of ER Stress, Inhibition of Wnt Signaling, and Activation of Apoptosis.Oncol Res. 2017 May 24;25(5):799-808. doi: 10.3727/096504016X14783691306605. Epub 2016 Nov 8.
• [1276] Upregulation of the Non-Coding RNA OTUB1-isoform 2 Contributes to Gastric Cancer Cell Proliferation and Invasion and Predicts Poor Gastric Cancer Prognosis.Int J Biol Sci. 2016 Mar 3;12(5):545-57. doi: 10.7150/ijbs.13540. eCollection 2016.
• [1277] Dowregulation of OTX1 attenuates gastric cancer cell proliferation, migration and invasion.Oncol Rep. 2018 Oct;40(4):1907-1916. doi: 10.3892/or.2018.6596. Epub 2018 Jul 24.
• [1278] Prognostic value of hypoxia-inducible factor-1 alpha and prolyl 4-hydroxylase beta polypeptide overexpression in gastric cancer.World J Gastroenterol. 2018 Jun 14;24(22):2381-2391. doi: 10.3748/wjg.v24.i22.2381.
• [1279] High expression of P21-activated kinase 5 protein is associated with poor survival in gastric cancer.Oncol Lett. 2017 Jul;14(1):404-410. doi: 10.3892/ol.2017.6115. Epub 2017 May 3.
• [1280] Meta-analysis of genome-wide association studies and functional assays decipher susceptibility genes for gastric cancer in Chinese populations.Gut. 2020 Apr;69(4):641-651. doi: 10.1136/gutjnl-2019-318760. Epub 2019 Aug 5.
• [1281] Expression of both poly r(C) binding protein 1 (PCBP1) and miRNA-3978 is suppressed in peritoneal gastric cancer metastasis.Sci Rep. 2017 Nov 14;7(1):15488. doi: 10.1038/s41598-017-15448-9.
• [1282] Downregulated PITX1 Modulated by MiR-19a-3p Promotes Cell Malignancy and Predicts a Poor Prognosis of Gastric Cancer by Affecting Transcriptionally Activated PDCD5.Cell Physiol Biochem. 2018;46(6):2215-2231. doi: 10.1159/000489590. Epub 2018 May 3.
• [1283] Role of the PEBP4 protein in the development and metastasis of gastric cancer.Oncotarget. 2017 Mar 14;8(11):18177-18184. doi: 10.18632/oncotarget.15255.
• [1284] Multi-disciplinary team for early gastric cancer diagnosis improves the detection rate of early gastric cancer.BMC Gastroenterol. 2017 Dec 6;17(1):147. doi: 10.1186/s12876-017-0711-9.
• [1285] Downregulation of Piwil3 suppresses cell proliferation, migration and invasion in gastric cancer.Cancer Biomark. 2017 Dec 6;20(4):499-509. doi: 10.3233/CBM-170324.
• [1286] The pseudogene derived long noncoding RNA DUXAP8 promotes gastric cancer cell proliferation and migration via epigenetically silencing PLEKHO1 expression.Oncotarget. 2016 Aug 5;8(32):52211-52224. doi: 10.18632/oncotarget.11075. eCollection 2017 Aug 8.
• [1287] Isoprenaline/2-AR activates Plexin-A1/VEGFR2 signals via VEGF secretion in gastric cancer cells to promote tumor angiogenesis.BMC Cancer. 2017 Dec 20;17(1):875. doi: 10.1186/s12885-017-3894-0.
• [1288] miR-509-3-5P inhibits the invasion and lymphatic metastasis by targeting PODXL and serves as a novel prognostic indicator for gastric cancer.Oncotarget. 2017 May 23;8(21):34867-34883. doi: 10.18632/oncotarget.16802.
• [1289] POU2F2-oriented network promotes human gastric cancer metastasis.Gut. 2016 Sep;65(9):1427-38. doi: 10.1136/gutjnl-2014-308932. Epub 2015 May 27.
• [1290] AMPK phosphatase Ppm1E upregulation in human gastric cancer is required for cell proliferation.Oncotarget. 2017 May 9;8(19):31288-31296. doi: 10.18632/oncotarget.16126.
• [1291] Role of Kruppel-like factor 4 in regulating inhibitor of apoptosis-stimulating protein of p53 in the progression of gastric cancer.Oncol Lett. 2018 May;15(5):6865-6872. doi: 10.3892/ol.2018.8203. Epub 2018 Mar 7.
• [1292] Arginine methyltransferase inhibitor 1 inhibits gastric cancer by downregulating eIF4E and targeting PRMT5.Toxicol Appl Pharmacol. 2017 Dec 1;336:1-7. doi: 10.1016/j.taap.2017.10.002. Epub 2017 Oct 4.
• [1293] Downregulation of PPP2R5E expression by miR-23a suppresses apoptosis to facilitate the growth of gastric cancer cells.FEBS Lett. 2014 Aug 25;588(17):3160-9. doi: 10.1016/j.febslet.2014.05.068. Epub 2014 Jul 2.
• [1294] Elevated PRC1 in gastric carcinoma exerts oncogenic function and is targeted by piperlongumine in a p53-dependent manner.J Cell Mol Med. 2017 Jul;21(7):1329-1341. doi: 10.1111/jcmm.13063. Epub 2017 Feb 12.
• [1295] Proline-Rich Protein 11 Regulates Self-Renewal and Tumorigenicity of Gastric Cancer Stem Cells.Cell Physiol Biochem. 2018;47(4):1721-1728. doi: 10.1159/000491005. Epub 2018 Jul 13.
• [1296] Effects of taxol resistance gene 1 on the cisplatin response in gastric cancer.Oncol Lett. 2018 Jun;15(6):8287-8294. doi: 10.3892/ol.2018.8390. Epub 2018 Mar 30.
• [1297] PTBP3 contributes to the metastasis of gastric cancer by mediating CAV1 alternative splicing.Cell Death Dis. 2018 May 1;9(5):569. doi: 10.1038/s41419-018-0608-8.
• [1298] CD155T/TIGIT Signaling Regulates CD8(+) T-cell Metabolism and Promotes Tumor Progression in Human Gastric Cancer.Cancer Res. 2017 Nov 15;77(22):6375-6388. doi: 10.1158/0008-5472.CAN-17-0381. Epub 2017 Sep 7.
• [1299] Inhibition of the miR-192/215-Rab11-FIP2 axis suppresses human gastric cancer progression.Cell Death Dis. 2018 Jul 13;9(7):778. doi: 10.1038/s41419-018-0785-5.
• [1300] Upregulation of miR-802 suppresses gastric cancer oncogenicity via targeting RAB23 expression.Eur Rev Med Pharmacol Sci. 2017 Sep;21(18):4071-4078.
• [1301] RAB32 hypermethylation and microsatellite instability in gastric and endometrial adenocarcinomas.Int J Cancer. 2006 Aug 15;119(4):801-6. doi: 10.1002/ijc.21912.
• [1302] Promotion of Cell Proliferation through Inhibition of Cell Autophagy Signalling Pathway by Rab3IP is Restrained by MicroRNA-532-3p in Gastric Cancer.J Cancer. 2018 Oct 22;9(23):4363-4373. doi: 10.7150/jca.27533. eCollection 2018.
• [1303] Reduced RanBPM Expression Is Associated with Distant Metastasis in Gastric Cancer and Chemoresistance.Anticancer Res. 2016 Mar;36(3):1295-303.
• [1304] Quantitative assessment of gene methylation in neoplastic and non-neoplastic gastric epithelia using methylation-specific DNA microarray.Pathol Int. 2009 Dec;59(12):895-9. doi: 10.1111/j.1440-1827.2009.02458.x.
• [1305] miR-181a-5p promotes the progression of gastric cancer via RASSF6-mediated MAPK signalling activation.Cancer Lett. 2017 Mar 28;389:11-22. doi: 10.1016/j.canlet.2016.12.033. Epub 2016 Dec 30.
• [1306] Down regulation of RNA binding motif, single-stranded interacting protein 3, along with up regulation of nuclear HIF1A correlates with poor prognosis in patients with gastric cancer.Oncotarget. 2017 Jan 3;8(1):1262-1277. doi: 10.18632/oncotarget.13605.
• [1307] Regulator of G-protein signaling 3 targeted by miR-126 correlates with poor prognosis in gastric cancer patients.Anticancer Drugs. 2017 Feb;28(2):161-169. doi: 10.1097/CAD.0000000000000446.
• [1308] Upregulation and secretion of macrophage inhibitory cytokine-1 (MIC-1) in gastric cancers.Clin Chim Acta. 2009 Mar;401(1-2):128-33. doi: 10.1016/j.cca.2008.12.008. Epub 2008 Dec 14.
• [1309] Correlations between gastric cancer family history and ROBO2 and RASSF2A gene methylations.J Cancer Res Ther. 2016 Apr-Jun;12(2):597-600. doi: 10.4103/0973-1482.146089.
• [1310] Inhibition of CREPT restrains gastric cancer growth by regulation of cycle arrest, migration and apoptosis via ROS-regulated p53 pathway.Biochem Biophys Res Commun. 2018 Feb 19;496(4):1183-1190. doi: 10.1016/j.bbrc.2018.01.167. Epub 2018 Jan 31.
• [1311] Interplay between human nucleolar GNL1 and RPS20 is critical to modulate cell proliferation.Sci Rep. 2018 Jul 30;8(1):11421. doi: 10.1038/s41598-018-29802-y.
• [1312] Calcium-binding protein S100A14 induces differentiation and suppresses metastasis in gastric cancer.Cell Death Dis. 2017 Jul 20;8(7):e2938. doi: 10.1038/cddis.2017.297.
• [1313] Downregulated SASH1 expression indicates poor clinical prognosis in gastric cancer.Hum Pathol. 2018 Apr;74:83-91. doi: 10.1016/j.humpath.2018.01.008. Epub 2018 Jan 7.
• [1314] Hypomethylation of repetitive elements in blood leukocyte DNA and risk of gastric lesions in a Chinese population.Cancer Epidemiol. 2016 Apr;41:122-8. doi: 10.1016/j.canep.2016.02.004. Epub 2016 Mar 1.
• [1315] Scinderin promotes the invasion and metastasis of gastric cancer cells and predicts the outcome of patients.Cancer Lett. 2016 Jun 28;376(1):110-7. doi: 10.1016/j.canlet.2016.03.035. Epub 2016 Mar 24.
• [1316] Status of c-erbB-2 in gastric adenocarcinoma: a comparative study of immunohistochemistry, fluorescence in situ hybridization and enzyme-linked immuno-sorbent assay.Int J Cancer. 2002 Apr 20;98(6):833-7. doi: 10.1002/ijc.10257.
• [1317] Juxtaposed genes in 7q21-22 amplicon contribute for two major gastric cancer sub-Types by mutual exclusive expression.Mol Carcinog. 2017 Apr;56(4):1239-1250. doi: 10.1002/mc.22586. Epub 2016 Nov 15.
• [1318] Helicobacter pylori-induced modulation of the promoter methylation of Wnt antagonist genes in gastric carcinogenesis.Gastric Cancer. 2018 Mar;21(2):237-248. doi: 10.1007/s10120-017-0741-6. Epub 2017 Jun 22.
• [1319] Tumor suppressor microRNA-31 inhibits gastric carcinogenesis by targeting Smad4 and SGPP2.Cancer Gene Ther. 2015 Dec;22(12):564-72. doi: 10.1038/cgt.2015.41. Epub 2015 Oct 23.
• [1320] Sex hormone-binding globulin (SHBG) is a potential early diagnostic biomarker for gastric cancer.Cancer Med. 2018 Jan;7(1):64-74. doi: 10.1002/cam4.1254. Epub 2017 Nov 17.
• [1321] Dynamic relationship between SIPA1 gene and protein expression and the development of gastric cancer.Genet Mol Res. 2017 Mar 16;16(1). doi: 10.4238/gmr16019271.
• [1322] SIX1 is upregulated in gastric cancer and regulates proliferation and invasion by targeting the ERK pathway and promoting epithelial-mesenchymal transition.Cell Biochem Funct. 2018 Dec;36(8):413-419. doi: 10.1002/cbf.3361. Epub 2018 Oct 31.
• [1323] SCHLAFEN 5 expression correlates with intestinal metaplasia that progresses to gastric cancer.J Gastroenterol. 2017 Jan;52(1):39-49. doi: 10.1007/s00535-016-1202-4. Epub 2016 Mar 31.
• [1324] SLPI promotes the gastric cancer growth and metastasis by regulating the expression of P53, Bcl-2 and Caspase-8.Eur Rev Med Pharmacol Sci. 2017 Apr;21(7):1495-1501.
• [1325] Gastric cancer and paraneoplastic dermatomyositis as complications of an unrecognized juvenile polyposis syndrome.Z Gastroenterol. 2019 Apr;57(4):497-500. doi: 10.1055/a-0855-4404. Epub 2019 Mar 14.
• [1326] DNA methylation contributes to silencing the expression of linc00086 in gastric cancer.Oncol Lett. 2018 Aug;16(2):1931-1936. doi: 10.3892/ol.2018.8868. Epub 2018 Jun 1.
• [1327] SNRPA enhances tumour cell growth in gastric cancer through modulating NGF expression.Cell Prolif. 2018 Oct;51(5):e12484. doi: 10.1111/cpr.12484. Epub 2018 Jul 24.
• [1328] BMX-ARHGAP fusion protein maintains the tumorigenicity of gastric cancer stem cells by activating the JAK/STAT3 signaling pathway.Cancer Cell Int. 2019 May 17;19:133. doi: 10.1186/s12935-019-0847-5. eCollection 2019.
• [1329] Circular RNA circ-DONSON facilitates gastric cancer growth and invasion via NURF complex dependent activation of transcription factor SOX4.Mol Cancer. 2019 Mar 28;18(1):45. doi: 10.1186/s12943-019-1006-2.
• [1330] miR-221 and miR-222 synergistically regulate hepatocyte growth factor activator inhibitor type 1 to promote cell proliferation and migration in gastric cancer.Tumour Biol. 2017 Jun;39(6):1010428317701636. doi: 10.1177/1010428317701636.
• [1331] miRNA-543 promotes cell migration and invasion by targeting SPOP in gastric cancer.Onco Targets Ther. 2018 Aug 21;11:5075-5082. doi: 10.2147/OTT.S161316. eCollection 2018.
• [1332] MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2.Cell Physiol Biochem. 2018;47(4):1465-1481. doi: 10.1159/000490839. Epub 2018 Jun 21.
• [1333] Increasing HER2 2,6 sialylation facilitates gastric cancer progression and resistance via the Akt and ERK pathways.Oncol Rep. 2018 Nov;40(5):2997-3005. doi: 10.3892/or.2018.6680. Epub 2018 Aug 31.
• [1334] Stress-inducible Protein-1 promotes metastasis of gastric cancer via Wnt/-catenin signaling pathway.J Exp Clin Cancer Res. 2018 Jan 15;37(1):6. doi: 10.1186/s13046-018-0676-8.
• [1335] MiRNA-194 activates the Wnt/-catenin signaling pathway in gastric cancer by targeting the negative Wnt regulator, SUFU.Cancer Lett. 2017 Jan 28;385:117-127. doi: 10.1016/j.canlet.2016.10.035. Epub 2016 Oct 31.
• [1336] SUMO-1 Gene Silencing Inhibits Proliferation and Promotes Apoptosis of Human Gastric Cancer SGC-7901 Cells.Cell Physiol Biochem. 2017;41(3):987-998. doi: 10.1159/000460836. Epub 2017 Feb 21.
• [1337] Ubiquitin-specific protease 3 promotes cell migration and invasion by interacting with and deubiquitinating SUZ12 in gastric cancer.J Exp Clin Cancer Res. 2019 Jun 24;38(1):277. doi: 10.1186/s13046-019-1270-4.
• [1338] Systemic immune-inflammation index as a useful prognostic indicator predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy.Cancer Manag Res. 2017 Dec 14;9:849-867. doi: 10.2147/CMAR.S151026. eCollection 2017.
• [1339] TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis.Oncogene. 2017 Nov 23;36(47):6518-6530. doi: 10.1038/onc.2017.257. Epub 2017 Jul 31.
• [1340] TES functions as a Mena-dependent tumor suppressor in gastric cancer carcinogenesis and metastasis.Cancer Commun (Lond). 2019 Feb 6;39(1):3. doi: 10.1186/s40880-019-0347-y.
• [1341] miR-144 suppresses cell proliferation and invasion in gastric cancer through downregulation of activating enhancer-binding protein 4.Oncol Lett. 2019 Jun;17(6):5686-5692. doi: 10.3892/ol.2019.10214. Epub 2019 Apr 4.
• [1342] MicroRNA-140-5p inhibits cell proliferation, migration and promotes cell apoptosis in gastric cancer through the negative regulation of THY1-mediated Notch signaling.Biosci Rep. 2019 Jul 23;39(7):BSR20181434. doi: 10.1042/BSR20181434. Print 2019 Jul 31.
• [1343] High expression of mitochondrial intermembrane chaperone TIMM9 represents a negative prognostic marker in gastric cancer.J Formos Med Assoc. 2017 Jun;116(6):476-483. doi: 10.1016/j.jfma.2016.08.007. Epub 2016 Oct 6.
• [1344] Polymorphisms at Locus 4p14 of Toll-Like Receptors TLR-1 and TLR-10 Confer Susceptibility to Gastric Carcinoma in Helicobacter pylori Infection.PLoS One. 2015 Nov 11;10(11):e0141865. doi: 10.1371/journal.pone.0141865. eCollection 2015.
• [1345] MicroRNA-9 inhibits the gastric cancer cell proliferation by targeting TNFAIP8.Cell Prolif. 2017 Apr;50(2):e12331. doi: 10.1111/cpr.12331. Epub 2017 Jan 27.
• [1346] DcR3 induces proliferation, migration, invasion, and EMT in gastric cancer cells via the PI3K/AKT/GSK-3/-catenin signaling pathway.Onco Targets Ther. 2018 Jul 19;11:4177-4187. doi: 10.2147/OTT.S172713. eCollection 2018.
• [1347] Difference of p53AIP1 mRNA expression in gastric mucosa between patients with gastric cancer and chronic gastritis infected with Helicobacter pylori.J Clin Gastroenterol. 2008 Apr;42(4):351-5. doi: 10.1097/MCG.0b013e318054493e.
• [1348] Global gene expression analysis of knockdown Triosephosphate isomerase (TPI) gene in human gastric cancer cell line MGC-803.Gene. 2018 Mar 20;647:61-72. doi: 10.1016/j.gene.2018.01.014. Epub 2018 Jan 5.
• [1349] EBV down-regulates COX-2 expression via TRAF2 and ERK signal pathway in EBV-associated gastric cancer.Virus Res. 2019 Oct 15;272:197735. doi: 10.1016/j.virusres.2019.197735. Epub 2019 Aug 29.
• [1350] Gene expression study and pathway analysis of histological subtypes of intestinal metaplasia that progress to gastric cancer.PLoS One. 2017 Apr 25;12(4):e0176043. doi: 10.1371/journal.pone.0176043. eCollection 2017.
• [1351] Exosomal TRIM3 is a novel marker and therapy target for gastric cancer.J Exp Clin Cancer Res. 2018 Jul 21;37(1):162. doi: 10.1186/s13046-018-0825-0.
• [1352] TRIM32 promotes cell proliferation and invasion by activating -catenin signalling in gastric cancer.J Cell Mol Med. 2018 Oct;22(10):5020-5028. doi: 10.1111/jcmm.13784. Epub 2018 Aug 5.
• [1353] Decreased expression of TROAP suppresses cellular proliferation, migration and invasion in gastric cancer.Mol Med Rep. 2018 Sep;18(3):3020-3026. doi: 10.3892/mmr.2018.9230. Epub 2018 Jun 27.
• [1354] Quantitative proteomics analysis of the role of tetraspanin-8 in the drug resistance of gastric cancer.Int J Oncol. 2018 Feb;52(2):473-484. doi: 10.3892/ijo.2017.4231. Epub 2017 Dec 19.
• [1355] Downregulation of ABI1 expression affects the progression and prognosis of human gastric carcinoma.Med Oncol. 2010 Sep;27(3):632-9. doi: 10.1007/s12032-009-9260-6. Epub 2009 Jun 25.
• [1356] Angiotensin-converting enzyme insertion/deletion polymorphism and gastric cancer: a systematic review and meta-analysis.Clin Res Hepatol Gastroenterol. 2015 Feb;39(1):136-44. doi: 10.1016/j.clinre.2014.06.015. Epub 2014 Aug 18.
• [1357] Associations of a PTPN11 G/A polymorphism at intron 3 with Helicobactor pylori seropositivity, gastric atrophy and gastric cancer in Japanese.BMC Gastroenterol. 2009 Jul 9;9:51. doi: 10.1186/1471-230X-9-51.
• [1358] Tumor-suppressive functions of long-chain acyl-CoA synthetase 4 in gastric cancer.IUBMB Life. 2016 Apr;68(4):320-7. doi: 10.1002/iub.1486. Epub 2016 Mar 7.
• [1359] The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer.Int J Oncol. 2005 Jan;26(1):17-24.
• [1360] ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation.Oncogene. 2005 Dec 1;24(54):8051-60. doi: 10.1038/sj.onc.1208952.
• [1361] Downregulation of ADAMTS8 by DNA Hypermethylation in Gastric Cancer and Its Clinical Significance.Biomed Res Int. 2016;2016:5083841. doi: 10.1155/2016/5083841. Epub 2016 Jul 14.
• [1362] ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer.Oncogene. 2013 Jul 11;32(28):3319-28. doi: 10.1038/onc.2012.359. Epub 2012 Aug 20.
• [1363] Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer.Dig Dis Sci. 2018 Jul;63(7):1835-1850. doi: 10.1007/s10620-018-5081-9. Epub 2018 Apr 25.
• [1364] ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer.Gastroenterology. 2016 Oct;151(4):637-650.e10. doi: 10.1053/j.gastro.2016.06.043. Epub 2016 Jul 1.
• [1365] A phosphorylation-related variant ADD1-rs4963 modifies the risk of colorectal cancer.PLoS One. 2015 Mar 27;10(3):e0121485. doi: 10.1371/journal.pone.0121485. eCollection 2015.
• [1366] Augmentation of antitumor effects of p53 gene therapy by combination with HDAC inhibitor.Cancer Biol Ther. 2005 Apr;4(4):421-8. doi: 10.4161/cbt.4.4.1620. Epub 2005 Apr 21.
• [1367] CircRNA_100269 is downregulated in gastric cancer and suppresses tumor cell growth by targeting miR-630.Aging (Albany NY). 2017 Jun 27;9(6):1585-1594. doi: 10.18632/aging.101254.
• [1368] Association of variants on ADIPOQ and AdipoR1 and the prognosis of gastric cancer patients after gastrectomy treatment.Mol Biol Rep. 2015 Feb;42(2):355-61. doi: 10.1007/s11033-014-3775-4. Epub 2014 Oct 1.
• [1369] ADRM1 gene amplification is a candidate driver for metastatic gastric cancers.Clin Exp Metastasis. 2014 Aug;31(6):727-33. doi: 10.1007/s10585-014-9663-4. Epub 2014 Jun 27.
• [1370] Circulatinglong non-coding RNA FEZF1-AS1 and AFAP1-AS1 serve as potential diagnostic biomarkers for gastric cancer.Pathol Res Pract. 2020 Jan;216(1):152757. doi: 10.1016/j.prp.2019.152757. Epub 2019 Nov 22.
• [1371] Silencing of XB130 is associated with both the prognosis and chemosensitivity of gastric cancer.PLoS One. 2012;7(8):e41660. doi: 10.1371/journal.pone.0041660. Epub 2012 Aug 23.
• [1372] RAB31 Targeted by MiR-30c-2-3p Regulates the GLI1 Signaling Pathway, Affecting Gastric Cancer Cell Proliferation and Apoptosis.Front Oncol. 2018 Nov 26;8:554. doi: 10.3389/fonc.2018.00554. eCollection 2018.
• [1373] Knockdown of AGGF1 inhibits the invasion and migration of gastric cancer via epithelial-mesenchymal transition through Wnt/-catenin pathway.Cancer Cell Int. 2019 Feb 27;19:41. doi: 10.1186/s12935-019-0765-6. eCollection 2019.
• [1374] Antitumor activity of the novel human cytokine AIMP1 in an in vivo tumor model.Mol Cells. 2006 Apr 30;21(2):213-7.
• [1375] A-kinase-interacting protein 1 facilitates growth and metastasis of gastric cancer cells via Slug-induced epithelial-mesenchymal transition.J Cell Mol Med. 2019 Jun;23(6):4434-4442. doi: 10.1111/jcmm.14339. Epub 2019 Apr 24.
• [1376] Generation of monoclonal antibody MS17-57 targeting secreted alkaline phosphatase ectopically expressed on the surface of gastrointestinal cancer cells.PLoS One. 2013 Oct 15;8(10):e77398. doi: 10.1371/journal.pone.0077398. eCollection 2013.
• [1377] Methylation status of ANAPC1, CDKN2A and TP53 promoter genes in individuals with gastric cancer.Braz J Med Biol Res. 2008 Jun;41(6):539-43. doi: 10.1590/s0100-879x2008000600017.
• [1378] ANGPTL6-mediated angiogenesis promotes alpha fetoprotein-producing gastric cancer progression.Pathol Res Pract. 2019 Aug;215(8):152454. doi: 10.1016/j.prp.2019.152454. Epub 2019 May 23.
• [1379] ANKRD9 is associated with tumor suppression as a substrate receptor subunit of ubiquitin ligase.Biochim Biophys Acta Mol Basis Dis. 2018 Oct;1864(10):3145-3153. doi: 10.1016/j.bbadis.2018.07.001. Epub 2018 Jul 3.
• [1380] In silico analysis of expression pattern of a Wnt/-catenin responsive gene ANLN in gastric cancer.Gene. 2014 Jul 15;545(1):23-9. doi: 10.1016/j.gene.2014.05.013. Epub 2014 May 5.
• [1381] Impact of Annexin A3 expression in gastric cancer cells.Neoplasma. 2014;61(3):257-64. doi: 10.4149/neo_2014_033.
• [1382] Downregulation of annexin A7 decreases proliferation, migration, and invasion of gastric cancer cells by reducing matrix metalloproteinase 1 and 9 expression.Am J Transl Res. 2019 May 15;11(5):2754-2764. eCollection 2019.
• [1383] Rationales for expression and altered expression of apoptotic protease activating factor-1 gene in gastric cancer.World J Gastroenterol. 2007 Oct 14;13(38):5060-4. doi: 10.3748/wjg.v13.i38.5060.
• [1384] Circulating methylated MINT2 promoter DNA is a potential poor prognostic factor in gastric cancer.Dig Dis Sci. 2014 Jun;59(6):1160-8. doi: 10.1007/s10620-013-3007-0. Epub 2014 Jan 3.
• [1385] The roles of APOBEC3B in gastric cancer.Int J Clin Exp Pathol. 2015 May 1;8(5):5089-96. eCollection 2015.
• [1386] Expression profile of multiple aquaporins in human gastric carcinoma and its clinical significance.Biomed Pharmacother. 2010 May;64(5):313-8. doi: 10.1016/j.biopha.2009.12.003. Epub 2010 Jan 8.
• [1387] Circular RNA ARHGAP26 is over-expressed and its downregulation inhibits cell proliferation and promotes cell apoptosis in gastric cancer cells.Saudi J Gastroenterol. 2019 Mar-Apr;25(2):119-125. doi: 10.4103/sjg.SJG_283_18.
• [1388] RhoGDI2 promotes epithelial-mesenchymal transition via induction of Snail in gastric cancer cells.Oncotarget. 2014 Mar 30;5(6):1554-64. doi: 10.18632/oncotarget.1733.
• [1389] Loss of ARID1A, ARID1B, and ARID2 Expression During Progression of Gastric Cancer.Anticancer Res. 2015 Dec;35(12):6819-27.
• [1390] Overexpression of ARNT2 is associated with decreased cell proliferation and better prognosis in gastric cancer.Mol Cell Biochem. 2019 Jan;450(1-2):97-103. doi: 10.1007/s11010-018-3376-y. Epub 2018 Jun 12.
• [1391] Reduced expression of the insulin-induced protein 1 and p41 Arp2/3 complex genes in human gastric cancers.Int J Cancer. 2002 Jul 1;100(1):57-62. doi: 10.1002/ijc.10464.
• [1392] Role of ARPC2 in Human Gastric Cancer.Mediators Inflamm. 2017;2017:5432818. doi: 10.1155/2017/5432818. Epub 2017 Jun 13.
• [1393] MALAT1 promotes cell proliferation in gastric cancer by recruiting SF2/ASF.Biomed Pharmacother. 2014 Jun;68(5):557-64. doi: 10.1016/j.biopha.2014.04.007. Epub 2014 Apr 28.
• [1394] Role of -glutamyltranspeptidase in the pathogenesis of Helicobacter pylori infection.Microbiol Immunol. 2013 Oct;57(10):665-73. doi: 10.1111/1348-0421.12089.
• [1395] Meta-analysis of association studies of CYP1A1 genetic polymorphisms with digestive tract cancer susceptibility in Chinese.Asian Pac J Cancer Prev. 2014;15(11):4689-95. doi: 10.7314/apjcp.2014.15.11.4689.
• [1396] LncRNA MALAT1 potentiates autophagyassociated cisplatin resistance by regulating the microRNA?0b/autophagyrelated gene 5 axis in gastric cancer.Int J Oncol. 2019 Jan;54(1):239-248. doi: 10.3892/ijo.2018.4609. Epub 2018 Oct 26.
• [1397] ATOH1 Can Regulate the Tumorigenicity of Gastric Cancer Cells by Inducing the Differentiation of Cancer Stem Cells.PLoS One. 2015 May 7;10(5):e0126085. doi: 10.1371/journal.pone.0126085. eCollection 2015.
• [1398] Expression of acidosis-dependent genes in human cancer nests.Mol Clin Oncol. 2014 Nov;2(6):1160-1166. doi: 10.3892/mco.2014.344. Epub 2014 Jul 11.
• [1399] Stem Cells Antigen-1 Enriches for a Cancer Stem Cell-Like Subpopulation in Mouse Gastric Cancer.Stem Cells. 2016 May;34(5):1177-87. doi: 10.1002/stem.2329.
• [1400] ATXN2L upregulated by epidermal growth factor promotes gastric cancer cell invasiveness and oxaliplatin resistance.Cell Death Dis. 2019 Feb 20;10(3):173. doi: 10.1038/s41419-019-1362-2.
• [1401] Mutations in components of the Wnt signaling pathway in gastric cancer.World J Gastroenterol. 2008 Mar 14;14(10):1570-4. doi: 10.3748/wjg.14.1570.
• [1402] Downregulation of homeobox gene Barx2 increases gastric cancer proliferation and metastasis and predicts poor patient outcomes.Oncotarget. 2016 Sep 13;7(37):60593-60608. doi: 10.18632/oncotarget.11260.
• [1403] A BAP31 intrabody induces gastric cancer cell death by inhibiting p27(kip1) proteasome degradation.Int J Cancer. 2019 Apr 15;144(8):2051-2062. doi: 10.1002/ijc.31930. Epub 2019 Jan 17.
• [1404] BCL2L10 is frequently silenced by promoter hypermethylation in gastric cancer.Oncol Rep. 2010 Jun;23(6):1701-8. doi: 10.3892/or_00000814.
• [1405] Molecular analysis and prognostic impact of the novel apoptotic gene BCL2L12 in gastric cancer.Biochem Biophys Res Commun. 2010 Jan 1;391(1):214-8. doi: 10.1016/j.bbrc.2009.11.034. Epub 2009 Nov 10.
• [1406] DEC1 is required for anti-apoptotic activity of gastric cancer cells under hypoxia by promoting Survivin expression.Gastric Cancer. 2018 Jul;21(4):632-642. doi: 10.1007/s10120-017-0780-z. Epub 2017 Dec 4.
• [1407] Inactivating mutation of the pro-apoptotic gene BID in gastric cancer. J Pathol. 2004 Apr;202(4):439-45. doi: 10.1002/path.1532.
• [1408] 1,25-Dihydroxyvitamin D(3) affects gastric cancer progression by repressing BMP3 promoter methylation.Onco Targets Ther. 2019 Mar 28;12:2343-2353. doi: 10.2147/OTT.S195642. eCollection 2019.
• [1409] RBBP8/CtIP suppresses P21 expression by interacting with CtBP and BRCA1 in gastric cancer.Oncogene. 2020 Feb;39(6):1273-1289. doi: 10.1038/s41388-019-1060-7. Epub 2019 Oct 21.
• [1410] The roles of BTG3 expression in gastric cancer: a potential marker for carcinogenesis and a target molecule for gene therapy.Oncotarget. 2015 Aug 14;6(23):19841-67. doi: 10.18632/oncotarget.3734.
• [1411] Frequent promoter hypermethylation and transcriptional downregulation of BTG4 gene in gastric cancer.Biochem Biophys Res Commun. 2009 Sep 11;387(1):132-8. doi: 10.1016/j.bbrc.2009.06.140. Epub 2009 Jul 1.
• [1412] Somatic mutations of the beta-TrCP gene in gastric cancer.APMIS. 2007 Feb;115(2):127-33. doi: 10.1111/j.1600-0463.2007.apm_562.x.
• [1413] Mad2 and BubR1 modulates tumourigenesis and paclitaxel response in MKN45 gastric cancer cells.Cell Cycle. 2014;13(22):3590-601. doi: 10.4161/15384101.2014.962952.
• [1414] Integrative genomics analysis reveals the multilevel dysregulation and oncogenic characteristics of TEAD4 in gastric cancer.Carcinogenesis. 2014 May;35(5):1020-7. doi: 10.1093/carcin/bgt409. Epub 2013 Dec 9.
• [1415] Helicobacter pylori promotes invasion and metastasis of gastric cancer cells through activation of AP-1 and up-regulation of CACUL1.Int J Biochem Cell Biol. 2013 Nov;45(11):2666-78. doi: 10.1016/j.biocel.2013.08.015. Epub 2013 Sep 1.
• [1416] CacyBP/SIP nuclear translocation regulates p27Kip1 stability in gastric cancer cells.World J Gastroenterol. 2016 Apr 21;22(15):3992-4001. doi: 10.3748/wjg.v22.i15.3992.
• [1417] LncRNA CADM1-AS1 serves as a new prognostic biomarker for gastric cancer.Eur Rev Med Pharmacol Sci. 2019 Aug;23(3 Suppl):232-238. doi: 10.26355/eurrev_201908_18652.
• [1418] Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer.Oncotarget. 2014 Apr 30;5(8):2318-29. doi: 10.18632/oncotarget.1913.
• [1419] Clinical Application of the DiversiLab Microbial Typing System Using Repetitive Sequence-Based PCR for Characterization of Helicobacter pylori in Japan.J Clin Lab Anal. 2015 May;29(3):250-3. doi: 10.1002/jcla.21758. Epub 2014 May 5.
• [1420] Cloning and characterization of a novel 90 kDa 'companion' auto-antigen of p62 overexpressed in cancer.Oncogene. 2002 Jul 25;21(32):5006-15. doi: 10.1038/sj.onc.1205625.
• [1421] Laser microdissection and two-dimensional difference gel electrophoresis reveal the role of a novel macrophage-capping protein in lymph node metastasis in gastric cancer.J Proteome Res. 2013 Aug 2;12(8):3780-91. doi: 10.1021/pr400439m. Epub 2013 Jul 9.
• [1422] microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-B by targeting CARD10 and COPS8 in gastric cancer.Mol Cancer. 2012 Sep 20;11:71. doi: 10.1186/1476-4598-11-71.
• [1423] Frequent epigenetic inactivation of hSRBC in gastric cancer and its implication in attenuated p53 response to stresses.Int J Cancer. 2008 Apr 1;122(7):1573-84. doi: 10.1002/ijc.23166.
• [1424] Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancer.Int J Cancer. 2005 Jan 10;113(2):221-8. doi: 10.1002/ijc.20551.
• [1425] CCDC134 is down-regulated in gastric cancer and its silencing promotes cell migration and invasion of GES-1 and AGS cells via the MAPK pathway.Mol Cell Biochem. 2013 Jan;372(1-2):1-8. doi: 10.1007/s11010-012-1418-4. Epub 2012 Aug 18.
• [1426] Expression of tumor related gene NAG6 in gastric cancer and restriction fragment length polymorphism analysis.World J Gastroenterol. 2004 May 1;10(9):1361-4. doi: 10.3748/wjg.v10.i9.1361.
• [1427] CCL18 promotes the invasion and migration of gastric cancer cells via ERK1/2/NF-B signaling pathway.Tumour Biol. 2016 Jan;37(1):641-51. doi: 10.1007/s13277-015-3825-0. Epub 2015 Aug 5.
• [1428] Differential expression of CCN family members CYR611, CTGF and NOV in gastric cancer and their association with disease progression.Oncol Rep. 2016 Nov;36(5):2517-2525. doi: 10.3892/or.2016.5074. Epub 2016 Sep 8.
• [1429] The miR27b-CCNG1-P53-miR-508-5p axis regulates multidrug resistance of gastric cancer.Oncotarget. 2016 Jan 5;7(1):538-49. doi: 10.18632/oncotarget.6374.
• [1430] Mycoplasma hyorhinis infection in gastric carcinoma and its effects on the malignant phenotypes of gastric cancer cells.BMC Gastroenterol. 2010 Nov 10;10:132. doi: 10.1186/1471-230X-10-132.
• [1431] MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1.Oncogene. 2016 Dec 1;35(48):6189-6202. doi: 10.1038/onc.2016.151. Epub 2016 May 9.
• [1432] Knockdown of CCNO decreases the tumorigenicity of gastric cancer by inducing apoptosis.Onco Targets Ther. 2018 Oct 26;11:7471-7481. doi: 10.2147/OTT.S176252. eCollection 2018.
• [1433] Long Noncoding RNA PVT1 Acts as a "Sponge" to Inhibit microRNA-152 in Gastric Cancer Cells.Dig Dis Sci. 2017 Nov;62(11):3021-3028. doi: 10.1007/s10620-017-4508-z. Epub 2017 Mar 3.
• [1434] Gene expression analysis of a Helicobacter pylori-infected and high-salt diet-treated mouse gastric tumor model: identification of CD177 as a novel prognostic factor in patients with gastric cancer.BMC Gastroenterol. 2013 Jul 30;13:122. doi: 10.1186/1471-230X-13-122.
• [1435] CD81 is a candidate tumor suppressor gene in human gastric cancer.Cell Oncol (Dordr). 2013 Apr;36(2):141-53. doi: 10.1007/s13402-012-0119-z. Epub 2012 Dec 21.
• [1436] Immunoreactivity of CD99 in stomach cancer.J Korean Med Sci. 2002 Aug;17(4):483-9. doi: 10.3346/jkms.2002.17.4.483.
• [1437] Upregulation of CDCA5 promotes gastric cancer malignant progression via influencing cyclin E1.Biochem Biophys Res Commun. 2018 Feb 5;496(2):482-489. doi: 10.1016/j.bbrc.2018.01.046. Epub 2018 Jan 8.
• [1438] Methylation pattern of CDH13 gene in digestive tract cancers.Br J Cancer. 2004 Sep 13;91(6):1139-42. doi: 10.1038/sj.bjc.6602095.
• [1439] Frequent aberrant methylation of the CDH4 gene promoter in human colorectal and gastric cancer.Cancer Res. 2004 Nov 15;64(22):8156-9. doi: 10.1158/0008-5472.CAN-04-3000.
• [1440] Downregulated CDK10 expression in gastric cancer: Association with tumor progression and poor prognosis.Mol Med Rep. 2018 May;17(5):6812-6818. doi: 10.3892/mmr.2018.8662. Epub 2018 Mar 1.
• [1441] Lentivirus-mediated knockdown of CUGBP1 suppresses gastric cancer cell proliferation in vitro.Appl Biochem Biotechnol. 2014 Jul;173(6):1529-36. doi: 10.1007/s12010-014-0937-8. Epub 2014 May 13.
• [1442] Combined evaluation of centromere protein H and Ki-67 as prognostic biomarker for patients with gastric carcinoma.Eur J Surg Oncol. 2013 Feb;39(2):141-9. doi: 10.1016/j.ejso.2012.08.023. Epub 2012 Sep 19.
• [1443] CENPO expression regulates gastric cancer cell proliferation and is associated with poor patient prognosis.Mol Med Rep. 2019 Oct;20(4):3661-3670. doi: 10.3892/mmr.2019.10624. Epub 2019 Aug 29.
• [1444] The hypoxia-regulated transcription factor DEC1 (Stra13, SHARP-2) and its expression in gastric cancer.OMICS. 2009 Aug;13(4):301-6. doi: 10.1089/omi.2009.0014.
• [1445] CEP55 contributes to human gastric carcinoma by regulating cell proliferation.Tumour Biol. 2014 May;35(5):4389-99. doi: 10.1007/s13277-013-1578-1. Epub 2014 Jan 4.
• [1446] Downregulation of 425G>a variant of calcium-binding protein S100A14 associated with poor differentiation and prognosis in gastric cancer.J Cancer Res Clin Oncol. 2015 Apr;141(4):691-703. doi: 10.1007/s00432-014-1830-0. Epub 2014 Sep 30.
• [1447] Single nucleotide polymorphisms (SNPs) at CDH1 promoter region in familial gastric cancer.Rev Esp Enferm Dig. 2006 Jan;98(1):36-41. doi: 10.4321/s1130-01082006000100005.
• [1448] CHD5 is down-regulated through promoter hypermethylation in gastric cancer.J Biomed Sci. 2009 Oct 19;16(1):95. doi: 10.1186/1423-0127-16-95.
• [1449] CHD8 is an independent prognostic indicator that regulates Wnt/-catenin signaling and the cell cycle in gastric cancer.Oncol Rep. 2013 Sep;30(3):1137-42. doi: 10.3892/or.2013.2597. Epub 2013 Jul 8.
• [1450] Predictive value of CHFR and MLH1 methylation in human gastric cancer.Gastric Cancer. 2015 Apr;18(2):280-7. doi: 10.1007/s10120-014-0370-2. Epub 2014 Apr 21.
• [1451] Aberrant DNA methylation of cancer-associated genes in gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).Cancer Lett. 2011 Dec 1;311(1):85-95. doi: 10.1016/j.canlet.2011.06.038. Epub 2011 Jul 14.
• [1452] Expression of CIAPIN1 in human colorectal cancer and its correlation with prognosis.BMC Cancer. 2010 Sep 3;10:477. doi: 10.1186/1471-2407-10-477.
• [1453] Increase in CIP2A expression is associated with cisplatin chemoresistance in gastric cancer.Cancer Biomark. 2018 Feb 6;21(2):307-316. doi: 10.3233/CBM-170416.
• [1454] Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients.J Cancer Res Clin Oncol. 2015 Mar;141(3):443-52. doi: 10.1007/s00432-014-1838-5. Epub 2014 Sep 28.
• [1455] Up-regulation of cytoskeletal-associated protein 2 in primary human gastric adenocarcinomas.J Cancer Res Clin Oncol. 2003 Nov;129(11):621-30. doi: 10.1007/s00432-003-0484-0. Epub 2003 Aug 26.
• [1456] Clinicopathological and biological significance of CDC28 protein kinase regulatory subunit 2 overexpression in human gastric cancer.Int J Oncol. 2011 Aug;39(2):361-72. doi: 10.3892/ijo.2011.1056. Epub 2011 May 25.
• [1457] The expression of claudin 1 correlates with -catenin and is a prognostic factor of poor outcome in gastric cancer.Int J Oncol. 2014 Apr;44(4):1293-301. doi: 10.3892/ijo.2014.2298. Epub 2014 Feb 12.
• [1458] Expression of claudin-11, -23 in different gastric tissues and its relationship with the risk and prognosis of gastric cancer.PLoS One. 2017 Mar 28;12(3):e0174476. doi: 10.1371/journal.pone.0174476. eCollection 2017.
• [1459] Differential expression of claudin-2 in normal human tissues and gastrointestinal carcinomas.Virchows Arch. 2006 Apr;448(4):428-34. doi: 10.1007/s00428-005-0120-2. Epub 2005 Nov 17.
• [1460] Down-regulation of claudin-3 is associated with proliferative potential in early gastric cancers.Dig Dis Sci. 2012 Jun;57(6):1562-7. doi: 10.1007/s10620-012-2043-5.
• [1461] CLIC4 abrogation promotes epithelial-mesenchymal transition in gastric cancer.Carcinogenesis. 2020 Jul 10;41(6):841-849. doi: 10.1093/carcin/bgz156.
• [1462] Functional polymorphisms in circadian positive feedback loop genes predict postsurgical prognosis of gastric cancer.Cancer Med. 2019 Apr;8(4):1919-1929. doi: 10.1002/cam4.2050. Epub 2019 Mar 7.
• [1463] Clinicopathological significance of claspin overexpression and its association with spheroid formation in gastric cancer.Hum Pathol. 2019 Feb;84:8-17. doi: 10.1016/j.humpath.2018.09.001. Epub 2018 Sep 18.
• [1464] CMTM3 decreases EGFR expression and EGF-mediated tumorigenicity by promoting Rab5 activity in gastric cancer.Cancer Lett. 2017 Feb 1;386:77-86. doi: 10.1016/j.canlet.2016.11.015. Epub 2016 Nov 17.
• [1465] Bioinformatic analysis of the prognostic value of ZNF860 in recurrence-free survival and its potential regulative network in gastric cancer.Eur Rev Med Pharmacol Sci. 2019 Jan;23(1):162-170. doi: 10.26355/eurrev_201901_16760.
• [1466] Underexpressed CNDP2 participates in gastric cancer growth inhibition through activating the MAPK signaling pathway.Mol Med. 2014 Mar 13;20(1):17-28. doi: 10.2119/molmed.2013.00102.
• [1467] Chondromodulin-1 functions as a tumor suppressor in gastric adenocarcinoma.Int J Oncol. 2015 Sep;47(3):941-50. doi: 10.3892/ijo.2015.3081. Epub 2015 Jul 13.
• [1468] Knockdown of calponin 2 suppressed cell growth in gastric cancer cells.Tumour Biol. 2017 Jul;39(7):1010428317706455. doi: 10.1177/1010428317706455.
• [1469] Calponin 3 Regulates Cell Invasion and Doxorubicin Resistance in Gastric Cancer.Gastroenterol Res Pract. 2019 Feb 18;2019:3024970. doi: 10.1155/2019/3024970. eCollection 2019.
• [1470] TMED6-COG8 is a novel molecular marker of TFE3 translocation renal cell carcinoma.Int J Clin Exp Pathol. 2015 Mar 1;8(3):2690-9. eCollection 2015.
• [1471] Discovery of signature genes in gastric cancer associated with prognosis.Neoplasma. 2016;63(2):239-45. doi: 10.4149/209_150531N303.
• [1472] Loss of COP1 expression determines poor prognosisin patients with gastric cancer.Oncol Rep. 2013 Oct;30(4):1971-5. doi: 10.3892/or.2013.2664. Epub 2013 Aug 8.
• [1473] M-COPA, a Golgi Disruptor, Inhibits Cell Surface Expression of MET Protein and Exhibits Antitumor Activity against MET-Addicted Gastric Cancers.Cancer Res. 2016 Jul 1;76(13):3895-903. doi: 10.1158/0008-5472.CAN-15-2220. Epub 2016 Apr 12.
• [1474] Silencing of COPB2 inhibits the proliferation of gastric cancer cells and induces apoptosis via suppression of the RTK signaling pathway.Int J Oncol. 2019 Apr;54(4):1195-1208. doi: 10.3892/ijo.2019.4717. Epub 2019 Feb 18.
• [1475] Preoperative Capecitabine, Oxaliplatin, and Irinotecan in Resectable Gastric or Gastroesophageal Junction Cancer: Pathological Response as Primary Endpoint and FDG-PET Predictions.Oncology. 2017;93(5):279-286. doi: 10.1159/000479154. Epub 2017 Sep 8.
• [1476] CPEB1, a novel gene silenced in gastric cancer: a Drosophila approach.Gut. 2012 Aug;61(8):1115-23. doi: 10.1136/gutjnl-2011-300427. Epub 2011 Nov 3.
• [1477] Potential miRNA-target interactions for the screening of gastric carcinoma development in gastric adenoma/dysplasia.Int J Med Sci. 2018 Mar 14;15(6):610-616. doi: 10.7150/ijms.24061. eCollection 2018.
• [1478] A retrospective comparative exploratory study on two methylentetrahydrofolate reductase (MTHFR) polymorphisms in esophagogastric cancer: the A1298C MTHFR polymorphism is an independent prognostic factor only in neoadjuvantly treated gastric cancer patients.BMC Cancer. 2014 Feb 3;14:58. doi: 10.1186/1471-2407-14-58.
• [1479] Exosomal miR-27a Derived from Gastric Cancer Cells Regulates the Transformation of Fibroblasts into Cancer-Associated Fibroblasts.Cell Physiol Biochem. 2018;49(3):869-883. doi: 10.1159/000493218. Epub 2018 Sep 5.
• [1480] Cystatin M expression is reduced in gastric carcinoma and is associated with promoter hypermethylation.Biochem Biophys Res Commun. 2010 Jan 1;391(1):1070-4. doi: 10.1016/j.bbrc.2009.12.022. Epub 2009 Dec 10.
• [1481] CSTB Downregulation Promotes Cell Proliferation and Migration and Suppresses Apoptosis in Gastric Cancer SGC-7901 Cell Line.Oncol Res. 2016 Oct 27;24(6):487-494. doi: 10.3727/096504016X14685034103752.
• [1482] Cancer targeting by TCR gene-engineered T cells directed against Kita-Kyushu Lung Cancer Antigen-1.J Immunother Cancer. 2019 Aug 28;7(1):229. doi: 10.1186/s40425-019-0678-x.
• [1483] Let-7b inhibits cell proliferation, migration, and invasion through targeting Cthrc1 in gastric cancer.Tumour Biol. 2015 May;36(5):3221-9. doi: 10.1007/s13277-014-2950-5. Epub 2014 Dec 16.
• [1484] An -E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancer.J Pathol. 2013 Mar;229(4):621-9. doi: 10.1002/path.4152.
• [1485] Detection and evaluation of antibodies against neutrophil-activating protein of Helicobacter pylori in patients with gastric cancer.World J Gastroenterol. 2009 May 21;15(19):2381-8. doi: 10.3748/wjg.15.2381.
• [1486] Catenin-1, negatively regulated by miR-145, promotes tumour aggressiveness in gastric cancer.J Pathol. 2015 May;236(1):53-64. doi: 10.1002/path.4495. Epub 2015 Jan 5.
• [1487] p150 overexpression in gastric carcinoma: the association with p53, apoptosis and cell proliferation.Int J Cancer. 2004 Nov 10;112(3):393-8. doi: 10.1002/ijc.20443.
• [1488] MiRNA-545 negatively regulates the oncogenic activity of EMS1 in gastric cancer.Cancer Med. 2018 Jun;7(6):2452-2462. doi: 10.1002/cam4.1520. Epub 2018 May 7.
• [1489] miR?81 and miR?89 suppress cell proliferation and invasion by targeting CUL4B via the Wnt/catenin pathway in gastric cancer.Int J Oncol. 2019 Feb;54(2):733-743. doi: 10.3892/ijo.2018.4646. Epub 2018 Nov 26.
• [1490] Abnormal hypermethylation of promoter region downregulates chemokine CXC ligand 14 expression in gastric cancer.Int J Oncol. 2013 Nov;43(5):1487-94. doi: 10.3892/ijo.2013.2078. Epub 2013 Aug 23.
• [1491] Epigenetic alterations of CYLD promoter modulate its expression in gastric adenocarcinoma: A footprint of infections.J Cell Physiol. 2019 Apr;234(4):4115-4124. doi: 10.1002/jcp.27220. Epub 2018 Aug 21.
• [1492] Systematic search for gastric cancer-specific genes based on SAGE data: melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer.Oncogene. 2006 Apr 20;25(17):2546-57. doi: 10.1038/sj.onc.1209279.
• [1493] Genome-wide long non-coding RNAs identified a panel of novel plasma biomarkers for gastric cancer diagnosis.Gastric Cancer. 2019 Jul;22(4):731-741. doi: 10.1007/s10120-018-00915-7. Epub 2019 Jan 2.
• [1494] Identification of tubulin beta chain, thymosin beta-4-like protein 3, and cytochrome b-c?complex subunit 1 as serological diagnostic biomarkers of gastric cancer.Clin Biochem. 2013 Oct;46(15):1578-84. doi: 10.1016/j.clinbiochem.2013.05.068. Epub 2013 Jun 6.
• [1495] Epigenetic silencing of DACH1 induces the invasion and metastasis of gastric cancer by activating TGF- signalling.J Cell Mol Med. 2014 Dec;18(12):2499-511. doi: 10.1111/jcmm.12325. Epub 2014 Jun 9.
• [1496] Increased number of CpG island hypermethylation in tumor suppressor genes of non-neoplastic gastric mucosa correlates with higher risk of gastric cancer.Digestion. 2010;82(1):27-36. doi: 10.1159/000252766. Epub 2010 Feb 11.
• [1497] Depletion of death-associated protein-3 induces chemoresistance in gastric cancer cells through the -catenin/LGR5/Bcl-2 axis.J Investig Med. 2019 Jun;67(5):856-861. doi: 10.1136/jim-2018-000934. Epub 2019 Feb 20.
• [1498] Identification of specific and common diagnostic antibody markers for gastrointestinal cancers by SEREX screening using testis cDNA phage library.Oncotarget. 2018 Jan 1;9(26):18559-18569. doi: 10.18632/oncotarget.24963. eCollection 2018 Apr 6.
• [1499] Bcl-2 antisense oligonucleotides chemosensitize human gastric cancer in a SCID mouse xenotransplantation model.J Mol Med (Berl). 2001 Oct;79(10):587-93. doi: 10.1007/s001090100251.
• [1500] SP1 reduces autophagic flux through activating p62 in gastric cancer cells.Mol Med Rep. 2018 Mar;17(3):4633-4638. doi: 10.3892/mmr.2018.8400. Epub 2018 Jan 9.
• [1501] An integrative approach identified genes associated with drug response in gastric cancer.Carcinogenesis. 2015 Apr;36(4):441-51. doi: 10.1093/carcin/bgv014. Epub 2015 Mar 5.
• [1502] Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA, babA2 genotypes and correlation with clinical outcome in Turkish patients with dyspepsia.Helicobacter. 2006 Dec;11(6):574-80. doi: 10.1111/j.1523-5378.2006.00461.x.
• [1503] Oncogene RNA helicase DDX6 promotes the process of c-Myc expression in gastric cancer cells.Mol Carcinog. 2018 May;57(5):579-589. doi: 10.1002/mc.22781. Epub 2018 Jan 30.
• [1504] Prognostic impact of expression and methylation status of DENN/MADD domain-containing protein 2D in gastric cancer.Gastric Cancer. 2015 Apr;18(2):288-96. doi: 10.1007/s10120-014-0372-0. Epub 2014 Apr 3.
• [1505] Epigenetic suppression of the immunoregulator MZB1 is associated with the malignant phenotype of gastric cancer.Int J Cancer. 2016 Nov 15;139(10):2290-8. doi: 10.1002/ijc.30286. Epub 2016 Aug 6.
• [1506] Epigenetic alteration of CCDC67 and its tumor suppressor function in gastric cancer.Carcinogenesis. 2012 Aug;33(8):1494-501. doi: 10.1093/carcin/bgs178. Epub 2012 May 18.
• [1507] C14orf159 suppresses gastric cancer cells' invasion and proliferation by inactivating ERK signaling.Cancer Manag Res. 2019 Feb 19;11:1717-1723. doi: 10.2147/CMAR.S176771. eCollection 2019.
• [1508] Understanding h-prune biology in the fight against cancer.Clin Exp Metastasis. 2007;24(8):637-45. doi: 10.1007/s10585-007-9109-3. Epub 2007 Oct 19.
• [1509] Cerium oxide nanoparticles inhibit the migration and proliferation of gastric cancer by increasing DHX15 expression.Int J Nanomedicine. 2016 Jul 15;11:3023-34. doi: 10.2147/IJN.S103648. eCollection 2016.
• [1510] Selective PI3K inhibition by BKM120 and BEZ235 alone or in combination with chemotherapy in wild-type and mutated human gastrointestinal cancer cell lines.Cancer Chemother Pharmacol. 2012 Jun;69(6):1601-15. doi: 10.1007/s00280-012-1869-z. Epub 2012 Apr 29.
• [1511] Examination of the expression and prognostic significance of DLGAPs in gastric cancer using the TCGA database and bioinformatic analysis.Mol Med Rep. 2018 Dec;18(6):5621-5629. doi: 10.3892/mmr.2018.9574. Epub 2018 Oct 23.
• [1512] Increased Expression of DNAJC12 is Associated with Aggressive Phenotype of Gastric Cancer.Ann Surg Oncol. 2019 Mar;26(3):836-844. doi: 10.1245/s10434-018-07149-y. Epub 2019 Jan 7.
• [1513] Overexpression of ZRF1 is related to tumor malignant potential and a poor outcome of gastric carcinoma.Carcinogenesis. 2018 Feb 9;39(2):263-271. doi: 10.1093/carcin/bgx139.
• [1514] Oncogenic CagA promotes gastric cancer risk via activating ERK signaling pathways: a nested case-control study.PLoS One. 2011;6(6):e21155. doi: 10.1371/journal.pone.0021155. Epub 2011 Jun 16.
• [1515] Clinicopathologic and molecular characteristics of gastric cancer showing gastric and intestinal mucin phenotype.Cancer Sci. 2015 Aug;106(8):951-8. doi: 10.1111/cas.12706. Epub 2015 Jul 7.
• [1516] Decreased expression of the adhesion molecule desmoglein-2 is associated with diffuse-type gastric carcinoma.Eur J Cancer. 2006 Sep;42(14):2397-403. doi: 10.1016/j.ejca.2006.03.024. Epub 2006 Aug 4.
• [1517] MiR-122-5p inhibits cell migration and invasion in gastric cancer by down-regulating DUSP4.Cancer Biol Ther. 2018 May 4;19(5):427-435. doi: 10.1080/15384047.2018.1423925. Epub 2018 Mar 6.
• [1518] CpG island methylator phenotype and Helicobacter pylori infection associated with gastric cancer.World J Gastroenterol. 2012 Sep 28;18(36):5129-34. doi: 10.3748/wjg.v18.i36.5129.
• [1519] Aberrant intracellular localization of RCAS1 is associated with tumor progression of gastric cancer.Int J Oncol. 2001 Oct;19(4):695-700. doi: 10.3892/ijo.19.4.695.
• [1520] Aberrant DNA methylation and tumor suppressive activity of the EBF3 gene in gastric carcinoma.Int J Cancer. 2012 Feb 15;130(4):817-26. doi: 10.1002/ijc.26038. Epub 2011 May 5.
• [1521] P53 and Protein Phosphorylation Regulate the Oncogenic Role of Epithelial Cell Transforming 2 (ECT2).Med Sci Monit. 2017 Jun 27;23:3154-3160. doi: 10.12659/msm.905388.
• [1522] G-A variant in miR-200c binding site of EFNA1 alters susceptibility to gastric cancer.Mol Carcinog. 2014 Mar;53(3):219-29. doi: 10.1002/mc.21966. Epub 2012 Oct 12.
• [1523] Overexpression of Ephrin A2 receptors in cancer stromal cells is a prognostic factor for the relapse of gastric cancer.Gastric Cancer. 2015 Jul;18(3):485-94. doi: 10.1007/s10120-014-0390-y. Epub 2014 Jun 8.
• [1524] Expression profile of EFNB1, EFNB2, two ligands of EPHB2 in human gastric cancer.J Cancer Res Clin Oncol. 2002 Jul;128(7):343-8. doi: 10.1007/s00432-002-0355-0. Epub 2002 Jun 26.
• [1525] Knockdown of Livin inhibits growth and invasion of gastric cancer cells through blockade of the MAPK pathway in vitro and in vivo.Int J Oncol. 2014 Jan;44(1):276-84. doi: 10.3892/ijo.2013.2171. Epub 2013 Nov 12.
• [1526] MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2.Biochem Biophys Res Commun. 2010 Feb 12;392(3):340-5. doi: 10.1016/j.bbrc.2009.12.182. Epub 2010 Jan 11.
• [1527] Long noncoding RNA VCAN-AS1 contributes to the progression of gastric cancer via regulating p53 expression.J Cell Physiol. 2020 May;235(5):4388-4398. doi: 10.1002/jcp.29315. Epub 2019 Oct 21.
• [1528] Identification of specific modules and hub genes associated with the progression of gastric cancer.Carcinogenesis. 2019 Oct 16;40(10):1269-1277. doi: 10.1093/carcin/bgz040.
• [1529] Detection of coding microsatellite frameshift mutations in DNA mismatch repair-deficient mouse intestinal tumors.Mol Carcinog. 2015 Nov;54(11):1376-86. doi: 10.1002/mc.22213. Epub 2014 Sep 11.
• [1530] IRF6 Is Directly Regulated by ZEB1 and ELF3, and Predicts a Favorable Prognosis in Gastric Cancer.Front Oncol. 2019 Apr 4;9:220. doi: 10.3389/fonc.2019.00220. eCollection 2019.
• [1531] Silencing ELMO3 Inhibits the Growth, Invasion, and Metastasis of Gastric Cancer.Biomed Res Int. 2018 Sep 24;2018:3764032. doi: 10.1155/2018/3764032. eCollection 2018.
• [1532] Association of EMP1 with gastric carcinoma invasion, survival and prognosis.Int J Oncol. 2014 Sep;45(3):1091-8. doi: 10.3892/ijo.2014.2488. Epub 2014 Jun 10.
• [1533] EMP3 is induced by TWIST1/2 and regulates epithelial-to-mesenchymal transition of gastric cancer cells.Tumour Biol. 2017 Jul;39(7):1010428317718404. doi: 10.1177/1010428317718404.
• [1534] Adenoviral delivery of the EMX2 gene suppresses growth in human gastric cancer.PLoS One. 2012;7(9):e45970. doi: 10.1371/journal.pone.0045970. Epub 2012 Sep 21.
• [1535] Gene expression profile analysis of ENO1 knockdown in gastric cancer cell line MGC-803.Oncol Lett. 2019 Apr;17(4):3881-3889. doi: 10.3892/ol.2019.10053. Epub 2019 Feb 19.
• [1536] Selective high-level expression of epsin 3 in gastric parietal cells, where it is localized at endocytic sites of apical canaliculi.Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21511-6. doi: 10.1073/pnas.1016390107. Epub 2010 Nov 29.
• [1537] MiR-192-5p reverses cisplatin resistance by targeting ERCC3 and ERCC4 in SGC7901/DDP cells.J Cancer. 2019 Jan 29;10(4):1039-1051. doi: 10.7150/jca.25814. eCollection 2019.
• [1538] Association of XPG gene rs751402 polymorphism with gastric cancer risk: a meta-analysis in the Chinese population.Int J Biol Markers. 2018 May;33(2):174-179. doi: 10.5301/ijbm.5000313. Epub 2017 Sep 11.
• [1539] BCL6 degradation caused by the interaction with the C-terminus of pro-HB-EGF induces cyclin D2 expression in gastric cancers.Br J Cancer. 2009 Apr 21;100(8):1320-9. doi: 10.1038/sj.bjc.6605010. Epub 2009 Mar 31.
• [1540] Induction of cell differentiation and promotion of endocan gene expression in stomach cancer by melatonin.Mol Biol Rep. 2012 Mar;39(3):2843-9. doi: 10.1007/s11033-011-1043-4. Epub 2011 Jun 17.
• [1541] Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implications. Cancer Sci. 2004 May;95(5):385-92.
• [1542] Expression of ets-related transcriptional factor E1AF is associated with tumor progression and over-expression of matrilysin in human gastric cancer.Carcinogenesis. 2004 Mar;25(3):325-32. doi: 10.1093/carcin/bgh011. Epub 2003 Nov 6.
• [1543] Single-nucleotide polymorphism of the Exo1 gene: association with gastric cancer susceptibility and interaction with smoking in Taiwan.Chin J Physiol. 2009 Dec 31;52(6):411-8. doi: 10.4077/cjp.2009.amh076.
• [1544] EYA1 expression in gastric carcinoma and its association with clinicopathological characteristics: a pilot study.Med Oncol. 2014 May;31(5):955. doi: 10.1007/s12032-014-0955-y. Epub 2014 Apr 12.
• [1545] miR-107 regulates growth and metastasis of gastric cancer cells via activation of the PI3K-AKT signaling pathway by down-regulating FAT4.Cancer Med. 2019 Sep;8(11):5264-5273. doi: 10.1002/cam4.2396. Epub 2019 Jul 12.
• [1546] Low expression of fibulin-1 correlates with unfavorable prognosis in gastric cancer.Tumour Biol. 2016 Jul;37(7):9399-410. doi: 10.1007/s13277-015-4537-1. Epub 2016 Jan 16.
• [1547] Decreased fructose-1,6-bisphosphatase-2 expression promotes glycolysis and growth in gastric cancer cells.Mol Cancer. 2013 Sep 25;12(1):110. doi: 10.1186/1476-4598-12-110.
• [1548] F-box protein FBXL2 inhibits gastric cancer proliferation by ubiquitin-mediated degradation of forkhead box M1.FEBS Lett. 2016 Feb;590(4):445-52. doi: 10.1002/1873-3468.12071. Epub 2016 Feb 8.
• [1549] F-box and leucine-rich repeat protein 5 promotes colon cancer progression by modulating PTEN/PI3K/AKT signaling pathway.Biomed Pharmacother. 2018 Nov;107:1712-1719. doi: 10.1016/j.biopha.2018.08.119. Epub 2018 Sep 8.
• [1550] Significance of FBX8 in progression of gastric cancer.Exp Mol Pathol. 2015 Jun;98(3):360-6. doi: 10.1016/j.yexmp.2015.03.015. Epub 2015 Mar 20.
• [1551] Flap endonuclease 1 is a promising candidate biomarker in gastric cancer and is involved in cell proliferation and apoptosis.Int J Mol Med. 2014 May;33(5):1268-74. doi: 10.3892/ijmm.2014.1682. Epub 2014 Feb 28.
• [1552] Prognostic value of Kindlin-2 expression in patients with solid tumors: a meta-analysis.Cancer Cell Int. 2018 Oct 22;18:166. doi: 10.1186/s12935-018-0651-7. eCollection 2018.
• [1553] Fisher linear discriminant analysis for classification and prediction of genomic susceptibility to stomach and colorectal cancers based on six STR loci in a northern Chinese Han population.PeerJ. 2019 May 28;7:e7004. doi: 10.7717/peerj.7004. eCollection 2019.
• [1554] Expression of fibroblast growth factor 2 mRNA in early and advanced gastric cancer.Acta Oncol. 1997;36(7):695-700. doi: 10.3109/02841869709001339.
• [1555] FGF9 inhibition by a novel binding peptide has efficacy in gastric and bladder cancer per se and reverses resistance to cisplatin.Pharmacol Res. 2020 Feb;152:104575. doi: 10.1016/j.phrs.2019.104575. Epub 2019 Dec 2.
• [1556] Downregulation of FKBP14 by RNA interference inhibits the proliferation, adhesion and invasion of gastric cancer cells.Oncol Lett. 2017 Apr;13(4):2811-2816. doi: 10.3892/ol.2017.5781. Epub 2017 Feb 28.
• [1557] miR-449a targets Flot2 and inhibits gastric cancer invasion by inhibiting TGF--mediated EMT.Diagn Pathol. 2015 Nov 14;10:202. doi: 10.1186/s13000-015-0435-5.
• [1558] FNDC3B circular RNA promotes the migration and invasion of gastric cancer cells via the regulation of E-cadherin and CD44 expression.J Cell Physiol. 2019 Nov;234(11):19895-19910. doi: 10.1002/jcp.28588. Epub 2019 Apr 8.
• [1559] The ubiquitinase ZFP91 promotes tumor cell survival and confers chemoresistance through FOXA1 destabilization.Carcinogenesis. 2020 Mar 13;41(1):56-66. doi: 10.1093/carcin/bgz085.
• [1560] Helicobacter pylori causes epigenetic dysregulation of FOXD3 to promote gastric carcinogenesis.Gastroenterology. 2013 Jan;144(1):122-133.e9. doi: 10.1053/j.gastro.2012.10.002. Epub 2012 Oct 8.
• [1561] The transcription factor FOXO4 is down-regulated and inhibits tumor proliferation and metastasis in gastric cancer.BMC Cancer. 2014 May 28;14:378. doi: 10.1186/1471-2407-14-378.
• [1562] Fraser extracellular matrix complex subunit 1 promotes liver metastasis of gastric cancer.Int J Cancer. 2020 May 15;146(10):2865-2876. doi: 10.1002/ijc.32705. Epub 2019 Oct 23.
• [1563] FRAT1 and FRAT2, clustered in human chromosome 10q24.1 region, are up-regulated in gastric cancer.Int J Oncol. 2001 Aug;19(2):311-5. doi: 10.3892/ijo.19.2.311.
• [1564] Gastric cancer cell proliferation is suppressed by frizzled-2 short hairpin RNA.Int J Oncol. 2015 Mar;46(3):1018-24. doi: 10.3892/ijo.2015.2830. Epub 2015 Jan 9.
• [1565] Expression profiles of 10 members of Frizzled gene family in human gastric cancer.Int J Oncol. 2001 Oct;19(4):767-71. doi: 10.3892/ijo.19.4.767.
• [1566] Grb2-associated binder 1 polymorphism was associated with the risk of Helicobactor pylori infection and gastric atrophy.Int J Med Sci. 2006 Nov 1;4(1):1-6. doi: 10.7150/ijms.4.1.
• [1567] MicroRNA-143 enhances chemosensitivity of Quercetin through autophagy inhibition via target GABARAPL1 in gastric cancer cells.Biomed Pharmacother. 2015 Aug;74:169-77. doi: 10.1016/j.biopha.2015.08.005. Epub 2015 Aug 15.
• [1568] Combined GADD45A and thymidine phosphorylase expression levels predict response and survival of neoadjuvant-treated gastric cancer patients.Clin Cancer Res. 2005 Apr 15;11(8):3025-31. doi: 10.1158/1078-0432.CCR-04-1605.
• [1569] The Effect of Hexavalent Chromium on the Incidence and Mortality of Human Cancers: A Meta-Analysis Based on Published Epidemiological Cohort Studies.Front Oncol. 2019 Feb 4;9:24. doi: 10.3389/fonc.2019.00024. eCollection 2019.
• [1570] Detection of cerebroside sulfotransferase mRNA in human gastric mucosa and adenocarcinoma.Cancer Lett. 1999 Apr 26;138(1-2):45-51. doi: 10.1016/s0304-3835(98)00373-5.
• [1571] Increased sensitivity of gastric cancer cells to natural killer and lymphokine-activated killer cells by antisense suppression of N-acetylgalactosaminyltransferase.J Immunol. 1997 Sep 15;159(6):2645-51.
• [1572] Polypeptide N-acetylgalactosaminyltransferase 2 regulates cellular metastasis-associated behavior in gastric cancer. Int J Mol Med. 2012 Dec;30(6):1267-74.
• [1573] Polypeptide N-acetylgalactosaminyltransferase-6 expression in gastric cancer.Onco Targets Ther. 2017 Jul 7;10:3337-3344. doi: 10.2147/OTT.S138590. eCollection 2017.
• [1574] Growth arrest-specific gene 1 is downregulated and inhibits tumor growth in gastric cancer.FEBS J. 2012 Oct;279(19):3652-3664. doi: 10.1111/j.1742-4658.2012.08726.x. Epub 2012 Aug 31.
• [1575] Co-Expression of NEU2 and GBA3 Causes a Drastic Reduction in Cytosolic Sialyl Free N-glycans in Human MKN45 Stomach Cancer Cells-Evidence for the Physical Interaction of NEU2 and GBA3.Biomolecules. 2015 Jul 16;5(3):1499-514. doi: 10.3390/biom5031499.
• [1576] Oncogenic role of long non-coding RNA SNHG12 in gastric cancer cells by targeting miR-16.Exp Ther Med. 2019 Jul;18(1):199-208. doi: 10.3892/etm.2019.7526. Epub 2019 Apr 24.
• [1577] Epigenetic silencing of GDF1 disrupts SMAD signaling to reinforce gastric cancer development.Oncogene. 2016 Apr 21;35(16):2133-44. doi: 10.1038/onc.2015.276. Epub 2015 Jul 27.
• [1578] The expression of growth hormone-releasing hormone (GHRH) and splice variants of its receptor in human gastroenteropancreatic carcinomas.Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11866-71. doi: 10.1073/pnas.182433099. Epub 2002 Aug 19.
• [1579] Expression of human GIPC1 in normal tissues, cancer cell lines, and primary tumors.Int J Mol Med. 2002 May;9(5):509-13.
• [1580] Up-regulation of GIPC2 in human gastric cancer.Int J Oncol. 2002 Jun;20(6):1183-7.
• [1581] The G-protein 3 polymorphism is associated with diffuse type gastric cancer in Japanese.Asian Pac J Cancer Prev. 2010;11(5):1195-9.
• [1582] Role of nucleostemin in growth regulation of gastric cancer, liver cancer and other malignancies.World J Gastroenterol. 2004 May 1;10(9):1246-9. doi: 10.3748/wjg.v10.i9.1246.
• [1583] GM130 regulates epithelial-to-mesenchymal transition and invasion of gastric cancer cells via snail.Int J Clin Exp Pathol. 2015 Sep 1;8(9):10784-91. eCollection 2015.
• [1584] Expression of GOLPH2 is associated with the progression of and poor prognosis in gastric cancer.Oncol Rep. 2014 Nov;32(5):2077-85. doi: 10.3892/or.2014.3404. Epub 2014 Aug 14.
• [1585] MicroRNA-134 suppresses cell proliferation in gastric cancer cells via targeting of GOLPH3.Oncol Rep. 2017 Apr;37(4):2441-2448. doi: 10.3892/or.2017.5488. Epub 2017 Mar 2.
• [1586] Glypican-4 gene polymorphism (rs1048369) and susceptibility to Epstein-Barr virus-associated and -negative gastric carcinoma.Virus Res. 2016 Jul 15;220:52-6. doi: 10.1016/j.virusres.2016.04.005. Epub 2016 Apr 9.
• [1587] REG4 promotes peritoneal metastasis of gastric cancer through GPR37.Oncotarget. 2016 May 10;7(19):27874-88. doi: 10.18632/oncotarget.8442.
• [1588] Global gene expression and functional network analysis of gastric cancer identify extended pathway maps and GPRC5A as a potential biomarker.Cancer Lett. 2012 Dec 29;326(1):105-13. doi: 10.1016/j.canlet.2012.07.031. Epub 2012 Aug 3.
• [1589] Cyclooxygenase-2 mediated regulation of E-cadherin occurs in conventional but not early-onset gastric cancer cell lines.Cell Oncol. 2009;31(6):475-85. doi: 10.3233/CLO-2009-0496.
• [1590] Bombesin-mediated AP-1 activation in a human gastric cancer (SIIA).Surgery. 1996 Aug;120(2):130-6; discussion 136-7. doi: 10.1016/s0039-6060(96)80279-0.
• [1591] Distinctive expression and function of four GSDM family genes (GSDMA-D) in normal and malignant upper gastrointestinal epithelium.Genes Chromosomes Cancer. 2009 Mar;48(3):261-71. doi: 10.1002/gcc.20636.
• [1592] A GSDMB enhancer-driven HSV thymidine kinase-expressing vector for controlling occult peritoneal dissemination of gastric cancer cells.BMC Cancer. 2015 May 29;15:439. doi: 10.1186/s12885-015-1436-1.
• [1593] Interaction of polymorphisms in the interleukin 1B-31 and general transcription factor 2A1 genes on the susceptibility to gastric cancer.Cytokine. 2007 May;38(2):96-100. doi: 10.1016/j.cyto.2007.05.008. Epub 2007 Jun 26.
• [1594] GTSE1 expression represses apoptotic signaling and confers cisplatin resistance in gastric cancer cells.BMC Cancer. 2015 Jul 25;15:550. doi: 10.1186/s12885-015-1550-0.
• [1595] Identification of discrepancy between CTLA4 expression and CTLA4 activation in gastric cancer.Immunopharmacol Immunotoxicol. 2019 Jun;41(3):386-393. doi: 10.1080/08923973.2018.1533968. Epub 2018 Nov 13.
• [1596] Loss of heterozygosity and histone hypoacetylation of the PINX1 gene are associated with reduced expression in gastric carcinoma.Oncogene. 2005 Jan 6;24(1):157-64. doi: 10.1038/sj.onc.1207832.
• [1597] Accumulation of DNA methylation is associated with tumor stage in gastric cancer.Cancer. 2006 Mar 15;106(6):1250-9. doi: 10.1002/cncr.21754.
• [1598] Hath1 up-regulates gastric mucin gene expression in gastric cells.Biochem Biophys Res Commun. 2006 Jun 16;344(4):1166-71. doi: 10.1016/j.bbrc.2006.03.238. Epub 2006 Apr 21.
• [1599] Hedgehog Interacting Protein 1 is a Prognostic Marker and Suppresses Cell Metastasis in Gastric Cancer.J Cancer. 2018 Nov 24;9(24):4642-4649. doi: 10.7150/jca.27686. eCollection 2018.
• [1600] HHLA2 overexpression is a novel biomarker of malignant status and poor prognosis in gastric cancer.Hum Cell. 2020 Jan;33(1):116-122. doi: 10.1007/s13577-019-00280-2. Epub 2019 Sep 24.
• [1601] Inactivation of tumor suppressor gene HIC1 in gastric cancer is reversed via small activating RNAs.Gene. 2013 Sep 15;527(1):102-8. doi: 10.1016/j.gene.2013.05.034. Epub 2013 Jun 12.
• [1602] Down-regulation of locus-specific human lymphocyte antigen class I expression in Epstein-Barr virus-associated gastric cancer: implication for viral-induced immune evasion.Cancer. 2006 Apr 15;106(8):1685-93. doi: 10.1002/cncr.21784.
• [1603] Association of Helicobacter pylori-related distal gastric cancer with the HLA class II gene DQB10602 and cagA strains in a southern European population.Helicobacter. 2005 Feb;10(1):12-21. doi: 10.1111/j.1523-5378.2005.00287.x.
• [1604] Human leukocyte antigen (HLA)-E and HLA-F expression in gastric cancer.Anticancer Res. 2015 Apr;35(4):2279-85.
• [1605] Promoter methylation of helicase-like transcription factor is associated with the early stages of gastric cancer with family history.Ann Oncol. 2006 Apr;17(4):657-62. doi: 10.1093/annonc/mdl018. Epub 2006 Feb 23.
• [1606] High expression of HMBOX1 contributes to poor prognosis of gastric cancer by promoting cell proliferation and migration.Biomed Pharmacother. 2019 Jul;115:108867. doi: 10.1016/j.biopha.2019.108867. Epub 2019 Apr 18.
• [1607] The nucleosome binding protein 1 promotes the growth of gastric cancer cells.J Cancer. 2019 Jan 29;10(5):1132-1137. doi: 10.7150/jca.29292. eCollection 2019.
• [1608] HSP70/HSP90-Organizing Protein Contributes to Gastric Cancer Progression in an Autocrine Fashion and Predicts Poor Survival in Gastric Cancer.Cell Physiol Biochem. 2018;47(2):879-892. doi: 10.1159/000490080. Epub 2018 May 22.
• [1609] Elevated HOXA1 expression correlates with accelerated tumor cell proliferation and poor prognosis in gastric cancer partly via cyclin D1.J Exp Clin Cancer Res. 2016 Jan 21;35:15. doi: 10.1186/s13046-016-0294-2.
• [1610] HOXB5 induces invasion and migration through direct transcriptional up-regulation of -catenin in human gastric carcinoma.Biochem J. 2015 Dec 15;472(3):393-403. doi: 10.1042/BJ20150213. Epub 2015 Oct 14.
• [1611] Homeobox B7 accelerates the cancer progression of gastric carcinoma cells by promoting epithelial-mesenchymal transition (EMT) and activating Src-FAK pathway.Onco Targets Ther. 2019 May 16;12:3743-3751. doi: 10.2147/OTT.S198115. eCollection 2019.
• [1612] Experimental and clinicopathological analysis of HOXB9 in gastric cancer.Oncol Lett. 2019 Mar;17(3):3097-3102. doi: 10.3892/ol.2019.10008. Epub 2019 Feb 4.
• [1613] Homeobox C10 Influences on the Malignant Phenotype of Gastric Cancer Cell Lines and its Elevated Expression Positively Correlates with Recurrence and Poor Survival.Ann Surg Oncol. 2019 May;26(5):1535-1543. doi: 10.1245/s10434-019-07166-5. Epub 2019 Jan 23.
• [1614] HOXC6 promotes gastric cancer cell invasion by upregulating the expression of MMP9.Mol Med Rep. 2016 Oct;14(4):3261-8. doi: 10.3892/mmr.2016.5640. Epub 2016 Aug 19.
• [1615] Combined Detection of Plasma ZIC1, HOXD10 and RUNX3 Methylation is a Promising Strategy for Early Detection of Gastric Cancer and Precancerous Lesions.J Cancer. 2017 Apr 8;8(6):1038-1044. doi: 10.7150/jca.18169. eCollection 2017.
• [1616] Polymorphisms of PRLHR and HSPA12A and risk of gastric and colorectal cancer in the Chinese Han population.BMC Gastroenterol. 2015 Aug 25;15:107. doi: 10.1186/s12876-015-0336-9.
• [1617] Stomach cancer-derived del223V-226L mutation of the STCH gene causes loss of sensitization to TRAIL-mediated apoptosis.Biochem Biophys Res Commun. 2008 Nov 21;376(3):499-503. doi: 10.1016/j.bbrc.2008.09.013. Epub 2008 Sep 13.
• [1618] Protective role of genetic polymorphism of heat shock protein 70-2 for gastric cancer risk.Dig Dis Sci. 2009 Jan;54(1):70-4. doi: 10.1007/s10620-008-0313-z. Epub 2008 May 14.
• [1619] Downregulation of Sp1 by Minnelide leads to decrease in HSP70 and decrease in tumor burden of gastric cancer.PLoS One. 2017 Feb 13;12(2):e0171827. doi: 10.1371/journal.pone.0171827. eCollection 2017.
• [1620] Deletion in HSP110 T(17): correlation with wild-type HSP110 expression and prognostic significance in microsatellite-unstable advanced gastric cancers.Hum Pathol. 2017 Sep;67:109-118. doi: 10.1016/j.humpath.2017.08.001. Epub 2017 Aug 12.
• [1621] Decreased IFIT2 Expression Promotes Gastric Cancer Progression and Predicts Poor Prognosis of the Patients.Cell Physiol Biochem. 2018;45(1):15-25. doi: 10.1159/000486219. Epub 2017 Dec 22.
• [1622] Overexpression of IFITM1 has clinicopathologic effects on gastric cancer and is regulated by an epigenetic mechanism.Am J Pathol. 2012 Jul;181(1):43-52. doi: 10.1016/j.ajpath.2012.03.027. Epub 2012 May 18.
• [1623] IFRD1 polymorphisms and gastric cancer risk in a Chinese population.Med Oncol. 2014 Sep;31(9):135. doi: 10.1007/s12032-014-0135-0. Epub 2014 Jul 30.
• [1624] IGSF11 gene, frequently up-regulated in intestinal-type gastric cancer, encodes adhesion molecule homologous to CXADR, FLJ22415 and ESAM.Int J Oncol. 2003 Aug;23(2):525-31.
• [1625] Hedgehog signaling pathway and gastric cancer.Cancer Biol Ther. 2005 Oct;4(10):1050-4. doi: 10.4161/cbt.4.10.2184. Epub 2005 Oct 18.
• [1626] Increased chemokine receptor IL-17RA expression is associated with poor survival in gastric cancer patients.Int J Clin Exp Pathol. 2015 Jun 1;8(6):7002-8. eCollection 2015.
• [1627] Non-tumor tissue derived interleukin-17B activates IL-17RB/AKT/-catenin pathway to enhance the stemness of gastric cancer.Sci Rep. 2016 May 5;6:25447. doi: 10.1038/srep25447.
• [1628] Associations of Il-1 Family-Related Polymorphisms With Gastric Cancer Risk and the Role of Mir-197 In Il-1f5 Expression.Medicine (Baltimore). 2015 Nov;94(47):e1982. doi: 10.1097/MD.0000000000001982.
• [1629] Impact factors that modulate gastric cancer risk in Helicobacter pylori-infected rodent models.Helicobacter. 2019 Aug;24(4):e12580. doi: 10.1111/hel.12580. Epub 2019 Apr 4.
• [1630] Borealin/Dasra B is a cell cycle-regulated chromosomal passenger protein and its nuclear accumulation is linked to poor prognosis for human gastric cancer.Exp Cell Res. 2006 Apr 15;312(7):962-73. doi: 10.1016/j.yexcr.2005.12.015. Epub 2006 Jan 19.
• [1631] N-methyl-N-nitro-N-nitrosoguanidine-mediated ING4 downregulation contributed to the angiogenesis of transformed human gastric epithelial cells.Life Sci. 2018 Apr 15;199:179-187. doi: 10.1016/j.lfs.2018.02.034. Epub 2018 Feb 26.
• [1632] Decreased Sp1 Expression Mediates Downregulation of SHIP2 in Gastric Cancer Cells.Int J Mol Sci. 2017 Jan 22;18(1):220. doi: 10.3390/ijms18010220.
• [1633] Innate immunity and non-Hodgkin's lymphoma (NHL) related genes in a nested case-control study for gastric cancer risk.PLoS One. 2012;7(9):e45274. doi: 10.1371/journal.pone.0045274. Epub 2012 Sep 21.
• [1634] Deregulation of the cell polarity protein Lethal giant larvae 2 (Lgl2) correlates with gastric cancer progression.Gastric Cancer. 2014 Oct;17(4):610-20. doi: 10.1007/s10120-013-0324-0. Epub 2013 Dec 13.
• [1635] Importin-4 functions as a driving force in human primary gastric cancer.J Cell Biochem. 2019 Aug;120(8):12638-12646. doi: 10.1002/jcb.28530. Epub 2019 Mar 12.
• [1636] IQGAP2, A candidate tumour suppressor of prostate tumorigenesis.Biochim Biophys Acta. 2012 Jun;1822(6):875-84. doi: 10.1016/j.bbadis.2012.02.019. Epub 2012 Mar 2.
• [1637] Association of inducible nitric oxide synthetase genotype and Helicobacter pylori infection gastric cancer risk may be due to faulty primer design.World J Gastroenterol. 2013 Jan 21;19(3):429-30. doi: 10.3748/wjg.v19.i3.429.
• [1638] Overexpression of CD151 predicts prognosis in patients with resected gastric cancer.PLoS One. 2013;8(3):e58990. doi: 10.1371/journal.pone.0058990. Epub 2013 Mar 22.
• [1639] High expression of CD11c indicates favorable prognosis in patients with gastric cancer.World J Gastroenterol. 2015 Aug 21;21(31):9403-12. doi: 10.3748/wjg.v21.i31.9403.
• [1640] A cross-talk between integrin 4 and epidermal growth factor receptor induces gefitinib chemoresistance to gastric cancer.Cancer Cell Int. 2018 Apr 2;18:50. doi: 10.1186/s12935-018-0548-5. eCollection 2018.
• [1641] Gene expression signature analysis identifies vorinostat as a candidate therapy for gastric cancer.PLoS One. 2011;6(9):e24662. doi: 10.1371/journal.pone.0024662. Epub 2011 Sep 9.
• [1642] Decreased ITIH5 expression is associated with poor prognosis in primary gastric cancer.Med Oncol. 2014 Jul;31(7):53. doi: 10.1007/s12032-014-0053-1. Epub 2014 Jun 10.
• [1643] Intelectin 1 suppresses tumor progression and is associated with improved survival in gastric cancer.Oncotarget. 2015 Jun 30;6(18):16168-82. doi: 10.18632/oncotarget.3753.
• [1644] Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancer.Bosn J Basic Med Sci. 2019 May 20;19(2):164-171. doi: 10.17305/bjbms.2019.3713.
• [1645] Association of high-evidence gastric cancer susceptibility loci and somatic gene expression levels with survival.Carcinogenesis. 2017 Oct 26;38(11):1119-1128. doi: 10.1093/carcin/bgx090.
• [1646] Invivo and invitro inhibition of human gastric cancer progress by upregulating Kank1 gene.Oncol Rep. 2017 Sep;38(3):1663-1669. doi: 10.3892/or.2017.5823. Epub 2017 Jul 17.
• [1647] Calcyclin-binding protein inhibits proliferation, tumorigenicity, and invasion of gastric cancer.Mol Cancer Res. 2007 Dec;5(12):1254-62. doi: 10.1158/1541-7786.MCR-06-0426.
• [1648] TIP60 as a potential marker for the malignancy of gastric cancer.Anticancer Res. 2011 Jan;31(1):77-9.
• [1649] Targeted deletion of Kcne2 causes gastritis cystica profunda and gastric neoplasia.PLoS One. 2010 Jul 6;5(7):e11451. doi: 10.1371/journal.pone.0011451.
• [1650] MiR-448 promotes glycolytic metabolism of gastric cancer by downregulating KDM2B.Oncotarget. 2016 Apr 19;7(16):22092-102. doi: 10.18632/oncotarget.8020.
• [1651] Synergistic triad epistasis of epigenetic H3K27me modifier genes, EZH2, KDM6A, and KDM6B, in gastric cancer susceptibility.Gastric Cancer. 2019 May;22(3):640-644. doi: 10.1007/s10120-018-0888-9. Epub 2018 Oct 29.
• [1652] SerpinB5 interacts with KHDRBS3 and FBXO32 in gastric cancer cells.Oncol Rep. 2011 Nov;26(5):1115-20. doi: 10.3892/or.2011.1369. Epub 2011 Jul 1.
• [1653] KIF14 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in human gastric cancer.Biochim Biophys Acta Mol Basis Dis. 2019 Jan;1865(1):181-192. doi: 10.1016/j.bbadis.2018.10.039. Epub 2018 Nov 4.
• [1654] Leptin-mediated regulation of MT1-MMP localization is KIF1B dependent and enhances gastric cancer cell invasion.Carcinogenesis. 2013 May;34(5):974-83. doi: 10.1093/carcin/bgt028. Epub 2013 Jan 25.
• [1655] Upregulation of KIF20A correlates with poor prognosis in gastric cancer.Cancer Manag Res. 2018 Nov 23;10:6205-6216. doi: 10.2147/CMAR.S176147. eCollection 2018.
• [1656] Clinicopathological and biological significance of mitotic centromere-associated kinesin overexpression in human gastric cancer.Br J Cancer. 2007 Aug 20;97(4):543-9. doi: 10.1038/sj.bjc.6603905. Epub 2007 Jul 24.
• [1657] KLF11 promotes gastric cancer invasion and migration by increasing Twist1 expression.Neoplasma. 2019 Jan 15;66(1):92-100. doi: 10.4149/neo_2018_180325N201. Epub 2018 Sep 4.
• [1658] MicroRNA?8b acts as an oncogene in gastric cancer by directly targeting Kruppellike factor 6.Mol Med Rep. 2019 Mar;19(3):1926-1934. doi: 10.3892/mmr.2019.9830. Epub 2019 Jan 8.
• [1659] KLF9 suppresses gastric cancer cell invasion and metastasis through transcriptional inhibition of MMP28.FASEB J. 2019 Jul;33(7):7915-7928. doi: 10.1096/fj.201802531R. Epub 2019 Mar 26.
• [1660] NES1/KLK10 promotes trastuzumab resistance via activation of PI3K/AKT signaling pathway in gastric cancer.J Cell Biochem. 2018 Aug;119(8):6398-6407. doi: 10.1002/jcb.26562. Epub 2018 Apr 17.
• [1661] Identification and validation of Kallikrein-ralated peptidase 11 as a novel prognostic marker of gastric cancer based on immunohistochemistry.J Surg Oncol. 2011 Oct;104(5):516-24. doi: 10.1002/jso.21981. Epub 2011 May 25.
• [1662] Clinical significance of human kallikrein 12 gene expression in gastric cancer.World J Gastroenterol. 2012 Dec 7;18(45):6597-604. doi: 10.3748/wjg.v18.i45.6597.
• [1663] Kallikrein-related peptidase 13 (KLK13) gene expressional status contributes significantly in the prognosis of primary gastric carcinomas.Clin Biochem. 2010 Oct;43(15):1205-11. doi: 10.1016/j.clinbiochem.2010.07.016. Epub 2010 Jul 30.
• [1664] A missense mutation (S3660L) in MLL3 gene influences risk of gastric cancer.J BUON. 2014 Apr-Jun;19(2):394-7.
• [1665] Nuclear karyopherin-2 expression in primary lesions and metastatic lymph nodes was associated with poor prognosis and progression in gastric cancer.Carcinogenesis. 2013 Oct;34(10):2314-21. doi: 10.1093/carcin/bgt214. Epub 2013 Jun 8.
• [1666] KRT15, INHBA, MATN3, and AGT are aberrantly methylated and differentially expressed in gastric cancer and associated with prognosis.Pathol Res Pract. 2019 May;215(5):893-899. doi: 10.1016/j.prp.2019.01.034. Epub 2019 Jan 28.
• [1667] Aberrant Cytokeratin 20 mRNA Expression in Peripheral Blood and Lymph Nodes Indicates Micrometastasis and Poor Prognosis in Patients With Gastric Carcinoma.Technol Cancer Res Treat. 2019 Jan 1;18:1533033819832856. doi: 10.1177/1533033819832856.
• [1668] A miR-29c binding site genetic variant in the 3'-untranslated region of LAMTOR3 gene is associated with gastric cancer risk.Biomed Pharmacother. 2015 Feb;69:70-5. doi: 10.1016/j.biopha.2014.11.008. Epub 2014 Nov 15.
• [1669] LAT-1 functions as a promotor in gastric cancer associated with clinicopathologic features.Biomed Pharmacother. 2013 Oct;67(8):693-9. doi: 10.1016/j.biopha.2013.05.003. Epub 2013 Jun 14.
• [1670] LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.Front Immunol. 2019 Jan 29;10:6. doi: 10.3389/fimmu.2019.00006. eCollection 2019.
• [1671] LEM domain containing 1 promotes proliferation via activating the PI3K/Akt signaling pathway in gastric cancer.J Cell Biochem. 2019 Sep;120(9):15190-15201. doi: 10.1002/jcb.28783. Epub 2019 Apr 25.
• [1672] Up-regulation of Mac-2 binding protein by hTERT in gastric cancer.Int J Cancer. 2007 Feb 15;120(4):813-20. doi: 10.1002/ijc.22369.
• [1673] Galectin-7 is epigenetically-regulated tumor suppressor in gastric cancer.Oncotarget. 2013 Sep;4(9):1461-71. doi: 10.18632/oncotarget.1219.
• [1674] Association between Tim? and Gal? expression and gastric cancer prognosis.Oncol Rep. 2018 Oct;40(4):2115-2126. doi: 10.3892/or.2018.6627. Epub 2018 Aug 6.
• [1675] LIG3 gene polymorphisms and risk of gastric cancer in a Southern Chinese population.Gene. 2019 Jul 15;705:90-94. doi: 10.1016/j.gene.2019.04.072. Epub 2019 Apr 26.
• [1676] The epigenetic silencing of LIMS2 in gastric cancer and its inhibitory effect on cell migration.Biochem Biophys Res Commun. 2006 Oct 27;349(3):1032-40. doi: 10.1016/j.bbrc.2006.08.128. Epub 2006 Aug 30.
• [1677] Long non-coding RNA FAM84B-AS promotes resistance of gastric cancer to platinum drugs through inhibition of FAM84B expression.Biochem Biophys Res Commun. 2019 Feb 12;509(3):753-762. doi: 10.1016/j.bbrc.2018.12.177. Epub 2019 Jan 9.
• [1678] Downregulation of leucine-rich repeats and immunoglobulin-like domains 1 by microRNA-20a modulates gastric cancer multidrug resistance.Cancer Sci. 2018 Apr;109(4):1044-1054. doi: 10.1111/cas.13538. Epub 2018 Mar 23.
• [1679] Histologic demonstration of antigens reactive with anti-p21 ras monoclonal antibody (RAP-5) in human stomach cancers.J Natl Cancer Inst. 1986 Aug;77(2):379-85.
• [1680] Latexin expression is downregulated in human gastric carcinomas and exhibits tumor suppressor potential.BMC Cancer. 2011 Apr 6;11:121. doi: 10.1186/1471-2407-11-121.
• [1681] Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers.Eur J Cancer. 1999 Aug;35(8):1248-57. doi: 10.1016/s0959-8049(99)00135-5.
• [1682] LZTFL1 suppresses gastric cancer cell migration and invasion through regulating nuclear translocation of -catenin.J Cancer Res Clin Oncol. 2014 Dec;140(12):1997-2008. doi: 10.1007/s00432-014-1753-9. Epub 2014 Jul 9.
• [1683] Clinicopathological and prognostic significance of metastasis-associated in colon cancer-1 in gastric cancer: A meta-analysis.Int J Biol Markers. 2019 Mar;34(1):27-32. doi: 10.1177/1724600818813634. Epub 2019 Mar 10.
• [1684] QKI5-mediated alternative splicing of the histone variant macroH2A1 regulates gastric carcinogenesis.Oncotarget. 2016 May 31;7(22):32821-34. doi: 10.18632/oncotarget.8739.
• [1685] Identification of MAGEA12 as a prognostic outlier gene in gastric cancers.Neoplasma. 2017;64(2):238-243. doi: 10.4149/neo_2017_210.
• [1686] The Expression of Melanoma-Associated Antigen D2 Both in Surgically Resected and Serum Samples Serves as Clinically Relevant Biomarker of Gastric Cancer Progression.Ann Surg Oncol. 2016 Feb;23 Suppl 2:S214-21. doi: 10.1245/s10434-015-4457-8. Epub 2015 Mar 6.
• [1687] Enhanced expression of 2,3-linked sialic acids promotes gastric cancer cell metastasis and correlates with poor prognosis.Int J Oncol. 2017 Apr;50(4):1201-1210. doi: 10.3892/ijo.2017.3882. Epub 2017 Feb 20.
• [1688] MiR-2392 suppresses metastasis and epithelial-mesenchymal transition by targeting MAML3 and WHSC1 in gastric cancer.FASEB J. 2017 Sep;31(9):3774-3786. doi: 10.1096/fj.201601140RR. Epub 2017 May 16.
• [1689] Overexpression of MAPK15 in gastric cancer is associated with copy number gain and contributes to the stability of c-Jun.Oncotarget. 2015 Aug 21;6(24):20190-203. doi: 10.18632/oncotarget.4171.
• [1690] Epigenetic regulation of microRNA-10b and targeting of oncogenic MAPRE1 in gastric cancer.Epigenetics. 2011 Jun;6(6):740-51. doi: 10.4161/epi.6.6.15874. Epub 2011 Jun 1.
• [1691] Risk of stomach cancer in relation to consumption of cigarettes, alcohol, tea and coffee in Warsaw, Poland.Int J Cancer. 1999 Jun 11;81(6):871-6. doi: 10.1002/(sici)1097-0215(19990611)81:6<871::aid-ijc6>3.0.co;2-#.
• [1692] Association between tumor necrosis factor-alpha 857C/T polymorphism and gastric cancer: a meta-analysis.Tumour Biol. 2013 Dec;34(6):3383-8. doi: 10.1007/s13277-013-0910-0. Epub 2013 Jul 3.
• [1693] The expression and significance of P-glycoprotein, lung resistance protein and multidrug resistance-associated protein in gastric cancer.J Exp Clin Cancer Res. 2009 Nov 24;28(1):144. doi: 10.1186/1756-9966-28-144.
• [1694] The Glu346Lys polymorphism and frameshift mutations of the Methyl-CpG Binding Domain 4 gene in gastrointestinal cancer.Neoplasma. 2009;56(4):343-7. doi: 10.4149/neo_2009_04_343.
• [1695] Loss of BRCA1 expression leads to worse survival in patients with gastric carcinoma.World J Gastroenterol. 2013 Mar 28;19(12):1968-74. doi: 10.3748/wjg.v19.i12.1968.
• [1696] Frameshift mutations in the MBD4/MED1 gene in primary gastric cancer with high-frequency microsatellite instability.Cancer Lett. 2002 Jul 8;181(1):115-20. doi: 10.1016/s0304-3835(02)00043-5.
• [1697] Med19 promotes gastric cancer progression and cellular growth.Gene. 2012 Aug 10;504(2):262-7. doi: 10.1016/j.gene.2012.04.033. Epub 2012 Apr 28.
• [1698] MEF2D/Wnt/-catenin pathway regulates the proliferation of gastric cancer cells and is regulated by microRNA-19.Tumour Biol. 2016 Jul;37(7):9059-69. doi: 10.1007/s13277-015-4766-3. Epub 2016 Jan 13.
• [1699] Selenium-binding protein 1 may decrease gastric cellular proliferation and migration.Int J Oncol. 2013 May;42(5):1620-9. doi: 10.3892/ijo.2013.1850. Epub 2013 Mar 7.
• [1700] MFAP2 promotes epithelial-mesenchymal transition in gastric cancer cells by activating TGF-/SMAD2/3 signaling pathway.Onco Targets Ther. 2018 Jul 12;11:4001-4017. doi: 10.2147/OTT.S160831. eCollection 2018.
• [1701] MFSD2A expression predicts better prognosis in gastric cancer.Biochem Biophys Res Commun. 2018 Nov 2;505(3):699-704. doi: 10.1016/j.bbrc.2018.09.156. Epub 2018 Oct 3.
• [1702] Metastatic pathway-specific transcriptome analysis identifies MFSD4 as a putative tumor suppressor and biomarker for hepatic metastasis in patients with gastric cancer.Oncotarget. 2016 Mar 22;7(12):13667-79. doi: 10.18632/oncotarget.7269.
• [1703] Clinical and prognostic implications of 1, 6-N-acetylglucosaminyltransferase V in patients with gastric cancer.Cancer Sci. 2013 Feb;104(2):185-93. doi: 10.1111/cas.12049. Epub 2012 Dec 6.
• [1704] MICAL2 is a novel human cancer gene controlling mesenchymal to epithelial transition involved in cancer growth and invasion.Oncotarget. 2016 Jan 12;7(2):1808-25. doi: 10.18632/oncotarget.6577.
• [1705] Clinical significance of tumor expression of major histocompatibility complex class I-related chains A and B (MICA/B) in gastric cancer patients.Oncol Rep. 2016 Mar;35(3):1309-17. doi: 10.3892/or.2015.4510. Epub 2015 Dec 23.
• [1706] Expression of the matrix metalloproteases 2, 14, 24, and 25 and tissue inhibitor 3 as potential molecular markers in advanced human gastric cancer.Dis Markers. 2014;2014:285906. doi: 10.1155/2014/285906. Epub 2014 Feb 11.
• [1707] Mutations of the human MUT S homologue 6 gene in ampullary carcinoma and gastric cancer.Int J Cancer. 1998 Nov 23;78(5):576-80. doi: 10.1002/(sici)1097-0215(19981123)78:5<576::aid-ijc8>3.0.co;2-5.
• [1708] MORC2 regulates C/EBP-mediated cell differentiation via sumoylation.Cell Death Differ. 2019 Oct;26(10):1905-1917. doi: 10.1038/s41418-018-0259-4. Epub 2019 Jan 15.
• [1709] Chemoprevention of gastric cancer by Helicobacter pylori eradication and its underlying mechanism.J Gastroenterol Hepatol. 2019 Aug;34(8):1287-1295. doi: 10.1111/jgh.14646. Epub 2019 Mar 27.
• [1710] M-phase phosphoprotein 8 promotes gastric cancer growth and metastasis via p53/Bcl-2 and EMT-related signaling pathways.J Cell Biochem. 2020 Mar;121(3):2330-2342. doi: 10.1002/jcb.29456. Epub 2019 Nov 6.
• [1711] Isoforms S and L of MRPL33 from alternative splicing have isoformspecific roles in the chemoresponse to epirubicin in gastric cancer cells via the PI3K/AKT signaling pathway.Int J Oncol. 2019 May;54(5):1591-1600. doi: 10.3892/ijo.2019.4728. Epub 2019 Feb 27.
• [1712] PIG3 suppresses gastric cancer proliferation by regulating p53- mediated apoptosis.J Biol Regul Homeost Agents. 2018 Sep-Oct;32(5):1185-1189.
• [1713] Microsatellite instability in mismatch repair and tumor suppressor genes and their expression profiling provide important targets for the development of biomarkers in gastric cancer.Gene. 2019 Aug 20;710:48-58. doi: 10.1016/j.gene.2019.05.051. Epub 2019 May 28.
• [1714] Identification of candidate biomarkers that involved in the epigenetic transcriptional regulation for detection gastric cancer by iTRAQ based quantitative proteomic analysis.Clin Chim Acta. 2017 Aug;471:29-37. doi: 10.1016/j.cca.2017.05.015. Epub 2017 May 11.
• [1715] Genetic polymorphism at miR-181a binding site contributes to gastric cancer susceptibility.Carcinogenesis. 2012 Dec;33(12):2377-83. doi: 10.1093/carcin/bgs292. Epub 2012 Sep 12.
• [1716] Loss of MTUS1 in gastric cancer promotes tumor growth and metastasis.Neoplasma. 2014;61(2):128-35. doi: 10.4149/neo_2014_018.
• [1717] Overexpression of MUC13 is associated with intestinal-type gastric cancer.Cancer Sci. 2005 May;96(5):265-73. doi: 10.1111/j.1349-7006.2005.00043.x.
• [1718] Fukutin, identified by the Escherichia coli ampicillin secretion trap (CAST) method, participates in tumor progression in gastric cancer.Gastric Cancer. 2016 Apr;19(2):443-452. doi: 10.1007/s10120-015-0511-2. Epub 2015 Jul 30.
• [1719] Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas.J Transl Med. 2018 Sep 20;16(1):259. doi: 10.1186/s12967-018-1632-2.
• [1720] MiR-19a/b modulate the metastasis of gastric cancer cells by targeting the tumour suppressor MXD1.Cell Death Dis. 2014 Mar 27;5(3):e1144. doi: 10.1038/cddis.2014.110.
• [1721] Prognostic implications of MYBL2 in resected Chinese gastric adenocarcinoma patients.Onco Targets Ther. 2019 Feb 11;12:1129-1135. doi: 10.2147/OTT.S188820. eCollection 2019.
• [1722] Somatic Mutations and Intratumoral Heterogeneity of MYH11 Gene in Gastric and Colorectal Cancers.Appl Immunohistochem Mol Morphol. 2018 Sep;26(8):562-566. doi: 10.1097/PAI.0000000000000484.
• [1723] Inactivation of MYO5B promotes invasion and motility in gastric cancer cells.Dig Dis Sci. 2012 May;57(5):1247-52. doi: 10.1007/s10620-011-1989-z. Epub 2011 Dec 2.
• [1724] Clinical significance of MYT1L gene polymorphisms in Chinese patients with gastric cancer.PLoS One. 2013 Aug 28;8(8):e71979. doi: 10.1371/journal.pone.0071979. eCollection 2013.
• [1725] Overexpression of nuclear apoptosis-inducing factor 1 altered the proteomic profile of human gastric cancer cell MKN45 and induced cell cycle arrest at G1/S phase.PLoS One. 2014 Jun 13;9(6):e100216. doi: 10.1371/journal.pone.0100216. eCollection 2014.
• [1726] GSTT1 and GSTM1 null genotypes and the risk of gastric cancer: a case-control study in a Chinese population.Cancer Epidemiol Biomarkers Prev. 2000 Jan;9(1):73-80.
• [1727] Genetic polymorphisms of DNA repair pathways influence the response to chemotherapy and overall survival of gastric cancer.Tumour Biol. 2015 Apr;36(4):3017-23. doi: 10.1007/s13277-014-2936-3. Epub 2014 Dec 28.
• [1728] FBXO50 Enhances the Malignant Behavior of Gastric Cancer Cells.Ann Surg Oncol. 2017 Nov;24(12):3771-3779. doi: 10.1245/s10434-017-5882-7. Epub 2017 May 30.
• [1729] B7-H6 protein expression has no prognostic significance in human gastric carcinoma.Pathol Oncol Res. 2014 Jan;20(1):203-7. doi: 10.1007/s12253-013-9686-1. Epub 2013 Nov 16.
• [1730] Hec1/Ndc80 is overexpressed in human gastric cancer and regulates cell growth.J Gastroenterol. 2014 Mar;49(3):408-18. doi: 10.1007/s00535-013-0809-y. Epub 2013 Apr 17.
• [1731] NDRG2, suppressed expression associates with poor prognosis in pancreatic cancer, is hypermethylated in the second promoter in human gastrointestinal cancers.Biochem Biophys Res Commun. 2017 Feb 26;484(1):138-143. doi: 10.1016/j.bbrc.2017.01.055. Epub 2017 Jan 16.
• [1732] SNHG20/miR-140-5p/NDRG3 axis contributes to 5-fluorouracil resistance in gastric cancer.Oncol Lett. 2019 Aug;18(2):1337-1343. doi: 10.3892/ol.2019.10439. Epub 2019 Jun 5.
• [1733] NDRG4 in gastric cancer determines tumor cell proliferation and clinical outcome.Mol Carcinog. 2018 Jun;57(6):762-771. doi: 10.1002/mc.22798. Epub 2018 Mar 24.
• [1734] Intraperitoneal delivery of a small interfering RNA targeting NEDD1 prolongs the survival of scirrhous gastric cancer model mice.Cancer Sci. 2013 Feb;104(2):214-22. doi: 10.1111/cas.12054. Epub 2012 Dec 13.
• [1735] Inactivating mutations of the human base excision repair gene NEIL1 in gastric cancer.Carcinogenesis. 2004 Dec;25(12):2311-7. doi: 10.1093/carcin/bgh267. Epub 2004 Aug 19.
• [1736] Polymorphisms in NEIL-2, APE-1, CYP2E1 and MDM2 Genes are Independent Predictors of Gastric Cancer Risk in a Northern Jiangsu Population (China).J Nanosci Nanotechnol. 2015 Jul;15(7):4815-28. doi: 10.1166/jnn.2015.10028.
• [1737] Overexpression of NEK3 is associated with poor prognosis in patients with gastric cancer.Medicine (Baltimore). 2018 Jan;97(3):e9630. doi: 10.1097/MD.0000000000009630.
• [1738] miR-20a enhances cisplatin resistance of human gastric cancer cell line by targeting NFKBIB.Tumour Biol. 2016 Jan;37(1):1261-9. doi: 10.1007/s13277-015-3921-1. Epub 2015 Aug 20.
• [1739] Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancer.Mol Cancer. 2007 Feb 28;6:17. doi: 10.1186/1476-4598-6-17.
• [1740] Silencing NKD2 by Promoter Region Hypermethylation Promotes Esophageal Cancer Progression by Activating Wnt Signaling.J Thorac Oncol. 2016 Nov;11(11):1912-1926. doi: 10.1016/j.jtho.2016.06.015. Epub 2016 Jun 30.
• [1741] Long noncoding RNA OIP5-AS1 aggravates cell proliferation, migration in gastric cancer by epigenetically silencing NLRP6 expression via binding EZH2.J Cell Biochem. 2020 Jan;121(1):353-362. doi: 10.1002/jcb.29183. Epub 2019 Jun 20.
• [1742] Multi-marker analysis of genomic annotation on gastric cancer GWAS data from Chinese populations.Gastric Cancer. 2019 Jan;22(1):60-68. doi: 10.1007/s10120-018-0841-y. Epub 2018 Jun 1.
• [1743] EXPRESSION MECHANISM AND CLINICAL SIGNIFICANCE OF NOB1 IN GASTRIC CANCER TISSUE AND ADJACENT NORMAL TISSUE.J Biol Regul Homeost Agents. 2015 Apr-Jun;29(2):423-30.
• [1744] Gross genomic damage measured by DNA image cytometry independently predicts gastric cancer patient survival.Br J Cancer. 2009 Sep 15;101(6):1011-8. doi: 10.1038/sj.bjc.6605266.
• [1745] Identification of NOL8, a nucleolar protein containing an RNA recognition motif (RRM), which was overexpressed in diffuse-type gastric cancer.Cancer Sci. 2004 May;95(5):430-5. doi: 10.1111/j.1349-7006.2004.tb03227.x.
• [1746] PICT1 regulates TP53 via RPL11 and is involved in gastric cancer progression.Br J Cancer. 2013 Oct 15;109(8):2199-206. doi: 10.1038/bjc.2013.561. Epub 2013 Sep 17.
• [1747] The genomic landscape of Epstein-Barr virus-associated pulmonary lymphoepithelioma-like carcinoma.Nat Commun. 2019 Jul 16;10(1):3108. doi: 10.1038/s41467-019-10902-w.
• [1748] Altered expression of the human base excision repair gene NTH1 in gastric cancer.Carcinogenesis. 2009 Aug;30(8):1345-52. doi: 10.1093/carcin/bgp108. Epub 2009 May 4.
• [1749] High expression of nucleobindin 2 is associated with poor prognosis in gastric cancer.Tumour Biol. 2017 Jul;39(7):1010428317703817. doi: 10.1177/1010428317703817.
• [1750] NUCKS1 promotes gastric cancer cell aggressiveness by upregulating IGF-1R and subsequently activating the PI3K/Akt/mTOR signaling pathway.Carcinogenesis. 2019 Apr 29;40(2):370-379. doi: 10.1093/carcin/bgy142.
• [1751] Downregulation of NUSAP1 suppresses cell proliferation, migration, and invasion via inhibiting mTORC1 signalling pathway in gastric cancer.Cell Biochem Funct. 2020 Jan;38(1):28-37. doi: 10.1002/cbf.3444. Epub 2019 Nov 11.
• [1752] Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.Oncotarget. 2016 Sep 20;7(38):61390-61402. doi: 10.18632/oncotarget.11359.
• [1753] Opa interacting protein 5 (OIP5) is a novel cancer-testis specific gene in gastric cancer.Ann Surg Oncol. 2007 Feb;14(2):885-92. doi: 10.1245/s10434-006-9121-x. Epub 2006 Dec 7.
• [1754] Frizzled-7 Is Required for Wnt Signaling in Gastric Tumors with and Without Apc Mutations.Cancer Res. 2019 Mar 1;79(5):970-981. doi: 10.1158/0008-5472.CAN-18-2095. Epub 2019 Jan 8.
• [1755] Down-regulated expression of OPCML predicts an unfavorable prognosis and promotes disease progression in human gastric cancer.BMC Cancer. 2017 Apr 14;17(1):268. doi: 10.1186/s12885-017-3203-y.
• [1756] Odd-skipped related 1 is a novel tumour suppressor gene and a potential prognostic biomarker in gastric cancer.J Pathol. 2014 Nov;234(3):302-15. doi: 10.1002/path.4391. Epub 2014 Aug 28.
• [1757] Oolong tea polyphenol extract induces apoptosis in human stomach cancer cells.Anticancer Res. 2000 Nov-Dec;20(6B):4403-6.
• [1758] Upregulation of Mir-34a in AGS Gastric Cancer Cells by a PLGA-PEG-PLGA Chrysin Nano Formulation.Asian Pac J Cancer Prev. 2015;16(18):8259-63. doi: 10.7314/apjcp.2015.16.18.8259.
• [1759] Overexpression of miR-15b-5p promotes gastric cancer metastasis by regulating PAQR3.Oncol Rep. 2017 Jul;38(1):352-358. doi: 10.3892/or.2017.5673. Epub 2017 May 26.
• [1760] miRNA and mRNA expression profiles in gastric cancer patients and the relationship with circRNA.Neoplasma. 2019 Jun 29;66(6):879-886. doi: 10.4149/neo_2018_181211N952. Print 2019 Nov.
• [1761] Mitogen-activated protein kinase activator with WD40 repeats (MAWD) and MAWD-binding protein induce cell differentiation in gastric cancer.BMC Cancer. 2015 Sep 15;15:637. doi: 10.1186/s12885-015-1637-7.
• [1762] MicroRNA-320a suppresses tumor progression by targeting PBX3 in gastric cancer and is downregulated by DNA methylation.World J Gastrointest Oncol. 2019 Oct 15;11(10):842-856. doi: 10.4251/wjgo.v11.i10.842.
• [1763] PCDH17 gene promoter demethylation and cell cycle arrest by genistein in gastric cancer.Histol Histopathol. 2012 Feb;27(2):217-24. doi: 10.14670/HH-27.217.
• [1764] Mel-18 negatively regulates stem cell-like properties through downregulation of miR-21 in gastric cancer.Oncotarget. 2016 Sep 27;7(39):63352-63361. doi: 10.18632/oncotarget.11221.
• [1765] Identification of prognostic biomarkers in gastric cancer using endoscopic biopsy samples.Cancer Sci. 2008 Nov;99(11):2193-9. doi: 10.1111/j.1349-7006.2008.00935.x. Epub 2008 Jan 11.
• [1766] Anti-cancer effects of newly developed chemotherapeutic agent, glycoconjugated palladium (II) complex, against cisplatin-resistant gastric cancer cells.BMC Cancer. 2013 May 14;13:237. doi: 10.1186/1471-2407-13-237.
• [1767] Expression of protein disulfide isomeraseA3 and its clinicopathological association in gastric cancer.Oncol Rep. 2019 Apr;41(4):2265-2272. doi: 10.3892/or.2019.6999. Epub 2019 Feb 5.
• [1768] Epstein-Barr virus-encoded latent membrane protein-1 upregulates 14-3-3 and Reprimo to confer G(2)/M phase cell cycle arrest.C R Biol. 2012 Dec;335(12):713-21. doi: 10.1016/j.crvi.2012.11.002. Epub 2012 Dec 25.
• [1769] Podoplanin Expression as a Prognostic Factor in Gastric Cancer.Anticancer Res. 2018 May;38(5):2717-2722. doi: 10.21873/anticanres.12513.
• [1770] Decreased expression of prenyl diphosphate synthase subunit 2 correlates with reduced survival of patients with gastric cancer.J Exp Clin Cancer Res. 2014 Oct 22;33(1):88. doi: 10.1186/s13046-014-0088-3.
• [1771] Identification of a prognostic 28-gene expression signature for gastric cancer with lymphatic metastasis.Biosci Rep. 2019 May 2;39(5):BSR20182179. doi: 10.1042/BSR20182179. Print 2019 May 31.
• [1772] The Clinical Value of PELP1 for Breast Cancer: A Comparison with Multiple Cancers and Analysis in Breast Cancer Subtypes.Cancer Res Treat. 2019 Apr;51(2):706-717. doi: 10.4143/crt.2018.316. Epub 2018 Aug 23.
• [1773] Peripheral opioid antagonist enhances the effect of anti-tumor drug by blocking a cell growth-suppressive pathway in vivo.PLoS One. 2015 Apr 8;10(4):e0123407. doi: 10.1371/journal.pone.0123407. eCollection 2015.
• [1774] PES1 is transcriptionally regulated by BRD4 and promotes cell proliferation and glycolysis in hepatocellular carcinoma.Int J Biochem Cell Biol. 2018 Nov;104:1-8. doi: 10.1016/j.biocel.2018.08.014. Epub 2018 Aug 29.
• [1775] Hypoxic regulation of PFKFB-3 and PFKFB-4 gene expression in gastric and pancreatic cancer cell lines and expression of PFKFB genes in gastric cancers.Acta Biochim Pol. 2006;53(4):789-99. Epub 2006 Dec 4.
• [1776] Silencing profilin-1 inhibits gastric cancer progression via integrin 1/focal adhesion kinase pathway modulation.World J Gastroenterol. 2015 Feb 28;21(8):2323-35. doi: 10.3748/wjg.v21.i8.2323.
• [1777] Helicobacter pylori-related host gene polymorphisms associated with susceptibility of gastric carcinogenesis: a two-stage case-control study in Chinese.Carcinogenesis. 2013 Jul;34(7):1450-7. doi: 10.1093/carcin/bgt079. Epub 2013 Mar 1.
• [1778] Phosphoglycerate kinase 1 a promoting enzyme for peritoneal dissemination in gastric cancer.Int J Cancer. 2010 Mar 15;126(6):1513-20. doi: 10.1002/ijc.24835.
• [1779] MicroRNA-409-3p regulates cell proliferation and apoptosis by targeting PHF10 in gastric cancer.Cancer Lett. 2012 Jul 28;320(2):189-97. doi: 10.1016/j.canlet.2012.02.030. Epub 2012 Mar 1.
• [1780] PHF2 histone demethylase acts as a tumor suppressor in association with p53 in cancer.Oncogene. 2015 May 28;34(22):2897-909. doi: 10.1038/onc.2014.219. Epub 2014 Jul 21.
• [1781] MicroRNA-18a modulates STAT3 activity through negative regulation of PIAS3 during gastric adenocarcinogenesis.Br J Cancer. 2013 Feb 19;108(3):653-61. doi: 10.1038/bjc.2012.587. Epub 2013 Jan 15.
• [1782] MicroRNA-203 suppresses gastric cancer growth by targeting PIBF1/Akt signaling.J Exp Clin Cancer Res. 2016 Mar 15;35:47. doi: 10.1186/s13046-016-0323-1.
• [1783] Study on the association between PI3K/AKT/mTOR signaling pathway gene polymorphism and susceptibility to gastric cancer.J BUON. 2017 Nov-Dec;22(6):1488-1493.
• [1784] Silenced PITX1 promotes chemotherapeutic resistance to 5-fluorocytosine and cisplatin in gastric cancer cells.Exp Ther Med. 2019 May;17(5):4046-4054. doi: 10.3892/etm.2019.7459. Epub 2019 Apr 1.
• [1785] PIWI-like protein 1 upregulation promotes gastric cancer invasion and metastasis.Onco Targets Ther. 2018 Dec 6;11:8783-8789. doi: 10.2147/OTT.S186827. eCollection 2018.
• [1786] An atlas of gastric PIWI-interacting RNA transcriptomes and their utility for identifying signatures of gastric cancer recurrence.Gastric Cancer. 2016 Apr;19(2):660-665. doi: 10.1007/s10120-015-0487-y. Epub 2015 Mar 17.
• [1787] Epigenetic inactivation of protein kinase D1 in gastric cancer and its role in gastric cancer cell migration and invasion.Carcinogenesis. 2008 Mar;29(3):629-37. doi: 10.1093/carcin/bgm291. Epub 2008 Feb 17.
• [1788] Analysis of glycero-lysophospholipids in gastric cancerous ascites.J Lipid Res. 2017 Apr;58(4):763-771. doi: 10.1194/jlr.P072090. Epub 2017 Jan 31.
• [1789] Both gene deletion and promoter hyper-methylation contribute to the down-regulation of ZAC/PLAGL1 gene in gastric adenocarcinomas: a case control study.Clin Res Hepatol Gastroenterol. 2014 Dec;38(6):744-50. doi: 10.1016/j.clinre.2013.06.007. Epub 2014 Aug 1.
• [1790] Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer.Oncogene. 2009 Jul 2;28(26):2466-75. doi: 10.1038/onc.2009.92. Epub 2009 May 18.
• [1791] Correlation between PLCE1 rs2274223 variant and digestive tract cancer: A meta-analysis.Mol Genet Genomic Med. 2019 Apr;7(4):e00589. doi: 10.1002/mgg3.589. Epub 2019 Feb 19.
• [1792] Long noncoding RNA HOXA-AS2 promotes gastric cancer proliferation by epigenetically silencing P21/PLK3/DDIT3 expression.Oncotarget. 2015 Oct 20;6(32):33587-601. doi: 10.18632/oncotarget.5599.
• [1793] Enhanced expression of semaphorin 3E is involved in the gastric cancer development.Int J Oncol. 2016 Sep;49(3):887-94. doi: 10.3892/ijo.2016.3593. Epub 2016 Jun 30.
• [1794] Integrated assessment of PD-L1 expression and molecular classification facilitates therapy selection and prognosis prediction in gastric cancer.Cancer Manag Res. 2019 Jul 10;11:6397-6410. doi: 10.2147/CMAR.S206189. eCollection 2019.
• [1795] Association analysis of genetic variants in microRNA networks and gastric cancer risk in a Chinese Han population.J Cancer Res Clin Oncol. 2012 Jun;138(6):939-45. doi: 10.1007/s00432-012-1164-8. Epub 2012 Feb 17.
• [1796] Reduced Popdc3 expression correlates with high risk and poor survival in patients with gastric cancer.World J Gastroenterol. 2012 May 21;18(19):2423-9. doi: 10.3748/wjg.v18.i19.2423.
• [1797] The OCT4 pseudogene POU5F1B is amplified and promotes an aggressive phenotype in gastric cancer.Oncogene. 2015 Jan 8;34(2):199-208. doi: 10.1038/onc.2013.547. Epub 2013 Dec 23.
• [1798] Detection of OSR2, VAV3, and PPFIA3 Methylation in the Serum of Patients with Gastric Cancer.Dis Markers. 2016;2016:5780538. doi: 10.1155/2016/5780538. Epub 2016 Apr 7.
• [1799] Subtractive hybridization analysis of gastric diseases-associated Helicobacter pylori identifies peptidyl-prolyl isomerase as a potential marker for gastric cancer.FEMS Microbiol Lett. 2011 Jul;320(2):103-9. doi: 10.1111/j.1574-6968.2011.02296.x. Epub 2011 May 13.
• [1800] Biallelic inactivation of the RIZ1 gene in human gastric cancer.Oncogene. 2003 Oct 9;22(44):6954-8. doi: 10.1038/sj.onc.1206403.
• [1801] Adrenergic modulation of AMPKdependent autophagy by chronic stress enhances cell proliferation and survival in gastric cancer.Int J Oncol. 2019 May;54(5):1625-1638. doi: 10.3892/ijo.2019.4753. Epub 2019 Mar 18.
• [1802] Integrated analysis of whole genome exon array and array-comparative genomic hybridization in gastric and colorectal cancer cells.Cancer Sci. 2012 Feb;103(2):221-7. doi: 10.1111/j.1349-7006.2011.02132.x. Epub 2011 Nov 28.
• [1803] Endothelial cell protein C receptor promotes MGC803 gastric cancer cells proliferation and migration by activating ERK1/2.Med Oncol. 2015 May;32(5):162. doi: 10.1007/s12032-015-0614-y. Epub 2015 Apr 21.
• [1804] AAED1 modulates proliferation and glycolysis in gastric cancer.Oncol Rep. 2018 Aug;40(2):1156-1164. doi: 10.3892/or.2018.6478. Epub 2018 Jun 7.
• [1805] Genome-wide analysis of histone modifications by ChIP-chip to identify silenced genes in gastric cancer.Oncol Rep. 2015 May;33(5):2567-74. doi: 10.3892/or.2015.3824. Epub 2015 Feb 27.
• [1806] The transcription levels and prognostic values of seven proteasome alpha subunits in human cancers.Oncotarget. 2017 Jan 17;8(3):4501-4519. doi: 10.18632/oncotarget.13885.
• [1807] Overexpression of PSMA7 predicts poor prognosis in patients with gastric cancer.Oncol Lett. 2019 Nov;18(5):5341-5349. doi: 10.3892/ol.2019.10879. Epub 2019 Sep 19.
• [1808] CircPSMC3 suppresses the proliferation and metastasis of gastric cancer by acting as a competitive endogenous RNA through sponging miR-296-5p.Mol Cancer. 2019 Feb 18;18(1):25. doi: 10.1186/s12943-019-0958-6.
• [1809] Characterization of the immune escape phenotype of human gastric cancers with and without high-frequency microsatellite instability.J Pathol. 2007 Apr;211(5):516-523. doi: 10.1002/path.2142.
• [1810] Inhibition of Prostaglandin Reductase 2, a Putative Oncogene Overexpressed in Human Pancreatic Adenocarcinoma, Induces Oxidative Stress-Mediated Cell Death Involving xCT and CTH Gene Expressions through 15-Keto-PGE2.PLoS One. 2016 Jan 28;11(1):e0147390. doi: 10.1371/journal.pone.0147390. eCollection 2016.
• [1811] PTPN3 and PTPN4 tyrosine phosphatase expression in human gastric adenocarcinoma.Anticancer Res. 2006 Mar-Apr;26(2B):1643-9.
• [1812] MEG2 is regulated by miR-181a-5p and functions as a tumour suppressor gene to suppress the proliferation and migration of gastric cancer cells.Mol Cancer. 2017 Jul 26;16(1):133. doi: 10.1186/s12943-017-0695-7.
• [1813] A regulatory polymorphism at position -309 in PTPRCAP is associated with susceptibility to diffuse-type gastric cancer and gene expression.Neoplasia. 2009 Dec;11(12):1340-7. doi: 10.1593/neo.91132.
• [1814] Metastatic suppressor genes inactivated by aberrant methylation in gastric cancer. World J Gastroenterol. 2007 Nov 21;13(43):5692-8. doi: 10.3748/wjg.v13.i43.5692.
• [1815] Pituitary tumor-transforming gene-1 serves as an independent prognostic biomarker for gastric cancer.Gastric Cancer. 2016 Jan;19(1):107-15. doi: 10.1007/s10120-015-0459-2. Epub 2015 Jan 28.
• [1816] Fibronectin promotes tyrosine phosphorylation of paxillin and cell invasiveness in the gastric cancer cell line AGS.Tumori. 2009 Nov-Dec;95(6):769-79. doi: 10.1177/030089160909500621.
• [1817] Methylation of ASC/TMS1 promoter is associated with poor prognosis of patients with gastric cancer.Clin Transl Oncol. 2016 Mar;18(3):296-303. doi: 10.1007/s12094-015-1367-y. Epub 2015 Aug 11.
• [1818] Hypermethylation of miR-338-3p and Impact of its Suppression on Cell Metastasis Through N-Cadherin Accumulation at the Cell -Cell Junction and Degradation of MMP in Gastric Cancer.Cell Physiol Biochem. 2018;50(2):411-425. doi: 10.1159/000494153. Epub 2018 Oct 11.
• [1819] MiR-455-5p acts as a novel tumor suppressor in gastric cancer by down-regulating RAB18.Gene. 2016 Nov 5;592(2):308-15. doi: 10.1016/j.gene.2016.07.034. Epub 2016 Jul 19.
• [1820] miR-182-5p improves the viability, mitosis, migration, and invasion ability of human gastric cancer cells by down-regulating RAB27A.Biosci Rep. 2017 Jun 27;37(3):BSR20170136. doi: 10.1042/BSR20170136. Print 2017 Jun 30.
• [1821] Rab40b upregulation correlates with the prognosis of gastric cancer by promoting migration, invasion, and metastasis.Med Oncol. 2015 Apr;32(4):126. doi: 10.1007/s12032-015-0562-6. Epub 2015 Mar 20.
• [1822] Low-level expression of let-7a in gastric cancer and its involvement in tumorigenesis by targeting RAB40C.Carcinogenesis. 2011 May;32(5):713-22. doi: 10.1093/carcin/bgr035. Epub 2011 Feb 24.
• [1823] HDAC6 sustains growth stimulation by prolonging the activation of EGF receptor through the inhibition of rabaptin-5-mediated early endosome fusion in gastric cancer.Cancer Lett. 2014 Nov 1;354(1):97-106. doi: 10.1016/j.canlet.2014.07.041. Epub 2014 Aug 8.
• [1824] RABEX-5 is upregulated and plays an oncogenic role in gastric cancer development by activating the VEGF signaling pathway.PLoS One. 2014 Nov 26;9(11):e113891. doi: 10.1371/journal.pone.0113891. eCollection 2014.
• [1825] Expression of aurora kinase A correlates with the Wnt-modulator RACGAP1 in gastric cancer.Cancer Med. 2016 Mar;5(3):516-26. doi: 10.1002/cam4.610. Epub 2016 Jan 18.
• [1826] Circular RNA circ-RanGAP1 regulates VEGFA expression by targeting miR-877-3p to facilitate gastric cancer invasion and metastasis.Cancer Lett. 2020 Feb 28;471:38-48. doi: 10.1016/j.canlet.2019.11.038. Epub 2019 Dec 5.
• [1827] Knockdown of Rap1b Enhances Apoptosis and Autophagy in Gastric Cancer Cells via the PI3K/Akt/mTOR Pathway.Oncol Res. 2016;24(5):287-293. doi: 10.3727/096504016X14648701447779.
• [1828] Reduced expression of Rap1GAP as a prognostic biomarker for primary gastric cancer patients.Cancer Biomark. 2018;22(3):375-384. doi: 10.3233/CBM-170832.
• [1829] Frequent somatic demethylation of RAPGEF1/C3G intronic sequences in gastrointestinal and gynecological cancer.Int J Oncol. 2011 Jun;38(6):1575-7. doi: 10.3892/ijo.2011.972. Epub 2011 Mar 11.
• [1830] Association between High Levels of Circulating Chemerin and Colorectal Adenoma in Men.Digestion. 2020;101(5):571-578. doi: 10.1159/000501477. Epub 2019 Jul 3.
• [1831] Reduced expression of RAS protein activator like-1 in gastric cancer.Int J Cancer. 2011 Mar 15;128(6):1293-302. doi: 10.1002/ijc.25459.
• [1832] Aberrant methylation of RASGRF1 is associated with an epigenetic field defect and increased risk of gastric cancer.Cancer Prev Res (Phila). 2012 Oct;5(10):1203-12. doi: 10.1158/1940-6207.CAPR-12-0056. Epub 2012 Sep 7.
• [1833] Activating Hippo Pathway via Rassf1 by Ursolic Acid Suppresses the Tumorigenesis of Gastric Cancer.Int J Mol Sci. 2019 Sep 23;20(19):4709. doi: 10.3390/ijms20194709.
• [1834] The value of serum RASSF10 hypermethylation as a diagnostic and prognostic tool for gastric cancer.Tumour Biol. 2016 Aug;37(8):11249-57. doi: 10.1007/s13277-016-5001-6. Epub 2016 Mar 5.
• [1835] RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer.Br J Cancer. 2005 Dec 12;93(12):1395-9. doi: 10.1038/sj.bjc.6602854.
• [1836] RASSF10 is an epigenetically silenced tumor suppressor in gastric cancer.Oncol Rep. 2014 Apr;31(4):1661-8. doi: 10.3892/or.2014.3039. Epub 2014 Feb 20.
• [1837] Comparative proteomics analysis of gastric cancer stem cells.PLoS One. 2014 Nov 7;9(11):e110736. doi: 10.1371/journal.pone.0110736. eCollection 2014.
• [1838] High RNA-Binding Motif Protein 3 (RBM3) Expression is Independently Associated with Prolonged Overall Survival in Intestinal-Type Gastric Cancer.Med Sci Monit. 2017 Dec 21;23:6033-6041. doi: 10.12659/msm.905314.
• [1839] RNA-Binding Motif 4 (RBM4) Suppresses Tumor Growth and Metastasis in Human Gastric Cancer.Med Sci Monit. 2019 May 30;25:4025-4034. doi: 10.12659/MSM.914513.
• [1840] Critical role of histone demethylase RBP2 in human gastric cancer angiogenesis.Mol Cancer. 2014 Apr 9;13:81. doi: 10.1186/1476-4598-13-81.
• [1841] Targeting of the C-Jun/BCL-XL/P21 Axis Accelerates the Switch from Senescence to Apoptosis Upon ROC1 Knockdown in Gastric Cancer Cells.Cell Physiol Biochem. 2018;48(3):1123-1138. doi: 10.1159/000491979. Epub 2018 Jul 24.
• [1842] Clinicopathological significance of RCAN2 production in gastric carcinoma.Histopathology. 2019 Feb;74(3):430-442. doi: 10.1111/his.13764.
• [1843] Knockdown of Radixin Suppresses Gastric Cancer Metastasis In Vitro by Up-Regulation of E-Cadherin via NF-B/Snail Pathway.Cell Physiol Biochem. 2016;39(6):2509-2521. doi: 10.1159/000452518. Epub 2016 Nov 14.
• [1844] Overexpression of RECQL4 is associated with poor prognosis in patients with gastric cancer.Oncol Lett. 2018 Oct;16(4):5419-5425. doi: 10.3892/ol.2018.9318. Epub 2018 Aug 17.
• [1845] DNA Methylation-Mediated Silencing of Regenerating Protein 1 Alpha (REG1A) Affects Gastric Cancer Prognosis.Med Sci Monit. 2017 Dec 9;23:5834-5843. doi: 10.12659/msm.904706.
• [1846] Response of human REV3 gene to gastric cancer inducing carcinogen N-methyl-N'-nitro-N-nitrosoguanidine and its role in mutagenesis.World J Gastroenterol. 2003 May;9(5):888-93. doi: 10.3748/wjg.v9.i5.888.
• [1847] Reduced expression of epidermal growth factor receptor related protein in gastric cancer.Gut. 2005 Feb;54(2):201-6. doi: 10.1136/gut.2003.027078.
• [1848] Genetic analysis of the DBC2 gene in gastric cancer.Acta Oncol. 2008;47(3):366-71. doi: 10.1080/02841860701644094. Epub 2007 Sep 28.
• [1849] Expressions of Ras Homolog Gene Family, Member A (RhoA) and Cyclooxygenase-2 (COX-2) Proteins in Early Gastric Cancer and Their Role in the Development of Gastric Cancer.Med Sci Monit. 2017 Jun 18;23:2979-2984. doi: 10.12659/msm.902367.
• [1850] Mina53, a novel molecular marker for the diagnosis and prognosis of gastric adenocarcinoma.Oncol Rep. 2014 Feb;31(2):634-40. doi: 10.3892/or.2013.2918. Epub 2013 Dec 12.
• [1851] Reactive oxygen species regulate urokinase plasminogen activator expression and cell invasion via mitogen-activated protein kinase pathways after treatment with hepatocyte growth factor in stomach cancer cells.J Exp Clin Cancer Res. 2009 Jun 4;28(1):73. doi: 10.1186/1756-9966-28-73.
• [1852] p42.3 gene expression in gastric cancer cell and its protein regulatory network analysis.Theor Biol Med Model. 2012 Dec 11;9(1):53. doi: 10.1186/1742-4682-9-53.
• [1853] Molecular cloning and characterization of RNF26 on human chromosome 11q23 region, encoding a novel RING finger protein with leucine zipper.Biochem Biophys Res Commun. 2001 Apr 13;282(4):1038-44. doi: 10.1006/bbrc.2001.4671.
• [1854] RNH1 regulation of reactive oxygen species contributes to histone deacetylase inhibitor resistance in gastric cancer cells.Oncogene. 2014 Mar 20;33(12):1527-37. doi: 10.1038/onc.2013.104. Epub 2013 Apr 15.
• [1855] Association of Romo1 gene genetic polymorphisms with risk of gastric cancer in northwestern Chinese population.Pathol Oncol Res. 2015 Jul;21(3):581-7. doi: 10.1007/s12253-014-9858-7. Epub 2014 Nov 6.
• [1856] Elevated Expression of RPA3 Is Involved in Gastric Cancer Tumorigenesis and Associated with Poor Patient Survival.Dig Dis Sci. 2017 Sep;62(9):2369-2375. doi: 10.1007/s10620-017-4696-6. Epub 2017 Aug 1.
• [1857] Co-transduction of ribosomal protein L23 enhances the therapeutic efficacy of adenoviral-mediated p53 gene transfer in human gastric cancer.Oncol Rep. 2013 Oct;30(4):1989-95. doi: 10.3892/or.2013.2663. Epub 2013 Aug 7.
• [1858] RNAi-mediated RPL34 knockdown suppresses the growth of human gastric cancer cells.Oncol Rep. 2015 Nov;34(5):2267-72. doi: 10.3892/or.2015.4219. Epub 2015 Aug 21.
• [1859] The relationship between DNA methylation and Reprimo gene expression in gastric cancer cells.Oncotarget. 2017 Sep 28;8(65):108610-108623. doi: 10.18632/oncotarget.21296. eCollection 2017 Dec 12.
• [1860] Human ribosomal protein S13 promotes gastric cancer growth through down-regulating p27(Kip1).J Cell Mol Med. 2011 Feb;15(2):296-306. doi: 10.1111/j.1582-4934.2009.00969.x.
• [1861] Discovery of aberrant expression of R-RAS by cancer-linked DNA hypomethylation in gastric cancer using microarrays.Cancer Res. 2005 Mar 15;65(6):2115-24. doi: 10.1158/0008-5472.CAN-04-3340.
• [1862] RSPO2 enhances cell invasion and migration via the WNT/-catenin pathway in human gastric cancer.J Cell Biochem. 2019 Apr;120(4):5813-5824. doi: 10.1002/jcb.27867. Epub 2018 Oct 26.
• [1863] Podocalyxin-like protein promotes gastric cancer progression through interacting with RUN and FYVE domain containing 1 protein.Cancer Sci. 2019 Jan;110(1):118-134. doi: 10.1111/cas.13864. Epub 2018 Dec 15.
• [1864] HGF-mediated S100A11 overexpression enhances proliferation and invasion of gastric cancer.Am J Transl Res. 2018 Nov 15;10(11):3385-3394. eCollection 2018.
• [1865] Clinical significance of S100A2 expression in gastric cancer.Tumour Biol. 2014 Apr;35(4):3731-41. doi: 10.1007/s13277-013-1495-3. Epub 2013 Dec 7.
• [1866] Psoriasin overexpression confers drug resistance to cisplatin by activating ERK in gastric cancer.Int J Oncol. 2018 Sep;53(3):1171-1182. doi: 10.3892/ijo.2018.4455. Epub 2018 Jun 26.
• [1867] Identification of new splice variants and differential expression of the human kallikrein 10 gene, a candidate cancer biomarker.Tumour Biol. 2005 Sep-Oct;26(5):227-35. doi: 10.1159/000087377. Epub 2005 Aug 9.
• [1868] Cancer-associated fibroblasts promote malignancy of gastric cancer cells via Nodal signalling.Cell Biochem Funct. 2020 Jan;38(1):4-11. doi: 10.1002/cbf.3446. Epub 2019 Nov 16.
• [1869] Mammaglobin B gene as a novel marker for lymph node micrometastasis in patients with abdominal cancers.Cancer Lett. 2000 Mar 13;150(1):79-84. doi: 10.1016/s0304-3835(99)00378-x.
• [1870] Silence of HIN-1 expression through methylation of its gene promoter in gastric cancer.World J Gastroenterol. 2011 Jan 28;17(4):526-33. doi: 10.3748/wjg.v17.i4.526.
• [1871] Sodium Channel Subunit SCNN1B Suppresses Gastric Cancer Growth and Metastasis via GRP78 Degradation.Cancer Res. 2017 Apr 15;77(8):1968-1982. doi: 10.1158/0008-5472.CAN-16-1595. Epub 2017 Feb 15.
• [1872] No association of an SDHC gene polymorphism with gastric cancer.Asian Pac J Cancer Prev. 2006 Oct-Dec;7(4):525-8.
• [1873] Signal peptidase complex 18, encoded by SEC11A, contributes to progression via TGF- secretion in gastric cancer.Oncogene. 2014 Jul 24;33(30):3918-26. doi: 10.1038/onc.2013.364. Epub 2013 Sep 2.
• [1874] Selenoprotein S (SEPS1) gene -105G>A promoter polymorphism influences the susceptibility to gastric cancer in the Japanese population.BMC Gastroenterol. 2009 Jan 13;9:2. doi: 10.1186/1471-230X-9-2.
• [1875] Analysis of SEMA3B methylation and expression patterns in gastric cancer tissue and cell lines.Oncol Rep. 2014 Mar;31(3):1211-8. doi: 10.3892/or.2014.2972. Epub 2014 Jan 9.
• [1876] Semaphorin 3C is involved in the progression of gastric cancer.Cancer Sci. 2012 Nov;103(11):1961-6. doi: 10.1111/cas.12003. Epub 2012 Oct 15.
• [1877] Semaphorin 5A, an axon guidance molecule, enhances the invasion and metastasis of human gastric cancer through activation of MMP9.Pathol Oncol Res. 2013 Jan;19(1):11-8. doi: 10.1007/s12253-012-9550-8. Epub 2012 Jul 21.
• [1878] Protein Z/protein Z-dependent protease inhibitor system in loco in human gastric cancer.Ann Hematol. 2014 May;93(5):779-84. doi: 10.1007/s00277-013-1941-8. Epub 2013 Oct 26.
• [1879] RAD51 potentiates synergistic effects of chemotherapy with PCI-24781 and cis-diamminedichloroplatinum on gastric cancer.World J Gastroenterol. 2014 Aug 7;20(29):10094-107. doi: 10.3748/wjg.v20.i29.10094.
• [1880] CagY-Dependent Regulation of Type IV Secretion in Helicobacter pylori Is Associated with Alterations in Integrin Binding.mBio. 2018 May 15;9(3):e00717-18. doi: 10.1128/mBio.00717-18.
• [1881] Prognostic significance of SERPINE2 in gastric cancer and its biological function in SGC7901 cells.J Cancer Res Clin Oncol. 2015 May;141(5):805-12. doi: 10.1007/s00432-014-1858-1. Epub 2014 Oct 31.
• [1882] MicroRNA-21 inhibits Serpini1, a gene with novel tumour suppressive effects in gastric cancer.Dig Liver Dis. 2012 Jul;44(7):589-96. doi: 10.1016/j.dld.2012.02.016. Epub 2012 Mar 28.
• [1883] Integrative Omic Profiling Reveals Unique Hypoxia Induced Signatures in Gastric Cancer Associated Myofibroblasts.Cancers (Basel). 2019 Feb 23;11(2):263. doi: 10.3390/cancers11020263.
• [1884] Synergistic enhancement of cancer therapy using a combination of fusion protein MG7-scFv/SEB and tumor necrosis factor alpha.Protein Pept Lett. 2013 Apr;20(4):467-72.
• [1885] Circ-SFMBT2 promotes the proliferation of gastric cancer cells through sponging miR-182-5p to enhance CREB1 expression.Cancer Manag Res. 2018 Nov 16;10:5725-5734. doi: 10.2147/CMAR.S172592. eCollection 2018.
• [1886] The clinical implication of 14-3-3 sigma expression in primary gastrointestinal malignancy.Int J Oncol. 2004 Dec;25(6):1591-7.
• [1887] Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer.Oncogene. 2007 Jul 12;26(32):4699-713. doi: 10.1038/sj.onc.1210259. Epub 2007 Feb 5.
• [1888] Decreased expression of tumour suppressor Bax-interacting factor-1 (Bif-1), a Bax activator, in gastric carcinomas.Pathology. 2006 Aug;38(4):312-5. doi: 10.1080/00313020600820880.
• [1889] FAM60A, increased by Helicobacter pylori, promotes proliferation and suppresses apoptosis of gastric cancer cells by targeting the PI3K/AKT pathway.Biochem Biophys Res Commun. 2020 Jan 22;521(4):1003-1009. doi: 10.1016/j.bbrc.2019.11.029. Epub 2019 Nov 12.
• [1890] Spindle and kinetochore-associated protein 1 is overexpressed in gastric cancer and modulates cell growth.Mol Cell Biochem. 2014 Jun;391(1-2):167-74. doi: 10.1007/s11010-014-1999-1. Epub 2014 Mar 14.
• [1891] Cationic amino acid transporter PQLC2 is a potential therapeutic target in gastric cancer.Cancer Sci. 2019 Apr;110(4):1453-1463. doi: 10.1111/cas.13966. Epub 2019 Mar 19.
• [1892] MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor.PLoS Genet. 2010 Mar 12;6(3):e1000879. doi: 10.1371/journal.pgen.1000879.
• [1893] Latent membrane protein 2A inhibits expression level of Smad2 through regulating miR-155-5p in EBV-associated gastric cancer cell lines.J Med Virol. 2020 Jan;92(1):96-106. doi: 10.1002/jmv.25579. Epub 2019 Sep 18.
• [1894] Combinatorial epigenetic deregulation by Helicobacter pylori and Epstein-Barr virus infections in gastric tumourigenesis.J Pathol. 2016 Jul;239(3):245-9. doi: 10.1002/path.4731. Epub 2016 May 20.
• [1895] Frequent involvement of chromatin remodeler alterations in gastric field cancerization.Cancer Lett. 2015 Feb 1;357(1):328-338. doi: 10.1016/j.canlet.2014.11.038. Epub 2014 Nov 22.
• [1896] SMARCA5 methylation and expression in gastric cancer.Cancer Invest. 2011 Feb;29(2):162-6. doi: 10.3109/07357907.2010.543365.
• [1897] High expression of SMARCE1 predicts poor prognosis and promotes cell growth and metastasis in gastric cancer.Cancer Manag Res. 2019 Apr 23;11:3493-3509. doi: 10.2147/CMAR.S195137. eCollection 2019.
• [1898] PRL-3 promotes gastric cancer migration and invasion through a NF-B-HIF-1-miR-210 axis.J Mol Med (Berl). 2016 Apr;94(4):401-15. doi: 10.1007/s00109-015-1350-7. Epub 2015 Nov 9.
• [1899] miR-1254 inhibits cell proliferation, migration, and invasion by down-regulating Smurf1 in gastric cancer.Cell Death Dis. 2019 Jan 10;10(1):32. doi: 10.1038/s41419-018-1262-x.
• [1900] MiR-361-5p inhibits colorectal and gastric cancer growth and metastasis by targeting staphylococcal nuclease domain containing-1.Oncotarget. 2015 Jul 10;6(19):17404-16. doi: 10.18632/oncotarget.3744.
• [1901] Sorting nexin-1 is a candidate tumor suppressor and potential prognostic marker in gastric cancer.PeerJ. 2018 May 29;6:e4829. doi: 10.7717/peerj.4829. eCollection 2018.
• [1902] Suppressor of cytokine signaling 4 detected as a novel gastric cancer suppressor gene using double combination array analysis.World J Surg. 2012 Feb;36(2):362-72. doi: 10.1007/s00268-011-1358-2.
• [1903] miR-17-5p promotes proliferation by targeting SOCS6 in gastric cancer cells.FEBS Lett. 2014 Jun 5;588(12):2055-62. doi: 10.1016/j.febslet.2014.04.036. Epub 2014 May 5.
• [1904] SOSTDC1 down-regulation of expression involves CpG methylation and is a potential prognostic marker in gastric cancer.Cancer Genet. 2013 May;206(5):174-82. doi: 10.1016/j.cancergen.2013.04.005. Epub 2013 Jul 5.
• [1905] Assessment of SOX17 DNA methylation in cell free DNA from patients with operable gastric cancer. Association with prognostic variables and survival.Clin Chem Lab Med. 2013 Jul;51(7):1505-10. doi: 10.1515/cclm-2012-0320.
• [1906] Decreased expression of Sox7 correlates with the upregulation of the Wnt/-catenin signaling pathway and the poor survival of gastric cancer patients.Int J Mol Med. 2014 Jul;34(1):197-204. doi: 10.3892/ijmm.2014.1759. Epub 2014 Apr 25.
• [1907] SPAG5 contributes to the progression of gastric cancer by upregulation of Survivin depend on activating the wnt/-catenin pathway.Exp Cell Res. 2019 Jun 1;379(1):83-91. doi: 10.1016/j.yexcr.2019.03.024. Epub 2019 Mar 21.
• [1908] Down-regulated SPARCL1 is associated with clinical significance in human gastric cancer.J Surg Oncol. 2012 Jan;105(1):31-7. doi: 10.1002/jso.22025. Epub 2011 Aug 30.
• [1909] Methylomics analysis identifies a putative STAT3 target, SPG20, as a noninvasive epigenetic biomarker for early detection of gastric cancer.PLoS One. 2019 Jun 13;14(6):e0218338. doi: 10.1371/journal.pone.0218338. eCollection 2019.
• [1910] Epigenetic inactivation and tumor suppressor activity of HAI-2/SPINT2 in gastric cancer.Int J Cancer. 2010 Oct 1;127(7):1526-34. doi: 10.1002/ijc.25161.
• [1911] Oncofetal protein, IMP-3, a potential marker for prediction of postoperative peritoneal dissemination in gastric adenocarcinoma.J Surg Oncol. 2012 Jun 15;105(8):780-5. doi: 10.1002/jso.22108. Epub 2011 Oct 19.
• [1912] Identification of genes differentially expressed between gastric cancers and normal gastric mucosa with cDNA microarrays.Cancer Lett. 2002 Oct 28;184(2):197-206. doi: 10.1016/s0304-3835(02)00197-0.
• [1913] Overexpression of serum response factor is correlated with poor prognosis in patients with gastric cancer.Hum Pathol. 2019 Mar;85:10-17. doi: 10.1016/j.humpath.2018.10.018. Epub 2018 Nov 27.
• [1914] miR? reverses multidrug resistance in gastric cancer cells via downregulation of sorcin through promoting the accumulation of intracellular drugs and apoptosis of cells.Int J Oncol. 2019 Aug;55(2):451-461. doi: 10.3892/ijo.2019.4831. Epub 2019 Jun 25.
• [1915] Impact of overexpression of Sushi repeat-containing protein X-linked 2 gene on outcomes of gastric cancer.J Surg Oncol. 2014 Jun;109(8):836-40. doi: 10.1002/jso.23602. Epub 2014 Apr 2.
• [1916] OnclncRNA-626 promotes malignancy of gastric cancer via inactivated the p53 pathway through interacting with SRSF1.Am J Cancer Res. 2019 Oct 1;9(10):2249-2263. eCollection 2019.
• [1917] Comparative expression patterns and diagnostic efficacies of SR splicing factors and HNRNPA1 in gastric and colorectal cancer.BMC Cancer. 2016 Jun 10;16:358. doi: 10.1186/s12885-016-2387-x.
• [1918] Clinical relevance of sialyltransferases ST6GAL-I and ST3GAL-III in gastric cancer.Oncology. 2003;65(2):139-45. doi: 10.1159/000072339.
• [1919] RNAi-mediated gene silencing of ST6GalNAc I suppresses the metastatic potential in gastric cancer cells.Gastric Cancer. 2016 Jan;19(1):85-97. doi: 10.1007/s10120-014-0454-z. Epub 2014 Dec 23.
• [1920] PPP1R1B-STARD3 chimeric fusion transcript in human gastric cancer promotes tumorigenesis through activation of PI3K/AKT signaling.Oncogene. 2014 Nov 13;33(46):5341-7. doi: 10.1038/onc.2013.472. Epub 2013 Nov 25.
• [1921] Gastric cancer cells escape metabolic stress via the DLC3/MACC1 axis.Theranostics. 2019 Apr 6;9(7):2100-2114. doi: 10.7150/thno.29538. eCollection 2019.
• [1922] MiR-141-3p suppresses gastric cancer induced transition of normal fibroblast and BMSC to cancer-associated fibroblasts via targeting STAT4.Exp Mol Pathol. 2019 Apr;107:85-94. doi: 10.1016/j.yexmp.2018.11.014. Epub 2018 Nov 28.
• [1923] E2F1 induces TINCR transcriptional activity and accelerates gastric cancer progression via activation of TINCR/STAU1/CDKN2B signaling axis.Cell Death Dis. 2017 Jun 1;8(6):e2837. doi: 10.1038/cddis.2017.205.
• [1924] Overexpression of stromal interaction molecule 1 may promote epithelialmesenchymal transition and indicate poor prognosis in gastric cancer.Mol Med Rep. 2017 Jul;16(1):151-158. doi: 10.3892/mmr.2017.6607. Epub 2017 May 18.
• [1925] Shiga-like toxin I exerts specific and potent anti-tumour efficacy against gastric cancer cell proliferation when driven by tumour-preferential Frizzled-7 promoter.Cell Prolif. 2019 May;52(3):e12607. doi: 10.1111/cpr.12607. Epub 2019 Apr 6.
• [1926] The Oncogenic Potential of SUV39H2: A Comprehensive and Perspective View.J Cancer. 2019 Jan 1;10(3):721-729. doi: 10.7150/jca.28254. eCollection 2019.
• [1927] Altered splicing pattern of TACC1 mRNA in gastric cancer.Cancer Genet Cytogenet. 2002 Nov;139(1):78-83. doi: 10.1016/s0165-4608(02)00607-6.
• [1928] TAFA5 promotes proliferation and migration in gastric cancer.Mol Med Rep. 2019 Nov;20(5):4477-4488. doi: 10.3892/mmr.2019.10724. Epub 2019 Oct 2.
• [1929] Variations in TAS1R taste receptor gene family modify food intake and gastric cancer risk in a Korean population.Mol Nutr Food Res. 2016 Nov;60(11):2433-2445. doi: 10.1002/mnfr.201600145. Epub 2016 Aug 16.
• [1930] Genetic Variation in the TAS2R38 Bitter Taste Receptor and Gastric Cancer Risk in Koreans.Sci Rep. 2016 Jun 1;6:26904. doi: 10.1038/srep26904.
• [1931] Downregulation of TCEAL7 expression induces CCND1 expression in non-small cell lung cancer.Mol Biol Rep. 2019 Oct;46(5):5251-5256. doi: 10.1007/s11033-019-04982-6. Epub 2019 Jul 18.
• [1932] High expression of TCF12 contributes to gastric cancer development via being target regulated by miR-183 and activating PI3K/AKT pathway.J Cell Biochem. 2019 Aug;120(8):13903-13911. doi: 10.1002/jcb.28664. Epub 2019 Apr 15.
• [1933] TCF7L1 indicates prognosis and promotes proliferation through activation of Keap1/NRF2 in gastric cancer.Acta Biochim Biophys Sin (Shanghai). 2019 Apr 1;51(4):375-385. doi: 10.1093/abbs/gmz015.
• [1934] TC1(C8orf4) correlates with Wnt/beta-catenin target genes and aggressive biological behavior in gastric cancer.Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3541-8. doi: 10.1158/1078-0432.CCR-05-2440.
• [1935] Tectonic 1 accelerates gastric cancer cell proliferation and cell cycle progression in vitro.Mol Med Rep. 2015 Oct;12(4):5897-902. doi: 10.3892/mmr.2015.4177. Epub 2015 Aug 5.
• [1936] CagA increases DNA methylation and decreases PTEN expression in human gastric cancer.Mol Med Rep. 2019 Jan;19(1):309-319. doi: 10.3892/mmr.2018.9654. Epub 2018 Nov 13.
• [1937] Prognostic Value of Trefoil Factor 3 Expression in Patients with Gastric Cancer.World J Surg. 2018 Dec;42(12):3997-4004. doi: 10.1007/s00268-018-4737-0.
• [1938] High stromaltransforming growth factor -induced expression is a novel marker of progression and poor prognosis in gastric cancer.J Surg Oncol. 2018 Nov;118(6):966-974. doi: 10.1002/jso.25217. Epub 2018 Sep 9.
• [1939] MicroRNA-34a inhibits tumor invasion and metastasis in gastric cancer by targeting Tgif2.Int J Clin Exp Pathol. 2015 Aug 1;8(8):8921-8. eCollection 2015.
• [1940] THBS4 predicts poor outcomes and promotes proliferation and metastasis in gastric cancer.J Physiol Biochem. 2019 Feb;75(1):117-123. doi: 10.1007/s13105-019-00665-9. Epub 2019 Feb 12.
• [1941] TIMP2 is a Poor Prognostic Factor and Predicts Metastatic Biological Behavior in Gastric Cancer.Sci Rep. 2018 Jun 25;8(1):9629. doi: 10.1038/s41598-018-27897-x.
• [1942] Association Between Tissue Inhibitor of Metalloproteinase-3 Gene Methylation and Gastric Cancer Risk: A Meta-Analysis.Genet Test Mol Biomarkers. 2016 Aug;20(8):427-31. doi: 10.1089/gtmb.2015.0332. Epub 2016 Jun 17.
• [1943] Down-regulation of TRF1, TRF2 and TIN2 genes is important to maintain telomeric DNA for gastric cancers.Anticancer Res. 2002 Nov-Dec;22(6A):3303-7.
• [1944] Jaspine B induces nonapoptotic cell death in gastric cancer cells independently of its inhibition of ceramide synthase.J Lipid Res. 2017 Aug;58(8):1500-1513. doi: 10.1194/jlr.M072611. Epub 2017 Jun 1.
• [1945] TMEM100 expression suppresses metastasis and enhances sensitivity to chemotherapy in gastric cancer.Biol Chem. 2020 Feb 25;401(2):285-296. doi: 10.1515/hsz-2019-0161.
• [1946] Transmembrane protein 106A is silenced by promoter region hypermethylation and suppresses gastric cancer growth by inducing apoptosis.J Cell Mol Med. 2014 Aug;18(8):1655-66. doi: 10.1111/jcmm.12352. Epub 2014 Jun 28.
• [1947] DNA promoter and histone H3 methylation downregulate NGX6 in gastric cancer cells.Med Oncol. 2014 Jan;31(1):817. doi: 10.1007/s12032-013-0817-z. Epub 2013 Dec 14.
• [1948] TMPRSS4 promotes invasiveness of human gastric cancer cells through activation of NF-B/MMP-9 signaling.Biomed Pharmacother. 2016 Feb;77:30-6. doi: 10.1016/j.biopha.2015.11.002. Epub 2015 Dec 11.
• [1949] The miR-184 binding-site rs8126 T>C polymorphism in TNFAIP2 is associated with risk of gastric cancer.PLoS One. 2013 May 28;8(5):e64973. doi: 10.1371/journal.pone.0064973. Print 2013.
• [1950] A genetic polymorphism in TOX3 is associated with survival of gastric cancer in a Chinese population.PLoS One. 2013 Sep 17;8(9):e72186. doi: 10.1371/journal.pone.0072186. eCollection 2013.
• [1951] Identification of a TLR2-regulated gene signature associated with tumor cell growth in gastric cancer.Oncogene. 2017 Sep 7;36(36):5134-5144. doi: 10.1038/onc.2017.121. Epub 2017 May 8.
• [1952] Tumor protein D52-like 2 accelerates gastric cancer cell proliferation in vitro.Cancer Biother Radiopharm. 2015 Apr;30(3):111-6. doi: 10.1089/cbr.2014.1766. Epub 2015 Mar 6.
• [1953] miR-135a suppresses migration of gastric cancer cells by targeting TRAF5-mediated NF-B activation.Onco Targets Ther. 2019 Feb 1;12:975-984. doi: 10.2147/OTT.S189976. eCollection 2019.
• [1954] NIK?and IKKbinding protein contributes to gastric cancer chemoresistance by promoting epithelialmesenchymal transition through the NFB signaling pathway.Oncol Rep. 2018 Jun;39(6):2721-2730. doi: 10.3892/or.2018.6348. Epub 2018 Mar 30.
• [1955] Risk-association of DNA methyltransferases polymorphisms with gastric cancer in the Southern Chinese population.Int J Mol Sci. 2012;13(7):8364-8378. doi: 10.3390/ijms13078364. Epub 2012 Jul 5.
• [1956] Overexpression of TRIB3 promotes angiogenesis in human gastric cancer.Oncol Rep. 2016 Oct;36(4):2339-48. doi: 10.3892/or.2016.5017. Epub 2016 Aug 11.
• [1957] Long noncoding ribonucleic acid specific for distant metastasis of gastric cancer is associated with TRIM16 expression and facilitates tumor cell invasion in vitro.J Gastroenterol Hepatol. 2015 Sep;30(9):1367-75. doi: 10.1111/jgh.12976.
• [1958] The cellular level of TRIM31, an RBCC protein overexpressed in gastric cancer, is regulated by multiple mechanisms including the ubiquitin-proteasome system.Cell Biol Int. 2011 Jul;35(7):657-61. doi: 10.1042/CBI20100772.
• [1959] TRIM25 blockade by RNA interference inhibited migration and invasion of gastric cancer cells through TGF- signaling.Sci Rep. 2016 Jan 12;6:19070. doi: 10.1038/srep19070.
• [1960] High expression of TRIM36 is associated with radiosensitivity in gastric cancer.Oncol Lett. 2019 May;17(5):4401-4408. doi: 10.3892/ol.2019.10122. Epub 2019 Mar 7.
• [1961] Overexpression of TRIM44 contributes to malignant outcome in gastric carcinoma.Cancer Sci. 2012 Nov;103(11):2021-6. doi: 10.1111/j.1349-7006.2012.02407.x. Epub 2012 Sep 14.
• [1962] TRIM58 suppresses the tumor growth in gastric cancer by inactivation of -catenin signaling via ubiquitination.Cancer Biol Ther. 2020;21(3):203-212. doi: 10.1080/15384047.2019.1679554. Epub 2019 Nov 21.
• [1963] Association of polymorphisms and haplotype in the region of TRIT1, MYCL1 and MFSD2A with the risk and clinicopathological features of gastric cancer in a southeast Chinese population.Carcinogenesis. 2013 May;34(5):1018-24. doi: 10.1093/carcin/bgt010. Epub 2013 Jan 24.
• [1964] TSPAN1 functions as an oncogene in gastric cancer and is downregulated by miR-573.FEBS Lett. 2015 Jul 8;589(15):1988-94. doi: 10.1016/j.febslet.2015.05.044. Epub 2015 Jun 6.
• [1965] High Expression of ABRACL Is Associated with Tumorigenesis and Affects Clinical Outcome in Gastric Cancer.Genet Test Mol Biomarkers. 2019 Feb;23(2):91-97. doi: 10.1089/gtmb.2018.0195. Epub 2019 Jan 24.
• [1966] High expression of ALPPL2 is associated with poor prognosis in gastric cancer.Hum Pathol. 2019 Apr;86:49-56. doi: 10.1016/j.humpath.2018.11.019. Epub 2018 Nov 26.
• [1967] Apolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for gastric cancer.Ann Transl Med. 2019 Aug;7(16):380. doi: 10.21037/atm.2019.07.59.
• [1968] Epigenetic regulation of IncRNA KCNKI5-ASI in gastric cancer.Cancer Manag Res. 2019 Sep 20;11:8589-8602. doi: 10.2147/CMAR.S186002. eCollection 2019.
• [1969] BATF2 inhibits chemotherapy resistance by suppressing AP-1 in vincristine-resistant gastric cancer cells.Cancer Chemother Pharmacol. 2019 Dec;84(6):1279-1288. doi: 10.1007/s00280-019-03958-4. Epub 2019 Sep 23.
• [1970] High proportion of large genomic deletions and a genotype phenotype update in 80 unrelated families with juvenile polyposis syndrome.J Med Genet. 2007 Nov;44(11):702-9. doi: 10.1136/jmg.2007.052506. Epub 2007 Sep 14.
• [1971] Identification of CCDC62-2 as a novel cancer/testis antigen and its immunogenicity.Int J Cancer. 2009 May 15;124(10):2347-52. doi: 10.1002/ijc.24220.
• [1972] The survival analysis and oncogenic effects of CFP1 and 14-3-3 expression on gastric cancer.Cancer Cell Int. 2019 Aug 31;19:225. doi: 10.1186/s12935-019-0946-3. eCollection 2019.
• [1973] MicroRNA-1297 inhibits proliferation and promotes apoptosis in gastric cancer cells by downregulating CDC6 expression.Anticancer Drugs. 2019 Sep;30(8):803-811. doi: 10.1097/CAD.0000000000000776.
• [1974] Fucoidan suppresses the gastric cancer cell malignant phenotype and production of TGF-1 via CLEC-2.Glycobiology. 2020 Apr 20;30(5):301-311. doi: 10.1093/glycob/cwz097.
• [1975] Circ-HuR suppresses HuR expression and gastric cancer progression by inhibiting CNBP transactivation.Mol Cancer. 2019 Nov 13;18(1):158. doi: 10.1186/s12943-019-1094-z.
• [1976] CSN6 promotes tumorigenesis of gastric cancer by ubiquitin-independent proteasomal degradation of p16(INK4a).Cancer Biol Med. 2019 Aug;16(3):514-529. doi: 10.20892/j.issn.2095-3941.2018.0410.
• [1977] Deregulation of CSMD1 targeted by microRNA-10b drives gastric cancer progression through the NF-B pathway.Int J Biol Sci. 2019 Aug 6;15(10):2075-2086. doi: 10.7150/ijbs.23802. eCollection 2019.
• [1978] LMO4 promotes the invasion and proliferation of gastric cancer by activating PI3K-Akt-mTOR signaling.Am J Transl Res. 2019 Oct 15;11(10):6534-6543. eCollection 2019.
• [1979] Long non-coding RNA LINC01225 promotes proliferation, invasion and migration of gastric cancer via Wnt/-catenin signalling pathway.J Cell Mol Med. 2019 Nov;23(11):7581-7591. doi: 10.1111/jcmm.14627. Epub 2019 Aug 28.
• [1980] LncRNA MIR4435-2HG targets desmoplakin and promotes growth and metastasis of gastric cancer by activating Wnt/-catenin signaling.Aging (Albany NY). 2019 Sep 4;11(17):6657-6673. doi: 10.18632/aging.102164. Epub 2019 Sep 4.
• [1981] miR-183-5p acts as a potential prognostic biomarker in gastric cancer and regulates cell functions by modulating EEF2.Pathol Res Pract. 2019 Nov;215(11):152636. doi: 10.1016/j.prp.2019.152636. Epub 2019 Sep 16.
• [1982] EIF3B is associated with poor outcomes in gastric cancer patients and promotes cancer progression via the PI3K/AKT/mTOR signaling pathway.Cancer Manag Res. 2019 Aug 21;11:7877-7891. doi: 10.2147/CMAR.S207834. eCollection 2019.
• [1983] Fibulin-2 inhibits development of gastric cancer by downregulating -catenin.Oncol Lett. 2019 Sep;18(3):2799-2804. doi: 10.3892/ol.2019.10599. Epub 2019 Jul 10.
• [1984] Low Expression of FBXO45 Is Associated with Gastric Cancer Progression and Poor Prognosis.Anticancer Res. 2017 Jan;37(1):191-196. doi: 10.21873/anticanres.11305.
• [1985] The novel GINS4 axis promotes gastric cancer growth and progression by activating Rac1 and CDC42.Theranostics. 2019 Oct 21;9(26):8294-8311. doi: 10.7150/thno.36256. eCollection 2019.
• [1986] RETRACTED: Physcion 8-O--glucopyranoside induced ferroptosis via regulating miR-103a-3p/GLS2 axis in gastric cancer.Life Sci. 2019 Nov 15;237:116893. doi: 10.1016/j.lfs.2019.116893. Epub 2019 Oct 10.
• [1987] Clinical Significance of Serum Type III Interferons in Patients with Gastric Cancer.J Interferon Cytokine Res. 2019 Mar;39(3):155-163. doi: 10.1089/jir.2018.0119. Epub 2019 Jan 23.
• [1988] Down-regulation of interferon regulatory factor 2 binding protein 2 suppresses gastric cancer progression by negatively regulating connective tissue growth factor.J Cell Mol Med. 2019 Dec;23(12):8076-8089. doi: 10.1111/jcmm.14677. Epub 2019 Sep 27.
• [1989] High KIF2A expression promotes proliferation, migration and predicts poor prognosis in lung adenocarcinoma.Biochem Biophys Res Commun. 2018 Feb 26;497(1):65-72. doi: 10.1016/j.bbrc.2018.02.020. Epub 2018 Feb 7.
• [1990] Novel somatic frameshift mutations of genes related to cell cycle and DNA damage response in gastric and colorectal cancers with microsatellite instability.Tumori. 2010 Nov-Dec;96(6):1004-9.
• [1991] LDLRAD2 overexpression predicts poor prognosis and promotes metastasis by activating Wnt/-catenin/EMT signaling cascade in gastric cancer.Aging (Albany NY). 2019 Oct 24;11(20):8951-8968. doi: 10.18632/aging.102359. Epub 2019 Oct 24.
• [1992] Methylation pattern of the putative tumor-suppressor gene LRRC3B promoter in clear cell renal cell carcinomas.Mol Med Rep. 2012 Feb;5(2):509-12. doi: 10.3892/mmr.2011.681. Epub 2011 Nov 16.
• [1993] Paip1 overexpression is involved in the progression of gastric cancer and predicts shorter survival of diagnosed patients.Onco Targets Ther. 2019 Aug 16;12:6565-6576. doi: 10.2147/OTT.S202698. eCollection 2019.
• [1994] miR-200b induces cell cycle arrest and represses cell growth in esophageal squamous cell carcinoma.Carcinogenesis. 2016 Sep;37(9):858-869. doi: 10.1093/carcin/bgw079. Epub 2016 Aug 4.
• [1995] PEA?5 contributes to the clinicopathology and AKTregulated cisplatin resistance in gastric cancer.Oncol Rep. 2019 Mar;41(3):1949-1959. doi: 10.3892/or.2018.6934. Epub 2018 Dec 18.
• [1996] Prognostic Significance of PSMD1 Expression in Patients with Gastric Cancer.J Cancer. 2019 Jul 20;10(18):4357-4367. doi: 10.7150/jca.31543. eCollection 2019.
• [1997] Downregulation of CircRNA CDR1as specifically triggered low-dose Diosbulbin-B induced gastric cancer cell death by regulating miR-7-5p/REG axis.Biomed Pharmacother. 2019 Dec;120:109462. doi: 10.1016/j.biopha.2019.109462. Epub 2019 Sep 19.
• [1998] RAB13 as a novel prognosis marker promotes proliferation and chemotherapeutic resistance in gastric cancer.Biochem Biophys Res Commun. 2019 Oct 29;519(1):113-120. doi: 10.1016/j.bbrc.2019.08.141. Epub 2019 Aug 29.
• [1999] MicroRNA-1269 promotes cell proliferation via the AKT signaling pathway by targeting RASSF9 in human gastric cancer.Cancer Cell Int. 2019 Nov 21;19:308. doi: 10.1186/s12935-019-1026-4. eCollection 2019.
• [2000] Reduced folate carrier gene G80A polymorphism is associated with an increased risk of gastroesophageal cancers in a Chinese population.Eur J Cancer. 2006 Dec;42(18):3206-11. doi: 10.1016/j.ejca.2006.04.022. Epub 2006 Sep 8.
• [2001] MicroRNA-598 inhibits the growth and maintenance of gastric cancer stem-like cells by down-regulating RRS1.Cell Cycle. 2019 Oct;18(20):2757-2769. doi: 10.1080/15384101.2019.1657338. Epub 2019 Aug 23.
• [2002] MicroRNA-6884-5p Regulates the Proliferation, Invasion, and EMT of Gastric Cancer Cells by Directly Targeting S100A16.Oncol Res. 2020 May 29;28(3):225-236. doi: 10.3727/096504019X15753718797664. Epub 2019 Dec 3.
• [2003] MiR-4429 prevented gastric cancer progression through targeting METTL3 to inhibit m(6)A-caused stabilization of SEC62.Biochem Biophys Res Commun. 2019 Oct 1;517(4):581-587. doi: 10.1016/j.bbrc.2019.07.058. Epub 2019 Aug 5.
• [2004] STAMBPL1 knockdown has antitumour effects on gastric cancer biological activities.Oncol Lett. 2019 Nov;18(5):4421-4428. doi: 10.3892/ol.2019.10789. Epub 2019 Sep 3.
• [2005] STRA6 exerts oncogenic role in gastric tumorigenesis by acting as a crucial target of miR-873.J Exp Clin Cancer Res. 2019 Nov 6;38(1):452. doi: 10.1186/s13046-019-1450-2.
• [2006] Influence of miR-376c-3p/SYF2 Axis on the Progression of Gastric Cancer.Technol Cancer Res Treat. 2019 Jan 1;18:1533033819874808. doi: 10.1177/1533033819874808.
• [2007] TBX2 overexpression promotes proliferation and invasion through epithelial-mesenchymal transition and ERK signaling pathway.Exp Ther Med. 2019 Jan;17(1):723-729. doi: 10.3892/etm.2018.7028. Epub 2018 Nov 28.
• [2008] Phosphorylation of TOB1 at T172 and S320 is critical for gastric cancer proliferation and progression.Am J Transl Res. 2019 Aug 15;11(8):5227-5239. eCollection 2019.
• [2009] Clinicopathologic and Prognostic Significance of Thymopoietin- Overexpression in Gastric Cancer.J Cancer. 2019 Aug 28;10(21):5099-5107. doi: 10.7150/jca.30738. eCollection 2019.
• [2010] Expression of LGR5, FZD7, TROY, and MIST1 in Perioperatively Treated Gastric Carcinomas and Correlation with Therapy Response.Dis Markers. 2019 Nov 19;2019:8154926. doi: 10.1155/2019/8154926. eCollection 2019.
• [2011] Gene silencing of TSPYL5 mediated by aberrant promoter methylation in gastric cancers.Lab Invest. 2008 Feb;88(2):153-60. doi: 10.1038/labinvest.3700706. Epub 2007 Dec 3.